Sentence,class,file
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1725–1736Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1725Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S4021 3Risk factors for fatal and nonfatal repetition   of suicide attempts: a literature review Massimiliano Beghi1,2 Jerrold F Rosenbaum3 Cesare Cerri1,4 Cesare M Cornaggia1,5 1Psychiatry Clinic, University  of Milano Bicocca, Milan, italy;   2Department of Psychiatry, Salvini  Hospital, Rho, italy; 3Massachusetts  General Hospital, Harvard  Medical School, Boston, MA, USA;   4Department of Rehabilitation  Medicine, Zucchi Clinical institute,   Carate Brianza, italy; 5Forensic  Psychiatric Hospital, Castiglione delle  Stiviere, Mantua, italy Correspondence: Massimiliano Beghi   Psychosocial Center,   28 via Beatrice d’este, Rho, Milan, italy   Tel +39 02 9943 03919   Fax +39 02 9318 2492   email mbeghi@aogarbagnate.lombardia.itObjectives:  This review aimed to identify the evidence for predictors of repetition of suicide  attempts, and more specifically for subsequent completed suicide.",Non-OADS,/arxiv_data1/oa_pdf/aa/14/ndt-9-1725.PMC3825699.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/aa/14/ndt-9-1725.PMC3825699.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/14/ndt-9-1725.PMC3825699.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/1f/ijwh-5-753.PMC3825702.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 753–763International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  753RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S37846Diagnosis, management, and long-term outcomes  of rectovaginal endometriosis Nash S Moawad1 Andrea Caplin2 1Minimally Invasive Gynecologic  Surgery, Department of Obstetrics   and Gynecology, University of Florida,   2University of Florida College of  Medicine, Gainesville, FL, USA Correspondence: Nash S Moawad   Department of Obstetrics and   Gynecology, University of Florida   College of Medicine, PO Box 100294,   Gainesville, FL, USA 32610-0294   Tel +1 352 273 7660   Fax +1 352 392 3498   email nmoawad@ufl.ed uAbstract:  Rectovaginal endometriosis is the most severe form of endometriosis.",Non-OADS,/arxiv_data1/oa_pdf/10/1f/ijwh-5-753.PMC3825702.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/10/1f/ijwh-5-753.PMC3825702.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/1f/ijwh-5-753.PMC3825702.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/39/opth-7-2165.PMC3825704.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2165–2179Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2165Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5109 8Clinical applications of optical coherence  tomography in the posterior pole: the   2011 José Manuel espino Lecture - Part i J Fernando Arevalo1,2 Andres F Lasave3 Juan D Arias3 Martin A Serrano3 Fernando A Arevalo3 1Retina Division, wilmer eye  institute, Johns Hopkins University  School of Medicine, Baltimore, MD,   USA; 2vitreoretinal Division, King  Khaled eye Specialist Hospital,   Riyadh, Kingdom of Saudi Arabia;   3Retina and vitreous Service, Clinica  Oftalmologica Centro Caracas,   Caracas, venezuela Correspondence: J Fernando Arevalo   vitreoretinal Division, The King Khaled  eye Specialist Hospital, Al-Oruba Street,  PO Box 7191, Riyadh 11462, Kingdom of  Saudi Arabia   Tel +966 1 482 1234 ext 3860   Fax +966 1 482 1234 ext 3727   email arevalojf@jhmi.ed uAbstract:  Optical coherence tomography (OCT) is now a standard of care in ophthalmology  and is considered essential for the diagnosis and monitoring of many retinal diseases.",Non-OADS,/arxiv_data1/oa_pdf/86/39/opth-7-2165.PMC3825704.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/86/39/opth-7-2165.PMC3825704.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/39/opth-7-2165.PMC3825704.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ott-6-1597.PMC3825709.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.php OncoTargets and Therapy 2013:6 1597–1604 OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1597Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5235 3cancer stem cell-related marker expression in  lung adenocarcinoma and relevance of histologic  subtypes based on IASLC/ATS/ERS classification Y oshihisa shimada1 hisashi saji3 Masaharu nomura1,2 Jun Matsubayashi2 Koichi Y oshida1 Masatoshi Kakihana1 naohiro Kajiwara1 Tatsuo Ohira1 norihiko ikeda1 1Department of surgery i,   2Department of anatomic Pathology,   T okyo Medical University hospital,   T okyo, Japan; 3Department of chest  surgery, st Marianna University  school of Medicine, Kawasaki, Japan correspondence: Yoshihisa shimada   Department of surgery i, Tokyo  Medical University, 6-7-1 nishishinjuku,  shinjuku-ku, Tokyo, 160-0023, Japan   Tel +81 03 3342 6111   Fax +81 03 3342 6203   email zenkyu@za3.so-net.ne.j pBackground:  The cancer stem cell (CSC) theory has been proposed to explain tumor  heterogeneity and the carcinogenesis of solid tumors.",Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ott-6-1597.PMC3825709.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ott-6-1597.PMC3825709.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ott-6-1597.PMC3825709.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/49/jbm-4-141.PMC3825710.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2013:4 141–147Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  141Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S4507 1Contribution of blood platelets to vascular  pathology in Alzheimer’s disease wei Zhang1,2 wei Huang1 Fang Jing1 1Department of Pharmacology,   institutes for Advanced  interdisciplinary Research, east  China Normal University, Shanghai,   People’s Republic of China;   2Shanghai engineering Research  Center of Molecular Therapy and  Pharmaceutical innovation, Shanghai,   People’s Republic of China Correspondence: wei Zhang   east China Normal University,   3663 North Zhongshan Road,   Shanghai 200062,   People’s Republic of China   Tel +86 21 3253 0498   Fax +86 21 3253 0498   email wzhang@sat.ecnu.edu.c nAbstract:  Cerebral amyloid angiopathy (CAA) is a critical factor in the pathogenesis of  Alzheimer’ s disease (AD).",Non-OADS,/arxiv_data1/oa_pdf/9b/49/jbm-4-141.PMC3825710.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/9b/49/jbm-4-141.PMC3825710.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/49/jbm-4-141.PMC3825710.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/a1/ndt-9-1699.PMC3825712.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1699–1716Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1699Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5030 0The role of the serotonergic system   in suicidal behavior Marta Sadkowski1,* Brittany Dennis2–4,* Robert C Clayden2 wala elSheikh5 Sumathy Rangarajan5 Jane DeJesus5 Zainab Samaan3–6 1Arts and Sciences Program, 2Faculty  of Health Sciences, 3Department of  Clinical epidemiology and Biostatistics,  4Population Genomics Program,  McMaster University, Hamilton, ON,  Canada; 5Population Health Research  institute, Hamilton, ON, Canada;  6Department of Psychiatry and  Behavioral Neurosciences, McMaster  University, Hamilton, ON, Canada *These authors contributed equally   to this work Correspondence: Zainab Samaan   Department of Psychiatry and Behavioral  Neurosciences, Mood Disorders Program,  Centre for Mountain Health, St Joseph’s  Healthcare Hamilton, 100 west 5th,  Hamilton, ON, Canada, L8N 3K7   Tel +1 905 522 1155 ext 36372   Fax +1 905 575 6029   email samaanz@mcmaster.c aAbstract:  Serotonin is a widely investigated neurotransmitter in several psychopathologies,  including suicidal behavior (SB); however, its role extends to several physiological functions  involving the nervous system, as well as the gastrointestinal and cardiovascular systems.",Non-OADS,/arxiv_data1/oa_pdf/64/a1/ndt-9-1699.PMC3825712.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/64/a1/ndt-9-1699.PMC3825712.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/a1/ndt-9-1699.PMC3825712.pdf
"OncoImmunology 2013; 2:e26535; http://dx.doi.org/10.4161/onci.26535Inhibiting the inhibitors Checkpoints blockade in solid tumors Domenico Mavilio1,2 and e nrico Lugli1,* 1unit of Clinical and e xperimental Immunology; h umanitas Clinical and r esearch Center; r ozzano, Italy;  2Department of Medical Biotechnologies and Translational Medicine (BioMeTra); u niversity of Milan; Milan, Italy Keywords:  cancer immunotherapy, CTLA4, immune checkpoints, monoclonal antibodies, PD-1, T cells Abbreviations: APC, antigen-presenting cell; CTLA4, cytotoxic T lymphocyte-associated protein 4; FDA, US Food and Drug  Administration; HCV, hepatitis C virus; PD-1, programmed cell death 1; Treg, regulatory T cell",Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Trends Immunol 2013; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Oncoimmunology  2012 ; 1:1323 - 43; PMID:23243596 ; http://dx.doi.org/10.4161/ onci.22009 3.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Oncoimmunology   2012 ; 1:717-25; PMID:22934263 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Nat Rev Immunol 2012 ; 12:269-81;  PMID:22437939 ; http://dx.doi.org/10.1038/ nri3191 5.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Cancer Immunol Immunother   2013 ; 62:1137 -48; PMID:23666510 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Annu Rev Immunol 2008 ; 26:677-704;  PMID:18173375 ; http://dx.doi.org/10.1146/ annurev.immunol.26.021607.0903317.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Nat Rev Cancer 2012 ;  12:252-64; PMID:22437870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Nat Immunol   2011 ; 12:492-9; PMID:21739672 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Oncoimmunology  2012 ; 1:1223 -5; PMID:23243584 ;  http://dx.doi.org/10.4161/onci.21335 10.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Oncoimmunology  2013 ; 2:e22789 ;  PMID:23482847 ; http://dx.doi.org/10.4161/ onci.22789 11.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Oncoimmunology   2012 ; 1:28-37; PMID:22720209 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
N Engl J Med 2012 ; 366:2443 -54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 14.,OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
N Engl J Med  2013 ; 369:122-33; PMID:23724867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
Clin Cancer Res  2010 ; 16:6019 -28; PMID:20924130 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5b/onci-2-e26535.PMC3825718.pdf
" PaPer Ty Pe www.landesbioscience.com OncoImmunology e25996-1OncoImmunology 2:10, e25996; October 2013; © 2013 Landes BioscienceauThOr’s VIew Several strategies for the therapeutic  vaccination of cancer patients are currently  being developed, and several Phase II/III clinical studies are ongoing to evaluate the safety and efficacy of these approaches (http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
"OncoImmunology 2013; 2:e25996; http://dx.doi.org/10.4161/onci.25996Tumor-targeting vaccination instructs   graft-vs.-tumor immune responses Teresa Manzo1,2, rodrigo h ess Michelini1,3,†, Tabea s turmheit1,2, Veronica Basso1, Matteo Bellone3,‡, and a nna Mondino1,*,‡ 1Lymphocyte a ctivation u nit; Program in Immunology and Bio-Immunotherapy of Cancer; Division of Immunology, Transplantation and Infectious Disease;   san r affaele s cientific Institute; Milan, Italy; 2università Vita- salute s an r affaele; Milan, Italy; 3Cellular Immunology u nit, Program in Immunology and Bio-Immunotherapy   of Cancer, Division of Immunology, Transplantation and Infectious Disease, s an r affaele s cientific Institute; Milan, Italy †Current a ffiliation: Division of Biological s ciences; u niversity of California s an Diego; La Jolla, C a ‡These authors co-directed the study.",Non-OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
Blood  2008; 112:4371-83;  PMID:19029455 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
Adv Surg 2011 ; 45:341- 60; PMID:21954698 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
Proc Natl Acad Sci U S A 1995 ; 92:3439 - 43; PMID:7724580 ; http://dx.doi.org/10.1073/ pnas.92.8.3439 4.,OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
Eur J Immunol 2005 ; 35:66- 75; PMID:15597325 ; http://dx.doi.org/10.1002/ eji.2004255315.,Non-OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
"Eur J Immunol 1999 ; 29:1127 -38;  PMID:10229079 ; http://dx.doi.org/10.1002/ (SICI)1521-4141(199904)29:04<1127::AID- IMMU1127>3.0.CO;2-X 6. de Witte  MA, Bendle  GM, van den Boom MD,  Coccoris  M, Schell  TD, Tevethia  SS, van Tinteren  H,  Mesman  EM, Song  JY, Schumacher  TN.",OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
Cancer Res 2013 ; 73:4641 -52;  PMID:23749644 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-34648.,Non-OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
Hematology Am Soc  Hematol Educ Program  2011 :299-304; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
J Immunol 2011; 186:1361-8; PMID: 21209285; http://dx.doi.org/ 10.4049/jimmunol.1002030.,Non-OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
J Immunol  2013 ; 190:1351 - 9; PMID:23275602 ; http://dx.doi.org/10.4049/ jimmunol.1200391sites.,Non-OADS,/arxiv_data1/oa_pdf/53/1f/onci-2-e25996.PMC3825719.pdf
"OncoImmunology 2013; 2:e26091;  http://dx.doi.org/10.4161/onci.26091Extending the chimeric receptor-based   T-cell targeting strategy to solid tumors Claudia r ossig Department of Pediatric h ematology and Oncology; u niversity Children’s h ospital Muenster; Muenster, Germany Keywords:  chimeric receptor, target antigen, gangliosides, tumor microenvironment, CD19 The adoptive transfer of T  cells expressing chimeric antigen receptors (C ars) has emerged as a promising immu - notherapeutic strategy against cancer.",Non-OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
Sci Transl Med 2011; 3:95ra73; PMID:21832238 ;  http://dx.doi.org/10.1126/scitranslmed.3002842 2.,Non-OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
Sci Transl Med 2013; 5:In press; PMID :23515080 ;  http://dx.doi.org/10.1126/scitranslmed.3005930 3.,Non-OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
N Engl J Med  2013 ; 368:1509-18 ;  PMID:23527958 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
Blood 2011; 118:6050-6;  PMID:21984804 ; http://dx.doi.org/10.1182/ blood-2011-05-3544495.,Non-OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
Nat Med  2008; 14:1264-70;  PMID:18978797 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
EMBO Mol Med 2013; 5:38-51; PMID:23229821 ;  http://dx.doi.org/10.1002/emmm.201201703 8.,Non-OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
Br J Cancer  2012; 106:1123-33;  PMID:22374462 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
Br J Cancer 2013; 109:658-66;  PMID:23839490 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690,OADS,/arxiv_data1/oa_pdf/4d/c4/onci-2-e26091.PMC3825720.pdf
"OncoImmunology 2013; 2:e26199; http://dx.doi.org/10.4161/onci.26199Adoptive immunotherapy New assay for the identification   of T cells with optimal avidity Bianca w eissbrich1, Magdalena Nauerth1, and Dirk h Busch1,2,3,4,* 1Institute for Medical Microbiology; Immunology and h ygiene; Technische u niversität München; Munich, Germany; 2Focus Group “Clinical Cell Processing and Purification”;  Institute for a dvanced s tudy; Technische u niversität München; Munich, Germany; 3Clinical Cooperation Groups “ antigen-specific Immunotherapy” and “Immune Monitoring”;  helmholtz Center Munich and Technische u niversität München; Munich, Germany; 4DZIF–National Center for Infection r esearch; Munich, Germany Keywords:  T cell, CD8+ cytotoxic T cell, T cell receptor, avidity, Koff rate T  cells expressing high avidity T-cell receptors (TC rs) have been shown to mediate superior therapeutic effects.",Non-OADS,/arxiv_data1/oa_pdf/f6/74/onci-2-e26199.PMC3825721.pdf
Immunity 2007; 27:985-97; PMID:18082432 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/74/onci-2-e26199.PMC3825721.pdf
Science  2013; 340:630-5;  PMID:23493420 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/74/onci-2-e26199.PMC3825721.pdf
Sci Transl Med  2013; 5:192ra87;  PMID:23825303 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/74/onci-2-e26199.PMC3825721.pdf
PLoS One 2013; 8:e61384; PMID:23637823 ; http://dx.doi.org/10.1371/jour - nal.pone.00613848.,Non-OADS,/arxiv_data1/oa_pdf/f6/74/onci-2-e26199.PMC3825721.pdf
Eur J Immunol 2013; PMID:23893393 ; http://dx.doi.org/10.1002/ eji.201343397 9.,Non-OADS,/arxiv_data1/oa_pdf/f6/74/onci-2-e26199.PMC3825721.pdf
J Clin Oncol 2011; 29:917- 24; PMID:21282551 ; http://dx.doi.org/10.1200/ JCO.2010.32.2537 10.,Non-OADS,/arxiv_data1/oa_pdf/f6/74/onci-2-e26199.PMC3825721.pdf
Blood 2013; 122:863- 71; PMID:23770775 ; http://dx.doi.org/10.1182/ blood-2013-03-490565,Non-OADS,/arxiv_data1/oa_pdf/f6/74/onci-2-e26199.PMC3825721.pdf
OncoImmunology 2013; 2:e26148;   http://dx.doi.org/10.4161/onci.26148Assessing T-cell responses   in anticancer immunotherapy Dendritic cells or myeloid-derived suppressor cells?,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
"The approximate num - ber of publications dealing with conventional dendritic (DCs) or myeloid-derived suppressor cells (MDSCs), as retrieved by searching PubMed  (http://www.ncbi.nlm.nih.gov/pubmed) for entries whose title contains the term “dendritic cell” or “myeloid-derived suppressor cells,” is represented as a function of publication biennium.",OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Immunol Endocr Metab Agents Med Chem 2012; 12:224-35; PMID:22945252 ;  http://dx.doi.org/10.2174/187152212802001875 2.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
EMBO J 2006 ; 25:2623 - 33; PMID:16724117 ; http://dx.doi.org/10.1038/ sj.emboj.7601146 3.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Virus Res 2013 ; 176:1-15; PMID:23726846 ;  http://dx.doi.org/10.1016/j.virusres.2013.05.0075.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cell  2008 ; 133:775-87; PMID:18510923 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Nature  2012 ;  482:405-9; PMID:22318517 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Annu Rev Immunol 2007 ; 25:267- 96; PMID:17134371 ; http://dx.doi.org/10.1146/ annurev.immunol.25.022106.141609 9.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Leukoc Biol 2011 ; 90:31-6; PMID:21486906 ;  http://dx.doi.org/10.1189/jlb.0111021 11.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cancer Res 2010 ; 70:68-77;  PMID:20028852 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-2587 12.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cancer Immunol Immunother   2013 ; 62:909-18; PMID:23589106 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Proc Natl Acad Sci U S  A 1978 ; 75:5132 -6; PMID :154105 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Exp Med 2001 ; 193:233- 8; PMID:11208863 ; http://dx.doi.org/10.1084/ jem.193.2.233 16.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Exp Med 2001 ; 194:769-79; PMID:11560993 ;  http://dx.doi.org/10.1084/jem.194.6.769 17.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Endocr  Metab Immune Disord Drug Targets 2009 ;  9:328-43; PMID:19857199 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Exp Med  1992 ; 176:1693 -702; PMID:1460426 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Proc Natl Acad Sci U S A 1996 ;  93:2588 -92; PMID:8637918 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cell 1994 ;  76:275-85; PMID:7904901 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Annu Rev Immunol 1994 ; 12:991-1045 ;  PMID:8011301 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Anticancer Agents Med Chem  2012 ; 12:29-39; PMID:21707504 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Mol Ther  2004 ; 10:768- 79; PMID :15451461 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Blood  2001 ; 97:114-21;  PMID:11133750 ; http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Virol 2004 ; 78:10848 - 55; PMID:15452205 ; http://dx.doi.org/10.1128/ JVI.78.20.10848-10855.200427.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Blood   2008 ; 111:3050 -61; PMID:18180378 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Vaccine   2010 ; 28:6675 -83; PMID:20709004 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
FEBS Lett  2007 ;  581:3334 -40; PMID:17601575 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Arthritis Rheum  2011 ;  63:84-95; PMID:20967853 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Blood   2006 ; 108:1435 -40; PMID:16684955 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Crit Rev Immunol 2006 ; 26:291- 306; PMID:17073555 ; http://dx.doi.org/10.1615/ CritRevImmunol.v26.i4.10 38.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Mol Ther   2010 ; 18:1035 -45; PMID:20068554 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Nat Immunol  2009 ; 10:981-91; PMID:19668220 ;  http://dx.doi.org/10.1038/ni.177240.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Exp Med 2007 ; 204:191- 201; PMID:17210729 ; http://dx.doi.org/10.1084/ jem.20061631 41.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Nature  2007 ; 449:419-26;  PMID:17898760 ; http://dx.doi.org/10.1038/ nature06175 42.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Methods Mol Biol  2008 ;  423:139-53; PMID:18370195 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Am J Respir Crit Care Med 2005 ; 171:1168 - 77; PMID:15764728 ; http://dx.doi.org/10.1164/ rccm.200501-057OC 45.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Immunol  2010 ; 185:902-16; PMID:20548033 ;  http://dx.doi.org/10.4049/jimmunol.0902683 46.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Immunother   2003 ; 26:412-9; PMID:12973030 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Surg Res  2005 ; 124:264-73; PMID :15820257 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cancer Gene Ther  2007 ; 14:773- 80; PMID:17599092 ; http://dx.doi.org/10.1038/ sj.cgt.7701073 50.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Neurooncol  2005 ; 72:107- 13; PMID:15925989 ; http://dx.doi.org/10.1007/ s11060-004-3550-9 52.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cancer Immunol Immunother  2012 ;  61:1929 -39; PMID:22476408 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Immunol  2010 ; 184:824- 35; PMID:20018624 ; http://dx.doi.org/10.4049/ jimmunol.0902606 57.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Eur J Immunol 2000 ; 30:1048 - 52; PMID:10760792 ; http://dx.doi.org/10.1002/ (SICI)1521-4141(200004)30:4<1048::AID- IMMU1048>3.0.CO;2-W 58.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Exp Med 2006 ; 203:2691 - 702; PMID:17101732 ; http://dx.doi.org/10.1084/ jem.20061104 60.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Trends Immunol   2011 ; 32:19-25; PMID:21067974 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Nat Rev Immunol 2009 ; 9:162-74;  PMID:19197294 ;  http://dx.doi.org/10.1038/nri2506 62.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cancer Gene Ther   1999 ; 6:409-22; PMID:10505851 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Oncogene  2003 ; 22:3188 -92; PMID:12789295 ;  http://dx.doi.org/10.1038/sj.onc.1206459 66.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cancer Med 2013 ; 2:117-29; PMID:23634280 ;  http://dx.doi.org/10.1002/cam4.20 69.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cancer  Cell Int  2012 ; 12:2; PMID:22270330 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Eur J Immunol  2010 ; 40:22-35; PMID:19941314 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Immunity  2010 ; 32:790-802; PMID:20605485 ;  http://dx.doi.org/10.1016/j.immuni.2010.05.010 73.,OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
J Immunol  2010 ;  185:2273 -84; PMID:20644162 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Blood  2010 ; 116:5738 -47;  PMID:20807889 ; http://dx.doi.org/10.1182/ blood-2010-06-287839 75.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Int J Cancer 2009 ; 124:2621 - 33; PMID:19235923 ; http://dx.doi.org/10.1002/ ijc.24249 77.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cancer Res 2006 ; 66:9290 -8;  PMID:16982774 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-1819 78.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Mucosal  Immunol  2013 ; Forthcoming;  PMID :23715172 ;  http://dx.doi.org/10.1038/mi.2013.27 80.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
Cancer Res 2009 ;  69:2506 -13; PMID:19244102 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/a1/onci-2-e26148.PMC3825722.pdf
"OncoImmunology 2013; 2:e25990; http://dx.doi.org/10.4161/onci.25990Colorectal carcinoma infiltration   by myeloperoxidase-expressing   neutrophil granulocytes is associated   with favorable prognosis Christian h irt1,2, serenella e ppenberger-Castori3, Giuseppe s conocchia4, Giandomenica Iezzi2, Luigi Tornillo3,   Luigi Terracciano3, Giulio C spagnoli2, and r aoul a Droeser1,2,* 1Department of s urgery; u niversity h ospital Basel; Basel, s witzerland;   2Institute of s urgical r esearch and h ospital Management (ICF s) and Department of Biomedicine; u niversity of Basel; Basel, s witzerland;   3Institute of Pathology; u niversity h ospital Basel; Basel, s witzerland; 4Institute of Translational Pharmacology; National r esearch Council; r ome, Italy Keywords:  human colorectal cancer, CD15, myeloperoxidase, mismatch repair status, tissue microarray, prognosis The prognostic relevance of innate immune cells infiltrating colorectal carcinoma lesions is highly debated.",Non-OADS,/arxiv_data1/oa_pdf/ee/bc/onci-2-e25990.PMC3825723.pdf
Science 2006; 313:1960- 4; PMID:17008531 ; http://dx.doi.org/10.1126/ science.1129139 2.,OADS,/arxiv_data1/oa_pdf/ee/bc/onci-2-e25990.PMC3825723.pdf
"Cancer Res 2012; 72:5428-9,  author reply 5430; PMID:23047870 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ee/bc/onci-2-e25990.PMC3825723.pdf
Int  J Cancer 2011; 128:2663-72; PMID :20715106 ;  http://dx.doi.org/10.1002/ijc.256094.,Non-OADS,/arxiv_data1/oa_pdf/ee/bc/onci-2-e25990.PMC3825723.pdf
PLoS One  2013; 8:e64814;  PMID:23734221 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/bc/onci-2-e25990.PMC3825723.pdf
PLoS One 2012; 7:e30806; PMID:22295111 ;  http://dx.doi.org/10.1371/journal.pone.0030806 7.,Non-OADS,/arxiv_data1/oa_pdf/ee/bc/onci-2-e25990.PMC3825723.pdf
Nat Rev Immunol  2011; 11:519-31;  PMID:21785456 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/bc/onci-2-e25990.PMC3825723.pdf
Proc Natl Acad Sci U S A 2005; 102:431- 6; PMID :15625114 ; http://dx.doi.org/10.1073/ pnas.0405193102 9.,OADS,/arxiv_data1/oa_pdf/ee/bc/onci-2-e25990.PMC3825723.pdf
Clin  Cancer Res 2004; 10:4895-900; PMID :15297389 ;  http://dx.doi.org/10.1158/1078-0432.CCR-03-0760,Non-OADS,/arxiv_data1/oa_pdf/ee/bc/onci-2-e25990.PMC3825723.pdf
"OncoImmunology 2013; 2:e25821; http://dx.doi.org/10.4161/onci.25821precise characterization of so-called “can - cer-initiating cells” (CICs), which nowa - days are considered to be responsible for  setting off and sustaining tumor growth.1  CICs are resistant to commonly used che - motherapeutics, mainly due to (1) their location within a hypoxic niche; (2) their reduced proliferative rate; (3) an improved DNA repair capacity; and (4) the over - expression of antiapoptotic molecules.",Non-OADS,/arxiv_data1/oa_pdf/1b/ea/onci-2-e25821.PMC3825724.pdf
Cell  Death Differ 2008; 15:947-58; PMID:18259194;  http://dx.doi.org/10.1038/cdd.2008.202.,Non-OADS,/arxiv_data1/oa_pdf/1b/ea/onci-2-e25821.PMC3825724.pdf
Nat Rev Cancer 2005; 5:275-84;  PMID:15803154; http://dx.doi.org/10.1038/nrc1590 3.,Non-OADS,/arxiv_data1/oa_pdf/1b/ea/onci-2-e25821.PMC3825724.pdf
CA Cancer J Clin 2012; 62:309-35; PMID:22576456;  http://dx.doi.org/10.3322/caac.201324.,Non-OADS,/arxiv_data1/oa_pdf/1b/ea/onci-2-e25821.PMC3825724.pdf
J Immunol 2009; 182:7287-96;  PMID:19454726; http://dx.doi.org/10.4049/jimmu- nol.0804288 8.,Non-OADS,/arxiv_data1/oa_pdf/1b/ea/onci-2-e25821.PMC3825724.pdf
PLoS One 2013; 8:e65145; PMID:23762301; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1b/ea/onci-2-e25821.PMC3825724.pdf
Cancer Immunol Immunother 2007; 56:1285-97; PMID:17265022; http://dx.doi.org/10.1007/s00262- 007-0279-2 6.,Non-OADS,/arxiv_data1/oa_pdf/1b/ea/onci-2-e25821.PMC3825724.pdf
J Exp Med 2011; 208:491-503; PMID:21383056; http://dx.doi.org/10.1084/jem.20100269,Non-OADS,/arxiv_data1/oa_pdf/1b/ea/onci-2-e25821.PMC3825724.pdf
"OncoImmunology 2013; 2:e25789; http://dx.doi.org/10.4161/onci.25789dendritic cells (DCs).4 Genomic and  proteomic analyses have demonstrated  that cyclophosphamide alters the expres - sion of ~1000 genes in the bone marrow and spleen, as well as the levels of a high number of cytokines/chemokines in the plasma and bone marrow of tumor-bear - ing mice.",OADS,/arxiv_data1/oa_pdf/0d/a7/onci-2-e25789.PMC3825725.pdf
Clin Cancer Res 2007; 13:644-53;  PMID:17255288; http://dx.doi.org/10.1158/1078-0432.CCR-06-1209 3.,Non-OADS,/arxiv_data1/oa_pdf/0d/a7/onci-2-e25789.PMC3825725.pdf
J Immunol 2009; 182:2030-40;  PMID:19201856; http://dx.doi.org/10.4049/jimmu- nol.0801829 5.,Non-OADS,/arxiv_data1/oa_pdf/0d/a7/onci-2-e25789.PMC3825725.pdf
Cancer  Res 2011; 71:3528-39; PMID:21444678; http://dx.doi.org/10.1158/0008-5472.CAN-10-4523 6.,Non-OADS,/arxiv_data1/oa_pdf/0d/a7/onci-2-e25789.PMC3825725.pdf
Clin  Cancer Res 2013; PMID:23759676; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/a7/onci-2-e25789.PMC3825725.pdf
J Interferon Cytokine Res  2012; 32:235-47; PMID:22490303; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/a7/onci-2-e25789.PMC3825725.pdf
J Exp Med 2008; 205:1929-38; PMID:18663127;  http://dx.doi.org/10.1084/jem.20080383 9.,Non-OADS,/arxiv_data1/oa_pdf/0d/a7/onci-2-e25789.PMC3825725.pdf
Proc Natl Acad Sci U S A 2011; 108:20684-9; PMID:22143786; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/a7/onci-2-e25789.PMC3825725.pdf
J Leukoc Biol 2007; 81:584-92; PMID:17135573; http://dx.doi.org/10.1189/jlb.0806510,Non-OADS,/arxiv_data1/oa_pdf/0d/a7/onci-2-e25789.PMC3825725.pdf
"OncoImmunology 2013; 2:e25853;  http://dx.doi.org/10.4161/onci.25853Although in the last few years γδ  t lymphocytes have been the subject of growing interest as potential anticancer  immunotherapeutics, how the proliferative and effector responses of these cells are regulated remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/da/0b/onci-2-e25853.PMC3825728.pdf
Nat Immunol 2005; 6:90-8;  PMID:15568026; http://dx.doi.org/10.1038/ni1144 4.,Non-OADS,/arxiv_data1/oa_pdf/da/0b/onci-2-e25853.PMC3825728.pdf
Blood 2013; Forthcoming; PMID:23692853;  http://dx.doi.org/10.1182/blood-2012-11-4646855.,Non-OADS,/arxiv_data1/oa_pdf/da/0b/onci-2-e25853.PMC3825728.pdf
Blood 2009; 113:4875-84;  PMID:19278954; http://dx.doi.org/10.1182/blood- 2008-08-1722969.,Non-OADS,/arxiv_data1/oa_pdf/da/0b/onci-2-e25853.PMC3825728.pdf
Leukemia 2012; 26:559- 62; PMID:21941365; http://dx.doi.org/10.1038/ leu.2011.266 10.,Non-OADS,/arxiv_data1/oa_pdf/da/0b/onci-2-e25853.PMC3825728.pdf
Cancer Res 2010; 70:9166-74;  PMID:20884631; http://dx.doi.org/10.1158/0008- 5472.CAN-10-2460,Non-OADS,/arxiv_data1/oa_pdf/da/0b/onci-2-e25853.PMC3825728.pdf
"OncoImmunology 2013; 2:e26066; http://dx.doi.org/10.4161/onci.26066Tumor-infiltrating follicular helper T cells The new kids on the block Chunyan Gu-Trantien and Karen w illard-Gallo* Molecular Immunology u nit; Institut Jules Bordet; u niversité Libre de Bruxelles; Brussels, Belgium Keywords:  anticancer immunity, breast cancer, CXCL13, follicular helper T cells,  tertiary lymphoid structures, tumor-infiltrating lymphocytes Abbreviations: GC, germinal center; SLO, secondary lymphoid organ; TFH, follicular helper T;   TIL, tumor-infiltrating lymphocyte; TLS, tertiary lymphoid structures By analyzing CD4+ lymphocytes in human breast carcinomas, we have recently uncovered the presence of follicular  helper T cells in lesions exhibiting an extensive immune infiltrate.",Non-OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
Cell Immunol  2012; 279:21-4; PMID:23041206 ;  http://dx.doi.org/10.1016/j.cellimm.2012.08.004 2.,OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
Cancer Metastasis Rev  2010; 29:309-16;  PMID:20405169 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
Exp Biol Med (Maywood) 2011; 236:567-79; PMID:21486861 ;  http://dx.doi.org/10.1258/ebm.2011.0110074.,Non-OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
J Clin Invest 2013; 123:2873-92; PMID:23778140 ;  http://dx.doi.org/10.1172/JCI67428 5.,Non-OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
Immunol Rev 2013; 252:146- 55; PMID:23405902 ; http://dx.doi.org/10.1111/ imr.12031 6.,Non-OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
Nat Rev Immunol 2013; 13:412- 26; PMID:23681096 ; http://dx.doi.org/10.1038/ nri3447 7.,Non-OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
J Immunol 2010; 185:4977- 82; PMID:20962266 ; http://dx.doi.org/10.4049/ jimmunol.10013238.,Non-OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
Immunol Lett 2012; 145:62-7; PMID:22698185 ;  http://dx.doi.org/10.1016/j.imlet.2012.04.013 10.,Non-OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
Transplantation 2011; 92:121-6;  PMID:21555973 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/80/onci-2-e26066.PMC3825729.pdf
OncoImmunology 2013; 2:e25772; http://dx.doi.org/10.4161/onci.25772to immune cells may negatively impact the  efficacy of cell-based immunotherapeutic strategies for the treatment of both pri - mary and metastatic brain malignancies.,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/onci-2-e25772.PMC3825730.pdf
Cancer Res 2010;  70:8368-77; http://dx.doi.org/10.1158/0008-5472.CAN-10-1322 10.,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/onci-2-e25772.PMC3825730.pdf
OncoImmunology 2013; 2:e23430; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/onci-2-e25772.PMC3825730.pdf
Cancer J 2011; 17:343-50; http://dx.doi.org/10.1097/PPO.0b013e318233e5b2 6.,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/onci-2-e25772.PMC3825730.pdf
PLoS  ONE 2013; 8:e63933; http://dx.doi.org/10.1371/jour- nal.pone.0063933 7.,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/onci-2-e25772.PMC3825730.pdf
Ann N Y Acad Sci 2009;  1174:18-23; http://dx.doi.org/10.1111/j.1749- 6632.2009.04932.x 8.,OADS,/arxiv_data1/oa_pdf/ca/ba/onci-2-e25772.PMC3825730.pdf
Clin Cancer Res 2011; 17:1603-15; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/onci-2-e25772.PMC3825730.pdf
Brain 2012; 135:1042-54;  http://dx.doi.org/10.1093/brain/aws042 4.,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/onci-2-e25772.PMC3825730.pdf
Nature 1998; 393:413-4; http://dx.doi.org/10.1038/30845,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/onci-2-e25772.PMC3825730.pdf
OncoImmunology 2013; 2:e25854; http://dx.doi.org/10.4161/onci.25854HPV16/18 genome copy numbers also  exhibit a robust expression of IL-10 (at the mRNA level).,Non-OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
CA Cancer J Clin  2009; 59:352-65; PMID:19897839; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
Annu Rev Immunol 2001; 19:683-765; PMID:11244051; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
Nat Med  2006; 12:1301-9; PMID:17041596; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
J Exp Med 1996; 184:579-84; PMID:8760811; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
Chest 2000; 117:365-73; PMID:10669676;  http://dx.doi.org/10.1378/chest.117.2.365,Non-OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
Clin Cancer Res 2013; Forthcoming;  PMID:23743567; http://dx.doi.org/10.1158/1078- 0432.CCR-12-34399.,Non-OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
Cancer  Res 2006; 66:1491-9; PMID:16452205; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
PLoS  One 2012; 7:e47541; PMID:23118878; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
PLoS One 2012; 7:e39525; PMID:22848356;  http://dx.doi.org/10.1371/journal.pone.0039525,Non-OADS,/arxiv_data1/oa_pdf/cb/53/onci-2-e25854.PMC3825731.pdf
"OncoImmunology 2013; 2:e25989; http://dx.doi.org/10.4161/onci.25989Combining cellular and gene therapy approaches  for treatment of intracranial tumors Michelle J h ickey1, Noriyuki Kasahara2,3, Barbara M Mueller4, and Carol a Kruse1,* 1Department of Neurosurgery; u niversity of California Los a ngeles; Los a ngeles C a usa ;   2Department of Medicine; u niversity of California Los a ngeles; Los a ngeles C a usa ; 3Department of Molecular and Medical Pharmacology;   university of California Los a ngeles; Los a ngeles, C a usa ; 4Torrey Pines Institute for Molecular s tudies; s an Diego, C a usa Keywords:  breast cancer, brain cancer, metastasis, gene therapy, immunotherapy, alloCTL, retrovirus New treatments are needed for brain metastasis, which is associated with high morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/a6/58/onci-2-e25989.PMC3825732.pdf
Curr Oncol Rep 2012; 14:48-54;  http://dx.doi.org/10.1007/s11912-011-0203-y ;  PMID:22012633 2.,Non-OADS,/arxiv_data1/oa_pdf/a6/58/onci-2-e25989.PMC3825732.pdf
Clin Chem 2013; 59:180-9; PMID :23115057 ;  http://dx.doi.org/10.1373/clinchem.2012.193342 3.,Non-OADS,/arxiv_data1/oa_pdf/a6/58/onci-2-e25989.PMC3825732.pdf
CNS Drugs 2013; 27:121- 34; http://dx.doi.org/10.1007/s40263-012-0024-z ;  PMID:23239265 5.,Non-OADS,/arxiv_data1/oa_pdf/a6/58/onci-2-e25989.PMC3825732.pdf
Neuro Oncol  2012; 14:145-59; http://dx.doi.org/10.1093/neuonc/ nor199 ; PMID:22070930 7.,Non-OADS,/arxiv_data1/oa_pdf/a6/58/onci-2-e25989.PMC3825732.pdf
Methods Enzymol 2012; 507:199-228; http://dx.doi.org/10.1016/B978-0-12-386509-0.00011-9 ;  PMID:22365776 8.,OADS,/arxiv_data1/oa_pdf/a6/58/onci-2-e25989.PMC3825732.pdf
Clin Cancer Res  2013; 19:4137-48; http://dx.doi.org/10.1158/1078- 0432.CCR-12-3735 ; PMID:237808899.,Non-OADS,/arxiv_data1/oa_pdf/a6/58/onci-2-e25989.PMC3825732.pdf
J Immunother 2013; 36:152-7;  http://dx.doi.org/10.1097/CJI.0b013e3182811ae4 ;  PMID:23377664 10.,Non-OADS,/arxiv_data1/oa_pdf/a6/58/onci-2-e25989.PMC3825732.pdf
Cancer Immunol Immunother  2012 ; 61:1415-24 ;  PMID:22290073 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/58/onci-2-e25989.PMC3825732.pdf
"OncoImmunology 2013; 2:25820; http://dx.doi.org/10.4161/onci.25820Thus, NK cells are capable of recogniz - ing cells that express on their surface a  broad panel of stress-inducible proteins.",Non-OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
T rends Mol Med 2008; 14:179- 89; PMID:18353724; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
T rends Immunol  2008; 29:397-403; PMID:18602338; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
J Immunol 2013; 190:4408-19; PMID:23509364; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
Oncogene 2009; 28:2370-82; PMID:19430493; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
Nat Rev Cancer 2009; 9:265-73; PMID:19262571; http://dx.doi.org/10.1038/nrc2620 6.,Non-OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
J Biol Chem 2006; 281:30419-30; PMID:16901903;  http://dx.doi.org/10.1074/jbc.M604868200 7.,OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
Eur J Immunol  2007; 37:1938-53; PMID:17557375; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
Eur J Immunol  2007; 37:675-85; PMID:17304628; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
Nature 2007; 447:482-6; PMID:17495932; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
J Exp Med 2006; 203:289- 95; PMID:16461340; http://dx.doi.org/10.1084/ jem.20051986,Non-OADS,/arxiv_data1/oa_pdf/0d/7b/onci-2-e25820.PMC3825733.pdf
Anat Rec (Hoboken) 1925;  31:43-9; http://dx.doi.org/10.1002/ar.10903101062.,Non-OADS,/arxiv_data1/oa_pdf/20/86/onci-2-e25988.PMC3825734.pdf
Cell 2007 ; 131:966- 79; PMID:18045538 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/86/onci-2-e25988.PMC3825734.pdf
Cell Res  2009 ;  19:1350 -62; PMID:19786985 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/86/onci-2-e25988.PMC3825734.pdf
Cancer Lett 2007 ; 258:155-64;  PMID:17977647 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/86/onci-2-e25988.PMC3825734.pdf
Nat Cell Biol 2011 ;  13:1335 -43; PMID:22002674 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/86/onci-2-e25988.PMC3825734.pdf
Nat Cell Biol  2011 ; 13:324-30; PMID:21336303 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/86/onci-2-e25988.PMC3825734.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/dc/opth-7-2181.PMC3825852.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2181–2206Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2181Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5115 8Clinical applications of optical coherence  tomography in the posterior pole: the 2011   José Manuel espino Lecture – Part ii J Fernando Arevalo1,2 Andres F Lasave3 Juan D Arias3 Martin A Serrano3 Fernando A Arevalo3 1Retina Division, wilmer eye  institute, Johns Hopkins University  School of Medicine, Baltimore, MD,  USA; 2vitreoretinal Division, King  Khaled eye Specialist Hospital,  Riyadh, Kingdom of Saudi Arabia;  3Retina and vitreous Service, Clinica  Oftalmologica Centro Caracas,  Caracas, venezuela Correspondence: J Fernando Arevalo   vitreoretinal Division, The King Khaled  eye Specialist Hospital, Al-Oruba Street,  PO Box 7191, Riyadh 11462,   Kingdom of Saudi Arabia   Tel +966 1 482 1234 ext 3860   Fax +966 1 482 1234 ext 3727   email arevalojf@jhmi.ed uAbstract:  Optical coherence tomography (OCT) is a high-resolution, cross-sectional imaging  technique that allows detailed assessment of retinal thickness and morphologic evaluation of the  retinal layers.",Non-OADS,/arxiv_data1/oa_pdf/9f/dc/opth-7-2181.PMC3825852.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9f/dc/opth-7-2181.PMC3825852.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/dc/opth-7-2181.PMC3825852.pdf
ⓒ The Korean Society of Ginseng 379 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Review Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
"4, 379-388 (2013) http://dx.doi.org/10.5142/jgr.2013.37.379 E-mail: kkang@kist.re.kr Tel: +82-33-650-3512, Fax: +82-33-650-3529*Corresponding authorsINTRODUCTION The kidney is an excretory organ that plays a vital role  in excretion of waste through urine in the human body.",Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
http://dx.doi.org/10.5142/jgr.2013.37.379 380J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
"Effect of ginseng on diabetic renal damage    http://ginsengres.orgIn particular, ginseng that contains high concentration of  saponins includes ginsenosides Rb1, Rb2, Rc, Rd, Rg1,  and Re.",Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
http://dx.doi.org/10.5142/jgr.2013.37.379 382J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
Effect of ginseng on diabetic renal damage    http://ginsengres.orgdiabetic rats were significantly decreased in the groups  administered 20( S)-Rg3 or aminoguanidine (20 mg/kg  body weight/d).,Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
http://dx.doi.org/10.5142/jgr.2013.37.379 384J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
Effect of ginseng on diabetic renal damage    http://ginsengres.orgREFERENCES 91.,Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
http://dx.doi.org/10.5142/jgr.2013.37.379 386J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
Effect of ginseng on diabetic renal damage    http://ginsengres.org2-picrylhydrazyl radical scavenging activity changes of  ginsenosides Rb1 and Rg1 by Maillard reaction.,Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
http://dx.doi.org/10.5142/jgr.2013.37.379 388J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/6e/a7/grosbr-37-379.PMC3825853.pdf
ⓒ The Korean Society of Ginseng 389 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
"4, 389-400 (2013) http://dx.doi.org/10.5142/jgr.2013.37.389 E-mail: jshwang@khu.ac.kr Tel: +82-31-888-6179, Fax: +82-31-888-6173*Corresponding authorINTRODUCTION The root of ginseng ( Panax ginseng  Meyer) has been  known as folk medicine in East Asian countries since  time immemorial, and is now one of the most largely  used herbal drugs in the world [1,2].",Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
http://dx.doi.org/10.5142/jgr.2013.37.389 390J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
"Inhibitory effect of KRG on UV-induced melanocyte proliferation    http://ginsengres.org10% FBS, 1% P/S, and 200 nM PMA for 72 h. After  washing with Dulbecco’s phosphate buffered saline  (DPBS), the cells were dissolved in 100 μL of 1 N NaOH  at 60ºC for 30 min.",Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
http://dx.doi.org/10.5142/jgr.2013.37.389 392J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
Inhibitory effect of KRG on UV-induced melanocyte proliferation    http://ginsengres.orgup to 70% (Fig.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
http://dx.doi.org/10.5142/jgr.2013.37.389 394J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
Inhibitory effect of KRG on UV-induced melanocyte proliferation    http://ginsengres.orgto UV radiation by a UV irradiation system.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
http://dx.doi.org/10.5142/jgr.2013.37.389 396J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
"Inhibitory effect of KRG on UV-induced melanocyte proliferation    http://ginsengres.orgDISCUSSION KRG has a wide range of pharmacological and physi - ological actions, which include memory enhancing activ - ities, antihypertensive, antitumor, antistress, antidiabetic,  potentiation of erectile response, aphrodisiac, atopic der - matitis, anti-aging, anti-oxidant, and anti-inflammatory  activities [8-18].",Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
http://dx.doi.org/10.5142/jgr.2013.37.389 398J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
Inhibitory effect of KRG on UV-induced melanocyte proliferation    http://ginsengres.org1995;7:181-186.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
http://dx.doi.org/10.5142/jgr.2013.37.389 400J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/28/0f/grosbr-37-389.PMC3825854.pdf
ⓒ The Korean Society of Ginseng 401 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
"4, 401-412 (2013) http://dx.doi.org/10.5142/jgr.2013.37.401 E-mail: seunghwa.park@kku.ac.kr*Corresponding authorsINTRODUCTION Astrocytes are the most abundant type of cells in the  brain, which regulate energy and ion homeostasis of  extracellular milieu in central nervous system (CNS).",OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
http://dx.doi.org/10.5142/jgr.2013.37.401 402J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
Effects of Korean Red Ginseng extract on PAI-1 activity in astrocytes    http://ginsengres.orgwere obtained from embryonic day 18 cortex of SD rats.,Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
http://dx.doi.org/10.5142/jgr.2013.37.401 404J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
"Effects of Korean Red Ginseng extract on PAI-1 activity in astrocytes    http://ginsengres.orgRESUL TS Effects of Korean Red Ginseng on plasminogen ac - tivator inhibitor-1 and tissue plasminogen activa - tor activity To investigate the effects of KRG on tPA/PAI-1 activ - ity in neuron or astrocytes, we first incubated cultured  rat primary neuron or astrocytes with different concen - trations of KRG.",Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
http://dx.doi.org/10.5142/jgr.2013.37.401 406J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
"Effects of Korean Red Ginseng extract on PAI-1 activity in astrocytes    http://ginsengres.orgSP600125, U0126, and LY294002 prevented 1.0 mg/mL  KRG-induced expression of PAI-1 mRNA (Fig.",Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
http://dx.doi.org/10.5142/jgr.2013.37.401 408J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
Effects of Korean Red Ginseng extract on PAI-1 activity in astrocytes    http://ginsengres.orgCK also induced PAI-1 mRNA and protein expression in  rat primary astrocytes in a concentration dependent man - ner (Fig.,Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
http://dx.doi.org/10.5142/jgr.2013.37.401 410J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
"Effects of Korean Red Ginseng extract on PAI-1 activity in astrocytes    http://ginsengres.orgon brain function and responses to pathological insults  should be experimentally investigated in the future, the  results from the present study suggest that regulation of  tPA/PAI-1 activity by pretreatment of KRG may position  the balance of tPA/PAI-1 activity in brain in a way ben - eficial for the challenged situation.",Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
http://dx.doi.org/10.5142/jgr.2013.37.401 412J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b2/bc/grosbr-37-401.PMC3825855.pdf
ⓒ The Korean Society of Ginseng 413 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
"4, 413-424 (2013) http://dx.doi.org/10.5142/jgr.2013.37.413 E-mail: ymkim@kangwon.ac.kr Tel: +82-33-250-8831, Fax: +82-33-244-3286*Corresponding authorINTRODUCTION Endothelial cells, which constitute the inner cellular  lining of blood vessels, have a key role in regulating vas -Korean Red Ginseng protects endothelial cells from serum-deprived  apoptosis by regulating Bcl-2 family protein dynamics and caspase  S-nitrosylation Young-Mi Kim1†, Jung Hwan Kim2†, Hyuk Min Kwon3, Dong Heon Lee3, Moo-Ho Won4,   Young-Guen Kwon5, and Young-Myeong Kim1*  1Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University, Chuncheon 200- 701, Korea   2Department of Rehabilitation Medicine, Kangwon National University Hospital, School of Medicine, Kangwon National  University, Chuncheon 200-701, Korea   3Department of Obstetrics and Gynecology, Kangwon National University Hospital, Chuncheon 200-701, Korea   4Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon 200-701, Korea   5Department of Biochemistry, College of Sciences, Yonsei University, Seoul 120-749, Korea Korean Red Ginseng extract (KRGE) is a traditional herbal medicine utilized to prevent endothelium dysfunction in the  cardiovascular system; however, its underlying mechanism has not been clearly elucidated.",Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
http://dx.doi.org/10.5142/jgr.2013.37.413 414J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
Korean Red Ginseng prevents endothelial cell death    http://ginsengres.orgmined by CCK-8 assay.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
http://dx.doi.org/10.5142/jgr.2013.37.413 416J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
Korean Red Ginseng prevents endothelial cell death    http://ginsengres.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
http://dx.doi.org/10.5142/jgr.2013.37.413 418J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
"Korean Red Ginseng prevents endothelial cell death    http://ginsengres.orgdependent manner, which were highly correlated with  eNOS phosphorylation (Fig.",Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
http://dx.doi.org/10.5142/jgr.2013.37.413 420J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
"Korean Red Ginseng prevents endothelial cell death    http://ginsengres.orgdeprived culture condition, which is similar to in vitro   simulation of pathological ischemia.",Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
http://dx.doi.org/10.5142/jgr.2013.37.413 422J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
Korean Red Ginseng prevents endothelial cell death    http://ginsengres.orgtric oxide inhibition of homocysteine-induced human  endothelial cell apoptosis by down-regulation of p53- dependent Noxa expression through the formation of S- nitrosohomocysteine.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
http://dx.doi.org/10.5142/jgr.2013.37.413 424J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/38/13/grosbr-37-413.PMC3825856.pdf
ⓒ The Korean Society of Ginseng 425 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
"4, 425-434 (2013) http://dx.doi.org/10.5142/jgr.2013.37.425 E-mail: sunnykim@gachon.ac.kr Tel: +82-32-899-6411, Fax: +82-32-899-6591*Corresponding authorsINTRODUCTION Aging is a biological process that changes structural  integrity and physiological function [1].",Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
http://dx.doi.org/10.5142/jgr.2013.37.425 426J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
"Enzyme-processed red ginseng extracts protects against skin damages UVB irradiation    http://ginsengres.orgAnimals (Seoul, Korea).",Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
http://dx.doi.org/10.5142/jgr.2013.37.425 428J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
"Enzyme-processed red ginseng extracts protects against skin damages UVB irradiation    http://ginsengres.orglarly, our data has been shown that F2 content (3.45 mg/g)  showed the highest level in KRGE.",Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
http://dx.doi.org/10.5142/jgr.2013.37.425 430J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
Enzyme-processed red ginseng extracts protects against skin damages UVB irradiation    http://ginsengres.organ internal reference.,Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
http://dx.doi.org/10.5142/jgr.2013.37.425 432J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
Enzyme-processed red ginseng extracts protects against skin damages UVB irradiation    http://ginsengres.orga dietary supplement has potential beneficial effects on  photoaging.,Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
http://dx.doi.org/10.5142/jgr.2013.37.425 434J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/10/6b/grosbr-37-425.PMC3825857.pdf
ⓒ The Korean Society of Ginseng 435 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/67/c4/grosbr-37-435.PMC3825858.pdf
"4, 435-441 (2013) http://dx.doi.org/10.5142/jgr.2013.37.435 E-mail: shokim@chonnam.ac.kr Tel: +82-62-530-2837, Fax: +82-62-530-2841*Corresponding authorINTRODUCTION High-dose radiation therapy has been associated with  bone loss [1].",Non-OADS,/arxiv_data1/oa_pdf/67/c4/grosbr-37-435.PMC3825858.pdf
http://dx.doi.org/10.5142/jgr.2013.37.435 436J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/67/c4/grosbr-37-435.PMC3825858.pdf
"Effect of Korean Red Ginseng on irradiated bone    http://ginsengres.orgactivity was measured on a Dri-chem automatic analyzer  (Fuji, Tokyo, Japan) using a diagnostic slide.",OADS,/arxiv_data1/oa_pdf/67/c4/grosbr-37-435.PMC3825858.pdf
http://dx.doi.org/10.5142/jgr.2013.37.435 438J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/67/c4/grosbr-37-435.PMC3825858.pdf
Effect of Korean Red Ginseng on irradiated bone    http://ginsengres.orgpared with the irradiation control group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/67/c4/grosbr-37-435.PMC3825858.pdf
http://dx.doi.org/10.5142/jgr.2013.37.435 440J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/67/c4/grosbr-37-435.PMC3825858.pdf
Effect of Korean Red Ginseng on irradiated bone    http://ginsengres.org14.,Non-OADS,/arxiv_data1/oa_pdf/67/c4/grosbr-37-435.PMC3825858.pdf
ⓒ The Korean Society of Ginseng 442 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
"4, 442-450 (2013) http://dx.doi.org/10.5142/jgr.2013.37.442 E-mail: swlee1004@korea.kr Tel: +82-43-871-5611, Fax: +82-43-871-5589*Corresponding authorINTRODUCTION Reactive oxygen species (ROS) such as superoxide,  hydrogen peroxide (H2O2), and hydroxyl radical have  been recognized to be one of the factors involved in the  mechanisms of a variety of diseases including cardiovas - cular dysfunctions, atherosclerosis, inflammation, carci - nogenesis, reperfusion injury [1].",Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
Antioxidant activity of Korean White and Red Ginsengs    http://ginsengres.orgwith loss of their biological function and cell viability [4].,Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
http://dx.doi.org/10.5142/jgr.2013.37.442 444J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
Antioxidant activity of Korean White and Red Ginsengs    http://ginsengres.orgt-test.,Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
http://dx.doi.org/10.5142/jgr.2013.37.442 446J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
Antioxidant activity of Korean White and Red Ginsengs    http://ginsengres.orglevel in in H2O2-treated cells was significantly elevated as  much as 2-fold when compared to the control ( p<0.01)  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
http://dx.doi.org/10.5142/jgr.2013.37.442 448J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
Antioxidant activity of Korean White and Red Ginsengs    http://ginsengres.orgoxidative injury in mouse hepatocytes [27].,Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
http://dx.doi.org/10.5142/jgr.2013.37.442 450J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/46/45/grosbr-37-442.PMC3825859.pdf
ⓒ The Korean Society of Ginseng 451 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/grosbr-37-451.PMC3825860.pdf
"4, 451-456 (2013) http://dx.doi.org/10.5142/jgr.2013.37.",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/grosbr-37-451.PMC3825860.pdf
http://dx.doi.org/10.5142/jgr.2013.37.451 452J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/grosbr-37-451.PMC3825860.pdf
Pharmacokinetics of Rb1 and compound K    http://ginsengres.orgfor both compounds were linear throughout the concen - tration range used in the study with correlation coeffi - cients greater than 0.995.,OADS,/arxiv_data1/oa_pdf/a3/4b/grosbr-37-451.PMC3825860.pdf
http://dx.doi.org/10.5142/jgr.2013.37.451 454J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/grosbr-37-451.PMC3825860.pdf
"Pharmacokinetics of Rb1 and compound K    http://ginsengres.orgCorrelation between pharmacokinetic parameters  of ginsenoside Rb1 and compound K Many studies showed that ginsenoside Rb1 is trans - formed into compound K by intestinal microflora after  oral administration in humans [1,2,9,10].",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/grosbr-37-451.PMC3825860.pdf
http://dx.doi.org/10.5142/jgr.2013.37.451 456J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/grosbr-37-451.PMC3825860.pdf
ⓒ The Korean Society of Ginseng 457 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
"4, 457-467 (2013) http://dx.doi.org/10.5142/jgr.2013.37.457 E-mail: 20109042@kgc.or.kr Tel: +82-42-870-3051, Fax: +82-42-870-3182*Corresponding authorINTRODUCTION Korean ginseng ( Panax ginseng ) has been considered  one of the most valuable medicinal herbs in oriental  countries for 2,000 years, and in the modern age it is  widely used as a complementary and alternative medi - cine and health food [1].",Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
http://dx.doi.org/10.5142/jgr.2013.37.457 458J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
"Analysis of 30 ginsenosides    http://ginsengres.orgwas performed in an ultrasonic cleaner (60 Hz, Wise - clean) for 30 min.",Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
http://dx.doi.org/10.5142/jgr.2013.37.457 460J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
"Analysis of 30 ginsenosides    http://ginsengres.orgas to decrease the pressure at the higher flow rate, which  could improve the resolutions and peak shapes.",Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
http://dx.doi.org/10.5142/jgr.2013.37.457 462J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
Analysis of 30 ginsenosides    http://ginsengres.orgsubstance present in the sample matrix.,OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
http://dx.doi.org/10.5142/jgr.2013.37.457 464J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
"Analysis of 30 ginsenosides    http://ginsengres.orgAnalysis of 30 ginsenosides in Panax ginseng  prep - arations There are various types of commercial red ginseng  products such as red ginseng powder, concentrates, tonic,  tablets, tea, and candy.",Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
http://dx.doi.org/10.5142/jgr.2013.37.457 466J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
Analysis of 30 ginsenosides    http://ginsengres.orgChromatogr A 1996;736:77-81.,Non-OADS,/arxiv_data1/oa_pdf/ac/21/grosbr-37-457.PMC3825861.pdf
ⓒ The Korean Society of Ginseng 468 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/9c/grosbr-37-468.PMC3825862.pdf
"4, 468-474 (2013) http://dx.doi.org/10.5142/jgr.2013.37.468 E-mail: tack@kfri.re.kr Tel: +82-31-780-9096, Fax: +82-31-780-9876*Corresponding authorINTRODUCTION Ginseng root ( Panax ginseng  Meyer) has been used  as an Oriental herbal medicine ingredient, but the aerial  part of the plant has seldom been used.",Non-OADS,/arxiv_data1/oa_pdf/e0/9c/grosbr-37-468.PMC3825862.pdf
"Quality and characteristics of ginseng seed oil    http://ginsengres.orgincluding the antioxidant and antiaging effects of ginseng  berry extract [1], improvement of blood circulation [9],  and prevention of skin aging [10].",Non-OADS,/arxiv_data1/oa_pdf/e0/9c/grosbr-37-468.PMC3825862.pdf
http://dx.doi.org/10.5142/jgr.2013.37.468 470J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/9c/grosbr-37-468.PMC3825862.pdf
Quality and characteristics of ginseng seed oil    http://ginsengres.orgin roasted ginseng seed compared to that of unroasted  ginseng seeds.,Non-OADS,/arxiv_data1/oa_pdf/e0/9c/grosbr-37-468.PMC3825862.pdf
http://dx.doi.org/10.5142/jgr.2013.37.468 472J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/9c/grosbr-37-468.PMC3825862.pdf
"Quality and characteristics of ginseng seed oil    http://ginsengres.organalysis in ginseng seed oil showed that the phytosterol  content of oil following supercritical fluid extraction  was 100.4 to 135.5 mg/100 g, whereas that following  compression extraction and solvent extraction was 71.8  to 80.9 mg/100 g, The higher phytosterol content found  following supercritical fluid extraction was expected be - cause supercritical fluid carbon dioxide has the excellent  property of dissolving non-polar substances.",Non-OADS,/arxiv_data1/oa_pdf/e0/9c/grosbr-37-468.PMC3825862.pdf
http://dx.doi.org/10.5142/jgr.2013.37.468 474J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/9c/grosbr-37-468.PMC3825862.pdf
ⓒ The Korean Society of Ginseng 475 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/grosbr-37-475.PMC3825863.pdf
"4, 475-482 (2013) http://dx.doi.org/10.5142/jgr.2013.37.475 E-mail: skkim@kku.ac.kr Tel: +82-43-840-3574, Fax: +82-43-840-3929*Corresponding authorINTRODUCTION In Oriental countries, Panax ginseng  has been used as  a traditional medicine for various illnesses for more than  two thousand years.",Non-OADS,/arxiv_data1/oa_pdf/c9/a2/grosbr-37-475.PMC3825863.pdf
http://dx.doi.org/10.5142/jgr.2013.37.475 476J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/grosbr-37-475.PMC3825863.pdf
"An improved and validated analytical procedure for ginseng preparations    http://ginsengres.organd 2,500 mL of water was simmered (approximately  80°C) for 72 h. Aliquots (sample A, 100 mL) of the sim - mering ginseng root were removed at 3, 6, 12, 24, 36, 48,  60, and 72 h, and the samples were subjected to gel ad - sorption chromatography (MCI; Supelco, Bellefonte, PA,  USA) or butanol partition to determine the crude saponin  content.",Non-OADS,/arxiv_data1/oa_pdf/c9/a2/grosbr-37-475.PMC3825863.pdf
http://dx.doi.org/10.5142/jgr.2013.37.475 478J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/grosbr-37-475.PMC3825863.pdf
"An improved and validated analytical procedure for ginseng preparations    http://ginsengres.orgSystem suitability testing  The four marker ginsenosides were well separated  with retention times of 18.4, 45.4, 59.4, and 60.4 min for  ginsenoside Rg1, ginsenoside Rb1, (20 S)-ginsenoside  Rg3 and (20 R)-ginsenoside Rg3, respectively, in the  given HPLC conditions (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c9/a2/grosbr-37-475.PMC3825863.pdf
http://dx.doi.org/10.5142/jgr.2013.37.475 480J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/grosbr-37-475.PMC3825863.pdf
"An improved and validated analytical procedure for ginseng preparations    http://ginsengres.orgginsenoside Rg3 and from there to Rh2, while pro - topanaxatriol ones degrades into ginsenoside Rh1 and  then into sapogenin.",Non-OADS,/arxiv_data1/oa_pdf/c9/a2/grosbr-37-475.PMC3825863.pdf
http://dx.doi.org/10.5142/jgr.2013.37.475 482J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/grosbr-37-475.PMC3825863.pdf
ⓒ The Korean Society of Ginseng 483 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/8e/grosbr-37-483.PMC3825864.pdf
"4, 483-490 (2013) http://dx.doi.org/10.5142/jgr.2013.37.483 E-mail: jhkwon@knu.ac.kr Tel: +82-53-950-5775, Fax: +82-53-950-5775*Corresponding authorINTRODUCTION Medicinal plants, enriched with different functional  compounds, could enhance human health with their po - tent therapeutic benefits.",Non-OADS,/arxiv_data1/oa_pdf/b1/8e/grosbr-37-483.PMC3825864.pdf
http://dx.doi.org/10.5142/jgr.2013.37.483 484J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/8e/grosbr-37-483.PMC3825864.pdf
"Luminescence characteristics of irradiated ginsengs    http://ginsengres.orgence Institute, Daegu.",Non-OADS,/arxiv_data1/oa_pdf/b1/8e/grosbr-37-483.PMC3825864.pdf
http://dx.doi.org/10.5142/jgr.2013.37.483 486J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/8e/grosbr-37-483.PMC3825864.pdf
Luminescence characteristics of irradiated ginsengs    http://ginsengres.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/b1/8e/grosbr-37-483.PMC3825864.pdf
http://dx.doi.org/10.5142/jgr.2013.37.483 488J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/8e/grosbr-37-483.PMC3825864.pdf
"Luminescence characteristics of irradiated ginsengs    http://ginsengres.orgare in good agreement to those reported for irradiated  fresh mushrooms [17], onions [13], kiwifruits [18], and  sesame seeds [19].",Non-OADS,/arxiv_data1/oa_pdf/b1/8e/grosbr-37-483.PMC3825864.pdf
http://dx.doi.org/10.5142/jgr.2013.37.483 490J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/8e/grosbr-37-483.PMC3825864.pdf
ⓒ The Korean Society of Ginseng 491 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/b0/grosbr-37-491.PMC3825865.pdf
"4, 491-495 (2013) http://dx.doi.org/10.5142/jgr.2013.37.491 E-mail: kh4548@korea.kr Tel: +82-63-290-5452, Fax: +82-63-290-5512*Corresponding authorINTRODUCTION Wood-cultivated ginsengs are perennial plants that are  semi-heliophobic and commonly used in Chinese medi - cine.",Non-OADS,/arxiv_data1/oa_pdf/9c/b0/grosbr-37-491.PMC3825865.pdf
http://dx.doi.org/10.5142/jgr.2013.37.491 492J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/b0/grosbr-37-491.PMC3825865.pdf
Identification of suitable cultivation sites    http://ginsengres.orgplying weighted values that correspond to the specific  conditions of each factor to the respective raster database  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/9c/b0/grosbr-37-491.PMC3825865.pdf
http://dx.doi.org/10.5142/jgr.2013.37.491 494J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/b0/grosbr-37-491.PMC3825865.pdf
Available from: http://forest.go.kr/newkfsweb/cop/ bbs/selectBoardArticle.do?nttId=2310109&bbsId=BBSM STR_1005&pageUnit=10&pageIndex=1&searchtitle=titl e&searchcont=&searchkey=&searchwriter=&searchWrd =%ec%82%b0%ec%96%91%ec%82%bc&ctgryLrcls=& ctgryMdcls=&ctgrySmcls=&ntcStartDt=&ntcEndDt=&m n=KFS_06_03_04.,OADS,/arxiv_data1/oa_pdf/9c/b0/grosbr-37-491.PMC3825865.pdf
Identification of suitable cultivation sites    http://ginsengres.org69.,Non-OADS,/arxiv_data1/oa_pdf/9c/b0/grosbr-37-491.PMC3825865.pdf
Available from:  http://www.jinan.go.kr/board/view.sko?boardId=ADb01 &boardSid=14&menuCd=MM04002001000&contentsSi d=115&orderBy=dataTitle:asc&startPage=1&searchType =&keyword=&searchStartDt=&searchEndDt=&category Code1=1209971050800&categoryCode2=&categoryCod e3=&dataSid=31106.,Non-OADS,/arxiv_data1/oa_pdf/9c/b0/grosbr-37-491.PMC3825865.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.009,OADS,/arxiv_data1/oa_pdf/56/45/main.PMC3825926.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.007,OADS,/arxiv_data1/oa_pdf/f6/81/main.PMC3825927.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.030,OADS,/arxiv_data1/oa_pdf/71/0b/main.PMC3825928.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.004,OADS,/arxiv_data1/oa_pdf/35/ba/main.PMC3825929.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.002,OADS,/arxiv_data1/oa_pdf/9c/1e/main.PMC3825930.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.019,OADS,/arxiv_data1/oa_pdf/50/6f/main.PMC3825932.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.010,OADS,/arxiv_data1/oa_pdf/28/7b/main.PMC3825933.pdf
Annals of Rehabilitation MedicineEditorial Ann Rehabil Med 2013;37(5): 601-602 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.,Non-OADS,/arxiv_data1/oa_pdf/5b/64/arm-37-601.PMC3825934.pdf
"Keywords   Stroke, Aphasia, Transcranial direct current stimulation, Electrical stimulation therapyAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 603-610 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/3b/2f/arm-37-603.PMC3825935.pdf
"603 Received May 24, 2013; Accepted July 23, 2013 Corresponding author: Yun-Hee Kim Department of Physical and Rehabilitation Medicine, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel: +82-2-3410-2824, Fax: +82-2-3410-0052, E-mail: yunkim@skku.edu, yun1225.kim@samsung.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/2f/arm-37-603.PMC3825935.pdf
"Keywords   Hemispatial neglect, Anemia, HemoglobinsAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 611-618 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/66/6a/arm-37-611.PMC3825936.pdf
"611 Received May 28, 2013; Accepted August 7, 2013 Corresponding author: Tae Sik Yoon Department of Rehabilitation Medicine, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea Tel: +82-2-2650-5035, Fax: +82-2-2650-5145, E-mail: yoonreha@ewha.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/6a/arm-37-611.PMC3825936.pdf
"Keywords   Electrical stimulation, Ergometry, Bicycling, Stroke, Oxygen consumptionAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 619-627 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/17/ef/arm-37-619.PMC3825937.pdf
"619 Received March 29, 2013; Accepted August 16, 2013 Corresponding author: Eun Young Han  Department of Rehabilitation Medicine, Jeju National University Hospital, Jeju National University College of Medicine, 15 Aran 13-gil, Jeju 690-767,  Korea Tel: +82-64-717-1541, Fax: +82-64-717-1131, E-mail: clearblue10@naver.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/ef/arm-37-619.PMC3825937.pdf
"Keywords   Compliance, Deglutition disorders, Diet therapyAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 628-632 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/f9/50/arm-37-628.PMC3825938.pdf
"Keywords   Brain tumor, Dysphagia, Videofluoroscopic swallowing study, Infratentorial lesion, MalignancyAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 633-641 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/1e/6b/arm-37-633.PMC3825939.pdf
"633 Received April 23, 2013; Accepted July 18, 2013 Corresponding author: Min Ho Chun Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138- 736, Korea Tel: +82-2-3010-3800, Fax: +82-2-3010-6964, E-mail: mhchun@amc.seoul.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/6b/arm-37-633.PMC3825939.pdf
"Keywords   Speech disorders, Speech perception, Functional laterality, StrokeAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 642-648 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/12/dd/arm-37-642.PMC3825940.pdf
"Keywords   Cerebral palsy, Gross motor function, Physical therapy, Factor analysisAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 649-657 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/18/a7/arm-37-649.PMC3825941.pdf
"Keywords   Ultrasonography, Fluoroscopy, Cervical radiculopathy, Nerve blockAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 658-667 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/81/4e/arm-37-658.PMC3825942.pdf
"658 Received March 4, 2013; Accepted June 25, 2013 Corresponding author: Ki Deok Park Department of Rehabilitation Medicine, Gachon University Gil Medical Center, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 405-760, Korea Tel: +82-32-460-8374, Fax: +82-32-460-3051, E-mail: bduck@gachon.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/4e/arm-37-658.PMC3825942.pdf
"Keywords   Shoulder impingement syndrome, Corticosteroid, DosageAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 668-674 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/fc/b9/arm-37-668.PMC3825943.pdf
"668 Received December 26, 2012; Accepted July 1, 2013 Corresponding author: Seung Deuk Byun Department of Rehabilitation Medicine, Daegu Fatima Hospital, 99 Ayang-ro, Dong-gu, Daegu 701-724, Korea Tel: +82-53-940-7821, Fax: +82-53-940-7417, E-mail: sato1009@hanmail.net  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/b9/arm-37-668.PMC3825943.pdf
"Keywords   Ankylosing spondylitis, Joint range of motion, Pulmonary function tests, Quality of lifeAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 675-682 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/14/53/arm-37-675.PMC3825944.pdf
"675 Received July 18, 2013; Accepted August 12, 2013 Corresponding author: Kyu Hoon Lee Department of Rehabilitation Medicine, Hanyang University Medical Center, Hanyang University College of Medicine, 222 Wangsimni-ro, Seongdong- gu, Seoul 133-791, Korea Tel: +82-2-2290-9349, Fax: +82-2-2282-0772, E-mail: dumitru1@hanyang.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/53/arm-37-675.PMC3825944.pdf
"Keywords   Lymphedema, Ultrasonography, Complex decongestive physiotherapyAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 683-689 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/16/9a/arm-37-683.PMC3825945.pdf
"Keywords   Lymphedema, Physical therapy modalities, Breast neoplasmsAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 690-697 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/e3/13/arm-37-690.PMC3825946.pdf
"Keywords   Patellar tendon, Tendinopathy, Athletes, Reliability, ValidityAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 698-705 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/89/f5/arm-37-698.PMC3825947.pdf
"Keywords   Vibration, Spine, Degenerative changes, AircraftAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(5): 706-712 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/2b/a3/arm-37-706.PMC3825948.pdf
"Keywords   Lymhadenitis, Atlantoaxial joint, TorticollisAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(5): 713-716 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/e7/a5/arm-37-713.PMC3825949.pdf
"Keywords   Cervical anterior osteophyte, Paradoxical vocal cord motion, DysphagiaAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(5): 717-720 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/3e/e8/arm-37-717.PMC3825950.pdf
"Keywords   Abdominal pain, Neuropathic pain, Spinal cord injuriesAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(5): 721-724 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/49/5e/arm-37-721.PMC3825951.pdf
"Keywords   Spondylitis, Intervertebral disc displacement, Spinal cord compressionAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(5): 725-729 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/ff/fa/arm-37-725.PMC3825952.pdf
"Keywords   Intervertebral disc displacement, Cervical pain, Decompressive nucleoplastyAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(5): 730-734 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/16/f2/arm-37-730.PMC3825953.pdf
"Keywords   Motor cortex, Synergy, Gait, Brain neoplasmsAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(5): 735-739 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/de/cc/arm-37-735.PMC3825954.pdf
"Keywords   Guillain-Barre syndrome, Cranial neuropathies,  Bulbar palsyAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(5): 740-744 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/9a/86/arm-37-740.PMC3825955.pdf
"Keywords   Guillain-Barre syndrome, Syringomyelia, Posttraumatic syringomyeliaAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(5): 745-749 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/62/36/arm-37-745.PMC3825956.pdf
"Keywords   Aorta, Thrombus, Stroke, Transesohphageal echocardiographyAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(5): 750-754 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.",Non-OADS,/arxiv_data1/oa_pdf/63/76/arm-37-750.PMC3825957.pdf
"755 www.e-arm.orgCorrection: Changes in Balancing Ability of  Athletes With Chronic Ankle Instability   After Foot Orthotics Application and  Rehabilitation Exercises Hong-Jae Lee, MD1, Kil-Byung Lim, MD1, Tae-Ho Jung, MS2, Dug-Young Kim, MD3, Kyung-Rok Park, MD1 1Department of Physical Medicine and Rehabilitation, 2Institute of Sports Rehabilitation, Inje University Ilsan Paik Hospital,  Goyang; 3Department of Rehabilitation Medicine, CHA University College of Medicine, Seoul, Korea http://dx.doi.org/10.5535/arm.2013.37.4.523 Ann Rehabil Med 2013;37(4):523-533 We found the funding acknowledgment in this article was omitted as published.",Non-OADS,/arxiv_data1/oa_pdf/b3/72/arm-37-755.PMC3825958.pdf
"Yours sincerely, Hong-Jae LeeCorrigendum Corresponding author: Hong-Jae Lee Department of Physical Medicine and Rehabilitation, Institute of Sports Rehabilitation, Inje University Ilsan Paik Hospital, 170 Juhwa-ro, Ilsanseo-gu,  Goyang 411-706, Korea Tel: +82-31-910-7440, Fax: +82-31-910-7446, E-mail: honglee@paik.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/72/arm-37-755.PMC3825958.pdf
Copyright © 2013 by Korean Academy of Rehabilitation MedicineAnn Rehabil Med 2013;37(5): 755 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.,Non-OADS,/arxiv_data1/oa_pdf/b3/72/arm-37-755.PMC3825958.pdf
"Correction: Relationship Between Gross Motor  Function and Daily Functional Skill in Children  With Cerebral Palsy Tae Gun Kwon, MD1, Sook-Hee Yi, MD1, Tae Won Kim, MS1, Hyun Jung Chang, MD2, Jeong-Yi Kwon, MD1 1Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University  School of Medicine, Seoul; 2Department of Physical Medicine and Rehabilitation, Samsung Changwon Hospital,  Sungkyunkwan University School of Medicine, Changwon, Korea http://dx.doi.org/10.5535/arm.2013.37.1.41 Ann Rehabil Med 2013;37(1):41-49 To the Editor, We found that a number of tables were inadvertently omitted.",Non-OADS,/arxiv_data1/oa_pdf/b9/69/arm-37-756.PMC3825959.pdf
"In Table 4, ‘Table 4’ must be changed into ‘Table 6’ The following 2 tables (Tables 4 and 5) should appear in the manuscript.Corrigendum Corresponding author: Jeong-Yi Kwon Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam- gu, Seoul 135-710, Korea Tel: +82-2-3410-2818, Fax: +82-2-3410-0052, E-mail: jeongyi@gmail.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/69/arm-37-756.PMC3825959.pdf
Copyright © 2013 by Korean Academy of Rehabilitation MedicineAnn Rehabil Med 2013;37(5): 756-757 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.5.,Non-OADS,/arxiv_data1/oa_pdf/b9/69/arm-37-756.PMC3825959.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.003,OADS,/arxiv_data1/oa_pdf/d1/c6/main.PMC3825960.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.005,OADS,/arxiv_data1/oa_pdf/74/5e/main.PMC3825961.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.011,OADS,/arxiv_data1/oa_pdf/ce/3c/main.PMC3825962.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.017,OADS,/arxiv_data1/oa_pdf/94/00/main.PMC3825963.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.006,OADS,/arxiv_data1/oa_pdf/c9/2a/main.PMC3825964.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.019,OADS,/arxiv_data1/oa_pdf/ca/5e/main.PMC3825966.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.003,OADS,/arxiv_data1/oa_pdf/30/2e/main.PMC3825967.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.016,OADS,/arxiv_data1/oa_pdf/bf/4a/main.PMC3825968.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.034,OADS,/arxiv_data1/oa_pdf/90/5f/main.PMC3825969.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.001,OADS,/arxiv_data1/oa_pdf/2d/dc/main.PMC3825973.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.037,OADS,/arxiv_data1/oa_pdf/02/d5/main.PMC3825974.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.012,OADS,/arxiv_data1/oa_pdf/a2/14/main.PMC3825976.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.018,OADS,/arxiv_data1/oa_pdf/fd/09/main.PMC3825977.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.031,OADS,/arxiv_data1/oa_pdf/c5/8c/main.PMC3825979.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.015,OADS,/arxiv_data1/oa_pdf/b6/6f/main.PMC3825984.pdf
"www.jpis.orgpISSN 2093-2278 eISSN 2093-2286Editorial Copyright © 2013 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Waiting for innovations in   periodontal disease diagnosisJ Periodontal Implant Sci 2013;43:207-208 • http://dx.doi.org/10.5051/jpis.2013.43.5.207 Several biomolecules, which can be in the form of proteins or  nucleic acids, have been identified as biomarkers, serv - ing as telltale signs for specific diseases.",Non-OADS,/arxiv_data1/oa_pdf/c9/cb/jpis-43-207.PMC3825986.pdf
"www.jpis.orgJournal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286Copyright © 2013 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Changes in the fractal dimension of peri-implant  trabecular bone after loading: a retrospective  study Teh-Jing Mu1, Dong-Won Lee1, Kwang-Ho Park2, Ik-Sang Moon1,* 1Department of Periodontology, Gangnam Severance Dental Hospital, Yonsei University College of Dentistry, Seoul, Korea 2Department of Oral and Maxillofacial Surgery, Gangnam Severance Dental Hospital, Yonsei University College of Dentistry, Seoul, Korea Purpose:  To assess bony trabecular changes potentially caused by loading stress around dental implants using fractal dimen - sion analysis.",Non-OADS,/arxiv_data1/oa_pdf/d1/59/jpis-43-209.PMC3825987.pdf
"Keywords:  Bone remodeling, Dental implants, Fractals.J Periodontal Implant Sci 2013;43:209-214 • http://dx.doi.org/10.5051/jpis.2013.43.5.209Research Article INTRODUCTION Dental implants are osseointegrated into surrounding bone  without the periodontal ligament.",Non-OADS,/arxiv_data1/oa_pdf/d1/59/jpis-43-209.PMC3825987.pdf
"www.jpis.orgJournal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286Copyright © 2013 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Determination of levels of nitric oxide in smoker  and nonsmoker patients with chronic  periodontitis Deepti Wadhwa1,*, Afshan Bey1, Mukesh Hasija2, Shagufta Moin3, Arun Kumar4, Shazia Aman3, Vivek Kumar Sharma1 1Department of Periodontics, Dr. Z.A Dental College, Aligarh Muslim University, Aligarh, India  2Department of Conservative Dentistry & Endodontics, Faculty of Dental Sciences, King George’s Medical University, Lucknow, India  3Department of Biochemistry, JN Medical College, Aligarh Muslim University, Aligarh, India 4Department of Pedodontics, Government Dental College, Rohtak, India Purpose:  Cigarette smoking is a major risk factor in periodontal diseases.",Non-OADS,/arxiv_data1/oa_pdf/3e/fe/jpis-43-215.PMC3825988.pdf
"Keywords:  Chronic periodontitis, Colorimetry, Nitric oxide, Smoking.J Periodontal Implant Sci 2013;43:215-220 • http://dx.doi.org/10.5051/jpis.2013.43.5.215Research Article INTRODUCTION Nitric oxide (NO) is a gaseous, colorless, highly reactive,  short-lived free radical that plays a pivotal role in the regula - tion of various physiological and pathological mechanisms  in the body [1].",Non-OADS,/arxiv_data1/oa_pdf/3e/fe/jpis-43-215.PMC3825988.pdf
"www.jpis.orgJournal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286Copyright © 2013 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).The combined effect of dismantling for steam  sterilization and aging on the accuracy of   spring-style mechanical torque devices Minoo Mahshid, Aboulfazl Saboury*, Seyed Jalil Sadr, Ali Fayyaz, Mahdi Kadkhodazadeh Department of Prosthodontics, Dental School, Shahid Beheshti University of Medical Sciences, Tehran, Iran Purpose:  This study aimed to assess the combined effect of dismantling before sterilization and aging on the accuracy ( ± 10%  of the target torque) of spring-style mechanical torque devices (S-S MTDs).",Non-OADS,/arxiv_data1/oa_pdf/bf/65/jpis-43-221.PMC3825989.pdf
"Keywords:  Dental implants, Safety, Sterilization, Torque.J Periodontal Implant Sci 2013;43:221-226 • http://dx.doi.org/10.5051/jpis.2013.43.5.221Research Article INTRODUCTION Torque generally refers to twisting or turning momentum  and assesses the degree of screw and bolt tightening [1].",Non-OADS,/arxiv_data1/oa_pdf/bf/65/jpis-43-221.PMC3825989.pdf
"www.jpis.orgJournal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286Copyright © 2013 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Salivary soluble receptor activator of nuclear  factor kappa B ligand/osteoprotegerin ratio in  periodontal disease and health Zahra Alizadeh Tabari1, Abbas Azadmehr2, Mohammad Amir Alizadeh Tabrizi3, Jalaloddin Hamissi1,   Fatemeh Baharak Ghaedi1,* 1Department of Periodontics, Dental School, Qazvin University of Medical Sciences, Qazvin, Iran 2Department of Immunology, Qazvin University of Medical Sciences, Qazvin, Iran 3Private Practice, Qazvin, Iran Purpose:  The receptor activator of nuclear factor kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system plays  a significant role in osteoclastogenesis, activation of osteoclasts, and regulation of bone resorption.",Non-OADS,/arxiv_data1/oa_pdf/9e/5c/jpis-43-227.PMC3825990.pdf
"Keywords:  Biological markers, Osteoprotegerin, Periodontitis, RANK ligand, Saliva.J Periodontal Implant Sci 2013;43:227-232 • http://dx.doi.org/10.5051/jpis.2013.43.5.227Research Article INTRODUCTION Periodontitis is an inflammatory disease that results in the  loss of supporting bone in addition to mucosal inflammation  [1].",Non-OADS,/arxiv_data1/oa_pdf/9e/5c/jpis-43-227.PMC3825990.pdf
"www.jpis.orgJournal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286Copyright © 2013 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Comparative volumetric and clinical evaluation of  peri-implant sulcular fluid and gingival crevicular  fluid Smiti Bhardwaj*, Munivenkatappa Lakshmaiah Venkatesh Prabhuji  Department of Periodontology, Krishnadevaraya College of Dental Sciences and Hospital, Bangalore, India Purpose:  Peri-implant sulcular fluid (PISF) has a production mechanism similar to gingival crevicular fluid (GCF).",Non-OADS,/arxiv_data1/oa_pdf/8a/e9/jpis-43-233.PMC3825991.pdf
"J Periodontal Implant Sci 2013;43:233-242 • http://dx.doi.org/10.5051/jpis.2013.43.5.233Research Article INTRODUCTION Inflammation is the cellular and vascular response of tissues  to an injurious stimulus [1], which can be due to a physical,  chemical, or microbial insult.",Non-OADS,/arxiv_data1/oa_pdf/8a/e9/jpis-43-233.PMC3825991.pdf
"www.jpis.orgJournal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286Copyright © 2013 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Segmental osteotomy for mobilization of dental  implant  Sergio Olate1,2,*, Benjamin Weber1, Alvaro Marín1 1Department of Oral Implantology, Dental School, Universidad de La Frontera, Temuco, Chile 2Department of Oral and Maxillofacial Surgery, Dental School, Universidad de La Frontera, Temuco, Chile Purpose:  The aim of this work is to evaluate a surgical technique for mobilization of mal posed dental implant in anterior  area.",Non-OADS,/arxiv_data1/oa_pdf/30/84/jpis-43-243.PMC3825992.pdf
"Keywords:  Dental implants, Osteotomy.J Periodontal Implant Sci 2013;43:243-247 • http://dx.doi.org/10.5051/jpis.2013.43.5.243Case Report INTRODUCTION Implantology has greatly evolved in recent years.",Non-OADS,/arxiv_data1/oa_pdf/30/84/jpis-43-243.PMC3825992.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.002,OADS,/arxiv_data1/oa_pdf/68/ed/main.PMC3825993.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.029,OADS,/arxiv_data1/oa_pdf/ab/81/main.PMC3825994.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.014,OADS,/arxiv_data1/oa_pdf/22/c2/main.PMC3825995.pdf
Available from: http://cdsco.nic.in/GSR%20 379E.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a8/b6/JPP-4-227.PMC3825996.pdf
Available from: http://www.cdsco.nic.in/ GRIjuly13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a8/b6/JPP-4-227.PMC3825996.pdf
Available from: http://www.fda.gov/Safety/ MedW atch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm173081.htm.,Non-OADS,/arxiv_data1/oa_pdf/a8/b6/JPP-4-227.PMC3825996.pdf
Available from: http://www.fda.gov/ Drugs/DrugSafety/ucm259150.htm.,Non-OADS,/arxiv_data1/oa_pdf/a8/b6/JPP-4-227.PMC3825996.pdf
Available from: http://www.cdsco.nic.in/Minutes_63rd_dtab%20.pdf.,OADS,/arxiv_data1/oa_pdf/a8/b6/JPP-4-227.PMC3825996.pdf
Available from: http://articles.timesofindia.indiatimes.com/2012‑05‑10/ india/31654810_1_drug‑companies‑cdsco‑drug‑expert.,Non-OADS,/arxiv_data1/oa_pdf/a8/b6/JPP-4-227.PMC3825996.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/a8/b6/JPP-4-227.PMC3825996.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/a8/b6/JPP-4-227.PMC3825996.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/57/3c/JPP-4-230.PMC3825997.pdf
Available from: http://www.mims.com/ India/drug/search/phenytoin?page=3.,Non-OADS,/arxiv_data1/oa_pdf/1a/cd/JPP-4-243.PMC3825999.pdf
Available from:  http://www.medguideindia.com/find_brand_by_samepid.,Non-OADS,/arxiv_data1/oa_pdf/1a/cd/JPP-4-243.PMC3825999.pdf
A  library of 125  natural compounds was taken from Indian Plant Anticancer  Compounds Database  (InPACdb)  (http://www.inpacdb.org/)[7]  to test them for their efficiency as therapeutic agent for CDK4.,OADS,/arxiv_data1/oa_pdf/c6/7c/JPP-4-256.PMC3826001.pdf
A vailable from: http://www.uniprot.org/uniprot/P11802.,Non-OADS,/arxiv_data1/oa_pdf/c6/7c/JPP-4-256.PMC3826001.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/9f/63/JPP-4-275.PMC3826003.pdf
Available from: http://www.mciindia.org/know/ rules/rules_mbbs.htm.,Non-OADS,/arxiv_data1/oa_pdf/60/32/JPP-4-282.PMC3826005.pdf
Available from: http://www.mciindia.org/know/ rules/rules_mbbs.htm.,Non-OADS,/arxiv_data1/oa_pdf/a4/8a/JPP-4-283.PMC3826006.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/0d/e6/JPP-4-288.PMC3826008.pdf
Available from: http://www.uptodate.com/contents/stevens ‑ johnson ‑syndrome ‑and‑toxic ‑epidermal ‑necrolysis ‑management ‑prognosis ‑ and‑ long ‑term‑sequelae?source=search_result and search=rationale+ for+the+usage+of+predni solone+to+hydrocortisone+in+sjs and  selectedTitle=6 ‑150).,Non-OADS,/arxiv_data1/oa_pdf/d1/55/JPP-4-291.PMC3826009.pdf
"co.uk/html/6__power_and_sample_size.html, http://www.acuc.berkeley.edu/, http://www.bu.edu/orccommittees/iacuc/ policies‑  and‑guidelines/sample‑size‑calculations/, http://www.ucd.ie/researchethics/etc.).",Non-OADS,/arxiv_data1/oa_pdf/37/d6/JPP-4-303.PMC3826013.pdf
Charan and Kantharia: Sample size in animal studies306 Journal of Pharmacology and Pharmacotherapeutics |  October-December 2013 | Vol 4 | Issue 4Open Epi http://www.openepi.com/OE2.3/Menu/OpenEpiMenu.htm Biomath http://www.biomath.info/power/index.htmEpiTools epidemiological calculators.,Non-OADS,/arxiv_data1/oa_pdf/37/d6/JPP-4-303.PMC3826013.pdf
"http://epitools.ausvet.com.au/content.php?page  = SampleSize Java applets for power and sample sizehttp://homepage.stat.uiowa.edu/~rlenth/Power/#Download_ to_run_locally StatPageshttp://statpages.orgDepartment of Biostatistics, Vanderbilt University http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/ PowerSampleSizeG Power http://www.psycho.uni‑duesseldorf.de/aap/projects/gpower Power analysis for ANOV A http://www.math.yorku.ca/SCS/Online/power Statistics calculatorshttp://danielsoper.com/statcalc3/default.aspx REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/37/d6/JPP-4-303.PMC3826013.pdf
Available from: http://www.pvtoolkit.org/.,Non-OADS,/arxiv_data1/oa_pdf/86/5d/JPP-4-307.PMC3826014.pdf
Available from: http://www.pvtoolkit.org/.,Non-OADS,/arxiv_data1/oa_pdf/70/88/JPP-4-308.PMC3826015.pdf
Available from: http://www.who.int/whr/2006/en/.,OADS,/arxiv_data1/oa_pdf/d2/36/JEHP-2-49.PMC3826020.pdf
Available from: http://www.lawoffice.mohme.gov.ir.,Non-OADS,/arxiv_data1/oa_pdf/aa/4c/JEHP-2-44.PMC3826023.pdf
Available from: https://www.intranet.panda.org/documents/folder.cfm?uFolderID=60976.,Non-OADS,/arxiv_data1/oa_pdf/aa/4c/JEHP-2-44.PMC3826023.pdf
Available from: http://www.euro.who.int/document/E88584.pdf.,Non-OADS,/arxiv_data1/oa_pdf/37/30/JEHP-2-41.PMC3826024.pdf
Available from: http://www.health.vic.gov.au/healthpromotion/.../swan_hill_health.ppt.,Non-OADS,/arxiv_data1/oa_pdf/37/30/JEHP-2-41.PMC3826024.pdf
Available from: http://www.hdrstats.undp.org/en/countries/profiles/IND.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from: http://www.data.worldbank.org/indicator/SH.XPD.TOTL.ZS.,OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from: http://www.data.worldbank.org/indicator/SH.XPD.PUBL/countries.,OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from:  http://www.unicef.org/india/nutrition.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from: http://www.wcd.nic.in/icds.htm.,Non-OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from: http://www.en.wikipedia.org/wiki/Literacy_in_India.,Non-OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from: http://www.en.wikipedia.org/wiki/Poverty_in_India#Outlook_for_poverty_alleviation.,Non-OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from: http://www.nrega.nic.in/netnrega/home.aspx.,Non-OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from: Wikipedia http://www.en.wikipedia.org/wiki/Swarnajayanti_Gram_Swarozgar_Yojana.,Non-OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from: http://www.en.wikipedia.org/wiki/Sampoorna_Grameen_Rozgar_Yojana.,Non-OADS,/arxiv_data1/oa_pdf/2a/3e/JEHP-2-45.PMC3826027.pdf
Available from: http://www.conference.phuket.psu.ac.th/PSU_OPEN_WEEK_2008/data/tourism/4_13.,Non-OADS,/arxiv_data1/oa_pdf/f6/3d/JEHP-2-51.PMC3826028.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Gut microbiota is linked to the body mass index M Million et al 1466 International Journal of Obesity (2013) 1460 – 1466 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/56/cc/ijo201320a.PMC3826031.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)The MLL recombinome C Meyer et al 2176 Leukemia (2013) 2165 – 2176 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/46/2d/leu2013135a.PMC3826032.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Heritability of pediatric obesity using GCTA CH Llewellyn et al 1509 &2013 Macmillan Publishers Limited International Journal of Obesity (2013), 1506 – 1509",Non-OADS,/arxiv_data1/oa_pdf/65/20/ijo201330a.PMC3826033.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Obesity, PSA and prostate cancer aggressiveness AS Parker et al 356 Prostate Cancer and Prostatic Disease (2013), 352 – 356 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/4a/a8/pcan201327a.PMC3826034.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Improved CDC by fH-derived SCR18–20 SH o¨rlet al 2208 Leukemia (2013) 2200 – 2208 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/be/64/leu2013169a.PMC3826035.pdf
Available from:  http://dciindia.org/annoncment_pdf_files/pdf_files/ CODEOFETHICSREGULATIONS1976.pdf  [Last accessed on  2012  Aug 04].,OADS,/arxiv_data1/oa_pdf/7b/13/JFDS-5-138.PMC3826043.pdf
Available from: http://www.wma.net/s/policy/b3.htm [Last accessed on 2005 Jan].,Non-OADS,/arxiv_data1/oa_pdf/a5/41/JFDS-5-77.PMC3826047.pdf
Available from: http://www.actaodontologica.com/44_2_2006/estado_oclusal_rendimiento_ masticatorio.asp  [Last access on 2006  Jan].,OADS,/arxiv_data1/oa_pdf/a5/41/JFDS-5-77.PMC3826047.pdf
http://www.aoa.org/documen ts/nutrition/Diet_Nutrition_ Eye_Health_booklet.pdf .,Non-OADS,/arxiv_data1/oa_pdf/82/75/11130_2013_Article_381.PMC3826056.pdf
Supplementary Information for this article can be found on Emerging Microbes and Infections ’s website (http://www.nature.com/emi).,Non-OADS,/arxiv_data1/oa_pdf/77/50/emi201365a.PMC3826066.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0C.",Non-OADS,/arxiv_data1/oa_pdf/77/50/emi201365a.PMC3826066.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Trends in MRSA incidence in children XY Song et al 5 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/44/86/emi201369a.PMC3826068.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0Opportunistic human infections by Kocuria species S Purty et al 8 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/c5/8b/emi201371a.PMC3826069.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ed/85/srep03204.PMC3826093.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3204 | DOI: 10.1038/srep03204 7",Non-OADS,/arxiv_data1/oa_pdf/ed/85/srep03204.PMC3826093.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/84/51/srep03201.PMC3826094.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3201 | DOI: 10.1038/srep03201 7",Non-OADS,/arxiv_data1/oa_pdf/84/51/srep03201.PMC3826094.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Li, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/eb/00/srep03208.PMC3826095.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3208 | DOI: 10.1038/srep03208 7",Non-OADS,/arxiv_data1/oa_pdf/eb/00/srep03208.PMC3826095.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/42/7c/srep03209.PMC3826096.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3209 | DOI: 10.1038/srep03209 3",Non-OADS,/arxiv_data1/oa_pdf/42/7c/srep03209.PMC3826096.pdf
"All databases were obtained from the CAMERA website (http://camera.calit2.net/index.shtm).Based on the cynaopodovirus genomic conserved gene cluster ‘‘portal- psbA -cap- sid’’, we searched (BLAST) the GOS scaffold database using portal, capsid assembly, psbA and major capsid protein (MCP) genes using a reciprocal best-hit BLAST strategy but no e-value cutoff limitation (Fig.",OADS,/arxiv_data1/oa_pdf/d8/f7/srep03207.PMC3826097.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d8/f7/srep03207.PMC3826097.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3207 | DOI: 10.1038/srep03207 4",Non-OADS,/arxiv_data1/oa_pdf/d8/f7/srep03207.PMC3826097.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/srep03200.PMC3826099.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3200 | DOI: 10.1038/srep03200 8",Non-OADS,/arxiv_data1/oa_pdf/a7/1a/srep03200.PMC3826099.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f2/05/srep03210.PMC3826100.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3210 | DOI: 10.1038/srep03210 10",Non-OADS,/arxiv_data1/oa_pdf/f2/05/srep03210.PMC3826100.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0a/0c/srep03076.PMC3826101.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3076 | DOI: 10.1038/srep03076 10",Non-OADS,/arxiv_data1/oa_pdf/0a/0c/srep03076.PMC3826101.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3144 | DOI: 10.1038/srep03144 6",Non-OADS,/arxiv_data1/oa_pdf/3f/a8/srep03144.PMC3826102.pdf
Australian Water Availability Project Website: http://www.eoc.csiro.au/awap/ (September 2013).,Non-OADS,/arxiv_data1/oa_pdf/f2/f6/srep03188.PMC3826103.pdf
Australian Bureau of Meteorology web homepage: http://www.bom.gov.au/ (September 2013).,Non-OADS,/arxiv_data1/oa_pdf/f2/f6/srep03188.PMC3826103.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f2/f6/srep03188.PMC3826103.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Figure 4 |The NASA fire incidence data, the estimations from the Elman neural network and false negatives from the estimation for the February 2009.",Non-OADS,/arxiv_data1/oa_pdf/f2/f6/srep03188.PMC3826103.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3203 | DOI: 10.1038/srep03203 11",Non-OADS,/arxiv_data1/oa_pdf/db/8a/srep03203.PMC3826104.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/07/d9/srep03205.PMC3826116.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3205 | DOI: 10.1038/srep03205 11",Non-OADS,/arxiv_data1/oa_pdf/07/d9/srep03205.PMC3826116.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/66/rmhp-6-043.PMC3826289.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpRisk Management and Healthcare Policy 2013:6 43–49Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  43ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RMHP .S5247 0clinical indicators for severe prognosis   of scrub typhus Pamornsri sriwongpan1,2 Pornsuda Krittigamas3 Pacharee Kantipong4 naowarat Kunyanone5 Jayanton Patumanond1 sirianong namwongprom1,6 1clinical epidemiology Program,  Faculty of Medicine, chiang Mai  University, chiang Mai, Thailand;  2Department of social Medicine,  chiang Rai Prachanukroh Hospital,  chiang Rai, Thailand; 3Department  of general Pediatrics, nakornping  Hospital, chiang Mai, Thailand;  4Department of internal Medicine,  5Department of Medical Technology,  chiang Rai Prachanukroh Hospital,  chiang Rai, Thailand; 6Department  of Radiology, Faculty of Medicine,  chiang Mai University, chiang Mai,  Thailand correspondence: sirianong namwongprom   Department of Radiology, Faculty   of Medicine, chiang Mai University,  chiang Mai 50200, Thailand   Tel +66 53 945 458   Fax +66 53 945 476   email snamwong@med.cmu.ac.t hBackground:  The study explored clinical risk characteristics that may be used to forecast scrub  typhus severity under routine clinical practices.",Non-OADS,/arxiv_data1/oa_pdf/96/66/rmhp-6-043.PMC3826289.pdf
"available from: http://www.who.int/csr/resources/publications/surveillance/ whocdscsrisr992.pd f. accessed on July 21, 2013.9 Table 2  Definitions of severe scrub typhus System   involvementCharacteristics cardiovascular   systemPresence of any of the following:   systolic blood pressure ,90 mmHg   abnormal cardiac arrhythmia with no previous  history of the following:    1. atrial fibrillation;    2. supraventricular tachycardia;    3. frequent premature ventricular tachycardia.",Non-OADS,/arxiv_data1/oa_pdf/96/66/rmhp-6-043.PMC3826289.pdf
"Available from: http://www.who.int/csr/ resources/publications/surveillance/whocdscsrisr992.pd f. Accessed  on July 21, 2013.",OADS,/arxiv_data1/oa_pdf/96/66/rmhp-6-043.PMC3826289.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/96/66/rmhp-6-043.PMC3826289.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/66/rmhp-6-043.PMC3826289.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/01/ibpc-6-139.PMC3826290.pdf
Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpIntegrated Blood Pressure Control 2013:6 139–151Integrated Blood Pressure Control Dove press submit your manuscript | www.dovepress.co m Dove press  139RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IBPC.S3398 4Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/c6/01/ibpc-6-139.PMC3826290.pdf
"Or use: http://dvpr.es/17HMSm PManagement of patients with resistant  hypertension: current treatment options Nilay Kumar1 David A Calhoun2 Tanja Dudenbostel2 1Department of Medicine, 2Division   of Cardiovascular Disease,   Hypertension and vascular Biology  Program, University of Alabama at  Birmingham, Birmingham, AL, USA Correspondence: Tanja Dudenbostel   UAB Hypertension and vascular Biology   Program, Division of Cardiology,   Department of Medicine,   933 19th Street S, CHSB 115,   Birmingham, AL 35294, USA   Tel +1 205 934 9281   email tduden@uab.ed uAbstract:  Resistant hypertension (RHTN) is an increasingly common clinical problem that  is often heterogeneous in etiology, risk factors, and comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/c6/01/ibpc-6-139.PMC3826290.pdf
"Integrated Blood Pressure Control Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/integrated-blood-pressure-control-journa lIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing  hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/c6/01/ibpc-6-139.PMC3826290.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/01/ibpc-6-139.PMC3826290.pdf
"The Age-Related Eye Disease Study (AREDS)  did not significantly contribute to the association signal on Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > Received 5 March 2013 | Accepted 30 October 2013 | Published 2 November 2013© 2013 Molecular Vision 2173Regional replication of association with refractive error on 15q14  and 15q25 in the Age-Related Eye Disease Study cohort Claire L. Simpson,1 Robert Wojciechowski,1,2 Stephanie S. Yee,3 Poorva Soni,3 Joan E. Bailey-Wilson,1 Dwight  Stambolian3 1Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore,  MD; 2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; 3Department of  Ophthalmology, University of Pennsylvania, Philadelphia, P A Purpose:  Refractive error is a complex trait with multiple genetic and environmental risk factors, and is the most com - mon cause of preventable blindness worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2174both chromosome 15 loci.,Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
"Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2175alpha, cardiac muscle 1 ( ACTC1 ), and Ras protein-specific  guanine nucleotide-releasing factor 1 ( RASGRF1 ) genes  and were designed to provide better coverage of these  regions than was available from the SNPs on the Illumina  HumanOmni2.5–4v1_B chip array alone.",OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
"Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2176RESULTS Power calculations:  For each locus, we had good power for  detecting association for the quantitative trait expressed as  the MSE with a variant in this sample at the p=0.002 level  (which corrects for the number of independent loci as detailed  in the Methods and trait results) across a range of minor allele  frequencies.",Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
"Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2177Table  1. a ssocia Tion resul Ts using  The crea M replica Tion snp s wiTh refrac Tive error , Myopia  and hyperopia .",Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
"Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2178Refractive Error Myopia Hyperopia SNP Position (bp) Beta P OR P OR P rs939658 79,451,868 0.0523 0.4502 0.9283 0.3929 1.0360 0.6438 rs8033963 79,455,349 0.0556 0.4225 0.9297 0.4026 1.0480 0.5444 rs12439908 79,456,380 0.0556 0.4225 0.9297 0.4026 1.0480 0.5444 rs11629665 79,457,132 0.0556 0.4225 0.9297 0.4026 1.0480 0.5444 rs8031019 79,458,511 0.0556 0.4225 0.9297 0.4026 1.0480 0.5444 rs8031504 79,458,588 0.0556 0.4225 0.9297 0.4026 1.0480 0.5444 rs8027411 79,461,029 0.0584 0.4028 0.9240 0.3672 1.0500 0.5266 rs11072826 79,461,516 0.0647 0.3517 0.9195 0.3364 1.0590 0.4550 rs8038464 79,463,035 −0.0872 0.2182 1.0870 0.3444 0.9534 0.5405 rs1474256 79,463,847 −0.0882 0.2128 1.0850 0.3580 0.9511 0.5202 rs17175798 79,463,959 0.0479 0.4896 0.9392 0.4712 1.0430 0.5839 rs1434459 79,465,209 −0.0820 0.2459 1.0770 0.3988 0.9566 0.5682 rs8024572 79,465,599 −0.0876 0.2149 1.0730 0.4282 0.9550 0.5531 rs11634726 79,465,893 −0.0897 0.2040 1.0740 0.4202 0.9528 0.5340 rs11072829 79,470,998 −0.0936 0.1866 1.0790 0.3936 0.9512 0.5206",Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
"Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2179Table  2. a ssocia Tion resul Ts of addi Tional  geno Typed  snp s wiTh refrac Tive error , Myopia  and hyperopia .",Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2180the significance threshold of 0.002 for replication even in this  small sample (Appendix 1).15q25 results:  All the CREAM replication SNPs were not  even nominally significant.,Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
"Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2181significance at p=0.03 (Table 2), but this did not pass the  replication significance threshold of 0.0019.",OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2182Conclusions:  Early GWAS designs were frequently under - powered and did not adequately control for type I error.,Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2183between-population differences in sample size and different  tagging marker allele frequency allow us to control for chance  associations.,Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
"Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2184where alleles of modest effect are sought, this approach  misses many variants of interest.",Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  218512.,Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
"QUANTO 1.1: A computer  program for power and sample size calculations for genetic- epidemiology studies, http://hydra.usc.edu/gxe , 2006.",OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
"Molecular Vision  2013; 19:2173-2186 <http://www.molvis.org/molvis/v 19/2173 > © 2013 Molecular Vision  2186H, Wilson JF, Fleck BW, Nakata I, Yoshimura N, Yamada  R, Matsuda F, Ohno-Matsui K, Nag A, McMahon G, Pour - cain BS, Lu Y, Rahi JS, Cumberland PM, Bhattacharya S,  Simpson CL, Atwood LD, Li X, Raffel LJ, Murgia F, Portas  L, Despriet DD, van Koolwijk LM, Wolfram C, Lackner  KJ, Tonjes A, Magi R, Lehtimaki T, Kahonen M, Esko T,  Metspalu A, Rantanen T, Parssinen O, Klein BE, Meitinger  T, Spector TD, Oostra BA, Smith AV, de Jong PT, Hofman  A, Amin N, Karssen LC, Rivadeneira F, Vingerling JR,  Eiriksdottir G, Gudnason V, Doring A, Bettecken T, Uitter - linden AG, Williams C, Zeller T, Castagne R, Oexle K, van  Duijn CM, Iyengar SK, Mitchell P, Wang JJ, Hohn R, Pfeiffer  N, Bailey-Wilson JE, Stambolian D, Wong TY, Hammond  CJ, Klaver CC.",Non-OADS,/arxiv_data1/oa_pdf/c9/c0/mv-v19-2173.PMC3826323.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/b1/copd-8-509.PMC3826513.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 509–521International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  509RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5220 4Pathophysiology and clinical implications   of pulmonary arterial enlargement in COPD J Michael wells Mark T Dransfield Division of Pulmonary, Allergy,    and Critical Care, Department   of Medicine, University of Alabama  Birmingham and the Birmingham  veterans Affairs Medical Center,   Birmingham, AL, USA Correspondence: J Michael wells   Department of Medicine, University of  Alabama at Birmingham, 1900 University  Blvd, THT 422, Birmingham, AL 35294,  USA  Tel +1 205 934 6047   Fax +1 205 975 5666   email jmwells@uab.ed uAbstract:  Chronic obstructive pulmonary disease (COPD) is a complex condition defined  by progressive airflow limitation in response to noxious stimuli, inflammation, and vascular  changes.",Non-OADS,/arxiv_data1/oa_pdf/14/b1/copd-8-509.PMC3826513.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/14/b1/copd-8-509.PMC3826513.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/b1/copd-8-509.PMC3826513.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2013.3.4.241 Asia Pac Allergy 2013;3:241-248Immediate and nonimmediate reactions induced  by contrast media: incidence, severity and risk  factors Martín Bedolla-Barajas1,*, Dante D Hernández-Colín1, Jaime Morales-Romero2, and Carlos Serrano-Salinas3 1Allergy and Clinical Immunology Service, Division of Internal Medicine, Civil Hospital of Guadalajara “Dr.",Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
"http://apallergy.org Received : May 3, 2013 Accepted : October 5, 2013",Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
"Asia Pacific allergy242 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.241INTRODUCTION The undesired effect that occurs following the administration of a  medicine in therapeutic, diagnostic or prophylactic doses is defined  as an adverse reaction to medicine (ARM) [1].",Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
" Adverse reactions induced by contrast media 243       apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.241(asthma, allergic rhinitis, atopic dermatitis, hypersensitivity to  medicines) and likewise, the nonatopic comorbidities (diabetes  mellitus, hypertension, cardiovascular, and hematological diseases).",Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
"Asia Pacific allergy244 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.241shown in Table 5, the logistic regression analysis showed that the  AR-CM was 3.14 times more frequent when the baseline systolic  blood pressure was ≥135 mm Hg and almost 15 times more  frequent when the baseline SpO2 was ≤90%.DISCUSSION   In our country,  this is the first study to provide a more complete  description of the behavior of AR following the administration of a  CM in a sample of patients hospitalized in a teaching hospital.",Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
 Adverse reactions induced by contrast media 245 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.241usually considered under this heading: eosinophilia and CMIN.,Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
Asia Pacific allergy246 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.241intravenous urography showed transitory eosinophilia.,Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
" Adverse reactions induced by contrast media 247 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.241a control group, which would give us the opportunity to make a  deeper search for risk factors implicated in the AR-CM.",Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
Available from:  http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/ Resources/Contrast%20Manual/2013_Contrast_Media.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
Available  from: http://www.esur.org/esur-guidelines/contrast-media-70/.,Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
Asia Pacific allergy248 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.24117.,Non-OADS,/arxiv_data1/oa_pdf/a5/f1/apa-3-241.PMC3826601.pdf
"Case ReportAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.4.281 Asia Pac Allergy 2013;3:281-284A case of levocetirizine-induced fixed drug eruption  and cross-reaction with piperazine derivatives Mi-Yeong Kim1, Eun-Jung Jo2, Yoon-Seok Chang3,4,5, Sang-Heon Cho3,4, Kyung-Up Min3,4, and Sae-Hoon Kim3,4,5,*  1Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan 614-735, Korea 2Department of Internal Medicine, Pusan National University College of Medicine, Busan 602-739, Korea 3Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea 4Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 110-799, Korea 5Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea Fixed drug eruption is an uncommon adverse drug reaction caused by delayed cell-mediated hypersensitivity.",Non-OADS,/arxiv_data1/oa_pdf/e8/ce/apa-3-281.PMC3826602.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/e8/ce/apa-3-281.PMC3826602.pdf
"Asia Pacific allergy282 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.281INTRODUCTION H1-antihistamines act as antagonists to H1-receptor, and have  antiallergic and antiinflammatory activities [1].",Non-OADS,/arxiv_data1/oa_pdf/e8/ce/apa-3-281.PMC3826602.pdf
"Levocetirizine-induced fixed drug eruption283 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.281The patients took 120 mg fexofenadine a day for 3 days as the  open oral challenge test, and there was no adverse reaction.",Non-OADS,/arxiv_data1/oa_pdf/e8/ce/apa-3-281.PMC3826602.pdf
Images were extracted from website (http://en.wikipedia.,OADS,/arxiv_data1/oa_pdf/e8/ce/apa-3-281.PMC3826602.pdf
"Asia Pacific allergy284 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.281a levocetirizine induced fixed drug eruption, and the piperazine  derivatives such as cetirizine and hydroxyzine showed cross- reactions on the patch test.",Non-OADS,/arxiv_data1/oa_pdf/e8/ce/apa-3-281.PMC3826602.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2013.3.4.249 Asia Pac Allergy 2013;3:249-256Adverse events of intravenous immunoglobulin  infusions: a ten-year retrospective study  Frances Rose R. Palabrica*, Shirley L. Kwong , and Florecita R. Padua Allergy, Asthma and Immunology Unit, Dr. Fe del Mundo Medical Center, Quezon City, Metro Manila 1100, Philippines Background : Intravenous immunoglobulin (IVIG) is a biological product with adverse effects that appears to vary considerably among  different IVIG preparations.",Non-OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
Asia Pacific allergy250 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.249INTRODUCTION Immunoglobulin preparations were first used during the  1950s as a replacement therapy for primary immunodeficiency  disorders [1].,Non-OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
Adverse events of immunoglobulin infusions251       apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.249preparations among various types of patients.,Non-OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
Asia Pacific allergy252 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.249Patient characteristics of those with adverse reactions Table 1 also shows the demographics of patients who  experienced adverse events while receiving IVIG transfusion.,OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
"Adverse events of immunoglobulin infusions253 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.249hand, had 3 reactions during transfusion: from onset of infusion,  he developed a skin rash at 30 min, then complained of chest pain  and dyspnea 4½ h later, after which he again developed a rash at  18 h. The most common indication for IVIG infusion as previously  stated was Kawasaki disease.",Non-OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
"Asia Pacific allergy254 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.249common reactions such as fever, rash and chills to rare ones  such as hypothermia and chest pain with dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
Adverse events of immunoglobulin infusions255 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.249aggregate formation.,Non-OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
Asia Pacific allergy256 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.249prophylactic intravenous immunoglobulin; a 13-year experience with  3004 infusions in Iranian patients with primary immunodeficiency  diseases.,Non-OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
Available from: http://emedicine.medscape.com/ article/210367-overview.,Non-OADS,/arxiv_data1/oa_pdf/cf/21/apa-3-249.PMC3826603.pdf
"EditorialAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.4.207 Asia Pac Allergy 2013;3:207-208Allergic diseases in the Asia Pacific: path into the  future Gary Wing-Kin Wong Department of Paediatrics and School of Public Health, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong Infectious disease used to be the most common cause of  morbidity and mortality in the past.",Non-OADS,/arxiv_data1/oa_pdf/bd/4e/apa-3-207.PMC3826604.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/bd/4e/apa-3-207.PMC3826604.pdf
"apallergy.org  Wong GWAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.4.207208    For example, peanut allergy is very uncommon in many Asian  countries despite being widely consumed by many population  groups in the region [10].",Non-OADS,/arxiv_data1/oa_pdf/bd/4e/apa-3-207.PMC3826604.pdf
"Educational & Teaching Material  Review Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2013.3.4.266 Asia Pac Allergy 2013;3:266-280Recent applications of basophil activation tests in  the diagnosis of drug hypersensitivity Woo-Jung Song1,2 and Yoon-Seok Chang1,2,3,* 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 100-799, Korea 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center,  Seoul 100-799, Korea 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea Immediate-type drug hypersensitivity is an increasingly significant clinical issue; however, the diagnosis is frequently hindered due to  lack of safe and precise diagnostic tests.",Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Basophil activation test for drug hypersensitivity267 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266 suggest that the applications of BAT can be extrapolated to  additional drugs.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
PubMed (http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
"A manual search, using the  same keywords, in Google Scholar (http://scholar.google.com/)  was performed to identify additional papers.",Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Asia Pacific allergy268 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266encompassing IgE-mediated allergic reactions and non- immunological intolerances.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
"Basophil activation test for drug hypersensitivity269 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266naproxen have stronger in vitro  pharmacological activity than  aspirin, their inclusion has been suggested for enhancing the  sensitivity of BAT [41].",Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Asia Pacific allergy270 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Basophil activation test for drug hypersensitivity271       apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266[46-52]  have investigated the diagnostic utility of BAT (Table  4).,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
"Asia Pacific allergy272 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266the sensitivity to be 46.2%-61.5% and specificity 88.4%-100%,  depending on the cutoff values.",OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Basophil activation test for drug hypersensitivity273       apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266markers.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Asia Pacific allergy274 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266Table 7.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
"Basophil activation test for drug hypersensitivity275       apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266In the case of drugs that are not commercially available, dose  response curve analyses and cytotoxicity assays are mandatory  steps for determination of optimal concentrations [100].",Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Asia Pacific allergy276 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.2661:10 and 1:100.,OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Basophil activation test for drug hypersensitivity277       apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266considerations for skin test procedures in the diagnosis of drug  hypersensitivity.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
"Asia Pacific allergy278 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266Fusade P , Leynadier F, Frances C, Girot R. Comparison of CD63  upregulation induced by NSAIDs on basophils and monocytes  in patients with NSAID hypersensitivity.",OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Available from: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Basophil activation test for drug hypersensitivity279       apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266 54.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Available from: http://dx.doi.org/  10.3109/10428194.2013.794944.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
Asia Pacific allergy280 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.266 80.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
BMJ Case  Reports 2012. http://dx.doi.org/10.1136/bcr.02.2012.579.,Non-OADS,/arxiv_data1/oa_pdf/68/75/apa-3-266.PMC3826605.pdf
"Current ReviewAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2013.3.4.215 Asia Pac Allergy 2013;3:215-223Stevens-Johnson syndrome / toxic epidermal  necrolysis: an Asia-Pacific perspective Bernard Yu-Hor Thong Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore 308433, Singapore  Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCAR) to drugs  which are associated with significant morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
"Thong BYAsia Pacific allergy216 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.215These include fever, leukocytosis, eosinophilia, hepatitis and acute  interstitial nephritis where viral reactivation of herpes viruses have  been demonstrated to be one of the known triggers [6].",Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
"Stevens-Johnson syndrome and toxic epidermal necrolysis217 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.215cohorts of SJS/TEN patients from other centres have also included  patients managed in a tertiary burns unit with an attending  dermatologist, internist or allergist.",Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
"Thong BYAsia Pacific allergy218 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.215problems can at least be partially alleviated with autologous  serum drops, mucous membrane grafting to replace scarred tarsal  conjunctiva, specialized contact lenses, conjunctival replacement  surgery, limbal stem cell transplantation and kerotoprostheses [66].",Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
"Stevens-Johnson syndrome and toxic epidermal necrolysis219 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.215used interchangeably in the model rather than CBZ alone, and the  costs of long-term sequelae, especially ocular sequelae not being  considered in the model.",Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
Thong BYAsia Pacific allergy220 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.215Thai children: a 29-year study.,Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
Stevens-Johnson syndrome and toxic epidermal necrolysis221 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.215Are Multimorbidities Underestimated in Scoring Systems of Stevens- Johnson Syndrome and Toxic Epidermal Necrolysis Like in SCORTEN?,Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
"Thong BYAsia Pacific allergy222 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.215Koukourikos S, Chaidemenos G, Chrysomallis F, Sombolos K. Plasma  exchange in patients with toxic epidermal necrolysis.",Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
Stevens-Johnson syndrome and toxic epidermal necrolysis223 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.21579.,Non-OADS,/arxiv_data1/oa_pdf/ee/b6/apa-3-215.PMC3826606.pdf
"Current ReviewAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2013.3.4.224 Asia Pac Allergy 2013;3:224-230Measuring and imaging small airways     dysfunction in asthma Francis Thien Department of Respiratory Medicine, Eastern Health and Monash University, Box Hill Hospital, Box Hill, VIC 3128, Australia Asthma is a chronic inflammatory disorder of the airways causing typical symptoms, and the diagnosis is supported by evidence of  airflow obstruction which is variable, reversible or inducible.",Non-OADS,/arxiv_data1/oa_pdf/bd/80/apa-3-224.PMC3826607.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/bd/80/apa-3-224.PMC3826607.pdf
Small airways dysfunction in asthma225 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.224 responses to anti-inflammatory medication [1].,Non-OADS,/arxiv_data1/oa_pdf/bd/80/apa-3-224.PMC3826607.pdf
"Thien F Asia Pacific allergy226 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.224these small airways due to loss of parenchymal support with  emphysema and bronchiolitis with mucus production and airway  wall thickening, is the primary pathophysiology responsible for its  clinical manifestations.",Non-OADS,/arxiv_data1/oa_pdf/bd/80/apa-3-224.PMC3826607.pdf
"Small airways dysfunction in asthma227 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.224The contribution of small airways to ventilation  heterogeneity in asthma This ventilation heterogeneity in the periphery of the lung as  detected by the MBW and FOT has emerged as an important  marker of asthma disease activity, even in the absence of changes  in standard spirometric measurements.",Non-OADS,/arxiv_data1/oa_pdf/bd/80/apa-3-224.PMC3826607.pdf
Thien F Asia Pacific allergy228 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.224with bronchodilator indicating that hyperpolarised 3He MRI  detects the reversible ventilation defects known to characterise  asthma [31].,Non-OADS,/arxiv_data1/oa_pdf/bd/80/apa-3-224.PMC3826607.pdf
Small airways dysfunction in asthma229 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.2242012;44:146-56.,Non-OADS,/arxiv_data1/oa_pdf/bd/80/apa-3-224.PMC3826607.pdf
Thien F Asia Pacific allergy230 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.224lung disease.,Non-OADS,/arxiv_data1/oa_pdf/bd/80/apa-3-224.PMC3826607.pdf
"Hypothesis & Experience Review Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2013.3.4.257 Asia Pac Allergy 2013;3:257-265Nuts ‘n’ guts: transport of food allergens across  the intestinal epithelium Dwan Price1,2, Leigh Ackland1, and Cenk Suphioglu2,* 1Centre for Cellular and Molecular Biology, School of Life and Environmental Sciences, Faculty of Science, Engineering and Built Environment,  Deakin University, Burwood,  VIC 3125, Australia 2NeuroAllergy Research Laboratory, School of Life and Environmental Sciences, Faculty of Science, Engineering and Built Environment, Deakin  University, Geelong, VIC 3216, Australia The increase in the incidence of food allergy is a growing problem for the western world.",Non-OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
Asia Pacific allergy258 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.257A 2009 study—conducted in the United Kingdom by Venter et al.,Non-OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
 Nuts ‘n’ guts: allergen epithelial transport259        apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.257allergy.,Non-OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
"Asia Pacific allergy260 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.257this, levels of IFN-γ se creted by the CD4+ intestinal epithelial  lymphocytes was significantly higher when in the presence of  IEC compared to professional antigen presenting cells, where the  increase in IFN-γ secretion was unique to intestinal epithelial CD4+  lymphocytes and not those found elsewhere in the body [28].",Non-OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
 Nuts ‘n’ guts: allergen epithelial transport261 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.257addressed in the literature.,Non-OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
Asia Pacific allergy262 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.257during IEC transport [51].,Non-OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
 Nuts ‘n’ guts: allergen epithelial transport263 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.257REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
"Asia Pacific allergy264 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.257Lehr CM, editors.",OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
 Nuts ‘n’ guts: allergen epithelial transport265 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.257intestinal epithelial Caco-2 cell monolayers.,Non-OADS,/arxiv_data1/oa_pdf/36/dd/apa-3-257.PMC3826608.pdf
"Case ReportAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.4.285 Asia Pac Allergy 2013;3:285-288Recurrent intradialytic heparin induced     anaphylaxis: workup and management Amelia Santosa1,3, Seng Hoe Tan2, and Yew Kuang Cheng2,3,* 1Division of Rheumatology, University Medicine Cluster, National University Health System, Singapore 119228, Singapore 2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore  3Gleneagles Medical Centre, Singapore 258500, Singapore  Heparin has been widely used for intradialytic anticoagulation since the 1940s.",Non-OADS,/arxiv_data1/oa_pdf/46/8e/apa-3-285.PMC3826609.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/46/8e/apa-3-285.PMC3826609.pdf
Asia Pacific allergy286 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.285use syndrome was the postulated cause and she was discharged  after observation and treatment with intravenous hydrocortisone  and antihistamines.,Non-OADS,/arxiv_data1/oa_pdf/46/8e/apa-3-285.PMC3826609.pdf
"Recurrent heparin anaphylaxis287 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.285and fondaparinux [10] have also been tested as alternatives for  general anticoagulation, but these may not be applicable in the  setting of dialysis.",Non-OADS,/arxiv_data1/oa_pdf/46/8e/apa-3-285.PMC3826609.pdf
Asia Pacific allergy288 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.285REFERENCES  1.,OADS,/arxiv_data1/oa_pdf/46/8e/apa-3-285.PMC3826609.pdf
Available from: http://www.reuters.com/ article/2012/02/10/us-fda-heparin-idUSTRE8190RB20120210.,Non-OADS,/arxiv_data1/oa_pdf/46/8e/apa-3-285.PMC3826609.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2013.3.4.231 Asia Pac Allergy 2013;3:231-240CYP1A2 polymorphism and theophylline    clearance in Korean non-smoking asthmatics Eun-Young Yim1,2,3, Hye-Ryun Kang1,2, Jae-Woo Jung1,2, Seong-Wook Sohn4, and Sang-Heon Cho1,2,* 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 110-799, Korea 3Health Insurance Review and Assessment Service, Seoul 137-706, Korea 4Department of Internal Medicine, Dongguk University Medical Center, Goyang 410-773, Korea Background:  Theophylline is mainly metabolized by cytochrome P450 (CYP) 1A2 and CYP2E1 which show inter-individual variations.",Non-OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
Asia Pacific allergy232 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.231toxic and therapeutic effects [2].,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
"CYP1A2 polymorphism and theophylline clearance233       apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.231PCR mixtures (50 µL) were comprised of 1.25 U of Taq Polymerase  (Boehringer Mannheim, Germany), 200 μM of each dNTP  (Boehringer Mannheim, Germany), 5 µL 10× PCR reaction buffer (Boehringer Mannheim, Germany), 50 ng of genomic DNA and 10  pM of each primer.",OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
"Asia Pacific allergy234 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.231determined clearance values; volume of distribution (Vd) = 0.45  ± 0.10, bioavailability (F) = 1.00 (for Theoclear ® and Etheophyl ®),  and absorption rate constant (Ka) = 0.50 or 0.40 (for Theoclear ® or  Etheophyl ®).",OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
CYP1A2 polymorphism and theophylline clearance235 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.231number NM_00761).,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
"Asia Pacific allergy236 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.231EMSA (Gel retardation assay) Gel retardation assays were performed using two types of DNA  oligomers (GG and AA) presenting polymorphism at -3860 site  of the CYP1A2 gene (Wild-type: 5’-GCC TCT CGG ATT-3’, Mutant- type: 5’-GCC TCT CAG ATT-3’) to determine whether any factor  influenced the binding affinity of the variant at -3860G>A of the  CYP1A2 gene.",OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
CYP1A2 polymorphism and theophylline clearance237 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.231asthmatics.,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
Asia Pacific allergy238 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.231significantly higher than in the Changsha population (who have a  lower risk hepatocellular carcinoma).,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
CYP1A2 polymorphism and theophylline clearance239 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.2317.,Non-OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
"Asia Pacific allergy240 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.231F, Takenaka S, Mihara S, Marubayashi T, Nakagawa K. Phenotype- genotype analysis of CYP1A2 in Japanese patients receiving oral  theophylline therapy.",OADS,/arxiv_data1/oa_pdf/6e/4b/apa-3-231.PMC3826610.pdf
Current ReviewAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2013.3.4.209 Asia Pac Allergy 2013;3:209-214What Taiwan contributes to the world of allergy  and clinical immunology?,Non-OADS,/arxiv_data1/oa_pdf/97/1a/apa-3-209.PMC3826611.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/97/1a/apa-3-209.PMC3826611.pdf
"Wang JYAsia Pacific allergy210 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.209The prevalence studies of childhood allergy diseases in  Taiwan  Asthma, allergic rhinitis, and atopic dermatitis are very common  allergic diseases in Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/97/1a/apa-3-209.PMC3826611.pdf
"Research of allergy and clinical immunology in Taiwan211 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.209asthmatic medications among physician in different discipline,  the appropriateness of combinational therapy of inhaled  corticosteroid and long-acting beta agonist for moderate to  severe childhood asthma were far from satisfaction [7-9].",Non-OADS,/arxiv_data1/oa_pdf/97/1a/apa-3-209.PMC3826611.pdf
"Wang JYAsia Pacific allergy212 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.209has been approved for use in more than 90 countries, although  some countries restrict its use to patients over 12 years old.",Non-OADS,/arxiv_data1/oa_pdf/97/1a/apa-3-209.PMC3826611.pdf
"And the rest become  history (details of the development of Omalizumab can be  browsed in Wikipedia, http://en.wikipedia.org/wiki/Omalizumab).",Non-OADS,/arxiv_data1/oa_pdf/97/1a/apa-3-209.PMC3826611.pdf
"Research of allergy and clinical immunology in Taiwan213 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.209Department of Pediatric Allergy and Immunology, National Cheng  Kung University, Tainan, Taiwan, which use 0.09 mL of patients’  sera, and the results can be read out in 30 minutes [28].",Non-OADS,/arxiv_data1/oa_pdf/97/1a/apa-3-209.PMC3826611.pdf
Available from: http://www.apaaaci.org/ about.php.,Non-OADS,/arxiv_data1/oa_pdf/97/1a/apa-3-209.PMC3826611.pdf
Wang JYAsia Pacific allergy214 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.4.20921.,OADS,/arxiv_data1/oa_pdf/97/1a/apa-3-209.PMC3826611.pdf
"To prevent wheat rust epidemics, an international consortium known as the Borlaug Global Rust Initiative (http://www.globalrust.org/) was established.",Non-OADS,/arxiv_data1/oa_pdf/16/da/ncomms3673.PMC3826619.pdf
"However, over 90 Mb of the Sanger reads could not be assembled into the released 88.6-Mb Pgtgenome (http://www.broadinstitute.org), likely due to genome hetero- zygosity.",Non-OADS,/arxiv_data1/oa_pdf/16/da/ncomms3673.PMC3826619.pdf
"TEs and tandem repeats were identiﬁed by de novo and knowledge based (Repbase Update, v. 17.11) strategies for all three rust fungi with REPET53 (http://urgi.versailles.inra.fr/index.php/urgi/Tools/REPET).",OADS,/arxiv_data1/oa_pdf/16/da/ncomms3673.PMC3826619.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/16/da/ncomms3673.PMC3826619.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zheng, W. et al.",Non-OADS,/arxiv_data1/oa_pdf/16/da/ncomms3673.PMC3826619.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3673 10 NATURE COMMUNICATIONS | 4:2673 | DOI: 10.1038/ncomms3673 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/16/da/ncomms3673.PMC3826619.pdf
Preprint at http://arxiv.org/abs/1305.0848 (2013).,Non-OADS,/arxiv_data1/oa_pdf/02/53/ncomms3594.PMC3826620.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Banaszek, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/02/53/ncomms3594.PMC3826620.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3594 ARTICLE NATURE COMMUNICATIONS | 4:2594 | DOI: 10.1038/ncomms3594 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/02/53/ncomms3594.PMC3826620.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9c/8e/ncomms3529.PMC3826621.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Funamoto, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/8e/ncomms3529.PMC3826621.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3529 12 NATURE COMMUNICATIONS | 4:2529 | DOI: 10.1038/ncomms3529 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9c/8e/ncomms3529.PMC3826621.pdf
"Chan, K. New gold discoveries decline by 45% http://intierrarmg.com/Libraries/ Brochures_and_Flyers/New_gold_discoveries_decline_45_-_25_March_2013.sﬂb.ashx (2013).",Non-OADS,/arxiv_data1/oa_pdf/bd/75/ncomms3614.PMC3826622.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/bd/75/ncomms3614.PMC3826622.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article: Lintern, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/bd/75/ncomms3614.PMC3826622.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3614 8 NATURE COMMUNICATIONS | 4:2614 | DOI: 10.1038/ncomms3614 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/bd/75/ncomms3614.PMC3826622.pdf
Reprints and permission information is available online at http://www.nature.com/ reprintsandpermissions.,Non-OADS,/arxiv_data1/oa_pdf/96/c4/ncomms3691.PMC3826624.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3691 ARTICLE NATURE COMMUNICATIONS | 4:2691 | DOI: 10.1038/ncomms3691 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/96/c4/ncomms3691.PMC3826624.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, W. et al.",Non-OADS,/arxiv_data1/oa_pdf/82/10/ncomms3569.PMC3826625.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3569 6 NATURE COMMUNICATIONS | 4:2569 | DOI: 10.1038/ncomms3569 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/82/10/ncomms3569.PMC3826625.pdf
These data can beobtained free of charge from the Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif.,OADS,/arxiv_data1/oa_pdf/0d/02/ncomms3684.PMC3826626.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/0d/02/ncomms3684.PMC3826626.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Diring, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/0d/02/ncomms3684.PMC3826626.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3684 8 NATURE COMMUNICATIONS | 4:2684 | DOI: 10.1038/ncomms3684 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0d/02/ncomms3684.PMC3826626.pdf
Notch ﬁlter from EEGLAB package (http://sccn.ucsd.edu/eeglab) was used to remove 60 Hz noise and its second and third harmonics.,Non-OADS,/arxiv_data1/oa_pdf/88/56/ncomms3528.PMC3826627.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/88/56/ncomms3528.PMC3826627.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Dastjerdi, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/88/56/ncomms3528.PMC3826627.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3528 ARTICLE NATURE COMMUNICATIONS | 4:2528 | DOI: 10.1038/ncomms3528 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/88/56/ncomms3528.PMC3826627.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/06/73/ncomms3660.PMC3826628.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Herce, H. D. et al.",Non-OADS,/arxiv_data1/oa_pdf/06/73/ncomms3660.PMC3826628.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3660 8 NATURE COMMUNICATIONS | 4:2660 | DOI: 10.1038/ncomms3660 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/06/73/ncomms3660.PMC3826628.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/93/22/ncomms3652.PMC3826629.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Chen, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/93/22/ncomms3652.PMC3826629.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ 0 degree 3 degrees1 degrees 2 degrees 4 degrees 5 degrees Figure 7 | Characterization of the terrestrial cloak for different observation angles.",Non-OADS,/arxiv_data1/oa_pdf/93/22/ncomms3652.PMC3826629.pdf
Nodes are colour coded to reﬂect the level of induction by auxin of the corresponding genes according to the Genevestigator22(https://www.genevestigator.com) and the Bio-Array Resource57 (http://www.bar.utoronto.ca) websites.NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3625 ARTICLE NATURE COMMUNICATIONS | 4:2625 | DOI: 10.1038/ncomms3625 | www.nature.com/naturecommunications 3 &2013 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/07/80/ncomms3625.PMC3826630.pdf
"Expression data from this article were deposited according to MIAME (‘Minimum Information About a Microarray Experiment’) standards in the GEO (‘Gene Expression Omnibus’) database (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE10716 and at CATdb (‘Complete Arabidopsis Transcriptome database’, http://www.urgv.evry.inra.fr/CATdb/) under the project name ‘RS06-04_Noduline-like’.",OADS,/arxiv_data1/oa_pdf/07/80/ncomms3625.PMC3826630.pdf
Additional information Accession codes: Expression data from this article were deposited according to MIAME standards in the GEO database under Accession code GSE10716 and at CATdb (http://www.urgv.evry.inra.fr/CATdb/) under the project name RS06-04_Noduline-like.,OADS,/arxiv_data1/oa_pdf/07/80/ncomms3625.PMC3826630.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/07/80/ncomms3625.PMC3826630.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ranocha, P. et al.",Non-OADS,/arxiv_data1/oa_pdf/07/80/ncomms3625.PMC3826630.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3625 ARTICLE NATURE COMMUNICATIONS | 4:2625 | DOI: 10.1038/ncomms3625 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/07/80/ncomms3625.PMC3826630.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Bargieri, D. Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/19/ncomms3552.PMC3826631.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3552 ARTICLE NATURE COMMUNICATIONS | 4:2552 | DOI: 10.1038/ncomms3552 | www.nature.com/naturecommunications 13 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9f/19/ncomms3552.PMC3826631.pdf
"An R-library is available on https://sourceforge.net/projects/estimateproject/.DOI: 10.1038/ncomms3612 OPEN 1Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Centre, Houston, Texas 77030, USA.2Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.3Department of Systems Biology, The University of Texas MD Anderson Cancer Centre, Houston, Texas 77030, USA.4Catedra de Bioinformatica, Tecnologico de Monterrey, Campus Monterrey, Monterrey, Nuevo Leon 64849, Mexico.5USC Epigenome Centre, University of Southern California, Los Angeles, California 90033, USA.",OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
The method ispublicly available through the SourceForge software repository (https://sourceforge.net/projects/estimateproject/).,OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
The Cancer Genome Atlas Data Portal https://tcga-data.nci.nih.gov/tcga/.46.,Non-OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
REMBRANDT http://rembrandt.nci.nih.gov.,Non-OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
TCGA ovarian cancer uniﬁed expression data http://tcga-data.nci.nih.gov/docs/ publications/uniﬁed_expression/ (2010).,OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
Eureqa http://creativemachines.cornell.edu/eureqa (2000).,Non-OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
Affymetrix Power Tools http://www.affymetrix.com/partners_programs/ programs/developer/tools/powertools.affx (2013).ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3612 10 NATURE COMMUNICATIONS | 4:2612 | DOI: 10.1038/ncomms3612 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Yoshihara, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3612 ARTICLE NATURE COMMUNICATIONS | 4:2612 | DOI: 10.1038/ncomms3612 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9c/44/ncomms3612.PMC3826632.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/4a/ncomms3532.PMC3826633.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ageta-Ishihara, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/70/4a/ncomms3532.PMC3826633.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3532 ARTICLE NATURE COMMUNICATIONS | 4:2532 | DOI: 10.1038/ncomms3532 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/70/4a/ncomms3532.PMC3826633.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications.,Non-OADS,/arxiv_data1/oa_pdf/5f/c3/ncomms3661.PMC3826634.pdf
Reprints and permission information is available online at http://www.nature.com/ reprintsandpermissions.,Non-OADS,/arxiv_data1/oa_pdf/5f/c3/ncomms3661.PMC3826634.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3661 8 NATURE COMMUNICATIONS | 4:2661 | DOI: 10.1038/ncomms3661 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/5f/c3/ncomms3661.PMC3826634.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/13/cb/ncomms3643.PMC3826635.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Coslovich, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/13/cb/ncomms3643.PMC3826635.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3643 6 NATURE COMMUNICATIONS | 4:2643 | DOI: 10.1038/ncomms3643 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/13/cb/ncomms3643.PMC3826635.pdf
"Expression data analysis.The data from TCGA (http://cancergenome.nih.gov/) colorectal carcinoma data set (array) was analysed and visualized by Oncomine(Compendia Bioscience, Ann Arbor, MI, USA; http://www.oncomine.org).",OADS,/arxiv_data1/oa_pdf/a5/79/ncomms3610.PMC3826636.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/a5/79/ncomms3610.PMC3826636.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Voloshanenko, O. et al.",Non-OADS,/arxiv_data1/oa_pdf/a5/79/ncomms3610.PMC3826636.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3610 ARTICLE NATURE COMMUNICATIONS | 4:2610 | DOI: 10.1038/ncomms3610 | www.nature.com/naturecommunications 13 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a5/79/ncomms3610.PMC3826636.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare that they have no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/45/10/ncomms3575.PMC3826637.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Bousset, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/45/10/ncomms3575.PMC3826637.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3575 ARTICLE NATURE COMMUNICATIONS | 4:2575 | DOI: 10.1038/ncomms3575 | www.nature.com/naturecommunications 13 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/45/10/ncomms3575.PMC3826637.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/e3/62/ncomms3400.PMC3826638.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Abdelaziz, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/e3/62/ncomms3400.PMC3826638.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/.ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3400 10 NATURE COMMUNICATIONS | 4:2400 | DOI: 10.1038/ncomms3400 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/e3/62/ncomms3400.PMC3826638.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Takagi, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/d5/ncomms3685.PMC3826639.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3685 ARTICLE NATURE COMMUNICATIONS | 4:2685 | DOI: 10.1038/ncomms3685 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a9/d5/ncomms3685.PMC3826639.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c4/fd/ncomms3609.PMC3826640.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Corada, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/c4/fd/ncomms3609.PMC3826640.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3609 14 NATURE COMMUNICATIONS | 4:2609 | DOI: 10.1038/ncomms3609 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c4/fd/ncomms3609.PMC3826640.pdf
Additional Information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications.,Non-OADS,/arxiv_data1/oa_pdf/f1/b6/ncomms3706.PMC3826642.pdf
Reprints and permission information is available online at http://www.nature.com/ reprintsandpermissions.,Non-OADS,/arxiv_data1/oa_pdf/f1/b6/ncomms3706.PMC3826642.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3706 8 NATURE COMMUNICATIONS | 4:2706 | DOI: 10.1038/ncomms3706 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f1/b6/ncomms3706.PMC3826642.pdf
(GSE27047) record can be found at http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc=GSE27047.,OADS,/arxiv_data1/oa_pdf/44/17/ncomms3544.PMC3826643.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/44/17/ncomms3544.PMC3826643.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Guo, S.-L. et al.",Non-OADS,/arxiv_data1/oa_pdf/44/17/ncomms3544.PMC3826643.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3544 ARTICLE NATURE COMMUNICATIONS | 4:2544 | DOI: 10.1038/ncomms3544 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/44/17/ncomms3544.PMC3826643.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/78/ncomms3565.PMC3826644.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3565 ARTICLE NATURE COMMUNICATIONS | 4:2565 | DOI: 10.1038/ncomms3565 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f0/78/ncomms3565.PMC3826644.pdf
http://webbook.nist.gov/ chemistry/ (2011).,OADS,/arxiv_data1/oa_pdf/ae/a9/ncomms3653.PMC3826646.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications.,Non-OADS,/arxiv_data1/oa_pdf/ae/a9/ncomms3653.PMC3826646.pdf
Reprints and permission information is available online at http://www.nature.com/ reprintsandpermissions.,Non-OADS,/arxiv_data1/oa_pdf/ae/a9/ncomms3653.PMC3826646.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3653 ARTICLE NATURE COMMUNICATIONS | 4:2653 | DOI: 10.1038/ncomms3653 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/ae/a9/ncomms3653.PMC3826646.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/bc/ad/ncomms3677.PMC3826647.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article: Porter, I. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/bc/ad/ncomms3677.PMC3826647.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3677 ARTICLE NATURE COMMUNICATIONS | 4:2677 | DOI: 10.1038/ncomms3677 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/bc/ad/ncomms3677.PMC3826647.pdf
(version 1.0 gene models: http://lifecenter.sgst.cn/main/en/ Scorpion-Suppl/gene-models-v1.0.gff).,OADS,/arxiv_data1/oa_pdf/57/bd/ncomms3602.PMC3826648.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/bd/ncomms3602.PMC3826648.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Cao, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/57/bd/ncomms3602.PMC3826648.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3602 10 NATURE COMMUNICATIONS | 4:2602 | DOI: 10.1038/ncomms3602 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/57/bd/ncomms3602.PMC3826648.pdf
"Whole-genome assembly was performed using SOAP denovo43, and Gapcloser (version1.12, http://soap.genomics.org.cn/ soapdenovo.html) was used to ﬁll gap (N) regions.",OADS,/arxiv_data1/oa_pdf/20/3a/ncomms3708.PMC3826649.pdf
"Additionally, 17 fosmid clones were sequenced using Sanger methods and used as reference data to determinegenomic coverage.Genome annotation and evolution.Interspersed repeats were characterized by homolog-based identiﬁcation using RepeatMasker (http://www.repeatmasker.org)and the repeat database, Repbase44.",OADS,/arxiv_data1/oa_pdf/20/3a/ncomms3708.PMC3826649.pdf
"Repeated proteins were identiﬁed using RepeatProteinMask, and de novo interspersed repeat annotation was performed using RepeatModeler (http://www.repeatmasker.org/RepeatModeler.html.).",OADS,/arxiv_data1/oa_pdf/20/3a/ncomms3708.PMC3826649.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/3a/ncomms3708.PMC3826649.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhou, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/20/3a/ncomms3708.PMC3826649.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3708 6 NATURE COMMUNICATIONS | 4:2708 | DOI: 10.1038/ncomms3708 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/20/3a/ncomms3708.PMC3826649.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Miyamoto, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/1d/04/ncomms3586.PMC3826650.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3586 ARTICLE NATURE COMMUNICATIONS | 4:2586 | DOI: 10.1038/ncomms3586 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/1d/04/ncomms3586.PMC3826650.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/14/d1/ncomms3578.PMC3826652.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Nikkila ¨,J .et al.",Non-OADS,/arxiv_data1/oa_pdf/14/d1/ncomms3578.PMC3826652.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3578 8 NATURE COMMUNICATIONS | 4:2578 | DOI: 10.1038/ncomms3578 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/14/d1/ncomms3578.PMC3826652.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9b/ed/ncomms3699.PMC3826654.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Alberi, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/9b/ed/ncomms3699.PMC3826654.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3699 ARTICLE NATURE COMMUNICATIONS | 4:2699 | DOI: 10.1038/ncomms3699 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9b/ed/ncomms3699.PMC3826654.pdf
Preprint at http://arxiv.org/abs/1210.4455v1 (2012).,Non-OADS,/arxiv_data1/oa_pdf/51/b9/ncomms3582.PMC3826656.pdf
Preprint at http://arxiv.org/abs/1307.4498v1 (2013).,Non-OADS,/arxiv_data1/oa_pdf/51/b9/ncomms3582.PMC3826656.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/51/b9/ncomms3582.PMC3826656.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Collins, M. J. et al.",Non-OADS,/arxiv_data1/oa_pdf/51/b9/ncomms3582.PMC3826656.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3582 ARTICLE NATURE COMMUNICATIONS | 4:2582 | DOI: 10.1038/ncomms3582 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/51/b9/ncomms3582.PMC3826656.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/68/tcrm-9-451.PMC3826758.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 451–456Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  451Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S3885 2Developments in the treatment of moderate   to severe ulcerative colitis: focus on adalimumab Hugh J Freeman Department of Medicine  (Gastroenterology), University   of British Columbia, vancouver,    BC, Canada Correspondence: Hugh Freeman   Gastroenterology, UBC Hospital,  2211 wesbrook Mall, vancouver,   BC, Canada v6T 1w5   Tel +1 604 822 7216   Fax +1 604 822 7236   email hugfree@shaw.c aAbstract:  In selected patients with moderate to severe active ulcerative colitis who have failed  to respond or are poorly responsive to standard pharmacologic forms of treatment with corti - costeroids and immunosuppressive agents, therapy with a biological agent may be considered.",Non-OADS,/arxiv_data1/oa_pdf/4d/68/tcrm-9-451.PMC3826758.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4d/68/tcrm-9-451.PMC3826758.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/68/tcrm-9-451.PMC3826758.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/14/ijn-8-4303.PMC3826769.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4303–4314International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4303OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5007 0antiviral activity of mycosynthesized silver  nanoparticles against herpes simplex virus   and human parainfluenza virus type 3 swapnil gaikwad1 avinash Ingle1 aniket gade1 Mahendra rai1 annarita Falanga3 Novella Incoronato2 luigi russo2 stefania galdiero3 Massimilano galdiero2 1Department of Biotechnology, sant  gadge Baba amravati University,  amravati, Maharashtra, India;  2Department of experimental  Medicine, Division of Microbiology,  II University of Naples, 3Department  of Pharmacy, University of Naples  “Federico II”, DFM and Institute of  Biostructures and Bioimages,    Naples, Italy correspondence: stefania galdiero   Department of Pharmacy, University of  Naples “Federico II”, Via D. Montesano,  49 80131 Naples, Italy   Tel +39 08 1253 4503   Fax +39 08 1253 4560   email stefania.galdiero@unina.i tAbstract:  The interaction between silver nanoparticles and viruses is attracting great interest  due to the potential antiviral activity of these particles, and is the subject of much research effort  in the treatment of infectious diseases.",Non-OADS,/arxiv_data1/oa_pdf/20/14/ijn-8-4303.PMC3826769.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/20/14/ijn-8-4303.PMC3826769.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/14/ijn-8-4303.PMC3826769.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/db/ijn-8-4277.PMC3826770.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4277–4290International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4277OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4891 3synthesis, optimization, and characterization  of silver nanoparticles from Acinetobacter  calcoaceticus  and their enhanced antibacterial  activity when combined with antibiotics richa singh1 Priyanka Wagh1 sweety Wadhwani1 sharvari gaidhani2 avinash Kumbhar3 Jayesh Bellare4 Balu ananda chopade1 1Department of Microbiology,   University of Pune, Pune, Maharashtra,   India; 2Institute of Bioinformatics and  Biotechnology, University of Pune,   Pune, Maharashtra, India; 3Department  of chemistry, University of Pune,   Pune, Maharashtra, India; 4Department  of chemical engineering, Indian  Institute of T echnology Bombay, Powai,   Mumbai, Maharashtra, India correspondence: Balu ananda chopade   Department of Microbiology,   University of Pune, Pune 411007,  Maharashtra, India   Tel +91 20 2569 0643   Fax +91 20 2569 0087   email chopade@unipune.ac.i n;  bachopade@gmail.co mBackground:  The development of nontoxic methods of synthesizing nanoparticles is a major  step in nanotechnology to allow their application in nanomedicine.",Non-OADS,/arxiv_data1/oa_pdf/7a/db/ijn-8-4277.PMC3826770.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7a/db/ijn-8-4277.PMC3826770.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/db/ijn-8-4277.PMC3826770.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/11/ijn-8-4371.PMC3826771.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4371–4378International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4371OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4473 9Inhibition of choriocarcinoma by Fe3O4- dextran-anti- β-human chorionic gonadotropin  nanoparticles containing antisense  oligodeoxynucleotide of heparanase liu huining1 Zhang Yi1 Tang Dihong2 Pan Yifeng3 Xia Man2 Yang Ting2 cai Jingting1,2 1Department of Obstetrics and  gynecology, Xiangya hospital,   2Department of gynecological  Oncology, hunan Provincial Tumor  hospital, 3National hepatobiliary and  enteric surgery research center,   central south University, changsha,   hunan, People’s republic of china correspondence: cai Jingting   Department of gynecological Oncology,  hunan Provincial Tumor hospital,  changsha, hunan 410013, People’s  republic of china   Tel +86 731 8976 2081   Fax +86 731 8887 6554   email cjingting114@yahoo.com.c nObjective:  To observe the influence of Fe3O4-dextran-anti- β-human chorionic gonadotropin  (HCG) carrying heparanase (Hpa) antisense oligodeoxynucleotide (ASODN), via the invasion,  proliferation, and Hpa expression of JEG-3 cell lines and inhibitory effect of transplanted  choriocarcinoma tumor growth.",Non-OADS,/arxiv_data1/oa_pdf/40/11/ijn-8-4371.PMC3826771.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/40/11/ijn-8-4371.PMC3826771.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/11/ijn-8-4371.PMC3826771.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/da/ijn-8-4327.PMC3826772.pdf
Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4327–4338International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4327OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4944 7Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/31/da/ijn-8-4327.PMC3826772.pdf
"Or use: http://dvpr.es/1d05SB Msynthesis and characterization of surface- enhanced raman-scattered gold nanoparticles sushma Kalmodia1,2 Jaidev harjwani3 raguraman rajeswari1 Wenrong Yang2 colin J Barrow2 sundara ramaprabhu3 subramanian Krishnakumar1,* sailaja V elchuri1,* 1Department of Nanobiotechnology,  sankara Nethralaya, chennai, India;  2centre for chemistry and Biotechnology,  Deakin University, geelong, VIc , australia;  3alternative energy and Nanotechnology lab,  Indian Institute of T echnology, Madras, India *These authors contributed equally to this  work correspondence: sailaja V elchuri   Department of Nanobiotechnology, Vision  research Foundation,   sankara Nethralaya, 18 college road,  Nungambakkam, chennai,   Tamil Nadu 600 006, India   T el +91 44 28271616   Fax +91 44 28254180   email sailaja.elchuri@gmail.co mAbstract:  In this paper, we report a simple, rapid, and robust method to synthesize  surface-enhanced Raman-scattered gold nanoparticles (GNPs) based on green chemistry.",Non-OADS,/arxiv_data1/oa_pdf/31/da/ijn-8-4327.PMC3826772.pdf
Available from: http://www.cdc.gov/ hiv/topics/testing/resources/press_releases/FDArelease.htm .,Non-OADS,/arxiv_data1/oa_pdf/31/da/ijn-8-4327.PMC3826772.pdf
Available from: http://sciencebusiness.technewslit.com/?p= 6957.,Non-OADS,/arxiv_data1/oa_pdf/31/da/ijn-8-4327.PMC3826772.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/31/da/ijn-8-4327.PMC3826772.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/da/ijn-8-4327.PMC3826772.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/87/ijn-8-4351.PMC3826773.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4351–4359International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4351OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5257 7release of tissue inhibitor of metalloproteinase-2  from alginate microcapsule encapsulating   genetically engineered cells Yeon seong Kim1,* Y oung-Il Jeong2,* shu-guang Jin2 Jian Pei2 Min Wen2 In-Y oung Kim1 Kyung-sub Moon1 Tae-Y oung Jung1 hyang-hwa ryu2 shin Jung1–3 1Department of Neurosurgery,   2Brain T umor research laboratory,   3chonnam National University  research Institute of Medical  sciences, chonnam National  University hwasun hospital and  Medical school, Jeollanam-do, Korea *These authors contributed equally   to this work correspondence: shin Jung   Department of Neurosurgery, chonnam   National University hwasun hospital,   160 Ilsim-ri, hwasun-eup, hwasun-gun,   Jeollanam-do, 519-809, Korea   Tel +82 61 379 7666   Fax +82 61 379 7673   email sjung@chonnam.ac.k rBackground:  In this study, 293T cells were genetically engineered to secrete tissue inhibitor  of metalloproteinase-2 (TIMP2) and encapsulated into alginate microcapsules to continuously  release TIMP2 protein.",Non-OADS,/arxiv_data1/oa_pdf/d1/87/ijn-8-4351.PMC3826773.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d1/87/ijn-8-4351.PMC3826773.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/87/ijn-8-4351.PMC3826773.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4361–4369International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4361RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5465 7vincristine sulfate liposomal injection   for acute lymphoblastic leukemia Trisha A Soosay Raj1 Amanda M Smith2 Andrew S Moore1,2 1Royal Children’s Hospital, Children’s  Health Queensland Hospital and  Health Service, Brisbane, Queensland,   Australia; 2Queensland Children’s  Medical Research Institute, The  University of Queensland, Brisbane,   QLD, Australia Correspondence: Andrew S Moore   Level 4 Foundation Building, Royal   Children’s Hospital, Herston Road,   Herston, QLD 4029, Australia   Tel +61 7 3636 3981   Fax +61 7 3636 5578   email andrew.moore@uq.edu.a uAbstract:  Vincristine (VCR) is one of the most extensively used cytotoxic compounds in  hemato-oncology.",Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
Available from: http://clinicaltrials.gov/show/NCT01439347.,Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
Available from: http://clinicaltrials.gov/show/NCT01222780.,Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
Available form: http://clinicaltrials.gov/show/ NCT01478542.,Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
Available from:  http://clinicaltrials.gov/show/NCT01096368.,Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
Available from: http://clinicaltrials.gov/show/ NCT01055314.,Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
Available from: http://clinicaltrials.gov/ show/NCT00506142.,Non-OADS,/arxiv_data1/oa_pdf/a5/06/ijn-8-4361.PMC3826832.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/6f/ijn-8-4247.PMC3826853.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4247–4263International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4247OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5107 0Polymeric nanoparticles enhance the sonodynamic  activity of meso-tetrakis (4-sulfonatophenyl)  porphyrin in an in vitro neuroblastoma model roberto canaparo1,* greta Varchi2,* Marco Ballestri2 Federica Foglietta1 giovanna sotgiu2 andrea guerrini2 andrea Francovich3 Pierluigi civera3 roberto Frairia4 loredana serpe1 1Department of Drug science and  T echnology, University of T orino,   T orino, Italy; 2Institute of the Organic  synthesis and Photoreactivity,   National research council, Bologna,   Italy; 3Departments of electronics,   Politecnico of T orino, T orino, Italy;   4Department of Medical science,   University of T orino, T orino, Italy *These authors contributed equally  to this work correspondence: loredana serpe   Department of Drug science and  Technology, University of Torino,   Via Pietro giuria 13, 10125 Torino, Italy   Tel +39 011 6707803   Fax +39 011 6707788   email loredana.serpe@unito.i tPurpose:  Sonodynamic therapy is a developing noninvasive modality for cancer treatment,  based on the selective activation of a sonosensitizer agent by acoustic cavitation.",Non-OADS,/arxiv_data1/oa_pdf/ce/6f/ijn-8-4247.PMC3826853.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ce/6f/ijn-8-4247.PMC3826853.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/6f/ijn-8-4247.PMC3826853.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/29/ijn-8-4265.PMC3826867.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4265–4276International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4265OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5287 7synthesis of liver-targeting dual-ligand   modified GCGA/5-FU nanoparticles   and their characteristics in vitro and in vivo Mingrong cheng1,2,* Xiaoyan gao3,* Y ong Wang4,* houxiang chen5 Bing he6 Yingchun li2 Jiang han1 Zhiping Zhang1 1Department of general surgery,   Pudong New area District Zhoupu  hospital, shanghai, People’s republic  of china; 2Department of endoscopy,   3Department of Plastic surgery,   Pudong New area District Zhoupu  hospital, shanghai, People’s republic  of china; 4school of Materials science  and Engineering, Wuhan University of  Technology, Wuhan, People’s republic  of china; 5Zhejiang huafon Fiber  research Institute, Zhejiang huafon  spandex co, ltd, Wenzhou, People’s  republic of china; 6Department  of general surgery, shanghai Fifth  People’s Hospital, Fudan University,   shanghai, People’s republic of china *These authors equally contributed   to this research correspondence: Yong Wang   school of Materials science and  Engineering, Wuhan University of  Technology,   Wuhan 430070, People’s republic of china   Tel +86 189 713 74413   Fax +86 278 788 0734   email wangyong@whut.edu.c n    Bing he   Department of general surgery,   shanghai Fifth People’s hospital,   Fudan University, Shanghai 200240,   People’s republic of china   Tel +86 212 428 9005   Fax +86 216 430 7611   email 2011 cmr@sina.co mAbstract:  Nanoparticle drug delivery systems using polymers hold promise for clinical appli - cations.",Non-OADS,/arxiv_data1/oa_pdf/f8/29/ijn-8-4265.PMC3826867.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f8/29/ijn-8-4265.PMC3826867.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/29/ijn-8-4265.PMC3826867.pdf
"The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence ,http://creativecommons.org/licenses/by-nc-sa/3.0/ ..",Non-OADS,/arxiv_data1/oa_pdf/d2/fb/S0954579413000370a.PMC3826873.pdf
"Retrieved September 10, 2012, from http://factfinder2.census.gov/faces/tableservices/jsf/pages/ productview.xhtml?src ¼bkmkUS Department of Health and Human Services.",OADS,/arxiv_data1/oa_pdf/d2/fb/S0954579413000370a.PMC3826873.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/42/amep-4-237.PMC3826903.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 237–243Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  237OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S5153 6Factors contributing to lack of interest   in research among medical students Ali sibtain Farooq sheikh1,2 saman Ali sheikh3 Ahmad Kaleem1,2 Ahmad Waqas1 1King Edward Medical University,   lahore, 2Mayo hospital, lahore,   3Ziauddin University, Karachi, Pakistan correspondence: Ali sibtain Farooq   sheikh   King Edward Medical University, nila  gumbad, Anarkali, lahore 54000, Pakistan   Tel +92 300 443 8237   Email asfsheikh@gmail.co mBackground:  Research experiences early in the medical student’ s education are an important  factor for attracting a greater number of doctors to careers with a research component.",Non-OADS,/arxiv_data1/oa_pdf/9e/42/amep-4-237.PMC3826903.pdf
Available from: http://www.hec.gov.pk/ InsideHEC/Divisions/QALI/Others/RankingofUniversities/ Documents/ Quality%20and%20Research%20Based%20Ranking%20of% - 20Pakistan%20HEIs_Updated.pdf.,OADS,/arxiv_data1/oa_pdf/9e/42/amep-4-237.PMC3826903.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/9e/42/amep-4-237.PMC3826903.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/42/amep-4-237.PMC3826903.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/78/rru-5-139.PMC3826925.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpResearch and Reports in Urology 2013:5 139–145Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  139ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RRU.S4921 9effectiveness of epidural versus alternate analgesia  for pain relief after radical prostatectomy   and correlation with biochemical recurrence   in men with prostate cancer Maria c Mir1 Binoy Joseph1 Rona Zhao1 Damien M Bolton1 Dennis gyomber1 nathan lawrentschuk1,2 1University of Melbourne, Department  of surgery, austin hospital,   Melbourne, Vic , australia; 2ludwig  institute for cancer Research, austin  hospital, Melbourne, Vic , australia correspondence: nathan lawrentschuk   University of Melbourne, Department of   surgery and ludwig institute for cancer   Research, austin hospital, studley Road,   3084 heidelberg, Vic, australia   email urologiconcologist@gmail.co mObjectives:  Our objectives were to analyze the effectiveness of epidural anesthesia in patients  who underwent open retropubic radical prostatectomy (RRP) at our institution over the past  decade, and to examine subsequent oncologic outcomes, comparing those receiving with those  not receiving epidural anesthesia.",Non-OADS,/arxiv_data1/oa_pdf/11/78/rru-5-139.PMC3826925.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/11/78/rru-5-139.PMC3826925.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/78/rru-5-139.PMC3826925.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/d1/amep-4-227.PMC3826930.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 227–229Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  227Short rEPortopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S5196 2Interprofessional education: the inclusion   of dental hygiene in health care within   the United States – a call to action Allison A Vanderbilt1 Kim t Isringhausen2 Patricia Brown Bonwell2,3 1Center on health Disparities and  School of Medicine, 2Department  of oral health Promotion and  Community outreach, School   of Dentistry, 3Dental hygiene  Program, School of Dentistry,    Virginia Commonwealth University,    richmond, VA, USA Correspondence: Allison A Vanderbilt   Virginia Commonwealth University,   theatre row Building, 730 East Broad St,   Suite 4116, richmond, VA 23298, USA   tel +1 804 828 2805   Email avanderbilt@vcu.ed uAbstract:  There is a lack of access to oral health care in the United States for rural, underserved,  uninsured, and low-income populations.",Non-OADS,/arxiv_data1/oa_pdf/c6/d1/amep-4-227.PMC3826930.pdf
Available at: http://www.hrsa.gov/shortage /.,Non-OADS,/arxiv_data1/oa_pdf/c6/d1/amep-4-227.PMC3826930.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/c6/d1/amep-4-227.PMC3826930.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/d1/amep-4-227.PMC3826930.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/56/rru-5-147.PMC3826934.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpResearch and Reports in Urology 2013:5 147–157Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  147Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S3879 2impact of mirabegron extended-release   on the treatment of overactive bladder with urge  urinary incontinence, urgency, and frequency Raymond T Lee1 Mitchell Bamberger2 Pamela ellsworth3 1University of Massachusetts Medical  School, 2UMass Memorial Medical  Center, University of Massachusetts  Medical School, worcester, MA,   3Division of Urology/Surgery, warren  Alpert Medical School of Brown  University, Providence, Ri, USA Correspondence: Pamela ellsworth   Division of Urology/Surgery, warren  Alpert Medical School of Brown  University, Hasbro Children’s Hospital,   2 Dudley Street, Suite 174, Providence,  Ri 02905, USA   Tel +1 401 444 5795   Fax +1 401 444 6947   email pamelaellsworth@aol.co mAbstract:  Overactive bladder is a highly prevalent disorder with a significant impact on quality  of life.",Non-OADS,/arxiv_data1/oa_pdf/a2/56/rru-5-147.PMC3826934.pdf
"Available from: http://www.auanet.org/education/ guidelines/ overactive-bladder.cf m. Accessed July 4, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a2/56/rru-5-147.PMC3826934.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/a2/56/rru-5-147.PMC3826934.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/56/rru-5-147.PMC3826934.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/c2/ppa-7-1157.PMC3826938.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1157–1162Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1157OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5323 5A study of patient experience and perception   regarding postoperative pain management   in chinese hospitals liu Weiran1,* Zhang lei2,* stephanie Mu-lian Woo3,* Tang Anliu4,* Xie shumin4,* Zhang Jing5,* Zhang Kai6,* Zhang Zhen7 1Department of Anesthesia,   2Department of Thoracic surgery,   Key laboratory of cancer Prevention  and Therapy, Tianjin lung cancer  center, Tianjin Medical University  cancer institute and hospital,   Tianjin, People’s republic of china;   3harvard University, cambridge, MA,   UsA; 4Xiangya Medical school of  central south University, changsha,   People’s republic of china; 5Tianjin  Medical University, Tianjin, People’s  republic of china; 6Department of  cerebral surgery, Tumor hospital  Xiangya school of Medicine, central  south University, changsha, People’s  republic of china; 7Department of  Oncology, Third Xiangya hospital,   central south University, changsha,   People’s republic of china *These authors contributed equally   to this work correspondence: Zhang Zhen   Department of Oncology,   Third Xiangya hospital of central   south University, changsha 410000,   People’s republic of china   Tel +86 731 863 8888   Fax +86 731 863 8888   email zhangzhen0819@gmail.co mBackground:  This study aims to analyze the current status of postoperative pain management  in the People’ s Republic of China’ s provincial-level hospitals, and the existing knowledge and  opinions held by patients regarding these methods.",Non-OADS,/arxiv_data1/oa_pdf/90/c2/ppa-7-1157.PMC3826938.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/90/c2/ppa-7-1157.PMC3826938.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/c2/ppa-7-1157.PMC3826938.pdf
Available from: http://www.iasp-pain.org/AM/Template.,Non-OADS,/arxiv_data1/oa_pdf/90/c2/ppa-7-1157.PMC3826938.pdf
"Available from: http://www.hcanj.org/files/2013/09/hcan - jbp_painmgmt2_3.pd f. Accessed July 18, 2006.",OADS,/arxiv_data1/oa_pdf/90/c2/ppa-7-1157.PMC3826938.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/35/ppa-7-1163.PMC3826940.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1163–1170Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1163OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5184 1Factors associated with nonattendance at clinical  medicine scheduled outpatient appointments   in a university general hospital Diego giunta1,2 Agustina Briatore3 Analía Baum3 Daniel luna3 gabriel Waisman2 Fernán gonzalez Bernaldo  de Quiros1–3 1internal Medicine research Unit,  2internal Medicine Department,  3health informatics Department,  hospital italiano de Buenos Aires,  Buenos Aires, Argentina correspondence: Agustina Briatore   internal Medicine Department,   hospital italiano de Buenos Aires,   Juan D Perón 4190 (c1181Ach),   Buenos Aires, Argentina   Tel +54 11 4959200   email agusbriatore@gmail.co mIntroduction:  Nonattendance at scheduled outpatient appointments for primary care is a major  health care problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/17/35/ppa-7-1163.PMC3826940.pdf
Climate data for the Autonomous City of Buenos Aires  for the assessment period were requested from the Meteo - rological Information Center of the National Meteorological  Service ( http://www.smn.gov.a r).,OADS,/arxiv_data1/oa_pdf/17/35/ppa-7-1163.PMC3826940.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/17/35/ppa-7-1163.PMC3826940.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/35/ppa-7-1163.PMC3826940.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 231–236Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  231OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S5330 7Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
"Or use: http://dvpr.es/161b97 EImprovement of workflow and processes   to ease and enrich meaningful use of health   information technology ranjit singh1 Ashok singh2 Devan r singh3 gurdev singh1 1Department of Family Medicine,   UB Patient safety research center,   school of Medicine and Management,   state University of nY at Buffalo,   nY, UsA; 2niagara Family Medicine  Associates, niagara Falls, n Y, UsA;   3saferPatients llc, lewiston, nY, UsA  correspondence: gurdev singh   school of Medicine and Biomed.",Non-OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
Available from: http://healthit.hhs.gov/portal/ server.pt?ope n=512&objID =2996&mode =2.,OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
Available from: http://www.healthit.gov/unintended- consequences.,Non-OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
"Available  from: http://healthit.ahrq.gov/sites/default/files/events/healthit_2010_ grantee_and_contractor_meeting/materials/plenary_sessions/p3_  carayon_karsh.pd f. Accessed June 28, 2013.",OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
Available from: http://healthit.ahrq.gov/portal/ server.pt/community/health_it_tools_and_resources/919/workflow_  assessment_for_health_it_toolkit/2786 5.,OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
Available from: http://www.agiloft.com/business-process- automation-l.html?campaign=292135ou.,Non-OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
Available from: http://www.fmdrl.org/index.cfm?event =c.begin BrowseD&clearSelections =1&criteria =Singh.,OADS,/arxiv_data1/oa_pdf/9c/b4/amep-4-231.PMC3826941.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/bd/rru-5-129.PMC3826942.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpResearch and Reports in Urology 2013:5 129–137Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  129ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RRU.S5102 0The conceptualization and development   of a patient-reported neurogenic bladder   symptom score Blayne Welk1 sarah a Morrow2 Wendy Madarasz3 Patrick Potter4 Keith sequeira4 1Department of surgery, Division  of Urology, 2Department of clinical  neurosciences, Western University,   london, On , canada; 3st Joseph’s  health care, london, Ontario,   canada; 4Department of Physical  Medicine and Rehabilitation, Western  University, london, On , canada correspondence: Blayne Welk   Department of surgery, Division   of Urology, Western University,   Room B4-667, st Joseph’s health   care, 268 grosvenor street, london,  On n6a 4V2, canada   Tel +1 519 646 6367   Fax +1 519 646 6037   email bkwelk@gmail.co mBackground:  There is no single patient-reported instrument that was developed specifically  to assess symptoms and bladder-related consequences for neurogenic bladder dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/c7/bd/rru-5-129.PMC3826942.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/c7/bd/rru-5-129.PMC3826942.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/bd/rru-5-129.PMC3826942.pdf
", 2004), a nonavalent vaccine including 7 HR types is in clinical trials(http://clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/a4/88/jid2013253a.PMC3826974.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/C Schellenbacher et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/88/jid2013253a.PMC3826974.pdf
"Takamitsu Matsuzawa1, Tatsuyoshi Kawamura1, Youichi Ogawa1, Masaaki Takahashi2, Rui Aoki1, Kohji Moriishi3,Yoshio Koyanagi4,H i r o y u k iG a t a n a g a5, Andrew Blauvelt6and Shinji Shimada1 1Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi,Japan; 2Department of Pharmacy, Nagoya Medical Center, Aichi, Japan;3Department of Microbiology, Faculty of Medicine,University of Yamanashi, Yamanashi, Japan; 4Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Kyoto, Japan; 5AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan and 6Oregon Medical Research Center, Portland, Oregon, USAE-mail: tkawa@yamanashi.ac.jp SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Cohen MS, Chen YQ, McCauley M et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/2b/jid2013243a.PMC3826975.pdf
"This mutationwas not detected in B11,000 European and African American individuals’ exomesequencing data (NHLBI Exome Seq-uencing Project http://evs.gs.washington.edu/EVS/ accessed 27 March 2013), noris it reported in the 1000 GenomesCatalogue of Human Genetic Variation(http://www.1000genomes.org/ensembl-browser accessed 27 March 2013).",OADS,/arxiv_data1/oa_pdf/b0/2b/jid2013243a.PMC3826975.pdf
"This mutation wasnot detected in B11,000 European and African American individuals’exome sequencing data (NHLBIExome Sequencing Project http://evs.gs.washington.edu/EVS/ accessed 27 March 2013), nor is it reported in the 1000 Genomes Catalogue of HumanGenetic Variation (http://www.1000genomes.org/ensembl-browseraccessed 27 March 2013).",Non-OADS,/arxiv_data1/oa_pdf/b0/2b/jid2013243a.PMC3826975.pdf
"Irwin McLean1and Sara J. Brown1,3 1Dermatology and Genetic Medicine, College of Life Sciences and College ofMedicine, Dentistry and Nursing, Universityof Dundee, Dundee, UK; 2Department of Dermatology, University Hospital Crosshouse,Kilmarnock, UK; 3Department of Dermatology, Ninewells Hospital and Medical School,Dundee, UK; 4Basic Science Department, Universidad de Monterrey, Nuevo Leo ´n, Me´xico and5Department of Dermatology, Nottingham University Hospitals NHS Trust,Nottingham, UKE-mail: s.j.brown@dundee.ac.ukSUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Bennion SD, Patterson JW (1984) Keratosis punctate palmaris et plantaris and adenocar-cinoma of the colon.",Non-OADS,/arxiv_data1/oa_pdf/b0/2b/jid2013243a.PMC3826975.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ae/1f/3483.PMC3826987.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d7/26/3496.PMC3826988.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a6/2c/3511.PMC3826989.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4c/bf/3522.PMC3826990.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f2/eb/3534.PMC3826991.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d0/ce/3545.PMC3826992.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5c/4b/3557.PMC3826993.pdf
"The Web-based software tool GOrilla  (http://cbl-gorilla.cs.technion.ac.il; Eden et al., 2009) was used to  find Gene Ontology terms (Ashburner et al., 2000) for biological  process and function enriched in alternatively spliced and differen - tially expressed genes over the genes from the microarray annota - tion file as a background.",OADS,/arxiv_data1/oa_pdf/5c/4b/3557.PMC3826993.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/18/19/3569.PMC3826994.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4d/1d/3577.PMC3826995.pdf
"OncoImmunology 2013; 2:e25995; http://dx.doi.org/10.4161/onci.25995MAGE-A3-specific anticancer immunotherapy   in the clinical practice Vincent G Brichard1 and Quentin Godechal2,* 1Glaxos mithKline Biologicals; r ixensart, Belgium; 2XPe Pharma & s cience; w avre, Belgium c/o Glaxos mithKline Biologicals; r ixensart, Belgium Keywords:  biomarkers, cancer, immunotherapy, immunization, MAGE-A3 antigen-specific immunotherapy may offer a unique approach to fight cancer.",Non-OADS,/arxiv_data1/oa_pdf/f1/17/onci-2-e25995.PMC3827067.pdf
Immunogenetics 1994; 40: 360-9; PMID:7927540 ;  http://dx.doi.org/10.1007/BF01246677 2.,Non-OADS,/arxiv_data1/oa_pdf/f1/17/onci-2-e25995.PMC3827067.pdf
J Clin Oncol 2013; 31:2396-403; PMID :23715567 ;  http://dx.doi.org/10.1200/JCO.2012.43.7103 3.,Non-OADS,/arxiv_data1/oa_pdf/f1/17/onci-2-e25995.PMC3827067.pdf
J Clin Oncol 2013; 31:2388-95; PMID:23715562 ; http://dx.doi.org/10.1200/ JCO.2012.44.3762 5.,Non-OADS,/arxiv_data1/oa_pdf/f1/17/onci-2-e25995.PMC3827067.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 6.,OADS,/arxiv_data1/oa_pdf/f1/17/onci-2-e25995.PMC3827067.pdf
J Immunother 2013; 36:133- 51; PMID:23377668 ; http://dx.doi.org/10.1097/ CJI.0b013e3182829903 8.,Non-OADS,/arxiv_data1/oa_pdf/f1/17/onci-2-e25995.PMC3827067.pdf
J Immunol 2009; 183:4800-8; PMID:19734225 ;  http://dx.doi.org/10.4049/jimmunol.0900903 9.,Non-OADS,/arxiv_data1/oa_pdf/f1/17/onci-2-e25995.PMC3827067.pdf
"Curr Opin  Immunol 2013; 25:284-90; PMID:23566921 ;  http://dx.doi.org/10.1016/j.coi.2013.03.005To date, different immunotherapeutic  regimens have been investigated for their  ability to mediate clinically relevant anti - neoplastic effects.",Non-OADS,/arxiv_data1/oa_pdf/f1/17/onci-2-e25995.PMC3827067.pdf
"OncoImmunology 2013; 2:e26333; http://dx.doi.org/10.4161/onci.26333Adverse events to monoclonal antibodies   used for cancer therapy Focus on hypersensitivity responses Brian a  Baldo Molecular Immunology Unit; Kolling Institute of Medical r esearch; r oyal North Shore Hospital of Sydney; Sydney, australia;   Department of Medicine; University of Sydney; Sydney, australia author is retired.",Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Lancet  2000; 356:1255-9;  PMID:11072960 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Lancet  2000 ; 356:1667 -71;  PMID:11089838 ; http://dx.doi.org/10.1016/ S0140-6736(00)03167-6 5.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Allergy   2009 ; 64:234-41; PMID:19178403 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
J Allergy Clin Immunol  1976 ; 58:691-712; PMID:791988 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Cancer Metastasis Rev   1987 ; 6:413-32; PMID:3319275 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Anticancer Drugs  2004 ; 15:581-5;  PMID :15205600 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Br J Cancer  2006 ; 94:128-35; PMID:16404366 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
MAbs   2010 ; 2:129-36; PMID:20190561 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Curr Dir Autoimmun  2005 ; 8:140-74; PMID:15564720 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Exp Mol Med  2011 ; 43:539-49;  PMID:21811090 ; http://dx.doi.org/10.3858/ emm.2011.43.10.063 15.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
J Nucl Med  2007 ; 48:1767 -76; PMID:17942813 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Oncogene  2005 ; 24:2121 - 43; PMID :15789036 ; http://dx.doi.org/10.1038/ sj.onc.1208349 18.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Nat Rev Drug Discov 2010 ; 9:325- 38; PMID:20305665 ; http://dx.doi.org/10.1038/ nrd3003 19.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
MAbs  2009 ; 1:326-31;  PMID:20068404 ; http://dx.doi.org/10.4161/ mabs.1.4.889520.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Cancer Immunol Immunother  2002 ; 51:15- 24; PMID:11845256 ; http://dx.doi.org/10.1007/ s00262-001-0247-1 21.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Cancer Cell  2005 ; 7:301-11; PMID:15837620 ;  http://dx.doi.org/10.1016/j.ccr.2005.03.003 22.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
N Engl J Med 2007 ; 357:39- 51; PMID:17611206 ; http://dx.doi.org/10.1056/ NEJMra043186 24.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Cancer Res 2011 ; 71:1871 -82;  PMID:21324925 ; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1872 25.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Eur J Nucl Med Mol Imaging 2005 ;  32:1457- 62; PMID:16193312 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Cancer Cell  2004 ; 5:317- 28; PMID :15093539 ; http://dx.doi.org/10.1016/ S1535-6108(04)00083-2,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Nat Biotechnol  2012 ; 30:631- 7; PMID:22781692 ; http://dx.doi.org/10.1038/ nbt.2289 29.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Semin Oncol 2006 ; 33(Suppl 10 ):S1-7;  PMID:17145519 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Oncogene  2007 ; 26:3644- 53; PMID:17530018 ;  http://dx.doi.org/10.1038/sj.onc.1210380 31.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Immunology   2009 ; 128:260-70; PMID:19740383 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Onco Targets Ther  2010 ; 3:15-25; PMID:20616954 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"Available at http://www.tga.gov.au/pdf/ auspar/auspar-catumaxomab-121004.pdf  (accessed  July 1, 2013).",OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Available at http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125011s102lbl.pdf   (accessed July 1, 2013).",Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Available at http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
N Engl J Med 2010 ; 363:1812 - 21; PMID:21047225 ; http://dx.doi.org/10.1056/ NEJMoa1002965 41.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125084s168lbl.pdf   (accessed July 1, 2013).",Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Clin  J Oncol Nurs 2005 ; 9:332-8; PMID :15973844 ;  http://dx.doi.org/10.1188/05.CJON.332-33843.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
J Exp Clin Cancer Res  2009 ; 28:113; PMID:19682368 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Am J Hematol 2009 ; 84:247-50;  PMID:19260124 ; http://dx.doi.org/10.1002/ ajh.21372 47.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Medicine  (Baltimore)  2010 ; 89:308-18; PMID:20827108 ;  http://dx.doi.org/10.1097/MD.0b013e3181f2caef 48.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Intern Med  J 2011 ; 41:202-5; PMID:22747556 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Dermatology   2001 ; 203:83-4; PMID :11549810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Eur Respir J 2010 ;  35:681-7; PMID:19608586 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"Available at http://www.accessdata.fda.gov/drugsatfda_docs/ label/2007/103948s5070lbl.pdf  (accessed July 1,  2013).",Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Available at http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Am J Health  Syst Pharm  2009 ; 66:999-1013 ; PMID:19451611 ;  http://dx.doi.org/10.2146/ajhp080455 56.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Ann Oncol   2012 ; 23:1130 -7; PMID:21976387 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125409lbl.pdf   (accessed July 1, 2013).",Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Breast Cancer: Targets and Therapy 2012 ;  4:65-73; http://dx.doi.org/10.2147/BCTT.S23560 60.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103792s5256lbl.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Clin Breast Cancer 2008 ; 8:285- 6; PMID:18650161 ; http://dx.doi.org/10.3816/ CBC.2008.n.034 62.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125427lbl.pdf   (accessed July 1, 2013).",Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125320s094lbl.pdf   (accessed July 1, 2013).",Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125377s0000lbl.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Oncologist  2007 ; 12:864- 72; PMID:17673617 ; http://dx.doi.org/10.1634/ theoncologist.12-7-864 66.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Scientifica  2013 ; Forthcoming ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Available at http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Clin Cancer Res 2010 ; 16:4331 -8; PMID:20601446 ;  http://dx.doi.org/10.1158/1078-0432.CCR-10-0570 69.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125147s080lbl.pdf   (accessed July 1, 2013).",Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
N Engl J Med 2007 ; 357:580- 7; PMID:17687133 ; http://dx.doi.org/10.1056/ NEJMra066469 72.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Hematology  Am Soc Hematol Educ Program 2004 :63-79;  PMID :15561677 ; http://dx.doi.org/10.1182/ asheducation-2004.1.63 75.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Clin Translational  Allergy  2013 ;Forthcoming ; 3:5; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Toxicol Sci  2010 ; 115:307-21; PMID:20071422 ;  http://dx.doi.org/10.1093/toxsci/kfq009 79.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Oncologist   2007 ; 12:610-21; PMID:17522250 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Oncologist   2007 ; 12:601-9; PMID:17522249 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
N Engl J Med 2011 ; 364:1844 -54;  PMID :21561350 ; http://dx.doi.org/10.1056/ NEJMra0904569 87.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Cancer Treat Rev 2005 ; 31:456-73;  PMID:16054760 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Clin Nucl Med  2008 ; 33:94-6; PMID:18209526 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Cancer Metastasis Rev   1999 ; 18:465-71; PMID:10855789 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Oncologist  2008 ; 13:725-32; PMID:18586928 ;  http://dx.doi.org/10.1634/theoncologist.2008-0012 98.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Oncologist  2007 ;  12:338-40; PMID:17405899 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Leuk Lymphoma   2006 ; 47:1013 -7; PMID:16840190 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Ann Oncol   2009 ; 20:1607 -8; PMID:19633054 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Hematology   2004 ; 9:409-11; PMID :15763982 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Br  J Haematol 2005 ; 130:87-91; PMID :15982349 ;  http://dx.doi.org/10.1111/j.1365-2141.2005.05570.x 110.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
JAMA  2008 ; 300:2277 - 85; PMID:19017914 ; http://dx.doi.org/10.1001/ jama.2008.656 112.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Semin Hematol  2010 ;  47:180-6; PMID:20350665 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"N  Engl J Med 2003 ; 348:2691 -4, discussion 2691- 4; PMID:12826650 ; http://dx.doi.org/10.1056/ NEJM200306263482620 114.",OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Leuk Res 2002 ; 26:597- 600; PMID:12007508 ; http://dx.doi.org/10.1016/ S0145-2126(01)00183-7 115.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Haematologica  2007 ; 92:e20- 3; PMID:17405749 ; http://dx.doi.org/10.3324/ haematol.11031 118.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Leuk Lymphoma   2003 ; 44:889-90; PMID:12802933 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Haematologica  2007 ; 92:1029 - 36; PMID:17640860 ; http://dx.doi.org/10.3324/ haematol.10733 122.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Am J Hematol  2008 ; 83:247-9; PMID:17918251 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Cancer  2006 ;  107:2408 -16; PMID:17054106 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Cancer  2011 ; 117:116-24;  PMID:20806349 ; http://dx.doi.org/10.1002/ cncr.25379 125.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Lancet Oncol   2007 ; 8:177-8; PMID:17267332 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
N Engl J Med  2008 ; 358:1129 -36; PMID:18337603 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Intern Med J  2005 ;  35:638-40; PMID:16207269 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Arch  Dermatol  2006 ; 142:243-53; PMID:16490860 ;  http://dx.doi.org/10.1001/archderm.142.2.246 129.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
J Dermatol  2009 ;  36:284-7; PMID:19382999 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Arthritis Rheum   2001 ; 44:1717-8; PMID:11465726 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Ann Oncol  2003 ; 14:1792 ;  PMID:14630688 ; http://dx.doi.org/10.1093/ annonc/mdg488132.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
J Clin Oncol 2008 ; 26:5275 -83; PMID:18838703 ;  http://dx.doi.org/10.1200/JCO.2008.17.8954 134.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Oncologist  2007 ; 12:864- 72; PMID:17673617 ; http://dx.doi.org/10.1634/ theoncologist.12-7-864 136.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Clin Translational Allergy  2013 ; 3:5;  http://dx.doi.org/10.1186/2045-7022-3-5 137.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Case  Rep Med 2012 ; 2012 :680431 ; PMID:22778751 ;  http://dx.doi.org/10.1155/2012/680431 138.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
"N Engl J Med 2003 ; 348:2690 -1, discussion 2690- 1; PMID:12826649 ; http://dx.doi.org/10.1056/ NEJM200306263482619 139.",OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Am J Hematol  2007 ; 82:916-9; PMID:17597477 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Rheumatology (Oxford)   2009 ; 48:447-8; PMID :19202159 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Pediatr Nephrol  2009 ; 24:1753 -5; PMID:19396468 ;  http://dx.doi.org/10.1007/s00467-009-1195-9 143.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Intern Med J  2012 ; 42:e12-4; PMID:22432995 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
J Clin Rheumatol 2012 ; 18:39-41;  PMID :22157278 ; http://dx.doi.org/10.1097/ RHU.0b013e31823ee5bf 146.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Int J Hematol 2005 ; 82:324-6; PMID:16298824 ;  http://dx.doi.org/10.1532/IJH97.NA0506 147.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Transplantation  2003 ; 76:516-23;  PMID:12923437 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Leuk Lymphoma  2004 ;  45:2321 -5; PMID :15512824 ; http://dx.doi.org/10.1 080/10428190410001697359 150.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Ann Oncol  2002 ; 13:1948 -50; PMID:12453865 ;  http://dx.doi.org/10.1093/annonc/mdf350 152.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Ann Oncol  2005 ; 16:1425 - 33; PMID:16012181 ; http://dx.doi.org/10.1093/ annonc/mdi279 154.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Curr Oncol 2009 ; 16:16-26;  PMID:19229368 ; http://dx.doi.org/10.3747/ co.v16i1.361 155.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Semin  Oncol  2003 ; 30(Suppl 16 ):49-53; PMID:14613026 ;  http://dx.doi.org/10.1053/j.seminoncol.2003.08.007 157.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Nat Med  2002 ; 8:459- 65; PMID:11984589 ; http://dx.doi.org/10.1038/ nm0502-459 158.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
J Am Coll Cardiol 2004 ; 44:2231 - 8; PMID :15582322 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
N Engl J Med 2011 ; 364:1844 -54;  PMID :21561350 ; http://dx.doi.org/10.1056/ NEJMra0904569 160.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Blood  2010 ; 116:2127 - 33; PMID:20530792 ; http://dx.doi.org/10.1182/ blood-2010-03-276691 164.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
J Thromb Haemost   2012 ; 10:695-7; PMID:22332994 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Transfus Med Rev 1993 ; 7:268-74; PMID :8241615 ;  http://dx.doi.org/10.1016/S0887-7963(93)70146-7 166.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Respir  Res 2012 ; 13:39; PMID:22651223 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
AJR Am  J Roentgenol  2000 ; 175:1019 -24; PMID:11000156 ;  http://dx.doi.org/10.2214/ajr.175.4.1751019 169.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
Expert Rev Respir Med  2011 ; 5:353-61; PMID:21702658 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/onci-2-e26333.PMC3827071.pdf
OncoImmunology 2013; 2:e26294; http://dx.doi.org/10.4161/onci.26294,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
J  Clin Invest 2008; 118:1991-2001;  PMID:18523649 ;  http://dx.doi.org/10.1172/JCI35180 2.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Proc Natl Acad Sci U S A 2002; 99:931- 6; PMID:11792864 ; http://dx.doi.org/10.1073/ pnas.022634999 3.,OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Science 2011; 334:1573-7;  PMID:22174255 ; http://dx.doi.org/10.1126/ science.1208347 4.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
J Clin Invest 2010; 120:1111-24;  PMID:20234093 ; http://dx.doi.org/10.1172/ JCI40269 5.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Crit  Rev Immunol 2008; 28:109-26; PMID:18540827 ;  http://dx.doi.org/10.1615/CritRevImmunol.v28.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Nature  1965; 206:480-3;  PMID:5319105 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Pharmacol Res 2007; 56:275-87; PMID:17897837 ;  http://dx.doi.org/10.1016/j.phrs.2007.08.003 8.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Cancer Lett 2013; 332:237- 48 PMID:22261329 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Oncogene  2004; 23:359-67;  PMID:14724564 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Clin Cancer Res  2011; 17:1603-15;  PMID:21135147 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Am J Clin Oncol  2008; 31:173-81;  PMID:18391603 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Nat Med 2012; 18:1254-61; PMID:22842478 ;  http://dx.doi.org/10.1038/nm.2883 13.,OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Nat Rev Immunol 2012; 12:269-81;  PMID:22437939 ; http://dx.doi.org/10.1038/ nri3191 14.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Cancer Immunol  Immunother 2009; 58:1627-34; PMID:19221744 ;  http://dx.doi.org/10.1007/s00262-009-0671-1,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Immunity 2012; 36:873-84;  PMID:22560445 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
J Exp Med 2005; 201:1591-602; PMID:15883172 ; http://dx.doi.org/10.1084/ jem.20042167 18.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
J Exp Med 2002; 195:657- 64; PMID:11877489 ; http://dx.doi.org/10.1084/ jem.20001021 19.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
J Immunol 2013; 190:6259-68; PMID:23686484 ; http://dx.doi.org/10.4049/ jimmunol.1203539 20.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Neuro Oncol 2011;  13:393-400;  PMID:21339188 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Clin Cancer Res 2011; 17:5473-80;  PMID:21737504 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0774 22.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
"J Clin Oncol 2005;  23:4235-6, author reply 4236; PMID:15961774 ;  http://dx.doi.org/10.1200/JCO.2004.00.8417 23. d’Hennezel E, Ben-Shoshan M, Ochs HD, Torgerson  TR, Russell LJ, Lejtenyi C, Noya FJ, Jabado N, Mazer  B, Piccirillo CA.",Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Front Immunol 2012;  3:268;  PMID:22973270 ; http://dx.doi.org/10.3389/ fimmu.2012.00268 25.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Nat Med 2013; 19:747-52; PMID:23644516 ; http://dx.doi.org/10.1038/ nm.316126.,OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Am J Clin Oncol 2012; PMID :23241505 ;  http://dx.doi.org/10.1097/COC.0b013e318277d5c8 28.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Cancer Immunology Research 2013; 1:11-5; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
Curr Opin  Immunol 2013; 25:284-90; PMID:23566921 ;  http://dx.doi.org/10.1016/j.coi.2013.03.005 30.,OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
N Engl J Med 2011; 365:725- 33; PMID:21830940 ; http://dx.doi.org/10.1056/ NEJMoa1103849,OADS,/arxiv_data1/oa_pdf/c5/bc/onci-2-e26294.PMC3827073.pdf
"OncoImmunology 2013; 2:e26092; http://dx.doi.org/10.4161/onci.26092Chemokine-enhanced DNA vaccination   in cancer immunotherapy Olga Igoucheva, r ebecca Jonas, and Vitali a lexeev* Department of Dermatology and Cutaneous Biology; Jefferson Medical College; Thomas Jefferson u niversity; Philadelphia, P a usa Keywords:  chemokines, intratumoral vaccination, DNA vaccine, intradermal vaccination,   leukocyte recruitment, therapeutic vaccine we have demonstrated that priming of intratumoral and intradermal vaccination sites with chemokines enhances  cytotoxic immune response against established neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/0f/8a/onci-2-e26092.PMC3827092.pdf
Nat Rev Drug Discov  2011; 10:411-2;  PMID:21629286 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/8a/onci-2-e26092.PMC3827092.pdf
Mol Cancer Ther 2007; 6:1755-64;   PMID:17575105 ; http://dx.doi.org/10.1158/1535- 7163.MCT-06-07095.,Non-OADS,/arxiv_data1/oa_pdf/0f/8a/onci-2-e26092.PMC3827092.pdf
Gene Ther 2013; 20:939-48;  PMID:23552473 ;  http://dx.doi.org/10.1038/gt.2013.17 6.,OADS,/arxiv_data1/oa_pdf/0f/8a/onci-2-e26092.PMC3827092.pdf
Gene Ther 2011; 18:304-12;  PMID:20981112 ;  http://dx.doi.org/10.1038/gt.2010.151 7.,OADS,/arxiv_data1/oa_pdf/0f/8a/onci-2-e26092.PMC3827092.pdf
J Immunother 2010; 33:510- 22;  PMID:20463596 ; http://dx.doi.org/10.1097/ CJI.0b013e3181d75cef8.,Non-OADS,/arxiv_data1/oa_pdf/0f/8a/onci-2-e26092.PMC3827092.pdf
Cell Immunol  2004; 231:75-84;  PMID:15919372 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/8a/onci-2-e26092.PMC3827092.pdf
"OncoImmunology 2013; 2:e26615; http://dx.doi.org/10.4161/onci.26615BRAF inhibition   is associated with increased clonality   in tumor-infiltrating lymphocytes Zachary a Cooper1,2, Dennie T f rederick3, Vikram r  Juneja4,5, ryan J Sullivan6,7, Donald P Lawrence6,7,  adriano Piris7, 8, arlene H Sharpe4, David e f isher7,9, Keith T f laherty6,7, and Jennifer a  Wargo1,2,* 1Department of Surgical Oncology; University of Texas MD a nderson Cancer Center; Houston, TX US a;   2Department of Genomic Medicine; University of Texas MD a nderson Cancer Center; Houston, TX US a; 3Division of Surgical Oncology; Massachusetts General Hospital;  Boston, M a US a; 4Department of Microbiology and Immunobiology; Harvard Medical School; Boston, M a US a; 5Division of Health Sciences and Technology; Massachusetts  Institute of Technology; Cambridge, M a US a; 6Division of Medical Oncology; Massachusetts General Hospital; Boston, M a US a; 7Harvard Medical School; Boston, M a  USa; 8Division of Dermatopathology; Massachusetts General Hospital; Boston, M a US a; 9Division of Dermatology; Massachusetts General Hospital; Boston, M a US a Keywords:  BRAF; melanoma; T cells; TILs; vemurafenib There have been significant advances with regard to B raf -targeted therapies against metastatic melanoma.",Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Curr Opin Oncol  2010; 22:178-83;  PMID:20401974 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Nature 2002; 417:949-54;  PMID:12068308 ; http://dx.doi.org/10.1038/ nature00766 3.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
N Engl J Med 2011; 364:2507- 16;  PMID:21639808 ; http://dx.doi.org/10.1056/ NEJMoa1103782 4.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
N Engl J Med 2012; 366:707- 14;  PMID:22356324 ; http://dx.doi.org/10.1056/ NEJMoa1112302 5.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
N  Engl J Med 2012; 367:1694-703;  PMID:23020132 ;  http://dx.doi.org/10.1056/NEJMoa1210093 6.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Cancer Res  2010; 70:5213-9;  PMID:20551059 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Clin Cancer Res 2013;  19:1225-31;  PMID:23307859 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Clin Cancer Res 2012; 18:5329-40;  PMID:22850568 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Clin Cancer Res 2013; 19:393-403;   PMID:23204132 ; http://dx.doi.org/10.1158/1078- 0432.CCR-12-1626 10.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Clin  Cancer Res 2012; 18:1386-94;  PMID :22156613 ;  http://dx.doi.org/10.1158/1078-0432.CCR-11-2479 11.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Sci Transl Med 2010; 2:47ra64;   PMID:20811043 ; http://dx.doi.org/10.1126/ scitranslmed.3001442 12.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Nature 2012; 487:500- 4;  PMID:22763439 ; http://dx.doi.org/10.1038/ nature11183 13.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Nature 2010; 468:968-72;  PMID:21107320 ;  http://dx.doi.org/10.1038/nature09627 14.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
N Engl J Med 2011; 364:772- 4;  PMID:21345109 ; http://dx.doi.org/10.1056/ NEJMcibr1013704 16.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Cancer Cell 2010; 18:683- 95;  PMID :21156289 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Nature 2013; 494:251-5;  PMID:23302800 ;  http://dx.doi.org/10.1038/nature11814 18.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Cancer Res 2008; 68:4853-61;   PMID:18559533 ; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6787 20.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Nature  2010; 468:973-7;  PMID:21107323 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Cancer Discov  2013; 3:338-49;  PMID:23171796 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Cancer Discov 2013; 3:350-62;  PMID:23288408 ; http://dx.doi.org/10.1158/2159- 8290.CD-12-0470 24.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Mol Immunol  1998; 35:593-607;  PMID:9823758 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
J  Invest Dermatol 2006; 126:393-8;  PMID:16374454 ;  http://dx.doi.org/10.1038/sj.jid.5700082 27.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Science  2013; 340:630-5;  PMID:23493420 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Blood 2013; 121:4617-26;  PMID:23575444 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
N  Engl J Med 2012; 366:2443-54;  PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 31.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
N Engl J Med 2010; 363:711-23;   PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466 32.,OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
Eur J Cancer 2009; 45:228- 47;  PMID:19097774 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/28/35/onci-2-e26615.PMC3827093.pdf
"Mobile Genetic Elements 2013; 3:e26219; http://dx.doi.org/10.4161/mge.26219Toxin–antitoxin systems Biology, identification, and application Simon J Unterholzner, Brigitte Poppenberger, and wilf ried Rozhon* Biotechnology of Horticultural Crops; Technische Universität München; Freising, Germany Keywords:  toxin, antitoxin, RNA interferase, translation, cloning, protein expression Toxin–antitoxin (TA) systems are small genetic elements  composed of a toxin gene and its cognate antitoxin.",OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nucleic Acids Res 2005 ; 33:966-76;  PMID :15718296 ; http://dx.doi.org/10.1093/nar/ gki201 3.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
FEMS Microbiol Lett 2009 ;  290:45-53; PMID:19016878 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nucleic  Acids Res 2011 ; 39:5513 -25; PMID:21422074 ;  http://dx.doi.org/10.1093/nar/gkr131 5.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nucleic  Acids Res 2010 ; 38:3743 -59; PMID :20156992 ;  http://dx.doi.org/10.1093/nar/gkq054 6.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Cell   2013 ; 50:136-48; PMID:23478446 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
RNA Biol  2012 ; 9: 1488 -90; PMID:23324552 ;  http://dx.doi.org/10.4161/rna.23045 8.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Microbiol Mol Biol Rev  2008 ; 72:579-89; PMID:19052321 ;  http://dx.doi.org/10.1128/MMBR.00025-08 9.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol  2007 ;  64:738-54; PMID:17462020 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol   2000 ; 35:1560 -72; PMID:10760155 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
RNA Biol  2012 ; 9:1513 - 9; PMID:23093802 ; http://dx.doi.org/10.4161/ rna.22578 12.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
RNA Biol  2012 ; 9:1504 - 12; PMID:23182878 ; http://dx.doi.org/10.4161/ rna.22568 13.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Mol Biol  1988 ;  203:119-29; PMID:2460630 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Mol Biol  1992 ; 226:637-49; PMID:1380562 ;  http://dx.doi.org/10.1016/0022-2836(92)90621-P 18.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
PLoS Genet  2012 ; 8:e1003181 ; PMID:23300471 ;  http://dx.doi.org/10.1371/journal.pgen.1003181 19.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol  Microbiol  2012 ; 83:579-98; PMID:22229825 ;  http://dx.doi.org/10.1111/j.1365-2958.2011.07952.x 20.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Plasmid   2013 ; 70:33-41; PMID:23396045 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Biol Chem 2004 ;  279:8252 -61; PMID:14672926 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Proc Natl Acad Sci U S A  1996 ; 93:6059-63;   PMID:8650219 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Plasmid   2013 ; 70:78-85; PMID:23419648 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Proc Natl Acad Sci USA  2001 ; 98:14328 -33; PMID:11717402 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Mol Biol 1994 ; 237:35-51; PMID:8133518 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Biol Chem 1996 ; 271:27730 - 8; PMID:8910366 ; http://dx.doi.org/10.1074/ jbc.271.44.27730 30.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Plasmid  2001 ; 45:63-74; PMID:11322821 ;  http://dx.doi.org/10.1006/plas.2000.1506 31.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Mol Biol  2009 ; 394:183-96; PMID:19747491 ;  http://dx.doi.org/10.1016/j.jmb.2009.09.006 33.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol  Microbiol  2008 ; 69:841-57; PMID:18532983 ;  http://dx.doi.org/10.1111/j.1365-2958.2008.06313.x 34.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Mol Biol  2008 ; 380:107-19; PMID:18501926 ;  http://dx.doi.org/10.1016/j.jmb.2008.04.039 35.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Structure  2012 ; 20:1641 - 8; PMID:22981948 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nucleic  Acids Res 2012 ; 40:6424 -34; PMID:22495927 ;  http://dx.doi.org/10.1093/nar/gks297 37.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nucleic Acids Res 2012 ; 40:4347 -57;  PMID:22287572 ; http://dx.doi.org/10.1093/nar/ gks029 39.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Biol Chem  2002 ; 383:1709 -13; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Proc Natl Acad Sci U S A  2003 ; 100:1661 -6; PMID:12571357 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J  Bacteriol  2009 ; 191:3677 -84; PMID:19346303 ;  http://dx.doi.org/10.1128/JB.01763-08 42.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Bacteriol 2005 ; 187:6094 -105;  PMID:16109951 ; http://dx.doi.org/10.1128/ JB.187.17.6094- 6105.2005,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
"Proc Natl Acad Sci U S A 2000 ; 97:728- 33; PMID:10639147 ; http://dx.doi.org/10.1073/ pnas.97.2.728 44.  de l a Hoz AB, Pratto  F, Misselwitz  R, Speck  C,  Weihofen  W, Welf le  K, Saenger  W, Welf le  H, Alonso   JC.",OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nucleic Acids Res  2004 ; 32:3136 -47; PMID :15190131 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol   2010 ; 76:719-32; PMID:20345661 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol   1997 ; 26:961-70; PMID:9426133 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol  2003 ; 47:1419 -32; PMID:12603745 ;  http://dx.doi.org/10.1046/j.1365-2958.2003.03387.x 49.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Mol Biol  2007 ; 372:894-905; PMID:17706670 ;  http://dx.doi.org/10.1016/j.jmb.2007.07.016 50.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Plasmid  2013 ; 70:216-25;  dx.doi.org/10.1016/j.plasmid.2013.1004.1002 ;  PMID:23632277 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mob Genet Elements 2011 ; 1:283- 90; PMID:22545240 ; http://dx.doi.org/10.4161/ mge.18477 52.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nat Struct Mol Biol  2011 ; 18:185- 90;   PMID:21240270 ; http://dx.doi.org/10.1038/ nsmb.1981 53.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nucleic Acids Res 2012 ; 40:6158 -73;  PMID:22434880 ; http://dx.doi.org/10.1093/nar/ gks231 54.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Proc Natl Acad Sci U S A  2009 ; 106:894-9; PMID:19124776 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol   2012 ; 84:979-89; PMID :22515815 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
FEMS  Microbiol Lett 2012 ; 328:174-81; PMID:22239607 ;  http://dx.doi.org/10.1111/j.1574-6968.2012.02496.x 58.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nat Chem Biol  2012 ; 8: 855-61; PMID:22941047 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol  2008 ; 70:258-70; PMID:18761622 ;  http://dx.doi.org/10.1111/j.1365-2958.2008.06416.x 61.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Mol Biol  1992 ;  225:39-52; PMID:1316444 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Cell  2011 ; 147:147-57; PMID:21944167 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Proc Natl Acad Sci U S A 2013 ; 110:8501 - 6; PMID:23650345 ; http://dx.doi.org/10.1073/ pnas.1222031110 66.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Bacteriol 2009 ; 191:1191- 9; PMID:19060138 ; http://dx.doi.org/10.1128/ JB.01013-08 68.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol  2003 ;  48:1389 -400; PMID:12787364 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Proc Natl Acad Sci U S A 2011 ;  108:7403 -7; PMID :21502523 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Proc Natl Acad Sci U S A 2008 ;  105:5885 -90; PMID:18398006 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol  2011 ;  79:1418 -29; PMID:21323758 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Science  2009 ; 323:396- 401; PMID :19150849 ; http://dx.doi.org/10.1126/ science.1163806 73.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
PLoS Biol  2011 ; 9:e1001033 ;  PMID:21445328 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Biol Chem 2005 ; 280:26080 -8; PMID:15901733 ;  http://dx.doi.org/10.1074/jbc.M502050200 75.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Biol Chem 2009 ; 284:28746 -53; PMID:19690171 ;  http://dx.doi.org/10.1074/jbc.M109.032904 76.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Bacteriol 2010 ; 192:2908 - 19; PMID:20233923 ; http://dx.doi.org/10.1128/ JB.01266-09 77.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Nat Commun  2012 ;  3:607; PMID:22215082 ; http://dx.doi.org/10.1038/ ncomms1621 78.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol   2011 ; 79:109-18; PMID:21166897 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Proc Natl Acad Sci U S  A 1986 ; 83:3116 -20; PMID:3517851 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Science  1995 ; 267:836- 7; PMID:7846528 ; http://dx.doi.org/10.1126/ science.7846528 82.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
PLoS Genet  2009 ; 5:e1000437 ; PMID:19325885 ;  http://dx.doi.org/10.1371/journal.pgen.1000437,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol  2007 ;  63:1588 -605; PMID:17367382 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Genome Res 2003 ; 13:428-42;  PMID:12618374 ; http://dx.doi.org/10.1101/gr.617103 86.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Genet  Genomics  2004 ; 272:227-34; PMID :15316771 ;  http://dx.doi.org/10.1007/s00438-004-1048-y 88.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
PLoS Genet  2012 ; 8:e1003023 ;  PMID:23109916 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Bacteriophage   2012 ; 2: 234-8; PMID:23739522 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Bacteriol  2004 ; 186:8172 -80; PMID:15576765 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
BMC Microbiol 2006 ; 6:53; PMID:16768798 ;  http://dx.doi.org/10.1186/1471-2180-6-53 94.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Proc Natl Acad Sci U S A 2011 ;  108:13206 -11; PMID:21788497 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol   2009 ; 72:918-30; PMID:19400780 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
BMC Microbiol  2013 ; 13:45; PMID:23432955 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Cell Sci 2005 ;  118:4327 -32; PMID:16179604 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Bacteriol 2001 ; 183:2041 -5;  PMID:11222603 ; http://dx.doi.org/10.1128/ JB.183.6.2041-2045.2001 99.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Cell Rep   2013 ; 3:528-37; PMID:23416055 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Science  2007 ; 318:652- 5; PMID:17962566 ; http://dx.doi.org/10.1126/ science.1147248 101.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Bacteriol 2008 ; 190:3169 - 75; PMID:18310334 ; http://dx.doi.org/10.1128/ JB.01918-07 102.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Cell   2011 ; 41:625-35; PMID:21419338 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Mol Biol  2003 ;  332:809-19; PMID:12972253 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Bacteriol 2007 ; 189:6101-8; PMID:17513477 ;  http://dx.doi.org/10.1128/JB.00527-07 105.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Annu Rev Microbiol  2012 ; 66:103-23;  PMID:22994490 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Appl Environ Microbiol   2011 ; 77:5577 -83; PMID :21685157 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Genome Biol  2007 ; 8:R155 ;  PMID:17678530 ; http://dx.doi.org/10.1186/ gb-2007-8-8-r155 108.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Bacteriol 2003 ;  185:6600 -8; PMID:14594833 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Microbiol  1998 ; 29:1065 -76; PMID:9767574 ;  http://dx.doi.org/10.1046/j.1365-2958.1998.00993.x 111.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Mol Biol  2009 ; 390:353-67; PMID:19445953 ;  http://dx.doi.org/10.1016/j.jmb.2009.05.006 112.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Biotechniques   2008 ; 45:344-6; PMID:18778262 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Mol Cell  2005 ; 18:253- 61; PMID :15837428 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
"Nucleic Acids Res 2010 ; 38:e32;  PMID:20007149 ; http://dx.doi.org/10.1093/nar/ gkp1140 117. de l a Cueva-Méndez  G, Mills  AD, Clay-Farrace  L,  Díaz-Orejas  R, Laskey  RA.",OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
EMBO J 2003 ; 22:246-51;   PMID:12514130 ;  http://dx.doi.org/10.1093/emboj/cdg026 118.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
RNA  2008 ; 14:233- 9; PMID:18083838 ; http://dx.doi.org/10.1261/ rna.693208 119.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Genes Dev  2007 ; 21:929-41; PMID:17403773 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Plasmid  2010 ; 63:31- 9; PMID:19800365 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Trends Microbiol  2012 ; 20:291-8; PMID:22445361 ;  http://dx.doi.org/10.1016/j.tim.2012.02.005 122.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Curr Opin Chem Biol 2008 ; 12:389-99; PMID:18625335 ;  http://dx.doi.org/10.1016/j.cbpa.2008.06.015 123.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
J Biol Chem  2010 ; 285:7254 -70; PMID:20022964 ;  http://dx.doi.org/10.1074/jbc.M109.073387 124.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
PLoS Biol  2012 ;  10:e1001281 ; PMID:22412352 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
MBio  2013 ; 4: e00314 -13;  PMID:23736285 ; http://dx.doi.org/10.1128/ mBio.00314-13 127.,Non-OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
Hum Gene Ther  2011; 22:35- 43;   PMID:20649483 ; http://dx.doi.org/10.1089/ hum.2010.001 128.,OADS,/arxiv_data1/oa_pdf/f3/67/mge-3-e26219.PMC3827094.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/f1/jpr-6-771.PMC3827105.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 771–784Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  771ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S5343 7Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/be/f1/jpr-6-771.PMC3827105.pdf
"Or use: http://dvpr.es/1ayqqe uReproducibility of the heat/capsaicin skin  sensitization model in healthy volunteers laura F cavallone1 Karen Frey1 Michael c Montana1 Jeremy Joyal1 Karen J Regina1 Karin l Petersen2 Robert W gereau iV1 1Department of anesthesiology,   Washington University in st louis,   school of Medicine, st louis, MO,   Usa; 2california Pacific Medical  center Research institute, san  Francisco, ca, Usa correspondence: laura F cavallone   campus Box 8054, Department of  anesthesiology, Washington University   in st louis, 660 s euclid ave, st louis,  MO 63110, Usa   Tel +1 314 362 2358   Fax +1 314 362 1185   email cavallol@wustl.ed uIntroduction:  Heat/capsaicin skin sensitization is a well-characterized human experimental  model to induce hyperalgesia and allodynia.",Non-OADS,/arxiv_data1/oa_pdf/be/f1/jpr-6-771.PMC3827105.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/be/f1/jpr-6-771.PMC3827105.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/f1/jpr-6-771.PMC3827105.pdf
"417 http://dx.doi.org/10.3345/kjp.2013.56.10.417Vitamin D status and childhood health Youn Ho Shin, MD1, Hye Jung Shin, MD2, Yong-Jae Lee, MD, MPH, PhD3 1Department of Pediatrics, Gangnam CHA Medical Center, CHA University School of Medicine, Seoul,  2Department of Pediatrics, National Medical Center, Seoul,  3Department of Family Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Vitamin D is an essential component of bone and mineral metabolism; its deficiency causes growth  retardation and skeletal deformities in children and osteomalacia and osteoporosis in adults.",Non-OADS,/arxiv_data1/oa_pdf/ec/1f/kjped-56-417.PMC3827489.pdf
"Key words:  Vitamin D, Vitamin D deficiency, Child, Adolescent, HealthCorresponding author: Yong­Jae Lee, MD, MPH,  PhD  Department of Family Medicine, Yongin Severance  Hospital, Yonsei University College of Medicine,  229 Geumhak ­ro, Cheoin ­gu, Yongin 449 ­930,  Korea  Tel: +82­31­331­8710 Fax: +82­31­331­5551 E­mail: ukyjhome@yuhs.ac Received: 17 March, 2013 Revised: 20 June, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2013;56(10):417-423 http://dx.doi.org/10.3345/kjp.2013.56.10.417 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Vitamin D, the sunshine vitamin, has long been recognized as essential for bone and  mineral metabolism.",Non-OADS,/arxiv_data1/oa_pdf/ec/1f/kjped-56-417.PMC3827489.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.417Shin YH, et al.",OADS,/arxiv_data1/oa_pdf/ec/1f/kjped-56-417.PMC3827489.pdf
"419 http://dx.doi.org/10.3345/kjp.2013.56.10.417Korean J Pediatr 2013;56(10):417-423 deficiency, and in winter, 100% of the adolescents and 93.7% of  school age children had vitamin D insufficiency18).",Non-OADS,/arxiv_data1/oa_pdf/ec/1f/kjped-56-417.PMC3827489.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.417Shin YH, et al.",OADS,/arxiv_data1/oa_pdf/ec/1f/kjped-56-417.PMC3827489.pdf
421 http://dx.doi.org/10.3345/kjp.2013.56.10.417Korean J Pediatr 2013;56(10):417-423 pregnant and lactating women with vitamin D deficiency75).,Non-OADS,/arxiv_data1/oa_pdf/ec/1f/kjped-56-417.PMC3827489.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.417Shin YH, et al.",OADS,/arxiv_data1/oa_pdf/ec/1f/kjped-56-417.PMC3827489.pdf
423 http://dx.doi.org/10.3345/kjp.2013.56.10.417Korean J Pediatr 2013;56(10):417-423 473-7.,Non-OADS,/arxiv_data1/oa_pdf/ec/1f/kjped-56-417.PMC3827489.pdf
"424 http://dx.doi.org/10.3345/kjp.2013.56.10.424Measurements of fractional exhaled nitric oxide  in pediatric asthma  Youn-Soo Hahn, MD Department of Pediatrics, Chungbuk National University College of Medicine, Cheongju, Korea Exhaled nitric oxide (NO) has been extensively investigated as a noninvasive marker of airway inflam­ ma tion in asthma.",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjped-56-424.PMC3827490.pdf
"Key words: Asthma, Breath test, Child, Nitric oxideCorresponding author: Youn­Soo Hahn, MD Department of Pediatrics, Chungbuk National  University College of Medicine, 410 Sunbong ­ro,  Heungdeok­gu, Cheongju 361­763, Korea Tel: +82­43­269­6042 Fax: +82­43­264­6620 E­mail: yshahn@chungbuk.ac.kr Received: 17 June 2013 Accepted: 27 August 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article  Korean J Pediatr 2013;56(10):424-430 http://dx.doi.org/10.3345/kjp.2013.56.10.424 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Although effective asthma control is achieved in the majority of asthmatic patients, a  significant numbers of patients still suffer from frequent asthma aggravations which are  usually related to airway inflammation1,2).",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjped-56-424.PMC3827490.pdf
"425 http://dx.doi.org/10.3345/kjp.2013.56.10.424Korean J Pediatr 2013;56(10):424-430 of FeNO measurements may be questioned because FeNO levels  are increased in asthma even in mild and asymptomatic condi - tions11,12).",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjped-56-424.PMC3827490.pdf
http://dx.doi.org/10.3345/kjp.2013.56.10.424Hahn YS  • FeNO in pediatric asthma 426involved in Th2-driven iNOS expression.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjped-56-424.PMC3827490.pdf
"427 http://dx.doi.org/10.3345/kjp.2013.56.10.424Korean J Pediatr 2013;56(10):424-430 among patients with atopic asthma, FeNO levels may be different  among these patients20).",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjped-56-424.PMC3827490.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.424Hahn YS  • FeNO in pediatric asthma 428However, further studies are required to elucidate whether sub - clinical airway inflammation identified by FeNO measure  ments  needs to be treated.",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjped-56-424.PMC3827490.pdf
Available from: http://www.nhlbi.nih.gov/guidelines/  asthma.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjped-56-424.PMC3827490.pdf
429 http://dx.doi.org/10.3345/kjp.2013.56.10.424Korean J Pediatr 2013;56(10):424-430 healthy subjects.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjped-56-424.PMC3827490.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.424Hahn YS  • FeNO in pediatric asthma 430chlan CR, et al.",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjped-56-424.PMC3827490.pdf
"431 http://dx.doi.org/10.3345/kjp.2013.56.10.431Magnetoencephalography in pediatric epilepsy Hunmin Kim, MD1, Chun Kee Chung, MD, PhD2,3, Hee Hwang, MD1,4 1Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, 2Department of Neurosurgery, Seoul National University College of Medicine,  Seoul, 3Magnetoencephalography Center, Seoul National University Hospital, Seoul, 4Department of Pediatrics, Seoul National University College of Medicine, Seoul,  Korea Magnetoencephalography (MEG) records the magnetic field generated by electrical activity of cortical  neurons.",OADS,/arxiv_data1/oa_pdf/97/b1/kjped-56-431.PMC3827491.pdf
"Key words: Magnetoencephalography, Epilepsy, PediatricsCorresponding author: Hee Hwang, MD Division of Pediatric Neurology, Department of  Pediatrics, Seoul National University Bundang  Hospital, 82 Gumi ­ro 173beon ­gil, Bundang ­gu,  Seongnam 463­707, Korea Tel: +82­31­787­7284, Fax: +82­31­787­4054  E­mail: neuroandy@snubh.org   Received: 13 February 2013 Accepted: 4 June 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article  Korean J Pediatr 2013;56(10):431-438 http://dx.doi.org/10.3345/kjp.2013.56.10.431 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Electrophysiologic evaluation is essential and critical for both clinical practice and basic  research of epilepsy.",Non-OADS,/arxiv_data1/oa_pdf/97/b1/kjped-56-431.PMC3827491.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.431Kim H, et al.",OADS,/arxiv_data1/oa_pdf/97/b1/kjped-56-431.PMC3827491.pdf
433 http://dx.doi.org/10.3345/kjp.2013.56.10.431Korean J Pediatr 2013;56(10):431-438 duced by neurons with radial orientation to the surface is not  detected by the sensors which cover the surface around the brain.,OADS,/arxiv_data1/oa_pdf/97/b1/kjped-56-431.PMC3827491.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.431Kim H, et al.",OADS,/arxiv_data1/oa_pdf/97/b1/kjped-56-431.PMC3827491.pdf
435 http://dx.doi.org/10.3345/kjp.2013.56.10.431Korean J Pediatr 2013;56(10):431-438 whose evaluations which failed to prove localization or even  lateralization to either hemisphere.,Non-OADS,/arxiv_data1/oa_pdf/97/b1/kjped-56-431.PMC3827491.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.431Kim H, et al.",OADS,/arxiv_data1/oa_pdf/97/b1/kjped-56-431.PMC3827491.pdf
437 http://dx.doi.org/10.3345/kjp.2013.56.10.431Korean J Pediatr 2013;56(10):431-438 of spatially distributed sources underlying epileptiform spikes in  the human brain.,OADS,/arxiv_data1/oa_pdf/97/b1/kjped-56-431.PMC3827491.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.431Kim H, et al.",OADS,/arxiv_data1/oa_pdf/97/b1/kjped-56-431.PMC3827491.pdf
"439 http://dx.doi.org/10.3345/kjp.2013.56.10.439Association between cord blood 25-hydroxyvi - tamin D concentrations and respiratory tract  infections in the first 6 months of age in a  Korean population: a birth cohort study (COCOA) Youn Ho Shin, MD1, Jinho Yu, MD, PhD2, Kyung Won Kim, MD, PhD3, Kangmo Ahn, MD, PhD4, Seo-Ah Hong, PhD2, Eun Lee, MD2,  Song-I Yang, MD2, Young-Ho Jung, MD2, Hyung Young Kim, MD5, Ju-Hee Seo, MD6, Ji-Won Kwon, MD7, Byoung-Ju Kim, MD, PhD8,  Hyo-Bin Kim, MD, PhD9, Jung Yeon Shim, MD, PhD10, Woo Kyung Kim, MD, PhD11, Dae Jin Song, MD, PhD12, So-Yeon Lee, MD, PhD13,  Soo Young Lee, MD, PhD14, Gwang Cheon Jang, MD, PhD15, Dong In Suh, MD16, Hyeon-Jong Yang, MD, PhD17, Bong Sung Kim, MD,  PhD2, Suk-Joo Choi, MD, PhD18, Soo-Young Oh, MD, PhD18, Ja-Young Kwon, MD, PhD19, Kyung-Ju Lee, MD, PhD20, Hee Jin Park, MD,  PhD20, Pil Ryang Lee, MD, PhD21, Hye-Sung Won, MD, PhD21, and Soo-Jong Hong, MD, PhD2, for the COCOA study group* 1Department of Pediatrics, Gangnam CHA Medical Center, CHA University School of Medicine, Seoul, 2Department of Pediatrics, Childhood Asthma Atopy Center,  Research Center for Standardization of Allergic Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 3Department of Pediatrics, Yonsei  University College of Medicine, Seoul, 4Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 5Department of  Pediatrics, Gosin University College of Medicine, Busan, 6Department of Pediatrics, Korean Cancer Hospital, Seoul, 7Department of Pediatrics, Seoul National University  Bundang Hospital, Seongnam, 8Department of Pediatrics, Inje University Haeundae Paik Hospital, Pusan, 9Department of Pediatrics, Inje University Sanggye Paik Hospital,  Seoul, 10Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 11Department of Pediatrics, Inje University Seoul  Paik Hospital, Seoul, 12Department of Pediatrics, Korea University College of Medicine, Seoul, 13Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym  University College of Medicine, Anyang, 14Department of Pediatrics, Ajou University School of Medicine, Suwon, 15Department of Pediatrics, National Health Insurance  Corporation Ilsan Hospital, Ilsan, 16Department of Pediatrics, Seoul National University College of Medicine, Seoul, 17Department of Pediatrics, Soonchunhyang University  School of Medicine, Seoul, 18Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 19Department  of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, 20Department of Obstetrics and Gynecology, Gangnam CHA Medical Center, CHA University  School of Medicine, Seoul, 21Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose:  Previous studies suggest that the concentration of 25-hydroxyvitamin D [25(OH)D] in cord  blood may show an inverse association with respiratory tract infections (RTI) during childhood.",Non-OADS,/arxiv_data1/oa_pdf/35/04/kjped-56-439.PMC3827492.pdf
"Key words: Cohort studies, Infant, Respiratory tract infections, Umbilical cord blood, Vitamin DCorresponding author: Soo-Jong Hong, MD, PhD Department of Pediatrics, Childhood Asthma Atopy  Center, Research Center for Standardization of Al - lergic Diseases, Asan Medical Center, University of  Ulsan College of Medicine, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 138-736, Korea  Tel: +82-2-3010-3379  Fax: +82-2-473-3725 E-mail: sjhong@amc.seoul.kr Received: 29 April 2013 Revised: 29 May 2013 Accepted: 30 August 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(10):439-445 http://dx.doi.org/10.3345/kjp.2013.56.10.439 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/35/04/kjped-56-439.PMC3827492.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.439Shin YH, et al.",OADS,/arxiv_data1/oa_pdf/35/04/kjped-56-439.PMC3827492.pdf
441 http://dx.doi.org/10.3345/kjp.2013.56.10.439Korean J Pediatr 2013;56(10):439-445 P values for trends were determined using the general linear  model for continuous variables.,OADS,/arxiv_data1/oa_pdf/35/04/kjped-56-439.PMC3827492.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.439Shin YH, et al.",OADS,/arxiv_data1/oa_pdf/35/04/kjped-56-439.PMC3827492.pdf
"443 http://dx.doi.org/10.3345/kjp.2013.56.10.439Korean J Pediatr 2013;56(10):439-445 tivariate logistic model adjusted for multivitamin use during  pregnancy, season of birth, and exposure to passive smoking  during pregnancy also demonstrated that infants showing cord  blood 25(OH)D concentrations less than 25.0 nmol/L were 5.21  times more likely to develop acute nasopharyngitis within the  first 6 months of life, and that newborns showing 25(OH)D  concentrations of 25.0–74.9 nmol/L were 2.99 times more likely  to develop acute nasopharyngitis than those with con  centrations  of 75.0 nmol/L or higher ( P for trend=0.0004) (Table 5).",OADS,/arxiv_data1/oa_pdf/35/04/kjped-56-439.PMC3827492.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.439Shin YH, et al.",OADS,/arxiv_data1/oa_pdf/35/04/kjped-56-439.PMC3827492.pdf
445 http://dx.doi.org/10.3345/kjp.2013.56.10.439Korean J Pediatr 2013;56(10):439-445  11.,Non-OADS,/arxiv_data1/oa_pdf/35/04/kjped-56-439.PMC3827492.pdf
"446 http://dx.doi.org/10.3345/kjp.2013.56.10.446Susceptibility of rat hippocampal neurons to  hypothermia during development Kyung Ah Seo, MD, Sehhyun Kim, MD, Na Mi Lee, MD, Soo Ahn Chae, MD Department of Pediatrics, Chung-Ang University College of Medicine, Seoul, Korea  Purpose:  This study evaluated the extent of damage due to hypothermia in the mature and immature  brain.",Non-OADS,/arxiv_data1/oa_pdf/fb/db/kjped-56-446.PMC3827493.pdf
"Key words: Hippocampus, Hypothermia, DevelopmentCorresponding author: Soo Ahn Chae, MD, PhD Department of Pediatrics, Chung-Ang University  Hospital, Chung-Ang University College of Medi - cine, 102 Heukseok-ro, Dongjak-gu, Seoul 156- 755, Korea Tel: +82-2-6299-1479 Fax: +82-2-6264-2167 E-mail: kidbrain@korea.com Received: 12 June 2013 Revised: 10 July 2013 Accepted: 19 August 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article  Korean J Pediatr 2013;56(10):446-450 http://dx.doi.org/10.3345/kjp.2013.56.10.446 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Organotypic slice culture has several advantages, including preservation of the gross  cytoarchitecture and the possibility of long-term observation and manipulation, and is  frequently used to examine physiologic or pathologic processes1).",Non-OADS,/arxiv_data1/oa_pdf/fb/db/kjped-56-446.PMC3827493.pdf
"447 http://dx.doi.org/10.3345/kjp.2013.56.10.446Korean J Pediatr 2013;56(10):446-450 few studies have investigated differences between the mature and  immature brain as a result of hypothermic injury12,13).",Non-OADS,/arxiv_data1/oa_pdf/fb/db/kjped-56-446.PMC3827493.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.446Seo KA, et al.",OADS,/arxiv_data1/oa_pdf/fb/db/kjped-56-446.PMC3827493.pdf
"449 http://dx.doi.org/10.3345/kjp.2013.56.10.446Korean J Pediatr 2013;56(10):446-450 control group, 10, 30, and 60 minutes exposed groups ( P=0.040).",OADS,/arxiv_data1/oa_pdf/fb/db/kjped-56-446.PMC3827493.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.446Seo KA, et al.",OADS,/arxiv_data1/oa_pdf/fb/db/kjped-56-446.PMC3827493.pdf
"451 http://dx.doi.org/10.3345/kjp.2013.56.10.451Parotid sialolithiasis in a  two-year-old boy Do Hoon Kim, MD, Woo Sun Song, MD, Yeong Jin Kim, MD, Won Duck Kim, MD Department of Pediatrics, Daegu Fatima Hospital, Daegu, Korea Sialolithiasis is caused by the obstruction of a salivary gland or its excretory duct by the formation of  calcareous concretions or sialoliths; this results in salivary ectasia and provokes subsequent dilation  of the salivary gland.",Non-OADS,/arxiv_data1/oa_pdf/84/6b/kjped-56-451.PMC3827494.pdf
"Key words: Salivary gland calculi, Parotid gland, Salivary duct calculi, Parotitis, ChildCorresponding author: Won Duck Kim, MD Department of Pediatrics, Daegu Fatima Hospital, 99  Ayang-ro, Dong-gu, Daegu 701-724, Korea Tel: +82-53-940-7246 Fax: +82-53-954-7417 E-mail: neogubugi@yahoo.co.kr Received: 29 October, 2012 Revised: 14 February, 2013 Accepted: 26 February, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(10):451-455 http://dx.doi.org/10.3345/kjp.2013.56.10.451 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Sialolithiasis refers to a type of salivary disease involving the formation of calcareous  concretions, or sialoliths, within a salivary gland or its excretory duct so as to obstruct  the salivary flow.",Non-OADS,/arxiv_data1/oa_pdf/84/6b/kjped-56-451.PMC3827494.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.451Kim DH, et al.",OADS,/arxiv_data1/oa_pdf/84/6b/kjped-56-451.PMC3827494.pdf
"453 http://dx.doi.org/10.3345/kjp.2013.56.10.451Korean J Pediatr 2013;56(10):451-455 reported to account for up to 30% of this disease category, but  is rarely observed in childhood and adolescence1).",Non-OADS,/arxiv_data1/oa_pdf/84/6b/kjped-56-451.PMC3827494.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.10.451Kim DH, et al.",OADS,/arxiv_data1/oa_pdf/84/6b/kjped-56-451.PMC3827494.pdf
455 http://dx.doi.org/10.3345/kjp.2013.56.10.451Korean J Pediatr 2013;56(10):451-455 reported.,OADS,/arxiv_data1/oa_pdf/84/6b/kjped-56-451.PMC3827494.pdf
"456 http://dx.doi.org/10.3345/kjp.2013.56.10.456Cystic fibrosis of pancreas and nephrotic syn­ drome: a rare association Selvi Kelekçi, MD1, Müsemma Karabel, MD1, Aydın Ece, MD2, Velat Şen, MD1, Ali Güneş, MD3, İlyas Yolbaş, MD3, Cahit Şahin, MD3  Departments of 1Pediatric Pulmonology, 2Pediatric Nephrology, and 3Pediatrics, Dicle University Faculty of Medicine, Diyarbakır, Turkey Cystic fibrosis (CF) is a genetic disease with autosomal recessive inheritance and is common in  Caucasian people.",Non-OADS,/arxiv_data1/oa_pdf/50/91/kjped-56-456.PMC3827495.pdf
"Key words:  Cystic fibrosis, Nephrotic syndrome, ChildCorresponding author: Selvi Kelekçi Department of Pediatric Pulmonology, Dicle Uni - versity Faculty of Medicine, Diyarbakır, Turkey Tel: +90-412 248 80 01-1208 Fax: +90-412 248 80 01 E-mail: selvikelekci@gmail.com Received: 13 February, 2013 Revised: 21 March, 2013 Accepted: 9 May 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(10):456 ­458 http://dx.doi.org/10.3345/kjp.2013.56.10.456 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Cystic fibrosis (CF) is a recessively inherited genetic disease that decreases quality of life  and is more commonly seen in Caucasian people.",Non-OADS,/arxiv_data1/oa_pdf/50/91/kjped-56-456.PMC3827495.pdf
"457 http://dx.doi.org/10.3345/kjp.2013.56.10.456Korean J Pediatr 2013;56(10):456-458 Case reports Case 1 A nine ­year­old male patient diagnosed with CF, lung disease,  and pancreatic insufficiency had been monitored for three years.",Non-OADS,/arxiv_data1/oa_pdf/50/91/kjped-56-456.PMC3827495.pdf
http://dx.doi.org/10.3345/kjp.2013.56.10.456S.,OADS,/arxiv_data1/oa_pdf/50/91/kjped-56-456.PMC3827495.pdf
Published  by Elsevier  B.V.   http://dx.doi.org/10.1016/j.jchromb.2013.10.005Open  access  under  CC BY-NC-ND  license .,OADS,/arxiv_data1/oa_pdf/3a/9f/main.PMC3827507.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be found,  in the online version, at http://dx.doi.org/10.1016/ j.jchromb.2013.10.005 .",OADS,/arxiv_data1/oa_pdf/3a/9f/main.PMC3827507.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Heart Journal (2013) 34, 3378–3388 doi:10.1093/eurheartj/ehs240",Non-OADS,/arxiv_data1/oa_pdf/f4/45/ehs240.PMC3827553.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/16/srep03214.PMC3827600.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3214 | DOI: 10.1038/srep03214 4",Non-OADS,/arxiv_data1/oa_pdf/20/16/srep03214.PMC3827600.pdf
"Q9 phage, 76 phage and TuIb phage come from the Institute of Immunology and Experimental Therapy collection of bacteriophages (http://www.iitd.pan.wroc.pl/en/PCM/index.html).",Non-OADS,/arxiv_data1/oa_pdf/c8/45/srep03220.PMC3827602.pdf
"Isolated plasmid DNA (PlasmidMini A&ABiotechnology) was applied in the reaction of sequencing (3730 DNA Analyzer, Applied Biosystems, Hitachi, DNA Sequencing Kit Big Dye TMTerminator Cycle Sequencing version 1.1): 94 uC for 10 s, 52 uC for 20 s, 60 uC for 4 min, 25 cycles; 100 ng DNA, 1 mlo f5 mM primer, 3 ml buffer, 1 ml enzyme premix, H 2O adjusted to 10ml (http://oligo.ibb.waw.pl).",OADS,/arxiv_data1/oa_pdf/c8/45/srep03220.PMC3827602.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3220 | DOI: 10.1038/srep03220 6",Non-OADS,/arxiv_data1/oa_pdf/c8/45/srep03220.PMC3827602.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3211 | DOI: 10.1038/srep03211 9",Non-OADS,/arxiv_data1/oa_pdf/c5/89/srep03211.PMC3827604.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3222 | DOI: 10.1038/srep03222 9",Non-OADS,/arxiv_data1/oa_pdf/34/0f/srep03222.PMC3827605.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/01/19/srep03219.PMC3827606.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3219 | DOI: 10.1038/srep03219 11",Non-OADS,/arxiv_data1/oa_pdf/01/19/srep03219.PMC3827606.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3221 | DOI: 10.1038/srep03221 7",Non-OADS,/arxiv_data1/oa_pdf/ce/ec/srep03221.PMC3827607.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3223 | DOI: 10.1038/srep03223 5",Non-OADS,/arxiv_data1/oa_pdf/af/29/srep03223.PMC3827608.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/21/dc/srep03215.PMC3827609.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3215 | DOI: 10.1038/srep03215 6",Non-OADS,/arxiv_data1/oa_pdf/21/dc/srep03215.PMC3827609.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0e/77/srep03212.PMC3827612.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3212 | DOI: 10.1038/srep03212 7",Non-OADS,/arxiv_data1/oa_pdf/0e/77/srep03212.PMC3827612.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/25/84/srep03216.PMC3827613.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3216 | DOI: 10.1038/srep03216 6",Non-OADS,/arxiv_data1/oa_pdf/25/84/srep03216.PMC3827613.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1e/a2/srep03218.PMC3827614.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3218 | DOI: 10.1038/srep03218 4",Non-OADS,/arxiv_data1/oa_pdf/1e/a2/srep03218.PMC3827614.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/74/6c/srep03098.PMC3827615.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3098 | DOI: 10.1038/srep03098 9",Non-OADS,/arxiv_data1/oa_pdf/74/6c/srep03098.PMC3827615.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cerebral Cortex December 2013;23:2803 –2817 doi:10.1093/cercor/bhs254Advance Access publication September 3, 2012",Non-OADS,/arxiv_data1/oa_pdf/b3/96/bhs254.PMC3827708.pdf
"The dendritic and axonallength of all neurons was measured in a 50 µm × 50 µm Cartesian grid, yielding a raw density map of the dendritic arborization and axonal collateralization by using the open-source software NEURON (http://www.neuron.yale.edu ).",OADS,/arxiv_data1/oa_pdf/b3/96/bhs254.PMC3827708.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cerebral Cortex December 2013;23:2987 –2993 doi:10.1093/cercor/bhs289Advance Access publication September 17, 2012",Non-OADS,/arxiv_data1/oa_pdf/35/ec/bhs289.PMC3827712.pdf
Multivariate Pattern Analysis Preprocessed functional data were further analyzed using custom soft- ware based on the MATLAB version of the Princeton MVPA toolbox (http://code.google.com/p/princeton-mvpa-toolbox/ ).,OADS,/arxiv_data1/oa_pdf/35/ec/bhs289.PMC3827712.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.oxford- journals.org/.,Non-OADS,/arxiv_data1/oa_pdf/35/ec/bhs289.PMC3827712.pdf
http://pi.amgen.com/united_states/epogen/epogen_pi_hcp_ english.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/3c/18/psp201339a.PMC3828003.pdf
http://pi.amgen.com/united_states/aranesp/ckd/aranesp_pi_hcp_english.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/3c/18/psp201339a.PMC3828003.pdf
http://www.medsafe.govt.nz/profs/datasheet/m/mircerainj.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/3c/18/psp201339a.PMC3828003.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/3c/18/psp201339a.PMC3828003.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)CPT: Pharmacometrics & Systems Pharmacology is an   open-access journal published by Nature Publishing  Group.,Non-OADS,/arxiv_data1/oa_pdf/b0/ec/psp201340a.PMC3828004.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/b0/ec/psp201340a.PMC3828004.pdf
"12–14 As a result of this and the increasing  availability of com- mercial platforms which integrate these methodologies, such  as the Simcyp Population-Based Simulator (Simcyp, Shef- field, UK) (http://www.simcyp.com/), GastroPlus (Simulations Plus, Lancaster, CA) (http://www.simulations-plus.com/), and  PKSIM (Bayer Technology Services, Leverkusen, Germany)  (http://www.systems-biology.com/products/pk-sim.html), there has been growing interest in the application of PBPK modeling by the pharmaceutical industry.",Non-OADS,/arxiv_data1/oa_pdf/d0/b2/psp201341a.PMC3828005.pdf
"and oral absorption processes have been described in the literature 13,14 and are integrated  within commercial platforms, including Simcyp (http://www.simcyp.com), GastroPlus (http://www.simulations-plus.com),  and PKSIM (http://www.systems-biology.com/products/pk- sim.html).",Non-OADS,/arxiv_data1/oa_pdf/d0/b2/psp201341a.PMC3828005.pdf
"Food and Drug Admininstration, US  Department of Health and Human Services, February 2012 <http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm292362.pdf>.",Non-OADS,/arxiv_data1/oa_pdf/d0/b2/psp201341a.PMC3828005.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/d0/b2/psp201341a.PMC3828005.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/8f/7b/psp201342a.PMC3828006.pdf
<http://www.cypalleles.ki.se/>.,Non-OADS,/arxiv_data1/oa_pdf/9a/01/psp201343a.PMC3828007.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/9a/01/psp201343a.PMC3828007.pdf
"Despite a WHO press release in 2009, advising countries to phase out stavudine usage (http://www.who.int/mediacentre/news/releases/2009/world_aids_20091130/en/index.html), observations in Africa in 2013 indicate that the usage of this drug continues due to the large stockpiles in  resource-constrained treatment centers.",Non-OADS,/arxiv_data1/oa_pdf/82/0b/psp201345a.PMC3828009.pdf
"Africa has 24% of the global bur- den of disease (e.g., 90% of global malaria deaths occur in Africa), only 2 physicians per 10,000 people vs. 33 in Europe (http://www.who.int/gho/publications/world_health_ statistics/2012/en/), and very little medical research to  tackle the huge health problems its population faces.",Non-OADS,/arxiv_data1/oa_pdf/82/0b/psp201345a.PMC3828009.pdf
"Africa  is the home to many high-quality academic institutions  as acknowledged in university performance tables (e.g., http://www.timeshighereducation.co.uk/world-university-   rankings/2012–13/world-ranking); however, talented stu-dents in the biological sciences are often forced to move to the developed countries to access more sophisticated equipment, essential for their research.",Non-OADS,/arxiv_data1/oa_pdf/82/0b/psp201345a.PMC3828009.pdf
"Developing pharmacometrics will be mutually benefi- cial in improving the ability to conduct, access, verify, and Table 1 Examples and proposals to increase pharmacometrics research in Africa to improve patient care  Perceived gap Examples, comments, and proposals Skills training,   hands-on experience  and certificationTraining courses and workshops using a teaching format similar to the Uppsala Pharmacometrics Summer School (http://www.farmbio.",Non-OADS,/arxiv_data1/oa_pdf/82/0b/psp201345a.PMC3828009.pdf
A curriculum has been proposed by Holford and Karlsson.11  These  will need contextualization to Africa healthcare needs and should use a combination of available and affordable state-of-the-art  distance learning pedagogy as popularized by Coursera (https://www.coursera.org/) and traditional classroom teaching.,Non-OADS,/arxiv_data1/oa_pdf/82/0b/psp201345a.PMC3828009.pdf
"Retrospective PKPD data from completed clinical investigations represent an untapped rich resource for meta-modeling projects e.g.,  PKPDia Consortium and WWARN (http://www.wwarn.org/partnerships/data).",OADS,/arxiv_data1/oa_pdf/82/0b/psp201345a.PMC3828009.pdf
Infrastructure and   environmentCo-location of a critical mass of quantitative scientists (modelers/pharmacokineticists/statisticians) together with bioanalytics and clinical experts in the regions where the diseases exist such as the University of Cape Town (http://www.clinpharm.uct.ac.za) and   Thailand groups (http://www.tropmedres.ac/departments-units/pharmacology).,Non-OADS,/arxiv_data1/oa_pdf/82/0b/psp201345a.PMC3828009.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/82/0b/psp201345a.PMC3828009.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/0f/13/psp201346a.PMC3828010.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/76/amep-4-245.PMC3828015.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 245–250Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  245OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S5308 5next generation paramedics, agents of change, or  time for curricula renewal?",Non-OADS,/arxiv_data1/oa_pdf/7c/76/amep-4-245.PMC3828015.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/7c/76/amep-4-245.PMC3828015.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/76/amep-4-245.PMC3828015.pdf
"Published by the British Institute of Radiology under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported License http://creativecommons.org/licenses/by- nc/3.0/ , which permits unrestricted non-commercial reuse, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/6b/5a/dmfr-42-9-D13121.PMC3828017.pdf
http://dmfr.birjournals.org,Non-OADS,/arxiv_data1/oa_pdf/6b/5a/dmfr-42-9-D13121.PMC3828017.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/b4/08/psp201348a.PMC3828485.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/c6/ket169.PMC3828510.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/b3/ket300.PMC3828514.pdf
"http://www.reillyas sociates.net/WPAI_SHP.html (15 August 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/1a/b3/ket300.PMC3828514.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/81/59/2293.PMC3828515.pdf
"After six months, it is available under a Cr eative Commons License (Attribution- NonCommercial 3.0 Unporte d), as described at http://creativecommons.org/ licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/81/59/2293.PMC3828515.pdf
[Keywords :Drosophila ; ETS transcription factor; chromatin conforma- tion; gene regulation; heart development; robustness] 3Corresponding author E-mail irebay@uchicago.edu Article is online at http://www.genesde v.org/cgi/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/81/59/2293.PMC3828515.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/91/86/2299.PMC3828516.pdf
"After six months, it is available under a Cr eative Commons License (Attribution- NonCommercial 3.0 Unporte d), as described at http://creativecommons.org/ licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/91/86/2299.PMC3828516.pdf
4Corresponding author E-mail hiwasaki@bio.titech.ac.jp Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/91/86/2299.PMC3828516.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ef/38/2305.PMC3828517.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as desc ribed at http://creativecommons.org/ licenses/by-nc/3.0/.8Corresponding author E-mail eric.xu@vai.org.",Non-OADS,/arxiv_data1/oa_pdf/ef/38/2305.PMC3828517.pdf
Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.228544.113.,Non-OADS,/arxiv_data1/oa_pdf/ef/38/2305.PMC3828517.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.,Non-OADS,/arxiv_data1/oa_pdf/64/05/2320.PMC3828518.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.3Corresponding author E-mail suzi.mansour@genetics.utah.edu Article published online ahead of print.",Non-OADS,/arxiv_data1/oa_pdf/64/05/2320.PMC3828518.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.228957.113.,Non-OADS,/arxiv_data1/oa_pdf/64/05/2320.PMC3828518.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e7/4c/2332.PMC3828519.pdf
7Corresponding author E-mail mmercola@burnham.org Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.225144.113.,Non-OADS,/arxiv_data1/oa_pdf/e7/4c/2332.PMC3828519.pdf
Here we identify the type 2 iodothyronine deiodinase ( Dio2 ) gene This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/30/17/2345.PMC3828520.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCom- mercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.4Corresponding author E-mail roger.davis@umassmed.edu Article is online at http://www.genesdev.",Non-OADS,/arxiv_data1/oa_pdf/30/17/2345.PMC3828520.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c7/5e/2356.PMC3828521.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.5These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/c7/5e/2356.PMC3828521.pdf
6Corresponding author E-mail valery.krizhanovsky@weizmann.ac.il Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.227512.113.,Non-OADS,/arxiv_data1/oa_pdf/c7/5e/2356.PMC3828521.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/49/d5/2367.PMC3828522.pdf
"After six months, it is available under a Cr eative Commons License (Attribution- NonCommercial 3.0 Unporte d), as described at http://creativecommons.org/ licenses/by-nc/3.0/.3These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/49/d5/2367.PMC3828522.pdf
4Corresponding authors E-mail cmueller@embl.de E-mail muellerj@biochem.mpg.de Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/49/d5/2367.PMC3828522.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.229328.113.,Non-OADS,/arxiv_data1/oa_pdf/6a/d7/2380.PMC3828523.pdf
Adetailed protocol of 3 9-seq is available on the author’s Web page (http://www.mskcc.org/research/l ab/christine-mayr/protocols).,OADS,/arxiv_data1/oa_pdf/6a/d7/2380.PMC3828523.pdf
Direct links to the processed 3 9-seq data are available on our Web page (http://cbio.mskcc.org/leslielab/ApA/atlas).,OADS,/arxiv_data1/oa_pdf/6a/d7/2380.PMC3828523.pdf
"For both tasks, we applied a general linear model (GLM) to the single-subject data using a canonical hemodynamic response function, with the realignment parameters and a vector with the timing of the button presses convolved witha hemodynamic function as regressors of no interest, and a high-pass filter cutoff of 128 s. For both tasks, mean BOLD signal change from the bilateral amygdala were subse-quently extracted for all individual contrast maps using theMarsBar toolbox (http://marsbar.sourceforge.net) and tested in repeated measures ANOVAs.",OADS,/arxiv_data1/oa_pdf/3a/2b/npp2013183a.PMC3828542.pdf
"ROIs were based on the Wake Forest University pickatlas (http://www.fmri.w-fubmc.edu/download.htm), except for the hypothalamus, which was constructed by drawing an 8-mm sphere around the central coordinate (MNI: 0–2–13) of hypothalamussubregions recently described by Baroncini et al (2012).",OADS,/arxiv_data1/oa_pdf/3a/2b/npp2013183a.PMC3828542.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http:// www.nature.com/npp)Actions of Sceletium in the amygdala and hypothalamus D Terburg et al 2716 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/3a/2b/npp2013183a.PMC3828542.pdf
"Journal of Crystal Growth 110, 683–691, doi:http://dx.doi.org/ 10.1016/0022-0248(91)90624-E (1991).",OADS,/arxiv_data1/oa_pdf/5c/51/srep03227.PMC3828566.pdf
"Journal of Crystal Growth 128, 258–261, doi:http://dx.doi.",OADS,/arxiv_data1/oa_pdf/5c/51/srep03227.PMC3828566.pdf
"Journal of Crystal Growth 18, 250–256, doi:http://dx.doi.org/10.1016/0022-0248(73)90168-1 (1973).",OADS,/arxiv_data1/oa_pdf/5c/51/srep03227.PMC3828566.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5c/51/srep03227.PMC3828566.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3227 | DOI: 10.1038/srep03227 6",Non-OADS,/arxiv_data1/oa_pdf/5c/51/srep03227.PMC3828566.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/srep03226.PMC3828567.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3226 | DOI: 10.1038/srep03226 7",Non-OADS,/arxiv_data1/oa_pdf/f2/ed/srep03226.PMC3828567.pdf
25proposed two comorbidity measures (http://barabasilab.neu.edu/projects/ hudine) to quantify the distance between two diseases: a relative risk (defined below) and Pearson’s correlation between prevalences of two diseases ( w).,OADS,/arxiv_data1/oa_pdf/f9/74/srep03202.PMC3828568.pdf
"We extract 1,536 DO terms from the latest version of the disease ontology hosted by the OBO Foundry (http://www.obofoundry.org) and construct a binary matrix R 12from 22,084 associations between genes and diseases.",OADS,/arxiv_data1/oa_pdf/f9/74/srep03202.PMC3828568.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3202 | DOI: 10.1038/srep03202 9",Non-OADS,/arxiv_data1/oa_pdf/f9/74/srep03202.PMC3828568.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0e/5e/srep03229.PMC3828569.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3229 | DOI: 10.1038/srep03229 5",Non-OADS,/arxiv_data1/oa_pdf/0e/5e/srep03229.PMC3828569.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3225 | DOI: 10.1038/srep03225 6",Non-OADS,/arxiv_data1/oa_pdf/46/9c/srep03225.PMC3828570.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The author declares no competing financial interests.How to cite this article: Xu, X.S.",Non-OADS,/arxiv_data1/oa_pdf/58/ad/srep03228.PMC3828571.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3228 | DOI: 10.1038/srep03228 7",Non-OADS,/arxiv_data1/oa_pdf/58/ad/srep03228.PMC3828571.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/58/39/srep03224.PMC3828633.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3224 | DOI: 10.1038/srep03224 10",Non-OADS,/arxiv_data1/oa_pdf/58/39/srep03224.PMC3828633.pdf
An accompanying Data S1 is available at http://jaha.ahajournals.org/ content/2/4/e000199/suppl/DC1.,OADS,/arxiv_data1/oa_pdf/ed/59/jah3-2-e000199.PMC3828784.pdf
"Disclosures All authors have completed the Uni ﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare no support from any organization for the submitted work other than grant support listed above (Drs Abramsohn, Lindau, Decker, B. Garavalia, L. Garavalia, and Gosch).",Non-OADS,/arxiv_data1/oa_pdf/ed/59/jah3-2-e000199.PMC3828784.pdf
"Statistical Analysis QTL analysis was performed using J/qtl for atheroscleroticlesion size and plasma lipid levels in 246 male F 2s that were genotyped for 134 micosatellite markers across the entire genome (the data have been deposited in the Mouse Genome Informatics database), as we previously reported.7,17,19J/qtl is a Java graphic user interface for the popular QTL data analysis software R/qtl (http://churchill.jax.org/software/jqtl.shtml).",OADS,/arxiv_data1/oa_pdf/a9/80/jah3-2-e000260.PMC3828785.pdf
” Prioritization of Positional Candidate Genes The Sanger SNP database (http://www.sanger.ac.uk/cgi- bin/modelorgs/mousegenomes/snps.pl) was used to prior- itize candidate genes for signi ﬁcant atherosclerosis QTLs that had been mapped in ≥2 crosses generated from different parental strains.,OADS,/arxiv_data1/oa_pdf/a9/80/jah3-2-e000260.PMC3828785.pdf
"Apoe/C0//C0mice.29The suggestive QTLs on Chr4, Chr14, Chr15, and ChrX replicated Chol8 ,Chldq8 , Nhdlq9 , and Nhdlq2 , respectively (http://www.informatics.jax.org/phenotypes.shtml).",OADS,/arxiv_data1/oa_pdf/a9/80/jah3-2-e000260.PMC3828785.pdf
"Plasma triglyceride levels were controlled by 1 signi ﬁcant QTL on Chr1 and 2 suggestive QTLs on Chr2 and Chr16, corresponding to Tglq1 ,Tgq10 , and Tgq28 , respectively (http://www.informatics.jax.org/phenotypes.",OADS,/arxiv_data1/oa_pdf/a9/80/jah3-2-e000260.PMC3828785.pdf
These genes were further examined for associations with relevant human diseases using a public accessible genomewide associationstudy database (http://www.genome.gov/GWAStudies/).,OADS,/arxiv_data1/oa_pdf/a9/80/jah3-2-e000260.PMC3828785.pdf
Continued Gene Chromosome Position B6 C3H/HeJ 129 Consequence Apobec3 15 79728260 G C C NON_SYNONYMOUS_CODING Apobec3 15 79728323 G A A NON_SYNONYMOUS_CODING Apobec3 15 79728327 A G G NON_SYNONYMOUS_CODING Apobec3 15 79728339 C A A NON_SYNONYMOUS_CODING Apobec3 15 79728604 G A A NON_SYNONYMOUS_CODING Apobec3 15 79729463 T C C NON_SYNONYMOUS_CODING Apobec3 15 79729537 G C C NON_SYNONYMOUS_CODING Apobec3 15 79735878 A G G NON_SYNONYMOUS_CODING Apobec3 15 79735881 G C C NON_SYNONYMOUS_CODING Apobec3 15 79735885 C T T NON_SYNONYMOUS_CODING Apobec3 15 79735953 C G G NON_SYNONYMOUS_CODING Apobec3 15 79736838 C T T NON_SYNONYMOUS_CODING Apobec3 15 79737380 G A A NON_SYNONYMOUS_CODING Cbx7 15 79749323 C T T NON_SYNONYMOUS_CODING Cbx7 15 79749453 G C C NON_SYNONYMOUS_CODING Cbx7 15 79764235 T G G NON_SYNONYMOUS_CODING Cbx7 15 79764259 A T T STOP_GAINED Cbx7 15 79764307 A T T NON_SYNONYMOUS_CODING Cbx7 15 79801396 G T T 50_UTR Cbx7 15 79801461 A C C 50_UTR Pdgfb 15 79830813 C T T NON_SYNONYMOUS_CODING Pdgfb 15 79844499 T G G 50_UTR Pdgfb 15 79844550 A C C 50_UTR Pdgfb 15 79844807 G T T 50_UTR Pdgfb 15 79844895 G A A 50_UTR Analysis was performed using the Sanger SNP database (http://www.sanger.ac.uk/cgi-bin/modelorgs/mousegenomes/snps.pl).,Non-OADS,/arxiv_data1/oa_pdf/a9/80/jah3-2-e000260.PMC3828785.pdf
Accompanying Figures S1 through S9 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/3b/d7/jah3-2-e000284.PMC3828786.pdf
Accompanying Tables SA through SD are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/86/6b/jah3-2-e000264.PMC3828789.pdf
Available at http://www.ems.gov/ EducationStandards.htm.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/jah3-2-e000289.PMC3828790.pdf
Accompanying Tables S1 through S3 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/57/5a/jah3-2-e000354.PMC3828792.pdf
(Presentation slides at http://www.escardio.org/congresses/esc-2012/ congress-reports/Pages/710-5-CARDia.aspx#presenter) 23.,Non-OADS,/arxiv_data1/oa_pdf/57/5a/jah3-2-e000354.PMC3828792.pdf
"An accompanying appendix is available at http://jaha.ahajournals.org/ content/2/4/e000208.full Correspondence to: Elisabetta Patorno, MD, DrPH, Instructor in Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women ’s Hospital and Harvard Medical School, 1620 Tremont Street (Suite 3030), Boston, MA 02120.",Non-OADS,/arxiv_data1/oa_pdf/b6/67/jah3-2-e000208.PMC3828795.pdf
"Cary, NC: SAS Institute Inc, 2001. http://www2.sas.com/proceedings/sugi26/ p214-26.pdf.",OADS,/arxiv_data1/oa_pdf/b6/67/jah3-2-e000208.PMC3828795.pdf
Accompanying Tables S1 through S3 and Figures S1 through S12 are available at http://jaha.ahajournals.org/content/2/4/e000249/suppl/DC1.,OADS,/arxiv_data1/oa_pdf/1f/fb/jah3-2-e000249.PMC3828798.pdf
Accompanying Tables S1 through S5 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/jah3-2-e000251.PMC3828799.pdf
2008 Available at http://www.sign.ac.uk/pdf/sign108.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/jah3-2-e000251.PMC3828799.pdf
"Barry London, MD, PhD, Deputy Editor for JAHA, handled the manuscript independently.Accompanying Figures S1 through S5 are available at http://jaha.ahajournals.",Non-OADS,/arxiv_data1/oa_pdf/94/4f/jah3-2-e000184.PMC3828801.pdf
Accompanying Tables S1 through S3 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/31/59/jah3-2-e000092.PMC3828802.pdf
"Accompanying Tables S1 –S3 are available at http://jaha.ahajournals.org/ content/2/4/e001596/suppl/DC1 Portions of this study were presented at the American College of Cardiology 61st Annual Scienti ﬁc Session held March 24 –27, 2012, in Chicago, IL.",Non-OADS,/arxiv_data1/oa_pdf/89/2b/jah3-2-e000037.PMC3828803.pdf
Available at http://www.hps2-thrive.org/.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/jah3-2-e000037.PMC3828803.pdf
Accompanying Tables S1 and S2 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/36/37/jah3-2-e000318.PMC3828808.pdf
"Subsequently, CID and HCD peak lists were searched individually against an International Protein Index (IPI; http://www.ebi.ac.uk/ipi) database containing mouse sequences and common contaminants such as bovine serum albumin and human keratins (IPI-Mouse v3.84; 60 248 sequences) through a direct connection to our in-houseMascot server (Mascot v2.3.2, Matrix Science, London, UK).",OADS,/arxiv_data1/oa_pdf/36/37/jah3-2-e000318.PMC3828808.pdf
All raw and annotated data are freely available through ProteomeXchange (http://www.pro- teomexchange.org) under accession number PXD000174 and ProteomeXchange submission title CaMKII Cardiac Phospho- proteome.,OADS,/arxiv_data1/oa_pdf/36/37/jah3-2-e000318.PMC3828808.pdf
Available at: http://www.census.,OADS,/arxiv_data1/oa_pdf/c1/79/jah3-2-e000170.PMC3828815.pdf
Clinical Trial Registration Information- —URL: http://www.controlled-trials.com/ Unique identi ﬁer: ISRCTN no: 19987575.,Non-OADS,/arxiv_data1/oa_pdf/a8/4a/jah3-2-e000283.PMC3828816.pdf
19987575) (http://www.controlled-trials.com/ISRCTN199875 75/singhal).,Non-OADS,/arxiv_data1/oa_pdf/a8/4a/jah3-2-e000283.PMC3828816.pdf
"” The correction has been made to the current online version of the article, which is available at http://jaha.ahajournals.",Non-OADS,/arxiv_data1/oa_pdf/1d/11/jah3-2-e000240.PMC3828819.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/05/kft178.PMC3829570.pdf
"NEW TECHNOLOGIES IN TOXICITY TESTINGrisk assessment programs tasked with evaluating chemicals  with limited toxicity data, such as the U.S. Environmental  Protection Agency’s (EPA) Superfund Health Risk Technical  Support Center (STSC; http://www.epa.gov/superfund/health/ research.htm ).",Non-OADS,/arxiv_data1/oa_pdf/3c/05/kft178.PMC3829570.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/74/f5/jpr-6-785.PMC3829620.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 785–790Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  785Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S3743 4Pediatric pain management:   the multidisciplinary approach Shannon Odell1,2 Deirdre e Logan1,2 1Division of Pain Medicine,   Department of Anesthesiology,   Perioperative and Pain Medicine,   Boston Children’s Hospital,   2Department of Psychiatry, Harvard  Medical School, Boston, MA, USA Correspondence: Shannon Odell   Division of Pain Medicine, Department   of Anesthesiology, Perioperative and Pain  Medicine, Boston Children’s Hospital,   333 Longwood Avenue.",Non-OADS,/arxiv_data1/oa_pdf/74/f5/jpr-6-785.PMC3829620.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/74/f5/jpr-6-785.PMC3829620.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/f5/jpr-6-785.PMC3829620.pdf
Available from: http://www.iasp-pain.org/AM/Template.,Non-OADS,/arxiv_data1/oa_pdf/74/f5/jpr-6-785.PMC3829620.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/ac/opth-7-2225.PMC3829621.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2225–2234Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2225Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5247 4A Phase III clinical study to evaluate the efficacy  of combined azithromycin and dexamethasone   in the treatment of blepharoconjunctivitis Kamran hosseini1,2 Judith hutcheson1 richard l lindstrom3–5 1Clinical affairs, 2regulatory affairs,   insite Vision incorporated, alameda,   Ca, Usa; 3Minnesota eye Consultants,   Bloomington, M n, Usa; 4University  of Minnesota Department of  Ophthalmology, Minneapolis, M n,   Usa; 5University of California, irvine  gavin herbert eye institute, irvine,   Ca, Usa Correspondence: Kamran hosseini   insite Vision incorporated,   965 atlantic avenue, alameda,   Ca 94501, Usa   Tel +1 510 865 8800   Fax +1 510 865 5700   email k hosseini@insite.co mPurpose:  The purpose of this study was to evaluate the clinical and antimicrobial efficacy and  safety of ISV -502 (1.0% azithromycin and 0.1% dexamethasone) compared to 1.0% azithromycin  or 0.1% dexamethasone in the treatment of subjects with blepharoconjunctivitis.",Non-OADS,/arxiv_data1/oa_pdf/5f/ac/opth-7-2225.PMC3829621.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5f/ac/opth-7-2225.PMC3829621.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/ac/opth-7-2225.PMC3829621.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/56/dddt-7-1341.PMC3829622.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1341–1357Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1341Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4010 7Animal models of ulcerative colitis   and their application in drug research Daren Low1 Deanna D Nguyen1,2 emiko Mizoguchi1,2 1Gastrointestinal Unit, Department  of Medicine, 2Center for the Study  of inflammatory Bowel Disease,   Massachusetts General Hospital   and Harvard Medical School,    Boston, MA, USA Correspondence: emiko Mizoguchi   Massachusetts General Hospital,   GRJ 825D, 55 Fruit Street,   Boston, MA 02114, USA   Tel +1 617 726 7892   Fax +1 617 726-3673   email emizoguchi@partners.or gAbstract:  The specific pathogenesis underlying inflammatory bowel disease is complex, and it  is even more difficult to decipher the pathophysiology to explain for the similarities and differ - ences between two of its major subtypes, Crohn’ s disease and ulcerative colitis (UC).",Non-OADS,/arxiv_data1/oa_pdf/11/56/dddt-7-1341.PMC3829622.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/11/56/dddt-7-1341.PMC3829622.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/56/dddt-7-1341.PMC3829622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/f3/ott-6-1625.PMC3829675.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1625–1630OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1625Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5303 0increased expression of microrna-335   predicts a favorable prognosis in primary   gallbladder carcinoma hong-hua Peng1 Yang-de Zhang2 lian-sheng gong2 Wei-dong liu2 Yang Zhang2 1Department of Oncology, Third  Xiangya hospital, central south  University, 2national hepatobiliary  and enteric surgery research  center, Xiangya hospital, central  south University, changsha, People’s  republic of china correspondence: Yang Zhang   national hepatobiliary and enteric   surgery research center, Xiangya   hospital, central south University,   87 Xiangya road, changsha 410008,  hunan Province, People’s   republic of china   Tel +86 731 8975 3060   Fax +86 731 8529 5260   email zhangyangcsu@sina.c nBackground:  MicroRNAs (miRNAs) display aberrant expression patterns and functional  abnormalities in many types of cancer.",Non-OADS,/arxiv_data1/oa_pdf/83/f3/ott-6-1625.PMC3829675.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/83/f3/ott-6-1625.PMC3829675.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/f3/ott-6-1625.PMC3829675.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/26/ott-6-1635.PMC3829676.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1635–1642OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1635Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5174 9Development of an immunotherapeutic  adenovirus targeting hormone-independent  prostate cancer Jae sik Kim1 sang Don lee2 sang Jin lee3 Moon Kee chung2 1Department of Urology, The catholic  University of Korea incheon st Mary’s  hospital, incheon, 2Pusan national  University Yangsan hospital and  research institute for convergence  of Biomedical science and T echnology,   Yangsan, 3genitourinary cancer  Branch, national cancer center,   goyang, Korea correspondence: Moon Kee chung   Department of Urology, Pusan national  University Yangsan hospital, Beomeo-ri,  Mulgeum-eup, Yangsan-si 626-770, Korea   Tel +82 55 360 2134   Fax +82 55 360 2164   email mkchung@pusan.ac.k rBackground:  To develop a targeting therapy for hormone-independent prostate cancer, we  constructed and characterized conditionally replicating oncolytic adenovirus (Ad) equipped  with mRFP (monomeric red fluorescence protein)/ttk (modified herpes simplex virus thymidine  kinase).",Non-OADS,/arxiv_data1/oa_pdf/83/26/ott-6-1635.PMC3829676.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/83/26/ott-6-1635.PMC3829676.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/26/ott-6-1635.PMC3829676.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/fd/ott-6-1643.PMC3829677.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1643–1647OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1643Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5191 4The hedgehog inhibitor cyclopamine antagonizes  chemoresistance of breast cancer cells Feng chai1 Jiangang Zhou1 cheng chen1 song Xie2 Xiao chen1 Ping su3 Jun shi3 1Oncology Department, 2general  surgery Department, 3hematology  Department, Zhejiang Xiaoshan  hospital, hangzhou, People’s   republic of china correspondence: Jun shi   hematology Department, Zhejiang  Xiaoshan hospital, 728 Yu cai Bei road,  hangzhou, Zhejiang 311200,   People’s republic of china   email zhejiang_xiaoshan@163.co mAbstract:  Chemoresistance of cancer cells has been a severe problem in multiple types of  cancers.",Non-OADS,/arxiv_data1/oa_pdf/99/fd/ott-6-1643.PMC3829677.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/99/fd/ott-6-1643.PMC3829677.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/fd/ott-6-1643.PMC3829677.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/a1/ott-6-1631.PMC3829678.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1631–1634OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1631Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S4819 5pulmonary adenocarcinoma with osseous   metaplasia: a rare occurrence possibly   associated with early stage?,Non-OADS,/arxiv_data1/oa_pdf/aa/a1/ott-6-1631.PMC3829678.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/ott-6-1631.PMC3829678.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/a1/ott-6-1631.PMC3829678.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/d5/ijwh-5-773.PMC3829679.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 773–780International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  773OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5152 8experiences of pregnancy and motherhood  among teenage mothers in a suburb of accra,  ghana: a qualitative study nana Yaa Konadu gyesaw1 augustine ankomah2 1regional Health Directorate, ghana  Health service, Koforidua, eastern  region, 2Department of Population,  Family and reproductive Health,  school of Public Health, University   of ghana, accra, ghana correspondence: augustine ankomah   Department of Population, Family   and reproductive Health, school of  Public Health, University of ghana,   PO Box lg13, legon, accra, ghana   email augankomah@gmail.co mBackground:  The proportion of teenage girls who are mothers or who are currently pregnant  in sub-Saharan African countries is staggering.",Non-OADS,/arxiv_data1/oa_pdf/9d/d5/ijwh-5-773.PMC3829679.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/9d/d5/ijwh-5-773.PMC3829679.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/d5/ijwh-5-773.PMC3829679.pdf
Available from:  http://www.unfpa.org/webdav/site/global/shared/documents/ publications/2007/giving_girls.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9d/d5/ijwh-5-773.PMC3829679.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/4f/vhrm-9-703.PMC3829709.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2013:9 703–709Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  703ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5218 7Lipid profiles and inflammatory markers after  periodontal treatment in children with congenital  heart disease and at risk for atherosclerosis adriana chassot Bresolin1 Mariana Menegassi  Pronsatti2 larissa nicole Pasqualotto2 Patricia Oehlmeyer Nassar3 alex sandro Jorge4 edson antonio alves da  silva5 carlos augusto nassar3 1Department of Biosciences and  Health, 2School of Dentistry,   3Department of Periodontology,   4School of Biochemistry, 5graduate  Program, Western Paraná state  University (UNIOESTE), Cascavel,   Paraná, Brazil correspondence: carlos augusto nassar   Western Paraná State University  (UNIOESTE), 504/593 Rua Pernambuco,  cascavel, Paraná 85810-020, Brazil   Tel +55 45 9101 3369   email canassar@yahoo.co mAbstract:  Due to the biological associations between periodontal and cardiovascular diseases,  as well as the fact that atherosclerosis begins in childhood, behavior based on oral health care  and me tabolic control from an early age is essential for patients with cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/e8/4f/vhrm-9-703.PMC3829709.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/e8/4f/vhrm-9-703.PMC3829709.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/4f/vhrm-9-703.PMC3829709.pdf
"Commun Integr Biol 2013; 6: e25020; http://dx.doi.org/10.4161/cib.25020The two-component system is a cellular signaling module com - posed of two proteins, a sensor histidine kinase and a response  regulator (RR)1 and it has been identified in both prokaryotes  and eukaryotes except the animal kingdom.",OADS,/arxiv_data1/oa_pdf/66/31/cib-6-e25020.PMC3829895.pdf
Mol Cell 2008; 30:108-13;  PMID:18406331; http://dx.doi.org/10.1016/j.mol - cel.2008.01.017 12.,OADS,/arxiv_data1/oa_pdf/66/31/cib-6-e25020.PMC3829895.pdf
Annu Rev Biochem  2000; 69:183-215; PMID:10966457; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/31/cib-6-e25020.PMC3829895.pdf
Nature 1995; 378:739-43; PMID:7501024;  http://dx.doi.org/10.1038/378739a0 5.,Non-OADS,/arxiv_data1/oa_pdf/66/31/cib-6-e25020.PMC3829895.pdf
"Commun  Integr Biol; 6: e25004; http://dx.doi.org/10.4161/cib.25004Honey bees meet all three traditional criteria for eusociality1,2  and are considered to be at the extreme of the eusociality contin - uum.3,4 One reason for this view is that they exhibit high repro - ductive inequity (skew) in favor of the queen, in part because  queens secrete chemicals that inhibit the development of workers’  ovaries.5,6 Because reproduction in a queenright honey bee colony  is funneled almost exclusively through the queen, the genetic  interests of colony members overlap greatly and the colony as a  whole is expected to function as a highly cooperative, integrated  and relatively harmonious “superorganism,”7,8 where individu - als partition their energy in favor of between-group competi - tion (i.e., within-group cooperation) rather than within-group  competition.9 However, inhibition of workers’ ovary development is not  perfect, providing opportunities for movement along a “superor - ganism continuum”9 as reproductive conflict increases within col - onies.",Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Can J Zool 1970; http://dx.doi.org/10.1139/z70-019 32.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Behav Ecol Sociobiol 2006;  60:815-25; http://dx.doi.org/10.1007/s00265-006- 0225-x 36.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Insectes Soc 2006; 49:80-5; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Behav Ecol Sociobiol 2001;  50:371-7; http://dx.doi.org/10.1007/s002650100376 38.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
"Psyche (Camb, Mass) 2010; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Neotrop Entomol 2008; 37:691-701;  PMID:19169558; http://dx.doi.org/10.1590/S1519- 566X2008000600011 41.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
J  Kans Entomol Soc 2004; 77:470-83; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
J Zool 1984; 205:411-24; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Insectes Soc 2012; 59:381-8; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
J Comp Physiol  B 2006; 176:55-63; PMID:16228242; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Biol Lett 2006; 2:577-9;  PMID:17148292; http://dx.doi.org/10.1098/ rsbl.2006.0549 21.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Curr Biol 2012; 22:2027- 31; PMID:23022065; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Naturwissenschaften 2013; 100:473-7;  PMID:23455897; http://dx.doi.org/10.1007/s00114- 013-1025-6 23.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Nature 2006; 444:50-9; PMID:17080043;  http://dx.doi.org/10.1038/444050a 24.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Curr Biol 2009; 19:78- 81; PMID:19135369; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Insectes Soc  2004; 51:1-11; http://dx.doi.org/10.1007/s00040- 003-0707-z 28.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Curr Biol 2012; 22:707- 11; PMID:22464193; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Nature 2006; 439:76-8;  PMID:16397498; http://dx.doi.org/10.1038/ nature04340References 1.,OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Insectes  Soc 1966; 13:145-53; http://dx.doi.org/10.1007/ BF02223020 2.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Behav Ecol 1995; 6:102-8;  http://dx.doi.org/10.1093/beheco/6.1.102 5.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Naturwissenschaften  2003; 90:477-80; PMID:14564409; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Behav Ecol  Sociobiol 1996; 39:237-44; http://dx.doi.org/10.1007/ s002650050286 11.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Behav Ecol Sociobiol 1989;  25:247-54; http://dx.doi.org/10.1007/BF00300050 13.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
Behav Ecol Sociobiol 1994; 35:99-107; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/cib-6-e25004.PMC3829896.pdf
"Commun Integr Biol 2013; 6: e 25036; http://dx.doi.org/10.4161/cib.25036Endocytic recycling is an intracellular process that returns inter - nalized molecules back to the plasma membrane,1,2 and it plays  crucial roles not only in the reuse of receptor molecules but in  remodeling of the protein and lipid composition of the plasma membrane.",Non-OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Nat  Rev Mol Cell Biol 2004; 5:121-32; PMID:15040445;  http://dx.doi.org/10.1038/nrm1315 2.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Nat Rev Mol Cell Biol 2009; 10:597-608; PMID:19696797; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Curr  Opin Cell Biol 2006; 18:549-57; PMID:16904305; http://dx.doi.org/10.1016/j.ceb.2006.08.003 4.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Biochem Soc T rans  2008; 36:395-9; PMID:18481967; http://dx.doi.org/10.1042/BST03603955.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
T rends  Cell Biol 2009; 19:317-24; PMID:19540123; http://dx.doi.org/10.1016/j.tcb.2009.05.001 6. van IJzendoorn SCD.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
J Cell Sci  2006; 119:1679-81; PMID:16636069; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
J Cell Biol  2004; 167:531-43; PMID:15534004; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Proc Natl Acad Sci USA 2011; 108:15846- 51; PMID:21911378; http://dx.doi.org/10.1073/ pnas.1109101108 18.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
J Cell Sci 2013;  In press; PMID:23572513; http://dx.doi.org/10.1242/jcs.117846.12.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
EMBO J 2008; 27:1183-96; PMID:18354496; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
T raffic  2010; 11:491-507; PMID:20070612; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Cell Struct Funct  2011; 36:155-70; PMID:21737958; http://dx.doi.org/10.1247/csf.11001 15.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
J Cell Sci 2012; 125:2235- 43; PMID:22344257; http://dx.doi.org/10.1242/ jcs.0986577.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Curr Opin Cell Biol 2010; 22:528-34;  PMID:20541925; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Nat Rev Mol Cell  Biol 2006; 7:347-58; PMID:16633337; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Nat Rev Mol Cell Biol 2009; 10:513- 25; PMID:19603039; http://dx.doi.org/10.1038/ nrm2728 11.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
Curr Biol  2006; 16:1719-25; PMID:16950109; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/cd/cib-6-e25036.PMC3829897.pdf
"Commun Integr Biol 2013;6: e25299;  http://dx.doi.org/10.4161/cib.25299There has been recent interest in the possibility that plant roots can show oriented collective motion, or swarming behav - ior.",Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Phys Rev Lett 1995; 75:1226- 9; PMID:10060237 ; http://dx.doi.org/10.1103/ PhysRevLett.75.1226 2.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Phys Rev Lett 2006 ; 96:180602 ;  PMID:16712353 ; http://dx.doi.org/10.1103/ PhysRevLett.96.180602 3.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Phys Rev Lett 2012 ; 108:098102 ;  PMID:22463670 ; http://dx.doi.org/10.1103/ PhysRevLett.108.0981024.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Phys Rep  2012 ; 517:71-140; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
PLoS ONE  2012 ; 7:e29759 ;  PMID:22272246 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Nature  2007 ; 445:715;  PMID:17301775 ; http://dx.doi.org/10.1038/445715a 8.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Cogn Syst Res 2010 ; 11:378-95;  http://dx.doi.org/10.1016/j.cogsys.2010.07.0029.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Biol Bull  1951 ; 100:173-7;  PMID:14838926 ; http://dx.doi.org/10.2307/1538527 13.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
"Diatom Res  2012 ; 27:95-100; http://dx.doi.org/10.10 80/0269249X.2012.690204female gametophyte,103,104 during the final stages of pollen tube  growth within the style.",Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Nature  2005 ; 433:513-6; PMID:15690039 ;  http://dx.doi.org/10.1038/nature03236 15.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
New Phytol  2005 ; 166:73-82; PMID:15760352 ;  http://dx.doi.org/10.1111/j.1469-8137.2004.01310.x 18.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Ecol Modell ing  2012 ; 234:20-30; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Anim Behav  2008 ; 76:217-36;  http://dx.doi.org/10.1016/j.anbehav.2008.02.002 22.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
PLoS ONE  2012 ; 7:e38895 ; PMID:22723904 ;  http://dx.doi.org/10.1371/journal.pone.0038895 24.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
EMBO Rep 2011 ; 12:1221 -5; PMID:22094270 ;  http://dx.doi.org/10.1038/embor.2011.218 30.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Nature  2010 ; 465:918-21;  PMID:20520609 ; http://dx.doi.org/10.1038/ nature09113 32.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
New Phytol  1971 ; 70:1079 - 088; http://dx.doi.org/10.1111/j.1469-8137.1971.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Protoplasma  1983 ;  116:91-8; http://dx.doi.org/10.1007/BF01279826 48.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
( http://horizon.documentation.ird.fr/exl- doc/pleins_textes/pleins_textes_4/biologie/17568.pdf) 49.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Mycol Res   2002 ; 106:349-54; http://dx.doi.org/10.1017/ S0953756202005579 51.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Proc Natl Acad Sci USA 2004 ; 101:3863 -7;  PMID:15004281 ; http://dx.doi.org/10.1073/ pnas.0306604101 63.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Biol Lett  2007 ; 3:435-8; PMID:17567552 ;  http://dx.doi.org/10.1098/rsbl.2007.0232 64.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Am J Bot  2009 ; 96:1990 -6;  PMID:21622319 ; http://dx.doi.org/10.3732/ ajb.0900006 65.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Acta Bot Gallica 1995 ;  142:23-30; http://dx.doi.org/10.1080/12538078.199 5.10515688 69.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Mycol  Res 1991 ; 94:1138 -41; http://dx.doi.org/10.1016/ S0953-7562(09)81346-4 74.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Plant Soil  2003 ; 248:1-19;  http://dx.doi.org/10.1023/A:1022314613217 78.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Trends Plant Sci 2002 ; 7:162- 7; PMID:11950612 ; http://dx.doi.org/10.1016/ S1360-1385(02)02241-0 79.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Nat Genet 2007 ; 39:792-6;  PMID:17496893 ; http://dx.doi.org/10.1038/ng2041 81.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
New Phytol  1975 ; 75:479- 90; http://dx.doi.org/10.1111/j.1469-8137.1975.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Plant Soil  2003 ; 248:85- 96; http://dx.doi.org/10.1023/A:1022342025447 83.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Aust J Bot 1966 ; 14:269-76;  http://dx.doi.org/10.1071/BT966026988.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Biotropica  1993 ; 25:28-35;  http://dx.doi.org/10.2307/2388976 90.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Tree Physiol  2011 ; 31:575-8; PMID:21778291 ;  http://dx.doi.org/10.1093/treephys/tpr061 91.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Science  1975 ; 190:804-6; http://dx.doi.org/10.1126/ science.190.4216.804 93.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Transactions  of the Botanical Society of Edinburgh 1962 ; 39:302- 15; http://dx.doi.org/10.1080/13594866209441713 95.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Science  2012 ; 338:217- 9; PMID:23066074 ; http://dx.doi.org/10.1126/ science.1222003 97.,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Commun Integr  Biol 2013 ; 6:e23197 ; http://dx.doi.org/10.4161/ cib.23197 101.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
org/10.1247/csf.10003 105. http://ngm.nationalgeographic.com/2009/12/ pollen/oeggerli-photography .,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
106. http://www.sciencephoto.com/media/515703/view .,Non-OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Cogn Syst Res 2008 ; 9:136-49;  http://dx.doi.org/10.1016/j.cogsys.2007.06.009 112.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
New J Phys 2013 ; 15:035029 ; PMID:23712128 ;  http://dx.doi.org/10.1088/1367-2630/15/3/035029 113.,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
Nat Cell Biol 2007 ; 9:1392 -400; PMID:18037882 ;  http://dx.doi.org/10.1038/ncb1658,OADS,/arxiv_data1/oa_pdf/b7/60/cib-6-e25299.PMC3829901.pdf
"Commun Integr Biol 2013; 6: e25145; http://dx.doi.org/10.4161/cib.25145The human immunodeficiency virus type I (HIV-1) encodes  three structural ( gag, pol and env), four accessory ( vif, vpr, vpu  and nef) and two regulatory ( tat and rev) genes, the products of  which are responsible for establishing sophisticated interactions  between the virus and human host.",Non-OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Proc Natl Acad Sci USA  1989; 86:6925-9; PMID:2476805; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Cell  Host Microbe 2011; 10:426-35; PMID:22100159;  http://dx.doi.org/10.1016/j.chom.2011.11.002 3.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Nature 1990; 345:84-6; PMID:2184372;  http://dx.doi.org/10.1038/345084a0 4.,Non-OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Cell Biol Int 2010; 34:409- 13; PMID:19995346; http://dx.doi.org/10.1042/ CBI20090376 5.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Proc Natl Acad Sci USA  2000; 97:11466-71; PMID:11027346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Exp Neurol  2005; 193:218-27; PMID:15817280; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Brain Res 2011; 1399:96- 115; PMID:21641584; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Traffic 2012; 13:355-63;  PMID:21951552; http://dx.doi.org/10.1111/j.1600- 0854.2011.01286.x 10.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
EMBO J 2010; 29:1348- 62; PMID:20224549; http://dx.doi.org/10.1038/ emboj.2010.3211.,Non-OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Ann  N Y Acad Sci 2002; 971:178-83; PMID:12438117;  http://dx.doi.org/10.1111/j.1749-6632.2002.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Nat Med 2000; 6:1380-7; PMID:11100124;  http://dx.doi.org/10.1038/82199 13.,Non-OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
J Cell Sci 2013; 126:454- 63; PMID:23178941; http://dx.doi.org/10.1242/ jcs.111658 15.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Nat Commun 2011;  2:491; PMID:21971506; http://dx.doi.org/10.1038/ ncomms150018.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Biochim Biophys Acta 2004; 1742:37- 49; PMID:15590054; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
J Biol Chem 2011; 286:8459-71; PMID:21187285;  http://dx.doi.org/10.1074/jbc.M110.171223 20.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Dev Cell 2011; 21:813-24; PMID:22075145;  http://dx.doi.org/10.1016/j.devcel.2011.09.005 21.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Methods Cell Biol  2012; 108:445-59; PMID:22325614; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
J Biol Chem 2008; 284:4836-45; PMID:19124467;  http://dx.doi.org/10.1074/jbc.M806894200 23.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
J Biol Chem 2007; 282:21746- 57; PMID:17540765; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Mol Biol Cell  2008; 19:485-97; PMID:18003982; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/2a/cib-6-e25145.PMC3829902.pdf
Commun Integr Biol 2013; 6: e25288;  http://dx.doi.org/10.4161/cib.25288Abstract It has recently been described that aging in C.  elegans  is accompanied by the progressive development  of morphological changes in the nervous system.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Nature 2002; 419:808-14; PMID:12397350;  http://dx.doi.org/10.1038/nature01135 2.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
PLoS Genet 2011; 7:e1002082; PMID:21625567; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Annu Rev Pathol 2008; 3:41-66; PMID:18039130; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Nature 2010; 464:529- 35; PMID:20336135; http://dx.doi.org/10.1038/ nature08983 8.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
J Neurosci 2011; 31:9279-88; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
J Comp Neurol 1998; 400:103- 9; PMID:9762869; http://dx.doi.org/10.1002/ (SICI)1096-9861(19981012)400:1<103::AID- CNE7>3.0.CO;2-D 15.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Prog Neurobiol 1995; 45:223-52; PMID:7777673; http://dx.doi.org/10.1016/0301- 0082(94)00047-L 17.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Nature 1993; 366:461-4; PMID:8247153;  http://dx.doi.org/10.1038/366461a0 19.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
PLoS Genet  2012; 8:e1003133; PMID:23284299; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
J Biol Chem  2010; 285:1822-8; PMID:19923212; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Mol Biol Cell 2003; 15:657- 64; PMID:14668486; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Genetics  2012; 190:1379-88; PMID:22298704; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
EMBO J  2001; 20:5114-28; PMID:11566876; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Science 2009; 323:802-6;  PMID:19164707; http://dx.doi.org/10.1126/sci- ence.1165527 29.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
EMBO  Rep 2002; 3:56-62; PMID:11751572; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Aging Cell 2013; In press; PMID:23496208  In press; PMID:23496208; http://dx.doi.org/10.1111/ acel.12070 33.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
J Biol Chem  2004; 279:54479-86; PMID:15269213; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
J Biol Chem 2008;  283:26217-27; PMID:18635541; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Science 2000; 290:147- 50; PMID:11021802; http://dx.doi.org/10.1126/sci- ence.290.5489.147 53.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Cold Spring Harb Symp Quant Biol 2003; 68:159- 70; PMID:15338614; http://dx.doi.org/10.1101/ sqb.2003.68.159 55.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Development  2003; 130:3781-94; PMID:12835394; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Neurobiol Dis 2011; 43:495- 506; PMID:21569846; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
J Biol Chem  2009; 284:20909-16; PMID:19491104; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Science 2008; 319:1086- 9; PMID:18202255; http://dx.doi.org/10.1126/sci- ence.1152993 50.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Dev Genes Evol 2008; 218:541-51;  PMID:18807071; http://dx.doi.org/10.1007/s00427- 008-0250-z38.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Hum Mol Genet  2007; 16:431-44; PMID:17210671; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Mutat Res  1990; 237:165-71; PMID:2233820; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Cold Spring Harb Symp Quant Biol 2011; 76:113- 20; PMID:22123849; http://dx.doi.org/10.1101/sqb.2011.76.010660 41.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Biochemistry 1996; 35:9415-23; PMID:8755720;  http://dx.doi.org/10.1021/bi952646n 42.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Neuron 2011; 70:410-26; PMID:21555069; http://dx.doi.org/10.1016/j.neuron.2011.04.009 45.,OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Neurodegener Dis 2010; 7:10-2; PMID:20160450; http://dx.doi.org/10.1159/000283475,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cib-6-e25288.PMC3829903.pdf
Commun  Integr Biol 2013; 6: e25219; http://dx.doi.org/10.4161/cib.25159Organisms are consistently exposed to parasites causing mor - bidity and mortality.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
"While  E. coli  T4r significantly outcompeted E. coli  HK97 under all conditions  (Malthusian fitness > 0, p < 0.001), E. coli  λ either experienced no relative  fitness benefit or the entire culture went extinct (these latter results  were initially published in Refardt et al.,22 http://dx.doi.org/10.1098/ rspb.2012.3035).",Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Adv Water Resour 2007; 30:1505-27; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Evolution 2009; 63:1406-16;  PMID:19222568; http://dx.doi.org/10.1111/j.1558- 5646.2009.00654.x 29.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Ecol Lett 2011; 14:635-42;  PMID:21521436; http://dx.doi.org/10.1111/j.1461- 0248.2011.01624.x 31.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Proc Biol Sci 2012; 279:1896- 903; PMID:22171085; http://dx.doi.org/10.1098/ rspb.2011.2259 32.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
ISME  J 2011; 5:1451-60; PMID:21412345; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Bacteriophage 2012; 2:98- 104; PMID:23050220; http://dx.doi.org/10.4161/ bact.2009213.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
PLoS Pathog 2011; 7:e1002320;  PMID:22174671; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Genes Dev 1992; 6:497- 510; PMID:1372278; http://dx.doi.org/10.1101/ gad.6.3.497 15.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Mol Microbiol  1995; 15:415-20; PMID:7540246; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Curr  Opin Microbiol 2005; 8:473-9; PMID:15979388;  http://dx.doi.org/10.1016/j.mib.2005.06.006 17.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Nat Rev Microbiol 2010; 8:317-27;  PMID:20348932; http://dx.doi.org/10.1038/nrmi - cro2315 18.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
I. J Theor Biol 1964; 7:1-16; PMID:5875341;  http://dx.doi.org/10.1016/0022-5193(64)90038-4 20.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Nat Rev Microbiol  2006; 4:597-607; PMID:16845430; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Ecol Lett 2013; 16:446- 53; PMID:23331662; http://dx.doi.org/10.1111/ ele.12064 22.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Proc Biol Sci  2013; 280:20123035; PMID:23516238; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Science 2007; 318:812-4; PMID:17975068;  http://dx.doi.org/10.1126/science.1148526 3.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Am Nat 2012; 179:52-63;  PMID:22173460; http://dx.doi.org/10.1086/663199 4.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Anim Behav 1992; 44:177-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Curr Biol 2010; 20:249- 52; PMID:20116243; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
J Evol Biol 2010; 23:1538-46;  PMID:20500363; http://dx.doi.org/10.1111/j.1420- 9101.2010.02022.x 9.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Nature 1987; 330:701; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Int J Parasitol  1995; 25:1371-83; PMID:8719948; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Curr Biol 2008; 18:R1021- 3; PMID:19000802; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Evolution 2011; 65:3-20;  PMID:20722725; http://dx.doi.org/10.1111/j.1558- 5646.2010.01103.x,OADS,/arxiv_data1/oa_pdf/c4/83/cib-6-e25159.PMC3829904.pdf
Commun Integr Biol 2013; 6: e25460; http://dx.doi.org/10.4161/cib.25460The superfamily of small GTPases serves as a signal transducer  to regulate a diverse array of cellular functions.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Proc Natl Acad Sci USA 2011; 108:17337- 42; PMID:21987812; http://dx.doi.org/10.1073/ pnas.1103516108 32.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
J Cell Sci 2011; 124:3989-4000; PMID:22159412;  http://dx.doi.org/10.1242/jcs.085407 34.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Nature 2010; 464:721-7; PMID:20360735; http://dx.doi.org/10.1038/nature08869 35.,Non-OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Gene 2002; 293:77-86; PMID:12137945;  http://dx.doi.org/10.1016/S0378-1119(02)00509-7 36.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Nature 2005; 436:415-9; PMID:16034420;  http://dx.doi.org/10.1038/nature0379816.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Nat Rev Mol Cell Biol 2001;  2:107-17; PMID:11252952; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Curr Biol 2012; 22:147-53; PMID:22226746;  http://dx.doi.org/10.1016/j.cub.2011.11.058 18.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
"J Cell Sci 2012; 125:2235-43; PMID:22344257; http://dx.doi.org/10.1242/ jcs.098657 19. van der Sluijs P , Hull M, Huber LA, Mâle P , Goud B, Mellman I. Reversible phosphorylation--dephosphor- ylation determines the localization of rab4 during the  cell cycle.",OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
J Biol Chem 2002; 277:32029- 35; PMID:12036958; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Dev Cell 2008; 15:371- 85; PMID:18804435; http://dx.doi.org/10.1016/j.devcel.2008.08.001 22.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Oncogene 2012;  31:3597-606; PMID:22120710; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
EMBO J 2006; 25:278-89; PMID:16395330;  http://dx.doi.org/10.1038/sj.emboj.7600929 24.,Non-OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
EMBO  J 1999; 18:1772-82; PMID:10202141; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
T raffic 2013; 14:502-18; PMID:23387408;  http://dx.doi.org/10.1111/tra.12057 26.,Non-OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
T raffic 2007; 8:1385- 403; PMID:17725553; http://dx.doi.org/10.1111/ j.1600-0854.2007.00612.x 27.,Non-OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Cell Cycle 2012; 11:1340-53;  PMID:22421161; http://dx.doi.org/10.4161/cc.19711References 1.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Science 2000; 290:1717- 21; PMID:11099404; http://dx.doi.org/10.1126/sci- ence.290.5497.1717 2.,Non-OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Nat Rev Mol Cell Biol 2009; 10:513- 25; PMID:19603039; http://dx.doi.org/10.1038/ nrm2728 3.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Curr Biol 2004; 14:R953- 5; PMID:15556852; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Cell 2007; 131:847-60;  PMID:18045532; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Biochem Soc T rans  2005; 33:1290-4; PMID:16246101; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
J Cell Biol 2008; 181:1047- 54; PMID:18573914; http://dx.doi.org/10.1083/ jcb.200712137 7.,Non-OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Eur J Cell Biol 2007; 86:25-35; PMID:17157409; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Curr Biol 2001; 11:735-46;  PMID:11378383; http://dx.doi.org/10.1016/S0960- 9822(01)00231-7 9.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Biochem Biophys Res Commun 2004; 319:83-94; PMID:15158446;  http://dx.doi.org/10.1016/j.bbrc.2004.04.157 10.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
EMBO J 2005; 24:3389- 99; PMID:16148947; http://dx.doi.org/10.1038/ sj.emboj.7600803 11.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Proc Natl Acad Sci USA 2003; 100:13314- 9; PMID:14585930; http://dx.doi.org/10.1073/ pnas.2234055100 12.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
J Biol Chem  2002; 277:27210-6; PMID:12016212; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Nat Rev Mol Cell  Biol 2006; 7:347-58; PMID:16633337; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Curr Biol  2006; 16:1719-25; PMID:16950109; http://dx.doi.org/10.1016/j.cub.2006.07.020,OADS,/arxiv_data1/oa_pdf/f1/37/cib-6-e25460.PMC3829921.pdf
Commun Integr Biol 2013;  6: e25177; http://dx.doi.org/10.4161/cib.25177 *Correspondence to: Jason A. Peiffer;   Email: japeiffe@ncsu.eduMaize is one of the most economi - cally important crops in the world.,Non-OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
"World Corn Production, Consumption, and  Stocks , http://www.fas.usda.gov/grain/grain.asp  (2013).",Non-OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
FEMS Microbiol Ecol  2008; 65:323-38; PMID:18547325; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
Commun Soil Sci Plant Anal 2012;  43:1263-72; http://dx.doi.org/10.1080/00103624.2 012.666302 6.,OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
Appl Environ Microbiol 2005; 71:8228-35;  PMID:16332807; http://dx.doi.org/10.1128/ AEM.71.12.8228-8235.2005 19.,Non-OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
PLoS Comput Biol 2010; 6:e1000667;  PMID:20195499; http://dx.doi.org/10.1371/jour - nal.pcbi.100066712.,OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
Plant Physiol  2003; 132:44-51; PMID:12746510; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
PLoS ONE  2012; 7:e30438; PMID:22363438; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
Nat Methods 2010; 7:335-6; PMID:20383131;  http://dx.doi.org/10.1038/nmeth.f.303 15.,OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
Ecology 2003;  84:511-25; http://dx.doi.org/10.1890/0012- 9658(2003)084[0511:CAOPCA]2.0.CO;2 16.,Non-OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
Plant Soil 2002; 239:133-40;  http://dx.doi.org/10.1023/A:1014959701396 8.,OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
Nature  2012; 488:86-90; PMID:22859206; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
Nat Rev Microbiol 2011; 9:279-90;  PMID:21407244; http://dx.doi.org/10.1038/nrmi - cro2540 10.,OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
Appl Microbiol  Biotechnol 2011; 89:917-30; PMID:21104242;  http://dx.doi.org/10.1007/s00253-010-3004-6 11.,Non-OADS,/arxiv_data1/oa_pdf/9a/f8/cib-6-e25177.PMC3829924.pdf
"Commun Integr Biol 2013;  6: e25446; http://dx.doi.org/10.4161/cib.25446Introduction In a recent publication, we showed that growth factor signaling  through the receptor tyrosine kinase FGFR1, increased cellular  levels of PI5P and concomitantly cell migration.1 PI5P produc - tion in this case, was due to a phosphoinositide metabolic loop  consisting of three enzymes; phosphatidylinositol-3-kinase class  III (PI3KC3), PIKfyve and MTMR3.",Non-OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
EMBO Rep 2013; 14:57- 64; PMID:23154468; http://dx.doi.org/10.1038/ embor.2012.183 2.,Non-OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
J Cell Physiol  2005; 205:452-62; PMID:16113997; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
J Cell Biol  2005; 169:789-99; PMID:15928202; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
Adv Biol Regul 2012; 52:40-5; PMID:21945524;  http://dx.doi.org/10.1016/j.advenzreg.2011.09.002 5.,OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
Cell Adh Migr 2012; 6:409- 12; PMID:23076053; http://dx.doi.org/10.4161/ cam.21192 6.,Non-OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
Bioessays 2013; 35:513- 22; PMID:23575577; http://dx.doi.org/10.1002/ bies.2012001717.,Non-OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
Cell Signal 2007; 19:1309-14;  PMID:17303380; http://dx.doi.org/10.1016/j.cell - sig.2007.01.010 8.,OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
Am J Physiol Renal Physiol  2008; 295:F1422-30; PMID:18753295; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
FEBS Lett 2008; 582:1391-4;  PMID:18364242; http://dx.doi.org/10.1016/j.febs - let.2008.03.022 10.,OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
EMBO Rep 2013; 14:214-5;  PMID:23392221; http://dx.doi.org/10.1038/ embor.2013.2 11.,Non-OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
FEBS Lett  2005; 579:2868-72; PMID:15876433; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
Endocrinology  2004; 145:4853-65; PMID:15284192; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
EMBO J 2002; 21:5069-78;  PMID:12356723; http://dx.doi.org/10.1093/emboj/ cdf522 14.,Non-OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
Cell 2003; 114:99-111;  PMID:12859901; http://dx.doi.org/10.1016/S0092- 8674(03)00480-X 17.,OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
J Cell Sci  2005; 118:2005-12; PMID:15840652; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
J Biol Chem  2007; 282:26245-56; PMID:17616529; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/54/cib-6-e25446.PMC3829926.pdf
"Commun Integr Biol 2013; 6: e25387;  http://dx.doi.org/10.4161/cib.25387*Correspondence to: Jennifer L. Ross;  Email: rossj@physics.umass.eduIntracellular transport is the process by  which cellular cargos, such as organ - elles and proteins, are moved throughout the cell.",OADS,/arxiv_data1/oa_pdf/82/72/cib-6-e25387.PMC3829930.pdf
Trends Neurosci 2010; 33:335-44; PMID:20434225; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/72/cib-6-e25387.PMC3829930.pdf
Trends Cell Biol 2004; 14:233-40; PMID:15130579;  http://dx.doi.org/10.1016/j.tcb.2004.03.009 4.,OADS,/arxiv_data1/oa_pdf/82/72/cib-6-e25387.PMC3829930.pdf
Proc Natl Acad Sci USA 2012; 109:20814-9; PMID:23213204; http://dx.doi.org/10.1073/ pnas.1209304109 7.,OADS,/arxiv_data1/oa_pdf/82/72/cib-6-e25387.PMC3829930.pdf
Nature 1993; 365:721-7; PMID:8413650; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/72/cib-6-e25387.PMC3829930.pdf
Cell 1994; 77:773-84;  PMID:8205624; http://dx.doi.org/10.1016/0092- 8674(94)90060-4 9.,OADS,/arxiv_data1/oa_pdf/82/72/cib-6-e25387.PMC3829930.pdf
Macromolecules 2012; 45:8494-501; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/72/cib-6-e25387.PMC3829930.pdf
Commun  Integr Biol 2013; 6: e25260; http://dx.doi.org/10.4161/cib.25260,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
e25260-2  Communicative & Integrative Biology  Volume 6 Issue 5(LOC_Os09 g39780) was received from the Rice Genome  Annotation Project funded by NSF (http://rice.plantbiology.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
"The protein domain search, performed in the NCBI Conserved  Domain Database (NCBICDD; http://www.ncbi.nl m.nih.",OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
The human cyclophilin  A (PDB-ICWA) was used as template to generate model for  cyclophilins from rice (LOC_Os09 g39780) using ExPasy swiss  model web server (http://swissmodel.expasy.org).,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
The STRING computer ser - vice (http://string-db.org/) was used to find out the predicted  protein-protein interaction for OsCYP-25 rice cyclophilin.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
"The comparative study of amino acid  sequences of OsCYP-25 was performed using the UniProt  BlastP Service (http://www.uniprot.org/blast/), which revealed  a 87.36 and 74% similarities with CyP-S from Sorghum sp and  CyP-P from poplar ( Liriodendron  sp) ( Table  2).",OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
STRING program (http://string-db.org/) was used for the bioinformatic prediction of protein- protein interaction.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
e25260-6  Communicative & Integrative Biology  Volume 6 Issue 5multiple amino acid sequence alignment using Clustal W 2.0  program (http://www.ebi.ac.uk/clustalw).,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
"The  protein domain search, performed in the NCBI Conserved  Domain Database (NCBICDD; http://www.ncbi.nl m.nih.",OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
The human cyclophilin A (PDB-ICWA) was used as  template to generate model for cyclophilins from Rice (LOC_ Os09 g39780) and were created using ExPasy swiss model web  server (http://swissmodel.expasy.org).,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
PLACE (http://www.dna.affrc.go.jp/PLACE/) were  used to analyze the cis-acting regulatory elements and to ana - lyze the OsCYP-25 promoter sequences (http://rice.plantbiol - ogy.msu.edu).,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
The  protein-protein interaction for OsCYP-25 rice cyclophilin was  made using STRING computer service (http://string-db.org/).,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
The genomic  sequence of cyclophilin (OsCYP-25) (LOC_Os09 g39780) was  received from the Rice Genome Annotation Project funded by  NSF (http://rice.plantbiology.msu.edu/).,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Biochemistry 1997; 36:8224- 30; PMID:9204867; http://dx.doi.org/10.1021/ bi970288d 34.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant J 1993; 4:265-78;  PMID:8220482; http://dx.doi.org/10.1046/j.1365- 313X.1993.04020265.x 35.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Appl Environ Microbiol  2006; 72:4001-6; PMID:16751508; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Neuroreport  2002; 13:2429-32; PMID:12499843; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Hum Mol Genet 2004; 13:1535- 49; PMID:15175272; http://dx.doi.org/10.1093/hmg/ ddh167 40.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Biochem Soc Trans 2004; 32:571- 4; PMID:15270678; http://dx.doi.org/10.1042/ BST0320571 41.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Nature 2005; 433:326-30; PMID:15662426;  http://dx.doi.org/10.1038/nature03229 42.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Cell 2005; 17:2791- 804; PMID:16141451; http://dx.doi.org/10.1105/ tpc.105.034454 43.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Cell Rep  2012; 31:417-26; PMID:22041789; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
J Plant  Biochem Biotechnol 2003; 12:77-80; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Cell  2012; 24:2666-74; PMID:22706283; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Structure  2001; 9:431-8; PMID:11377203; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
BMC Plant  Biol 2011; 11:34; PMID:21324151; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
FEBS Lett 2013; 587:666-72; PMID:23376614;  http://dx.doi.org/10.1016/j.febslet.2013.01.028 22.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Physiol 2004; 134:1268- 82; PMID:15051864; http://dx.doi.org/10.1104/ pp.103.022160 23.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
EMBO J 1999; 18:4689-99; PMID:10469648;  http://dx.doi.org/10.1093/emboj/18.17.4689 24.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Mol Biol Rep  2011; 29:681-692; http://dx.doi.org/10.1007/s11105- 010-0275-0 26.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Genet Mol Res 2013; 12:293-301;  PMID:23408416; http://dx.doi.org/10.4238/2013.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
PLoS One  2013; 8:e57803; PMID:23469243; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Methods Enzymol 2007; 428:419-38;  PMID:17875432; http://dx.doi.org/10.1016/S0076- 6879(07)28024-3 29.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Int J Mol Sci  2013; 14:5842-78; PMID:23485989; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
RNA 2006; 12:631- 43; PMID:16497658; http://dx.doi.org/10.1261/ rna.2226106 31.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Biochem J 2005; 388:819-26; PMID:15686447;  http://dx.doi.org/10.1042/BJ20041297References 1.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Signal Behav  2012; 7:1138-43; PMID:22899052 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Science  1982; 218:443-8; PMID:17808529; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Curr Opin Plant Biol 2008; 11:171- 9; PMID:18329330; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Adv Agron 2008; 97:45-110; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Nature 2002; 418:671-7; PMID:12167873;  http://dx.doi.org/10.1038/nature01014 7.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant J 2010; 61:1041-52;  PMID:20409277; http://dx.doi.org/10.1111/j.1365- 313X.2010.04124.x 9.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Physiol Plant 2010; 138:405-13;  PMID:20028478; http://dx.doi.org/10.1111/j.1399- 3054.2009.01321.x 10.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
PLoS  One 2011; 6:e14823; PMID:21750695; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Genome Res  2005; 15:1643-50; PMID:16339361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Signal  Behav 2012; 7:1653-66; http://dx.doi.org/10.4161/ psb.22306 15.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Physiol 2004; 134:1268- 82; PMID:15051864; http://dx.doi.org/10.1104/ pp.103.022160 16.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Cell 2007; 19:2403- 16; PMID:17704213; http://dx.doi.org/10.1105/ tpc.107.053579,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Signal Behav 2011; 6:1079- 86; PMID:21778827; http://dx.doi.org/10.4161/ psb.6.8.15771 51.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Methods  2001; 25:402-8; PMID:11846609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Nucleic Acids Res 1999; 27:297- 300; PMID:9847208; http://dx.doi.org/10.1093/ nar/27.1.297 49.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Plant Signal Behav 2012; 7:733-740; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
Acta Crystallogr Sect F Struct Biol Cryst Commun  2012; 68:709-12; PMID:22684077; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/8f/cib-6-e25260.PMC3829931.pdf
"J  Biol Chem 2013; 288:9835-47; PMID:23430262;  http://dx.doi.org/10.1074/jbc.M112.427591Keywords:  axon, dendrite, guanine  nucleotide exchange factor (GEF), hip - pocampal neurons, polarized trafficking,  Rab17, Rabex-5, Rab-type small GTPase Submitted: 05/30/13 Revised: 06/16/13 Accepted: 06/17/13 Citation: Mori Y, Fukuda M. Rabex-5 determines the  neurite localization of its downstream Rab proteins  in hippocampal neurons.",OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
"Commun Integr Biol  2013; 6: e25433; http://dx.doi.org/10.4161/cib.25433 *Correspondence to: Mitsunori Fukuda;   Email: nori@m.tohoku.ac.jpRab family small GTPases function as  molecular switches in the regulation  of membrane traffic, and their activity  is thought to be controlled by guanine  nucleotide exchange factors (GEFs).",OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Traffic  2011; 12:627-43; PMID:21291502; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
J Cell Sci 2012; 125:1465-77; PMID:22328529;  http://dx.doi.org/10.1242/jcs.092916 10.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
J Biol Chem 2012; 287:8963-73;  PMID:22291024; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Neuron  2010; 67:588-602; PMID:20797536; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
J Neurosci 2013; 33:6112- 22; PMID:23554492; http://dx.doi.org/10.1523/ JNEUROSCI.4630-12.2013 13.,Non-OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Cell 1997; 90:1149-59; PMID:9323142;  http://dx.doi.org/10.1016/S0092-8674(00)80380-3 14.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Hum Mol Genet  2003; 12:1671-87; PMID:12837691; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
J Biol Chem 2013; 288:9835-47; PMID:23430262;  http://dx.doi.org/10.1074/jbc.M112.427591 16.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Curr Opin Cell Biol  2010; 22:479-87; PMID:20466533; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Cell 2004; 118:607-17; PMID:15339665;  http://dx.doi.org/10.1016/j.cell.2004.08.009 19.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Curr Opin Cell Biol 2013; PMID:23639309;  http://dx.doi.org/10.1016/j.ceb.2013.04.002Rab proteins to neurites at the cellular level.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Cell Mol Life Sci 2008; 65:2801- 13; PMID:18726178; http://dx.doi.org/10.1007/ s00018-008-8351-4 2.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Nat Rev Mol Cell Biol 2009; 10:513- 25; PMID:19603039; http://dx.doi.org/10.1038/ nrm2728 3.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Curr  Opin Cell Biol 2010; 22:461-70; PMID:20466531;  http://dx.doi.org/10.1016/j.ceb.2010.04.007 4.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
J Cell Biol 2010; 191:367-81; PMID:20937701;  http://dx.doi.org/10.1083/jcb.201008051 5.,Non-OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
J Cell Biol 1993; 121:553- 64; PMID:8486736; http://dx.doi.org/10.1083/ jcb.121.3.553 6.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
J Biol Chem 1998;  273:15734-41; PMID:9624171; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
J Cell Biol 1998; 140:1039- 53; PMID:9490718; http://dx.doi.org/10.1083/ jcb.140.5.1039the future it would be interesting to search  for Rab17-specific effectors that form a  link between Rabex-5 and motor proteins.,Non-OADS,/arxiv_data1/oa_pdf/82/98/cib-6-e25433.PMC3829932.pdf
Commun Integr Biol 2013; 6: e25466; http://dx.doi.org/10.4161/cib.25466Wound healing is a combination of cellular and molecular pro - cesses aimed at restoring the original architecture of damaged  tissues.,Non-OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
Nat Med  2012; 18:1369-77; PMID:22941276; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
Curr Opin Rheumatol  2013; 25:101-7; PMID:23114590; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
J Cell Sci  2009; 122:3209-13; PMID:19726630; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
J Diabetes Complications 2012; 26:554-61;  PMID:22739801; http://dx.doi.org/10.1016/j.jdia - comp.2012.05.015 5.,Non-OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
EMBO  Rep 2009; 10:881-6; PMID:19575012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
J Invest Dermatol  2012; 132:1908-17; PMID:22437320; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
Circ Res 2009; 104:1095- 102; PMID:19342601; http://dx.doi.org/10.1161/ CIRCRESAHA.108.1921388.,Non-OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
J Invest Dermatol 2008; 128:1545- 53; PMID:18239618; http://dx.doi.org/10.1038/ sj.jid.5701212 9.,Non-OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
J Biol Chem 2013; 288:11004- 12; PMID:23463510; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
Microsurgery 2005; 25:442-51; PMID:16044466;  http://dx.doi.org/10.1002/micr.20168 11.,Non-OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
Nanomedicine 2012; 8:1364- 71; PMID:22406184; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
Am J Pathol  2012; 180:1465-73; PMID:22306734; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
Bioorg Med Chem 2011; 19:3690- 701; PMID:21292492; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
J Biol Chem 2003; 278:19134- 40; PMID:12624111; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
J Cell Sci 2010; 123:3718- 26; PMID:20940255; http://dx.doi.org/10.1242/ jcs.068924,OADS,/arxiv_data1/oa_pdf/84/97/cib-6-e25466.PMC3829946.pdf
"Nat Commun 2013; 4:1634; PMID:23535655; http://dx.doi.org/10.1038/ncomms2648Keywords:  neonicotinoid, nicotinic   acetylcholine receptor, pollinator, apis  mellifera, mushroom body Submitted: 04/15/13Revised: 05/15/13Accepted: 05/16/13 Citation: Connolly CN.",Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Commun Integr Biol 2013; 6: e25074; http://dx.doi.org/10.4161/cib.25074Correspondence to: Christopher N. Connolly;   Email: c.n.connolly@dundee.ac.ukA key new risk to our pollinators has  been identified as exposure to neo - nicotinoid insecticides.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
"Therefore, the European Commission exercised their right to decide to push forward the moratorium, which will apply from December 1, 2013, until new information on the safety of these prod - ucts is available (http://europa.eu/rapid/press-release_IP-13-379_en.htm).",Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Environ Toxicol 2013; In  press; http://dx.doi.org/10.1002/tox.21842.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Microsc Res Tech 2013; 76:552-8; PMID:23483717;  http://dx.doi.org/10.1002/jemt.22199 15.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
"Copenhagen: European Environment Agency (EEA),  2013: 401-438. http://www.eea.europa.eu/publica - tions/late-lessons-2/late-lessons-chapters/late-les - sons-ii-chapter-16/view 16.",Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Science 2013; 340:675;  PMID:23661735; http://dx.doi.org/10.1126/sci - ence.340.6133.675References 1.,OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Ecotoxicology 2012; 21:973-92; PMID:22350105;  http://dx.doi.org/10.1007/s10646-012-0863-x 2.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Toxicology 2013; 309:39-51; PMID:23603429; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Zoology (Jena) 2012; 115:365-71; PMID:23044068; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Annu Rev Entomol 2007; 52:81-106; PMID:16842032; http://dx.doi.org/10.1146/annurev.ento.52.110405.091440 5.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Science 2012; 336:351-2; PMID:22461500; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Nature 2012; 491:105- 8; PMID:23086150; http://dx.doi.org/10.1038/ nature11585 7.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Stroke  2012; 43:2483-90; PMID:22738920; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
BMC Med  2012; 10:129; PMID:23106849; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
Nat Commun 2013; 4:1634; PMID:23535655; http://dx.doi.org/10.1038/ncomms2648 10.,OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
J Exp Biol 2013; In press;  http://dx.doi.org/10.1242/jeb.083931.,OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
"Science  2012; 336:348-50; PMID:22461498; http://dx.doi.org/10.1126/science.1215039specific alternatives, side by side, at the  pharmacological, physiological, individ-ual bee and colony level, it will be possible to step forward, one step at a time, toward progressively less toxic methods of con - trolling insect pests.",Non-OADS,/arxiv_data1/oa_pdf/16/6c/cib-6-e25074.PMC3829947.pdf
"Science 2013;  339:443–6; PMID:23349290;   http://dx.doi.org/10.1126/science.1227170Keywords:  long-term memory,  Drosophila , CREB, CRTC, CBP, insulin  signaling Submitted: 05/22/13 Accepted: 05/23/13 Citation: Hirano Y, Saito M. Hunger and memory;  CRTC coordinates long-term memory with the  physiological state, hunger.",Non-OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
"Commun Integr Biol  2013; 6: 25152; http://dx.doi.org/10.4161/cib.25152 *Correspondence to: Yukinori Hirano and Minoru  Saitoe; Email: hirano-yk@igakuken.or.jp and   saito-mn@igakuken.or.jpAnimals form and store memory,  which advantageously adjusts their  behavior later on.",OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Neuron  2012; 74:246-60; PMID:22542179; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Genetics  2004; 167:311-23; PMID:15166157; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Neuron 2006; 52:845-55;  PMID:17145505; http://dx.doi.org/10.1016/j.neu - ron.2006.10.030 5.,OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
J Neurosci 2008; 28:3103- 13; PMID:18354013; http://dx.doi.org/10.1523/ JNEUROSCI.5333-07.2008 6.,Non-OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Cell 1994; 79:49-58;  PMID:7923376; http://dx.doi.org/10.1016/0092- 8674(94)90399-9 7.,OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Cell 1994; 79:35-47; PMID:7923375;  http://dx.doi.org/10.1016/0092-8674(94)90398-0after the training ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Science  2012; 335:678-85; PMID:22323813; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Nat Rev Mol Cell Biol 2011; 12:141- 51; PMID:21346730; http://dx.doi.org/10.1038/ nrm3072 10.,OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Nature  2007; 449:366-9; PMID:17805301; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Cell Metab 2008; 7:434-44; PMID:18460334;  http://dx.doi.org/10.1016/j.cmet.2008.02.010 12.,OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
Science  2013; 339:440-2; PMID:23349289; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/e7/cib-6-e25152.PMC3829949.pdf
"OncoImmunology 2013; 2:e24959; http://dx.doi.org/10.4161/comment t o: Lujambio a , akkari L, s imon J,  Grace d , tschaharganeh d F, Bolden JE, et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
cell 2013; 153:449-60; PMI d:23562644;   http://dx.doi.org/10.1016/j.cell.2013.03.020by Lujambio et al.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Nature  1992; 358:15-6; PMID:1614522; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Cell 1997; 88:323-31; PMID:9039259; http://dx.doi.org/10.1016/S0092-8674(00)81871-1 3.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Cell  2013; 153:449-60; PMID:23562644; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
PLoS Biol  2008; 6:2853-68; PMID:19053174; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Genes Dev 2011; 25:2125-36; PMID:21979375; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Nature 2008; 454:436-44;  PMID:18650914; http://dx.doi.org/10.1038/ nature07205 8.,Non-OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Cell 2010; 140:883-99;  PMID:20303878; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
ScientificWorldJournal 2011; 11:2391-402; PMID:22194670; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
J Clin Invest 2012; 122:787-95; PMID:22378047; http://dx.doi.org/10.1172/ JCI59643 11.,Non-OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Cancer Lett 2008; 267:204-15; PMID:18448242; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
World J Gastroenterol 2012; 18:4071-81; PMID:22919237;  http://dx.doi.org/10.3748/wjg.v18.i31.4071 13.,Non-OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Surg  Today 2012; 42:1-7; PMID:22116397; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Hepatology 2009; 50:1464-74; PMID:19821482; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Oncogene 2009; 28:4022-33; PMID:19718050; http://dx.doi.org/10.1038/onc.2009.25317.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Cancer Res 2004; 64:6058-64; PMID:15342387; http://dx.doi.org/10.1158/0008- 5472.CAN-04-0292 20.,Non-OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Cell 2005; 121:977- 90; PMID:15989949; http://dx.doi.org/10.1016/j.cell.2005.04.014 21.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Cancer Cell 2007; 11:119- 32; PMID:17292824; http://dx.doi.org/10.1016/j.ccr.2006.12.016 22.,Non-OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
Nature  2004; 431:461-6; PMID:15329734; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/04/onci-2-e24959.PMC3829950.pdf
"Commun Integr Biol 2013; 6:e25030; http://dx.doi.org/10.4161/cib.25030Introduction Physarum polycephalum  is a true acellular slime mold that belongs  to the species of order Physarales , subclass Myxo-gastromycetidae ,  class Myxomycetes , division Myxostelida .",Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Biosystems 2004; 73:45- 55; PMID:14729281; http://dx.doi.org/10.1016/j.bio - systems.2003.08.001 27.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Int J Bifurcat Chaos 2009; 19:3109-17; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Biophys Chem 1999;  82:23-8; PMID:17030338; http://dx.doi.org/10.1016/ S0301-4622(99)00099-X 31.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Naturwissenschaften 2007; 94:975-80;  PMID:17603779; http://dx.doi.org/10.1007/s00114- 007-0276-5 32.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Cell Biol Int Rep  1981; 5:375-9; PMID:7226252; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Chaos Solitons Fractals  2009; 41:1605-15; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
J Cell  Biol 1976; 69:223-6; PMID:1254647; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
J Chem Ecol 1988;  14:1965-75; http://dx.doi.org/10.1007/BF0101348914.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
FEMS  Microbiol Lett 1985; 26:195-200; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Exp Cell  Res 1976; 100:337-44; PMID:945771; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Soft Matter and Biological  Physics 2010; 31:403-10; http://dx.doi.org/10.1140/ epje/i2010-10589-y 17.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Proc Natl Acad Sci USA 2010; 107:4607- 11; PMID:20142479; http://dx.doi.org/10.1073/ pnas.0912198107 18.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Comp  Biochem Physiol Part A Physiol 1978; 60:269-72;  http://dx.doi.org/10.1016/0300-9629(78)90247-5 19.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Biophysics (Oxf) 2006; 51:758-63;  http://dx.doi.org/10.1134/S0006350906050150 20.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Biosystems 2013; 112:1- 10; PMID:23438635; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Nature Proc 2011; http://dx.doi.org/10.1038/ npre.2011.5985.1 22.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Commun Integr  Biol 2012; 5:297-9; PMID:22896798; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Biochim  Biophys Acta 1979; 588:332-41; PMID:228761;  http://dx.doi.org/10.1016/0304-4165(79)90341-6 24.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
J Cell Biol 1965; 25:361- 74; PMID:14287186; http://dx.doi.org/10.1083/ jcb.25.2.361 3.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Cell Tissue Res 1981; 217:479- 95; PMID:7195774; http://dx.doi.org/10.1007/ BF00219359 4.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
J Cell Biol 1976;  69:218-23; PMID:943401; http://dx.doi.org/10.1083/ jcb.69.1.218 6.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Exp Cell  Res 1978; 116:365-75; PMID:30643; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
J Gen Microbiol  1970; 63:221-6; PMID:5534501; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
J Gen Microbiol 1977; 102:145-8;  http://dx.doi.org/10.1099/00221287-102-1-145 13.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Exp Cell Res 1978; 116:377-85; PMID:710529;  http://dx.doi.org/10.1016/0014-4827(78)90461-55590) attached to a PC.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
J Chem Ecol 2009; 35:1302-8;  PMID:19936835; http://dx.doi.org/10.1007/s10886- 009-9712-741.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
J  Am Chem Soc 2006; 128:8128-9; PMID:16787064;  http://dx.doi.org/10.1021/ja062669x 43.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
Ecol Lett 2010; 13:643-56;  PMID:20337694; http://dx.doi.org/10.1111/j.1461- 0248.2010.01451.x38.,OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
J Cell Comp Physiol 1962; 59:259-63;  PMID:14478116; http://dx.doi.org/10.1002/ jcp.1030590305 40.,Non-OADS,/arxiv_data1/oa_pdf/b1/82/cib-6-e25030.PMC3829954.pdf
"Commun Integr Biol 2013; 6: e25421;  http://dx.doi.org/10.4161/cib.25421RIN1 is a RAS effector protein.1 Through a guanine nucleotide  exchange factor (GEF) domain,2 RIN1 activates RAB5 GTPases  that promote early endosome maturation.3 In addition, RIN1  directly binds to and activates ABL tyrosine kinases.4,5 RIN1 asso - ciates directly with activated EGFR6 and binds STAM proteins that  escort receptors to lysosomes for degradation.7 RIN1 sub-cellular  localization, and hence its availability for interactions, is regulated  by binding 14-3-3 proteins that favor cytoplasmic positioning.8 Overexpression of RIN1 in HeLa cells increased RAB5 activ - ity and enhanced EGFR degradation compared with control cells, while silencing endogenous RIN1 had the opposite effect.",Non-OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Dev Cell 2001;  1:73-82; PMID:11703925; http://dx.doi.org/10.1016/ S1534-5807(01)00008-9 3.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Arch Biochem Biophys 2009; 482:83- 95; PMID:19032933; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
J Biol Chem 2008; 283:31401-7; PMID:18796434;  http://dx.doi.org/10.1074/jbc.M804002200 5.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Proc Natl Acad Sci  USA 1997; 94:4954-9; PMID:9144171; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
J Biol Chem  2003; 278:32027-36; PMID:12783862; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
J Biol Chem 2007; 282:15294- 301; PMID:17403676; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Mol Cell Biol 2002; 22:916-26; PMID:11784866;  http://dx.doi.org/10.1128/MCB.22.3.916-926.2001 9.,Non-OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
J Cell Sci 2012; 125:5887- 96; PMID:22976291; http://dx.doi.org/10.1242/ jcs.113688 10.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
J Cell Biol  2000; 151:539-50; PMID:11062256; http://dx.doi.org/10.1083/jcb.151.3.53911.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
J Biol Chem 2006; 281:32714-23; PMID:16943190;  http://dx.doi.org/10.1074/jbc.M603126200 12.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
T raffic 2012; 13:329-37; PMID:22017370;  http://dx.doi.org/10.1111/j.1600-0854.2011.01305.x 13.,Non-OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Nature  2004; 429:309-14; PMID:15152255; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Cell 2008; 134:135-47; PMID:18614017; http://dx.doi.org/10.1016/j.cell.2008.05.034 15.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Curr Biol 2005; 15:815-23; PMID:15886098; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Sci Signal 2010; 3:re6; PMID:20841568; http://dx.doi.org/10.1126/ scisignal.3139re6,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Mol Cell Biol 2008; 28:1573- 83; PMID:18160707; http://dx.doi.org/10.1128/ MCB.01087-07 24.,Non-OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Cancer Res 2007; 67:11510-6; PMID:18089779;  http://dx.doi.org/10.1158/0008-5472.CAN-07-114720.,Non-OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
J Cell Biol  2008; 182:741-52; PMID:18725540; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Infect Immun 2009; 77:60-9;  PMID:18936177; http://dx.doi.org/10.1128/ IAI.00639-08 22.,Non-OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
J Cell Sci 2003; 116:4159-68;  PMID:12972505; http://dx.doi.org/10.1242/ jcs.00718 18.,OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
Infect Immun 2012; 80:1252- 66; PMID:22158742; http://dx.doi.org/10.1128/IAI.06082-11,Non-OADS,/arxiv_data1/oa_pdf/65/94/cib-6-e25421.PMC3829955.pdf
"Commun Integr Biol 2013; 6: e25429; http://dx.doi.org/10.4161/cib.25429To Have a Look Upstream:   The Culprit(s) of the Changes in Ca2+ Signaling The role of Ca2+ signaling in autophagy regulation was met  with a great deal of controversy in the past years, with reports  suggesting inhibitory, as well as stimulatory, effects of Ca2+  on autophagy.1 We recently investigated the role of intracellu - lar Ca2+ homeostasis/signaling in canonical mTOR-controlled  autophagy upon rapamycin treatment.2 Rapamycin activates  autophagy via the inhibition of mTOR, which is regarded as a key regulator of autophagy, leading to its stimulation through a canonical pathway, involving downstream of mTOR, the ULK1 complex, the PI3K complex III (including Beclin 1), Atg5, Atg7 and LC3.",Non-OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
Cell Calcium  2011; 50:242-50; PMID:21571367; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
Autophagy 2011; 7:1472-89; PMID:22082873; http://dx.doi.org/10.4161/ auto.7.12.17909 4.,Non-OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
J Cell Biol  2005; 170:1101-11; PMID:16186256; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
Cell 2010; 142:270-83; PMID:20655468;  http://dx.doi.org/10.1016/j.cell.2010.06.007 6.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
Biochim Biophys Acta 2011; 1813:1003-13; PMID:21146562;  http://dx.doi.org/10.1016/j.bbamcr.2010.11.023 7.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
Mol Cell 2007; 25:193- 205; PMID:17244528; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
J Biol Chem 2008; 283:15370- 80; PMID:18356160; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
Cell Mol Life Sci  2008; 65:3640-52; PMID:18850067; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
Autophagy 2010; 6:506- 22; PMID:20505359; http://dx.doi.org/10.4161/ auto.6.4.11863 11.,Non-OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
Mol Pharmacol 2011; 80:1066-75;  PMID:21896713; http://dx.doi.org/10.1124/ mol.111.071761 12.,Non-OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
J Biol Chem 2011; 286:27875- 81; PMID:21610076; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
Nature  2009; 459:596-600; PMID:19387438; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
J Cell Sci 2013; 126:289- 300; PMID:23097044; http://dx.doi.org/10.1242/ jcs.116103 17.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
J Cell Sci 2013; 126:60- 6; PMID:23108667; http://dx.doi.org/10.1242/ jcs.118836 18.,OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
J Cell Biol 2013; 200:789- 805; PMID:23479744; http://dx.doi.org/10.1083/ jcb.201204078,Non-OADS,/arxiv_data1/oa_pdf/07/7b/cib-6-e25429.PMC3829968.pdf
http://dx.doi.org/10.1016/j.fob.2013.10.005,OADS,/arxiv_data1/oa_pdf/ef/52/main.PMC3829987.pdf
http://dx.doi.org/10.1016/j.fob.2013.10.003,OADS,/arxiv_data1/oa_pdf/b9/79/main.PMC3829988.pdf
http://dx.doi.org/10.1016/j.fob.2013.08.008,OADS,/arxiv_data1/oa_pdf/04/e7/main.PMC3829989.pdf
"[13] Accelrys Software  Inc., Discovery  studio modeling  environment,  Release  3.5, San Diego: Accelrys Software  Inc.; 2012, http://accelrys.com/products/   discovery-studio/  .",OADS,/arxiv_data1/oa_pdf/04/e7/main.PMC3829989.pdf
http://dx.doi.org/10.1021/ci400025f  .,Non-OADS,/arxiv_data1/oa_pdf/04/e7/main.PMC3829989.pdf
http://dx.doi.org/10.1016/j.fob.2013.09.002,OADS,/arxiv_data1/oa_pdf/5d/f8/main.PMC3829990.pdf
http://dx.doi.org/10.1016/j.fob.2013.10.008,OADS,/arxiv_data1/oa_pdf/28/3f/main.PMC3829991.pdf
http://dx.doi.org/10.1016/j.fob.2013.10.009,OADS,/arxiv_data1/oa_pdf/6a/25/main.PMC3829992.pdf
http://dx.doi.org/10.1016/j.fob.2013.09.008,OADS,/arxiv_data1/oa_pdf/74/3b/main.PMC3829993.pdf
"http://dx.doi.org/10.1016/j.redox.2013.10.005Abbreviations: DTT, Dithiothreitol; EGSH, Half cell reduction potential of glutathione; ER, Endoplasmic reticulum; GSH, Reduced glutathione; GSSG, Glutathione disul ﬁde; [GS tot], Total glutathione concentration; NEM, N- ethylmaleimide; OxD, Percentage of oxidation; PDI, Protein disul ﬁde isomerase; PERK, Double stranded RNA-activated protein kinase (PKR)-like ER kinase; Redox,Reduction –oxidation; R GS, [GSH]:[GSSG]; sCGrx1p, C30S mutant of yeast glutar- edoxin 1; TMM(PEG) 12, Maleimide-activated polyethylene glycol; UPR, Unfolded protein response; XBP1, X-box binding protein 1 ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c1/b8/main.PMC3830055.pdf
Densitometry Western blots were densitometrically quanti ﬁed using the ImageJ software (available at http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/c1/b8/main.PMC3830055.pdf
"http://dx.doi.org/10.1016/j.redox.2013.10.001Abbreviations: 8-oxodG, 8-oxo-7, 8-dihydro-20-deoxyguanosine;15[N5]2-dG, 15[N5]2′-deoxyguanosine;15[N5]8-oxodG, 8-oxo-7, 8-dihydro-15[N5]20-deoxygua- nosine; LC-MS/MS, liquid chromatography tandem mass spectrometry; ROS,reactive oxygen species; MTH1, Nudix hydrolase mut T homologue 1; NER,nucleotide excision repair system; NIR, nucleotide incision repair system; MRM,multiple reaction monitoring; SACI, surface-activated ionization; ESI, electrosprayionization; IQC, internal quality control; IS, internal standard; LOQ, limit ofquantitation; EIC, Extracted Ion Chromatogram; TIC, Total Ion Chromatogram ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/e2/dc/main.PMC3830056.pdf
([Epub ahead of print]) http://dx.doi.org/ 10.1016/j.bbagen.2013.06.009 .,Non-OADS,/arxiv_data1/oa_pdf/e2/dc/main.PMC3830056.pdf
http://dx.doi.org/10.1016/j.nicl.2013.09.012 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/14/ca/main.PMC3830057.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.011 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/97/2b/main.PMC3830058.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.005 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/74/0b/main.PMC3830060.pdf
Participants Twelve patients were recruited from the PLORAS database (http://www.ucl.ac.uk/ploras ) held at the Wellcome Trust Centre for Neuroimaging.,Non-OADS,/arxiv_data1/oa_pdf/74/0b/main.PMC3830060.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.001 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.12.026 .,OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/j.pneurobio.2009.03.001 (S0301- 0082(09)00035-5 [pii]).,OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1038/ 89472 .,Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.08.053 .,OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1097/ 01.prs.0000242487.62487.fb .,Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1146/annurev.ne.14.030191.001033 .,Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/S0079-6123(00)28015-1 .,OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1146/annurev.ne.06.030183.001545 .,Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/ j. pain.2004.03.013 .,OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/S0140-6736(07)60193-7 .,OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
"98, 261– 268. http://dx.doi.org/10.3171/jns.2003.98.2.0261 .",OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1093/brain/awl180 .,Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
"181, 41 –73.http://dx.doi.org/10.1002/cne.901810104 .",Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.07.049 .,OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
"103,65–73.http://dx.doi.org/10.1152/jn.00732.2009 .",Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1177/1073858407309466 .,Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1146/annurev.neuro.23.1.393 .,Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2004.11.036 .,OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.12.002 (S1053-8119(08) 01263-9 [pii]).,OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/ 10.1109/IEMBS.2011.6090248 .,Non-OADS,/arxiv_data1/oa_pdf/41/32/main.PMC3830062.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.006 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/67/41/main.PMC3830065.pdf
Inline Supplementary Table S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/41/main.PMC3830065.pdf
Inline Supplementary Table S2 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/41/main.PMC3830065.pdf
S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/41/main.PMC3830065.pdf
Inline Supplementary Table S3 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/41/main.PMC3830065.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.013 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/2c/e7/main.PMC3830066.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.003 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/cd/3a/main.PMC3830067.pdf
"In thenext step, two trained technicians manually outlined the identi ﬁed lesions on the 3DFLAIR using MIPAV ( http://mipav.cit.nih.gov ).",OADS,/arxiv_data1/oa_pdf/cd/3a/main.PMC3830067.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.007 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/b6/de/main.PMC3830070.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.009 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/1a/b3/main.PMC3830071.pdf
http://dx.doi.org/10.1016/j.nicl.2013.09.009 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/ea/34/main.PMC3830072.pdf
"Impaired gastric ac- commodation was reported to be related to early satiety and a Biomol  Ther 21(3), 181-189 (2013) *Corresponding Author E-mail: mwson@Donga.co.kr Tel: +82-70-8636-1387, Fax: +82-31-282-8564Received  Dec 7, 2012  Revised  Mar 12, 2013  Accepted  Mar 14, 2013http://dx.doi.org/10.4062/biomolther.2012.096 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/cd/ooomb4-21-181.PMC3830115.pdf
"182Biomol  Ther  21(3), 181-189 (2013) http://dx.doi.org/ 10.4062/biomolther.2012.096piride and so on.",Non-OADS,/arxiv_data1/oa_pdf/58/cd/ooomb4-21-181.PMC3830115.pdf
"184Biomol  Ther  21(3), 181-189 (2013) http://dx.doi.org/ 10.4062/biomolther.2012.096Lieb, 1911), and the other is “adaptive relaxation” (Jahnberg  et al.",Non-OADS,/arxiv_data1/oa_pdf/58/cd/ooomb4-21-181.PMC3830115.pdf
"186Biomol  Ther  21(3), 181-189 (2013) http://dx.doi.org/ 10.4062/biomolther.2012.096late with other symptoms suggesting other causes of the symp- toms might be present (Tack et al., 1998b; Tack et al., 2001).",Non-OADS,/arxiv_data1/oa_pdf/58/cd/ooomb4-21-181.PMC3830115.pdf
"188Biomol  Ther  21(3), 181-189 (2013) http://dx.doi.org/ 10.4062/biomolther.2012.096A.",Non-OADS,/arxiv_data1/oa_pdf/58/cd/ooomb4-21-181.PMC3830115.pdf
"Despite serious necessity  and much effort, widely accepted and sensitive biomarker for nephrotoxicity still has not been discovered yet and it needs to be investigated further.Original Article Biomol  Ther 21(3), 190-195 (2013) *Corresponding Author E-mail: yjchun@cau.ac.kr Tel: +82-2-820-5616, Fax: +82-2-825-5616Received  Apr 5, 2013  Revised  May 11, 2013  Accepted  May 14, 2013http://dx.doi.org/10.4062/biomolther.2013.026 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/f4/ooomb4-21-190.PMC3830116.pdf
The search program MASCOT (http://www.matrixscience.com/) was used for protein identi ﬁ cation by  peptide mass ﬁ ngerprinting.,OADS,/arxiv_data1/oa_pdf/be/f4/ooomb4-21-190.PMC3830116.pdf
"192Biomol  Ther  21(3), 190-195 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.026Transient transfection and cell viability assay HK-2 cells (2×104 cells/well) were plated onto well of 96- well plate after transfection with 400 ng of plasmid DNA (pcDNA3.1zeo-annexin A5) containing annexin A5 cDNA us-ing Neon TM transfection system (Invitrogen, Carlsbad, CA,  USA).",OADS,/arxiv_data1/oa_pdf/be/f4/ooomb4-21-190.PMC3830116.pdf
"194Biomol  Ther  21(3), 190-195 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.026in digestive or ductal organs, especially in kidney (Pepinsky et  al., 1988; Dreier et al.,  1998).",Non-OADS,/arxiv_data1/oa_pdf/be/f4/ooomb4-21-190.PMC3830116.pdf
"Key Words:  Human cardiac progenitor, Hypoxia preconditioning, U0126Modulation of Human Cardiac Progenitors via Hypoxia-ERK  Circuit Improves their Functional Bioactivities  Seok Yun Jung1, Sung Hyun Choi2, So Young Yoo1, Sang Hong Baek2,* and Sang Mo Kwon1,* 1Laboratory of Vascular Medicine and Stem Cell Biology, Department of Physiology, School of Medicine, Pusan National University,   Yangsan 626-870, 2Laboratory of Cardiovascular Disease, Division of Cardiology, School of Medicine, The Catholic University of  Korea, Seoul 137-040, Republic of Korea Abstract Copyright  © 2013 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: smkw on323@hotmail.com (Kwon SM), whitesh@catholic.ac.kr (Baek SH) Tel: +82-51-510-8075 (Kwon SM), +82-2-2258-6030 (Baek SH)Fax: +82-51-510-8076 (Kwon SM), +82-2-591-3614 (Baek SH)The fi  rst two authors contributed equally to this work.Received  Feb 20, 2013  Revised  Mar 23, 2013  Accepted  Apr 12, 2013 http://dx.doi.org/10.4062/biomolther.2013.019 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/e2/ooomb4-21-196.PMC3830117.pdf
"198Biomol  Ther  21(3), 196-203 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.019with the primary antibody (rabbit anti-human c-kit; Santa Cruz)  mixed in PBS containing 3% FBS and 1 mM EDTA.",Non-OADS,/arxiv_data1/oa_pdf/76/e2/ooomb4-21-196.PMC3830117.pdf
"200Biomol  Ther  21(3), 196-203 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.019DGF-BB (40 ng/ml), a typical SMC differentiation-inducing cy- tokine.",Non-OADS,/arxiv_data1/oa_pdf/76/e2/ooomb4-21-196.PMC3830117.pdf
"202Biomol  Ther  21(3), 196-203 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.019culturing cells at low-oxygen pressure can mimic the stem cell  niche condition and, thus, might preserve the increased stem-ness of hCSCs (Li et al.",Non-OADS,/arxiv_data1/oa_pdf/76/e2/ooomb4-21-196.PMC3830117.pdf
"Transamidation activity of Tgase is in-Original Article Biomol  Ther 21(3), 204-209 (2013) *Corresponding Author E-mail: uatheone@dongguk.edu Tel: +82-31-961-5213, Fax: +82-31-961-5206Received  Apr 25, 2013  Revised  May 21, 2013  Accepted  May 22, 2013http://dx.doi.org/10.4062/biomolther.2013.037 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/a2/ooomb4-21-204.PMC3830118.pdf
"206Biomol  Ther  21(3), 204-209 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.037cells (Fig.",OADS,/arxiv_data1/oa_pdf/4a/a2/ooomb4-21-204.PMC3830118.pdf
"208Biomol  Ther  21(3), 204-209 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.037erosclerosis in diabetic patients.",Non-OADS,/arxiv_data1/oa_pdf/4a/a2/ooomb4-21-204.PMC3830118.pdf
"Key Words:  Apoptosis, Cell damage, Fisetin, γ-irradiation, Reactive oxygen speciesProtective Effect of Fisetin (3,7,3',4'-Tetrahydroxyflavone)  against γ-Irradiation-Induced Oxidative Stress and Cell Damage Mei Jing Piao1, Ki Cheon Kim1, Sungwook Chae2, Young Sam Keum3, Hye Sun Kim4 and Jin Won Hyun1,* 1School of Medicine and Institute for Nuclear Science and Technology, Jeju National University, Jeju 690-756, 2Aging Research Center, Korea Institute of Oriental Medicine, Daejeon 305-811, 3Department of Biochemistry, College of Pharmacy, Dongguk University, Goyang 410-773,  4Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea Abstract *Corresponding Author E-mail: jinwonh@jejunu.ac.kr Tel: +82-64-754-3838, Fax: +82-64-726-4152Received  Feb 7, 2013  Revised  Mar 13, 2013  Accepted  Mar 20, 2013http://dx.doi.org/10.4062/biomolther.2013.017 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/b1/ooomb4-21-210.PMC3830119.pdf
"212Biomol  Ther  21(3), 210-215 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.017diation as described above.",OADS,/arxiv_data1/oa_pdf/cb/b1/ooomb4-21-210.PMC3830119.pdf
"214Biomol  Ther  21(3), 210-215 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.017partially prevented in ﬁ setin-treated irradiated cells.",Non-OADS,/arxiv_data1/oa_pdf/cb/b1/ooomb4-21-210.PMC3830119.pdf
", 2009), Cudrania tricuspidata Original Article Biomol  Ther 21(3), 216-221 (2013) *Corresponding Author E-mail: wchun@kangwon.ac.kr Tel: +82-33-250-8853, Fax: +82-33-255-8809Received  Mar 7, 2013  Revised  Apr 5, 2013  Accepted  Apr 12, 2013http://dx.doi.org/10.4062/biomolther.2013.023 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/d9/ooomb4-21-216.PMC3830120.pdf
"218Biomol  Ther  21(3), 216-221 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.023fects of aromadendrin on NO and PGE2 release in LPS-stimu- lated RAW 264.7 macrophage cells.",Non-OADS,/arxiv_data1/oa_pdf/1f/d9/ooomb4-21-216.PMC3830120.pdf
"220Biomol  Ther  21(3), 216-221 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.023(Fig.",Non-OADS,/arxiv_data1/oa_pdf/1f/d9/ooomb4-21-216.PMC3830120.pdf
", 2009).Original Article Biomol  Ther 21(3), 222-228 (2013) www.biomolther.org   *Corresponding Author E-mail: kjjasmine@hanmail.net  Tel: +82-2-2049-6025, Fax: +82-2-2030-7899The fi  rst two authors contributed equally to this work.Received  Jan 17, 2013  Revised  Apr 23, 2013  Accepted  May 2, 2013http://dx.doi.org/10.4062/biomolther.2013.006 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/aa/ooomb4-21-222.PMC3830121.pdf
"224Biomol  Ther  21(3), 222-228 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.006Statistical analysis Results were expressed as the mean ± S.E.M.",OADS,/arxiv_data1/oa_pdf/36/aa/ooomb4-21-222.PMC3830121.pdf
"226Biomol  Ther  21(3), 222-228 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.006tophagy pathway.",OADS,/arxiv_data1/oa_pdf/36/aa/ooomb4-21-222.PMC3830121.pdf
"228Biomol  Ther  21(3), 222-228 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.006Kawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A. and  Yao, T. P. (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.",OADS,/arxiv_data1/oa_pdf/36/aa/ooomb4-21-222.PMC3830121.pdf
Predicted acetylation sites on -synuclein were analyzed using a  web-based prediction algorithm ( http://www.aporc.org/EnsemblePail/index.html) .,OADS,/arxiv_data1/oa_pdf/36/aa/ooomb4-21-222.PMC3830121.pdf
"229Administration of Phytoceramide Enhances Memory and Up- regulates the Expression of pCREB and BDNF in Hippocampus of Mice Yeonju Lee, Jieun Kim, Soyong Jang and Seikwan Oh * Department of Neuroscience and Tissue Injury Defense Research Center, School of Medicine, Ewha Womans University,  Seoul 158-710, Republic of Korea Abstract *Corresponding Author E-mail: skoh@ewha.ac.kr Tel: +82-2-2650-5749, Fax: +82-2-2650-5850Received  Jan 3, 2013  Revised  Mar 19, 2013  Accepted  Mar 27, 2013http://dx.doi.org/10.4062/biomolther.2013.002 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/b2/ooomb4-21-229.PMC3830122.pdf
"230Biomol  Ther  21(3), 229-233 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.002rotransmitter systems in brain; (Bartus et al.,  1982; Durand et  al., 1996).",OADS,/arxiv_data1/oa_pdf/be/b2/ooomb4-21-229.PMC3830122.pdf
"232Biomol  Ther  21(3), 229-233 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.002proliferation enhances memory formation (Gould et al.,  1999).",OADS,/arxiv_data1/oa_pdf/be/b2/ooomb4-21-229.PMC3830122.pdf
"It has been stud-Original Article Biomol  Ther 21(3), 234-240 (2013) *Corresponding Author E-mail: hwangkh@duksung.ac.kr Tel: +82-2-901-8378, Fax: +82-2-901-8661Received  Dec 20, 2012  Revised  Mar 7, 2013  Accepted  Mar 20, 2013http://dx.doi.org/10.4062/biomolther.2012.100 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/c4/ooomb4-21-234.PMC3830123.pdf
"236Biomol  Ther  21(3), 234-240 (2013) http://dx.doi.org/ 10.4062/biomolther.2012.100Next, 0.4 ml of 3 M solution of trichloroacetic acid was added  to the reaction mixture to terminate the enzyme reaction.",Non-OADS,/arxiv_data1/oa_pdf/5a/c4/ooomb4-21-234.PMC3830123.pdf
"238Biomol  Ther  21(3), 234-240 (2013) http://dx.doi.org/ 10.4062/biomolther.2012.100Lotufo-Neto et al.",OADS,/arxiv_data1/oa_pdf/5a/c4/ooomb4-21-234.PMC3830123.pdf
"240Biomol  Ther  21(3), 234-240 (2013) http://dx.doi.org/ 10.4062/biomolther.2012.100Kimoto, K. (1999) Effects of angiotensin I-converting enzyme in- hibitor from Ashitaba ( Angelica keiskei ) on blood pressure of spon- taneously hypertensive rats.",OADS,/arxiv_data1/oa_pdf/5a/c4/ooomb4-21-234.PMC3830123.pdf
"Taken together, Original Article Biomol  Ther 21(3), 241-245 (2013) *Corresponding Author E-mail: mansu-kim@inje.ac.kr Tel: +82-55-320-3887, Fax: +82-55-320-3940Received  Mar 25, 2013  Revised  Apr 30, 2013  Accepted  May 2, 2013http://dx.doi.org/10.4062/biomolther.2013.024 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/67/ooomb4-21-241.PMC3830124.pdf
"242Biomol  Ther  21(3), 241-245 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.024these results suggest that Korean red ginseng may modulate  biological activities that alter organisms’ metabolic pathways toward extending healthy lifespan.",Non-OADS,/arxiv_data1/oa_pdf/27/67/ooomb4-21-241.PMC3830124.pdf
"244Biomol  Ther  21(3), 241-245 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.024which led to another set of identical experiments to validate  the result.",OADS,/arxiv_data1/oa_pdf/27/67/ooomb4-21-241.PMC3830124.pdf
"CB was washed with distilled water (DW) Original Article Biomol  Ther 21(3), 246-250 (2013) Copyright  © 2013 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: k angtj@syu.ac.kr (Kang TJ), slim@chungbuk.ac.kr (Lim SC) Tel: +82-2-3399-1608 (Kang TJ), +82-43-261-3590 (Lim SC)Fax: +82-2-3399-1617 (Kang TJ), +82-43-268-2732 (Lim SC)Received  Apr 24, 2013  Revised  May 10, 2013  Accepted  May 14, 2013 http://dx.doi.org/10.4062/biomolther.2013.036 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/69/ooomb4-21-246.PMC3830125.pdf
"248Biomol  Ther  21(3), 246-250 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.036ing (58oC 45 s), and extension (72oC, 45 s) with a ﬁ nal exten- sion at 72oC for 10 min.",Non-OADS,/arxiv_data1/oa_pdf/46/69/ooomb4-21-246.PMC3830125.pdf
"250Biomol  Ther  21(3), 246-250 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.036production of VEGF and TGF- β also increased in macro- phages treated with CB extract, suggesting that VEGF and TGF- β accelerate wound healing (Fig.",Non-OADS,/arxiv_data1/oa_pdf/46/69/ooomb4-21-246.PMC3830125.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/0e/89/JCN-3-118.PMC3830145.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ea/9b/JCN-3-121.PMC3830146.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b5/7b/JCN-3-125.PMC3830147.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs370/en/.,Non-OADS,/arxiv_data1/oa_pdf/ad/6c/JCN-3-131.PMC3830148.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/1f/ab/JCN-3-151.PMC3830155.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/1f/ab/JCN-3-151.PMC3830155.pdf
It will be co nducted in accordance with the standards of Good Clinical Practice for trials with medical products in the European Community ( http://www.ec.europa.,Non-OADS,/arxiv_data1/oa_pdf/35/e4/10557_2013_Article_6476.PMC3830203.pdf
16.http://www.wma.net/es/30publications/10policies/b3/ DoH Oct2008 17.,Non-OADS,/arxiv_data1/oa_pdf/35/e4/10557_2013_Article_6476.PMC3830203.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/d9/0a/JOMFP-17-153.PMC3830217.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/d9/0a/JOMFP-17-153.PMC3830217.pdf
Author Help: Online submission of the manuscripts Articles  can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/a1/d0/JOMFP-17-154.PMC3830218.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/a0/1b/JOMFP-17-156.PMC3830219.pdf
Available from:  http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_ en.pdf.,OADS,/arxiv_data1/oa_pdf/1e/4a/JOMFP-17-212.PMC3830229.pdf
Available from: http://www.doctorspiller.com/Tooth_wear/ attrition2.htm.,Non-OADS,/arxiv_data1/oa_pdf/3d/ba/JOMFP-17-222.PMC3830231.pdf
J  Oral  Maxillofac Surg Med Pathol 2012  http://dx.doi.org/10.1016/j.ajoms.,Non-OADS,/arxiv_data1/oa_pdf/81/0b/JOMFP-17-253.PMC3830236.pdf
Available from: http://mohfw.nic.in/NRHM/IPHS_Revised_Guidlenes_2012/Sub_Centers.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/IJEM-17-1.PMC3830267.pdf
Available from: http://mohfw.nic.in/NRHM/IPHS_Revised_,Non-OADS,/arxiv_data1/oa_pdf/47/5b/IJEM-17-1.PMC3830267.pdf
Available from: http://mohfw.nic.in/NRHM/IPHS_Revised_Guidlenes_2012/Community_Health_Centres.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/IJEM-17-1.PMC3830267.pdf
Available from: http://mohfw.nic.in/NRHM/IPHS_Revised_Guidlenes_2012/Sub_District_and_Sub-divisional_Hospital.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/IJEM-17-1.PMC3830267.pdf
Available from: http://mohfw.nic.in/NRHM/IPHS_Revised_Guidlenes_2012/District_Hospital.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/IJEM-17-1.PMC3830267.pdf
ClinicalTrials.gov Available from: http://clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/99/4d/IJEM-17-160.PMC3830289.pdf
Available from: http://www.wada-ama.org/en/World- Anti- Doping- Program /Sports-and-Anti-Doping-Organizations/International -Standards/Prohibited-List/.,Non-OADS,/arxiv_data1/oa_pdf/7e/72/IJEM-17-18.PMC3830297.pdf
Available from:  http://www.ukad.org.uk/news/article/newton-gets-two-years -for-world-first-hgh-finding.,Non-OADS,/arxiv_data1/oa_pdf/7e/72/IJEM-17-18.PMC3830297.pdf
Available from: http://www.cces.ca/en/news-137-cces- announces-four-anti-doping-rule-violations.,Non-OADS,/arxiv_data1/oa_pdf/7e/72/IJEM-17-18.PMC3830297.pdf
Available  from: http://www.wada-ama.org/en/Media-Center/Archives/Articles/Statement-on-positive-hGH-test-in-Minor-League-Baseball/.,Non-OADS,/arxiv_data1/oa_pdf/7e/72/IJEM-17-18.PMC3830297.pdf
Available from: http://www.tas-cas.org/d2wfiles/document/6633/5048/0/256620FINAL20Award20_internet_.pdf.,OADS,/arxiv_data1/oa_pdf/7e/72/IJEM-17-18.PMC3830297.pdf
Available from: http://www.paralympic.org/press-release/latest-testing-methods-result-suspension- two-russian-powerlifters-anti-doping.,Non-OADS,/arxiv_data1/oa_pdf/7e/72/IJEM-17-18.PMC3830297.pdf
Available from: http://www.hindawi.com/journals/ije/2012/324835/[Last cited on 2013 Jun 25].,Non-OADS,/arxiv_data1/oa_pdf/a8/62/IJEM-17-265.PMC3830328.pdf
Available from: http://www.fda.gov/MedicalDevices/Safety/ AlertsandNotices/PatientAlerts/ucm177189.htm.,Non-OADS,/arxiv_data1/oa_pdf/e1/fb/IJEM-17-289.PMC3830335.pdf
Available from: http://bhind.nic.in/Sparsh_MTP-Act-1971.pdf [Last accessed on 2012 Sep 1].,Non-OADS,/arxiv_data1/oa_pdf/4e/b7/IJEM-17-29.PMC3830336.pdf
: Diabetes mellitus and Ramadan Indian Journal of Endocrinology and Metabolism / 2013 / Vol 17 / Supplement 1 S298Available from: http://www.indexmundi.com [Last accessed on  2013 Jun 10].,Non-OADS,/arxiv_data1/oa_pdf/1e/b6/IJEM-17-295.PMC3830338.pdf
Available  from: http://islam.about.com [Last accessed on 2013 Jun 10].,Non-OADS,/arxiv_data1/oa_pdf/1e/b6/IJEM-17-295.PMC3830338.pdf
Available from: http://www.financesmediterranee.com.,Non-OADS,/arxiv_data1/oa_pdf/1e/b6/IJEM-17-295.PMC3830338.pdf
Available from: http://www.afd.asso.fr.,Non-OADS,/arxiv_data1/oa_pdf/1e/b6/IJEM-17-295.PMC3830338.pdf
"Available from: http://www.atsdr.cdc.gov/toxprofiles/tp1.pdf [Last accessed June 1 st,  2013].Table 3: Risk of metabolic syndrome with OCPs OCP Odds ratio 95% con ﬁ dence  IntervalP value* Lower Upper -HCH 1.07 0.92 1.26 0.370 -HCH 1.34 1.14 1.57 <0.001* -HCH 1.02 0.79 1.32 0.886 -endosulfan 0.975 0.81 1.1 7 0.781 -endosulfan 0.99 0.6 7 1.49 0.985 p, p’-DDE 1.01 0.81 1.26 0.928p, p’-DDT 1.02 0.65 1.59 0.945Aldrin 1.23 1.01 1.50 0.045*Dieldrin 1.02 0.81 1.27 0.901 *Logistic regression analysis (with adjustment for age, sex smoking,  alcohol), P<0.05 is statistically signiﬁ  cant, SD: Standard deviation, HCH:  Hexachlorocyclohexane, DDE: Dichloro-diphenyl-dichloro-ethylene,DDT: Dichloro-diphenyl-trichloro-ethane Cite this article as:  Tomar LR, Agarwal MP, Avasthi R, Tyagi V, Mustafa M,  Banerjee BD.",Non-OADS,/arxiv_data1/oa_pdf/ed/df/IJEM-17-342.PMC3830355.pdf
Available from: http://www.who.int/nutrition/publications/bmi_asia_strategies.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/86/IJEM-17-349.PMC3830357.pdf
Available from: http://www.pubmedcentral.nih.gov/.,OADS,/arxiv_data1/oa_pdf/17/63/IJEM-17-367.PMC3830363.pdf
Available from: http://www.who.int/child_adolescent_health/documents/frh_adh_97_9/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/17/63/IJEM-17-367.PMC3830363.pdf
Available from: http://whoindia.org/LinkFiles/Adolescent_Health_and_Development_(AHD)_UNFPA_Country_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/63/IJEM-17-367.PMC3830363.pdf
Available from: http://www.bnf.org.,Non-OADS,/arxiv_data1/oa_pdf/85/23/IJEM-17-55.PMC3830368.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 721 Korean J Urol 2013;54:721-731www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.721 Review Article Androgens Modulate Endothelial Function and Endothelial  Progenitor Cells in Erectile Physiology Abdulmaged M. Traish1,2, Artin Galoosian3 Departments of 1Biochemistry and 2Urology, Boston University School of Medicine, Boston, MA, 3Division of Graduate Medical Sciences,  Boston University School of Medicine, Boston, MA, USA The incidence of erectile dysfunction (ED) increases with age and cardiovascular dis- ease risk factors, such as hypertension, hy perlipidemia, insulin resistance, obesity, and  diabetes.",Non-OADS,/arxiv_data1/oa_pdf/ac/11/kju-54-721.PMC3830963.pdf
"Keywords:  Endothelium; Erectile dysfunction; Nitric oxide; Testosterone; Vascular  endothelial cells This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 3 September, 2013 accepted 24 September, 2013 Corresponding Author: Abdulmaged M. Traish Departments of Biochemistry and Urology, Boston University  School of Medicine, Boston, MA  02811, USATEL: +1-617-638-4578 FAX: +1-617-638-5412 E-mail: atraish@bu.edu INTRODUCTION  Erectile function is a complex neurovascular process that  requires the integration of a host of signaling pathways,  leading to increased blood inflow to the corpora cavernosa and reduced blood outflow perm itting entrapment of blood  under pressure and engorgemen t of the penis [1-6].",Non-OADS,/arxiv_data1/oa_pdf/ac/11/kju-54-721.PMC3830963.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 732 Korean J Urol 2013;54:732-737www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.732 Review Article Current Surgical Management of Vesicoureteral Reflux Minki Baek, Kyung Do Kim1 Department of Urology, Samsung Medical Center, S ungkyunkwan University School of Medicine, Seoul, 1Department of Urology,  Chung-Ang University College of Medicine, Seoul, Korea Vesicoureteral reflux (VUR), a common congen ital urinary tract anomaly, refers to ret- rograde flow of urine from the bladder into the upper urinary tract.",Non-OADS,/arxiv_data1/oa_pdf/cd/8c/kju-54-732.PMC3830964.pdf
"Keywords:  Pediatrics; Surgery; Therapy; Urinary tract infections; Vesico-ureteral reflux This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 July, 2013 accepted 6 September, 2013 Corresponding Author:  Kyung Do Kim Department of Urology,  Chung-Ang University Hospital, Chung-Ang University College of  Medicine, 102 Heukseok-ro,  Dongjak-gu, Seoul 156-755, Korea TEL: +82-2-6299-1806 FAX: +82-2-6293-1003E-mail: kim14141@hanafos.com INTRODUCTION Vesicoureteral reflux (VUR) o ccurs at a frequency of about  30% in children with urinary tract infection (UTI) [1].",Non-OADS,/arxiv_data1/oa_pdf/cd/8c/kju-54-732.PMC3830964.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 738 Korean J Urol 2013;54:738-743www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.738 Urological Oncology Comparative Analysis of Radiologically Measured Size and True  Size of Renal Tumors Kook Bin Lee, Sun Il Kim, Dae Sung Cho1, Seong Kon Park, Hyun Ik Jang, Se Joong Kim Department of Urology, Ajou University School of Medicine, Suwon, 1Department of Urology, Bundang Jesaeng Hospital, Seongnam, Korea Purpose:  We evaluated the differences between radiologically measured size and patho- logic size of renal tumors.",Non-OADS,/arxiv_data1/oa_pdf/0f/e7/kju-54-738.PMC3830965.pdf
"Keywords:  Kidney; Neoplasms; Pathology; Radiology This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 24 April, 2013 accepted 29 July, 2013 Corresponding Author: Se Joong Kim Department of Urology, Ajou  University School of Medicine, 206 World cup-ro, Yeongtong-gu,  Suwon 443-721, Korea TEL: +82-31-219-5272FAX: +82-31-219-5276 E-mail: sejoong@ajou.ac.kr INTRODUCTION Elective nephron-sparing surgery for small renal masses  (tumor size ＜4 cm, T1a) has been accepted as an oncologi- cally safe alternative with limited complications in the  presence of a healthy contrala teral kidney [1].",Non-OADS,/arxiv_data1/oa_pdf/0f/e7/kju-54-738.PMC3830965.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 744 Korean J Urol 2013;54:744-749www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.744 Urological Oncology Factors Affecting the Time to Recurrence After Radical  Nephrectomy for Localized Renal Cell Carcinoma Hee-Seo Son, Seung Hyun Jeon, Sung-Goo Chang Department of Urology, Kyung Hee University School of Medicine, Seoul, Korea Purpose:  The objective of this study was to dete rmine the factors affecting the time to  recurrence after radical nephrectomy for localized renal cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/56/6f/kju-54-744.PMC3830966.pdf
"Keywords:  Disease-free survival; Recu rrence; Renal cell carcinoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 21 June, 2013 accepted 9 August, 2013 Corresponding Author: Sung-Goo ChangDepartment of Urology, Kyung  Hee University School of  Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701,  Korea  TEL: +82-2-958-8533FAX: +82-2-959-6048 E-mail: sgchang@khu.ac.kr INTRODUCTION Worldwide, over 200,000 new cases of kidney cancer are di- agnosed and approximately 100,000 deaths occur from this disease each year.",Non-OADS,/arxiv_data1/oa_pdf/56/6f/kju-54-744.PMC3830966.pdf
Available from: http://www.uroweb.org/fileadmin/guidelines/  Total_file_2013_large_gu idelines_prints.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/6f/kju-54-744.PMC3830966.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 750 Korean J Urol 2013;54:750-755www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.750 Urological Oncology Impact of Treatment With Statins on Prostate-Specific Antigen and  Prostate Volume in Patients With Benign Prostatic Hyperplasia Sang Hun Lee, Tae Ju Park, Min Ho Bae, Sung Ho Choi, Young Sam Cho, Kwan Joong Joo,  Chil Hun Kwon, Heung Jae Park Department of Urology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Purpose:  We investigated the impact on prostate-specific antigen (PSA) and prostate  volume (PV) of statin medication for 1 year in patients with benign  prostatic hyperplasia  (BPH).Materials and Methods:  We retrospectively investigated 791 patients in whom BPH  was diagnosed.",Non-OADS,/arxiv_data1/oa_pdf/6e/ff/kju-54-750.PMC3830967.pdf
"Keywords:  Chemoprevention; Dutasteride; Prostate ; Prostate-specific antigen; Statins This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 27 May, 2013 accepted 18 July, 2013 Corresponding Author: Heung Jae ParkDepartment of Urology, Kangbuk  Samsung Hospital,  Sungkyunkwan University School of Medicine, 29  Saemunan-ro, Jongno-gu, Seoul  110-746, KoreaTEL: +82-2-2001-2240 FAX: +82-2-2001-2247 E-mail: hjae.park@samsung.com INTRODUCTION Benign prostatic hyperplasia (BPH) is a progressive dis- ease that occurs with lower urinary tract symptoms (LUTS).",Non-OADS,/arxiv_data1/oa_pdf/6e/ff/kju-54-750.PMC3830967.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 756 Korean J Urol 2013;54:756-761www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.756 Laparoscopy/Robotics Retropubic Versus Robot-Assisted Laparoscopic Prostatectomy for  Prostate Cancer: A Comparative Study of Postoperative Complications Jeman Ryu, Taekmin Kwon, Yoon Soo Kyung1, Sungwoo Hong2, Dalsan You, In Gab Jeong,  Choung-Soo Kim Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 1Department of Health Screening and  Promotion Center, Asan Medical Center, Unive rsity of Ulsan College of Medicine, Seoul, 2Department of Urology, Dankook University  College of Medicine, Cheonan, Korea Purpose:  To compare the complications of radica l retropubic prostatectomy (RRP) with  those of robot-assisted laparoscopic prosta tectomy (RALP) performed by a single sur- geon for the treatment of prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/8a/6d/kju-54-756.PMC3830968.pdf
"Keywords:  Complications; Prostate; Pros tate neoplasms; Prostatectomy This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 11 June, 2013 accepted 11 September, 2013 Corresponding Author: Choung-Soo Kim Department of Urology, Asan Medical Center, University of  Ulsan College of Medicine, 88  Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea TEL: +82-2-3010-3734 FAX: +82-2-477-8928E-mail: cskim@amc.seoul.kr INTRODUCTION Prostate cancer is the most common solid organ malig- nancy in men in the United States and the second leading cause of cancer death [1].",Non-OADS,/arxiv_data1/oa_pdf/8a/6d/kju-54-756.PMC3830968.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 762 Korean J Urol 2013;54:762-766www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.762 Voiding Dysfunction/Female Urology Effect of Urgency Symptoms on the Risk of Depression in  Community-Dwelling Elderly Men Young Ik Lee, Ji Won Kim, Sang Rak Bae, Sung Hyun Paick, Ki Woong Kim1, Hyeong Gon Kim,  Yong Soo Lho, Hyoung Keun Park Department of Urology, Konkuk University Medical Center, Seoul, 1Department of Neuropsychiatry, Seoul National University Bundang  Hospital, Seongnam, Korea Purpose:  To evaluate the association of a specif ic type of lower ur inary tract symptom  (LUTS) and the depression in co mmunity-dwelling elderly Korean men.",Non-OADS,/arxiv_data1/oa_pdf/dd/f5/kju-54-762.PMC3830969.pdf
"Keywords:  Depression; Longitudinal studies;  Lower urinary tract symptoms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 May, 2013 accepted 16 August, 2013 Corresponding Author: Hyoung Keun ParkDepartment of Urology, Konkuk  University Medical Center, 120  Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea TEL: +82-2-2030-7674 FAX: +82-2-2030-5319E-mail: drurol@naver.com INTRODUCTION Depression is correlated with urological symptoms as well  as quality of life.",Non-OADS,/arxiv_data1/oa_pdf/dd/f5/kju-54-762.PMC3830969.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 767 Korean J Urol 2013;54:767-771www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.767 Voiding Dysfunction/Female Urology Elimination of Hunner’s Ulcers by Fulguration in Patients With  Interstitial Cystitis: Is It Effective and Long Lasting?",Non-OADS,/arxiv_data1/oa_pdf/0f/60/kju-54-767.PMC3830970.pdf
"Keywords:  Electrocoagulation; Interstit ial cystitis; Urinary bladder This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 July, 2013 accepted 24 August, 2013 Corresponding Author: Myung-Soo ChooDepartment of Urology, Asan  Medical Center, University of  Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu,  Seoul 138-736, Korea TEL: +82-2-3010-3735FAX: +82-2-477-8928 E-mail: mschoo@amc.seoul.kr INTRODUCTION Painful bladder syndrome/interst itial cystitis (PBS/IC) is  diagnosed if a patient complains of chronic pelvic pain, pressure, or discomfort that is perceived to be related to the urinary bladder and these symptoms are accompanied by at least one other urinary symp tom, such as a persistent  urge to void or high urinary frequency.",Non-OADS,/arxiv_data1/oa_pdf/0f/60/kju-54-767.PMC3830970.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 772 Korean J Urol 2013;54:772-777www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.772 Endourology/Urolithiasis Predictive Value of Preoperative Unenhanced Computed  Tomography During Ureteroscopic Lithotripsy: A Single Institute’sExperience Sunchan Kim, Seung-Kwon Choi, Sol Min Lee, Taesoo Choi, Dong-Gi Lee, Gyeong Eun Min,  Seung Hyun Jeon, Hyung-Lae Lee, Jun-Young Chung1, Jin Hyun Joh2, Koo Han Yoo Departments of Urology, 1Anesthesiology and Pain Medicine, and 2Surgery, Kyung Hee University School of Medicine, Seoul, Korea Purpose:  Ureteroscopic stone removal is frequently used to remove ureteral stones.",Non-OADS,/arxiv_data1/oa_pdf/b0/be/kju-54-772.PMC3830971.pdf
"Keywords:  Ureteral calculi; Ureteroscopy ; X-ray computed tomography This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 31 December, 2012 accepted 9 August, 2013 Corresponding Author: Koo Han YooDepartment of Urology, Kyung  Hee University Hospital at  Gangdong, Kyung Hee University School of Medicine, 892  Dongnam-ro, Gangdong-gu,  Seoul 134-727, KoreaTEL: +82-2-440-7735 FAX: +82-2-440-7735 E-mail: yookoohan@khu.ac.kr INTRODUCTION Unenhanced computed tomography (UECT) is currently  being used to diagnose ureteral stones in patients with acute flank pain because this method is rapid, accurate, and safe [1,2].",Non-OADS,/arxiv_data1/oa_pdf/b0/be/kju-54-772.PMC3830971.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 778 Korean J Urol 2013;54:778-782www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.778 Sexual Dysfunction An Evidence-Based Evaluation of Health Information on Erectile  Dysfunction From 10 Nationwide Daily Newspapers in Korea Yoon Soo Hah1, Joo Yong Lee1, Sey Kiat Lim1, Kang Su Cho1, Young Deuk Choi1,2,3 1Department of Urology, Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul, 2Clinical Trial  Center for Medical Devices and 3Robot and Minimal Invasive Surgery Center, Severance Hospital, Yonsei University College of Medicine,  Seoul, Korea Purpose:  A rapid growth in the socioeconomic status of Koreans has triggered an un- precedented explosion of health information for the general population.",Non-OADS,/arxiv_data1/oa_pdf/cb/de/kju-54-778.PMC3830972.pdf
"Keywords:  Erectile dysfunction; Eviden ce-based medicine; Newspapers This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 12 June, 2013 accepted 31 July, 2013 Corresponding Author: Young Deuk Choi Department of Urology, Clinical Trial Center for Medical Devices  and Robot and Minimal Invasive  Surgery Center, Severance Hospital, Urological Science  Institute, Yonsei University  College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752,  Korea TEL: +82-2-2228-2317FAX: +82-2-312-2538 E-mail: youngd74@yuhs.ac  INTRODUCTION The general public is exposed to multiple sources of in- formation on medicine, either through traditional mass media (e.g., television, journals , and radio) or through the  Internet (e.g., blogs, Twitter, Facebook, and the many fea-tures of Web 2.0) [1,2].",Non-OADS,/arxiv_data1/oa_pdf/cb/de/kju-54-778.PMC3830972.pdf
Data extraction and analysis The websites of both the Chosun Ilbo and Korea Joongang Daily (http://www.chosun.com and http://joongang.joinsmsn.,Non-OADS,/arxiv_data1/oa_pdf/cb/de/kju-54-778.PMC3830972.pdf
"com) newspapers were used to search for relevant articles, whereas the website of the Korean Press Foundation (http://www.kinds.or.kr) was used to search for articles from the other newspapers identified above.",Non-OADS,/arxiv_data1/oa_pdf/cb/de/kju-54-778.PMC3830972.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 783 Korean J Urol 2013;54:783-790www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.783 Pediatric Efficacy of an Enuresis Alarm, Desmopressin, and Combination  Therapy in the Treatment of Saudi Children With Primary Monosymptomatic Nocturnal Enuresis  Abul-Fotouh Abdel-Maguid Ahmed1,2, Moamen Mohammed Amin1,3, Mahmoud Mohammed Ali1,4,  Essam Abdel-Moneim Shalaby5,6 1Department of Urology, Al-Azhar University, Cairo, Egypt, 2Department of Urology, Salman Bi n Abdul-Aziz University, Al-Kharj,  Kingdom of Saudi Arabia, 3Royal Commission Hospital, Jubail, Kingdom of Saudi Arabia, 4King Khalid Hospital, Tabouk, Kingdom  of Saudi Arabia, 5Department of Urology, Suez Canal University, Ismailia, Egypt, 6Department of Urology, King Khalid hospital, Al-Kharj,  Kingdom of Saudi Arabia Purpose:  We evaluated and compared the effect iveness of an enuresis alarm, desmo- pressin medication, and their combination in  the treatment of Saudi children with pri- mary monosymptomatic nocturnal enuresis (PMNE).",Non-OADS,/arxiv_data1/oa_pdf/56/5b/kju-54-783.PMC3830973.pdf
"Keywords:  Combined modality th erapy; Nocturnal enuresi s; Treatment efficacy This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 27 May, 2013 accepted 6 September, 2013 Corresponding Author: Abul-Fotouh Abdel-Maguid  AhmedDepartment of Urology, Salman  Bin Abdul-Aziz University, P.O.",Non-OADS,/arxiv_data1/oa_pdf/56/5b/kju-54-783.PMC3830973.pdf
Available from:  http://www.hawaii.edu/medici ne/pediatrics/pedtext/.,Non-OADS,/arxiv_data1/oa_pdf/56/5b/kju-54-783.PMC3830973.pdf
"Keywords:  MicroRNAs; Neoplasms; Recurrence; Urinary bladder  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 26 June, 2013 accepted 23 September, 2013 Corresponding Author: Seok Joong Yun Department of Urology, Chungbuk National University  College of Medicine, 410  Sunbong-ro, Heungdeok-gu, Cheongju 361-763, Korea TEL: +82-43-269-6134 FAX: +82-43-269-6144E-mail: sjyun@chungbuk.ac.kr INTRODUCTION Bladder cancer is the second most common urological ma- lignancy in humans, and it was estimated in 2012 in the  United States that 73,510 new cases of cancer of the urinary bladder were diagnosed along with 14,680 deaths [1].",Non-OADS,/arxiv_data1/oa_pdf/25/cb/kju-54-791.PMC3830974.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 797 Korean J Urol 2013;54:797-800www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.797 Case Report Inflammatory Myofibroblastic Tumor of the Urinary Bladder  Managed by Laparoscopic Partial Cystectomy Manas Ranjan Pradhan, Priyadarshi Ranjan, Ram Nawal Rao1, Saurabh Sudhir Chipde,  Krishna Pradhan2, Rakesh Kapoor Departments of Urology and Renal Transplantation, 1Pathology, and 2Anaesthesiology, Sanjay Gandhi Post Graduate Institute of Medical  Sciences, Lucknow, India Inflammatory myofibroblastic tumor of the urinary bladder is a rare mesenchymal tu- mor with uncertain malignant po tential.",Non-OADS,/arxiv_data1/oa_pdf/2a/3e/kju-54-797.PMC3830975.pdf
"Keywords:  Cystectomy; Laparoscopy; Plasma cell granuloma; Urinary bladder This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 25 February, 2012 accepted 14 May, 2012 Corresponding Author: Manas Ranjan Pradhan Department of Urology and Renal  Transplantation, C - Block Sanjay Gandhi Post Graduate Institute  of Medical Sciences, Lucknow  226014, India TEL: +91-522-2494890 FAX: +91-522-2668129 E-mail: drmrpradhan@yahoo.co.in INTRODUCTION Inflammatory myofibroblastic tumor (IMT) is a rare spin- dle cell tumor of unknown malig nant potential that often  masquerades as a soft tissue malignancy both clinically and radiologically.",Non-OADS,/arxiv_data1/oa_pdf/2a/3e/kju-54-797.PMC3830975.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 801 Korean J Urol 2013;54:801-804www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.11.801 Case Report Psoas Abscess Secondary to Renal Tuberculosis in a Middle-aged  Woman Sang Wook Lee Department of Urology, Clinical Research Institute, Kangwon Nati onal University Hospital, Kangwon National University School of   Medicine, Chunchon, Korea A psoas muscle abscess is a relatively unco mmon condition that can present with vague  clinical features.",Non-OADS,/arxiv_data1/oa_pdf/52/cf/kju-54-801.PMC3830976.pdf
"Keywords:  Abdominal pain; Psoas abscess; Renal tuberculosis This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 12 March, 2012 accepted 30 April, 2012 Corresponding Author: Sang Wook Lee Department of Urology, Kangwon  National University Hospital, 156 Baengnyeong-ro, Chuncheon  200-722, Korea  TEL: +82-33-258-9257FAX: +82-33-258-2455 E-mail: paulee@kangwon.ac.kr INTRODUCTION Psoas abscess is a rare disease with a subtle and often non- specific presentation that frequently provides a diagnostic challenge [1].",Non-OADS,/arxiv_data1/oa_pdf/52/cf/kju-54-801.PMC3830976.pdf
"403 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Perineural invasion is a diagnostic clue of malignancy and  may be indicative of a poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/91/ed/kjpathol-47-403.PMC3830985.pdf
"Conflicts of Interest No potential conflict of interest relevant to this article was  reported.Perineural Involvement in Benign Mixed Tumor Se Jin Jung ·Jong Cheol Lee1·Hye Jeong Choi ·Hee Jeong Cha ·Young Min Kim ·Young Wha Koh ·Jae Hee Suh Departments of Pathology and 1Otorhinolaryngology-Head and Neck Surgery, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, KoreaThe Korean Journal of Pathology  2013; 47: 403-404 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.403▒ LETTER TO THE EDITOR ▒ Corresponding Author Jae Hee Suh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/91/ed/kjpathol-47-403.PMC3830985.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.403404 • Jung SJ, et al.",OADS,/arxiv_data1/oa_pdf/91/ed/kjpathol-47-403.PMC3830985.pdf
"405 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Fine-needle aspiration (FNA) is a well-established and widely  used biopsy technique for the initial tissue diagnosis of many  diseases.",Non-OADS,/arxiv_data1/oa_pdf/23/54/kjpathol-47-405.PMC3830986.pdf
"Department of Pathology, The Johns Hopkins  Hospital, Pathology 406A, 600 N. Wolfe St.,  Baltimore, MD 21287, USA Tel: +1-410-955-1180 Fax: +1-410-614-9556 E-mail: molson8@jhmi.eduThe Korean Journal of Pathology  2013; 47: 405-410 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.405▒ REVIEW & PERSPECTIVE ▒",Non-OADS,/arxiv_data1/oa_pdf/23/54/kjpathol-47-405.PMC3830986.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.405406 • Collins JA, et al.",Non-OADS,/arxiv_data1/oa_pdf/23/54/kjpathol-47-405.PMC3830986.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.405Cytotechnologists and On-Site Evaluation of Adequacy • 407 the diagnostic accuracy of a cytotechnologist can improve with  advanced training in histology from a cytopathologist.,Non-OADS,/arxiv_data1/oa_pdf/23/54/kjpathol-47-405.PMC3830986.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.405408 • Collins JA, et al.",Non-OADS,/arxiv_data1/oa_pdf/23/54/kjpathol-47-405.PMC3830986.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.405Cytotechnologists and On-Site Evaluation of Adequacy • 409 mous cells in pancreatic aspirates: from contamination to adeno - squamous carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/23/54/kjpathol-47-405.PMC3830986.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.405410 • Collins JA, et al.",Non-OADS,/arxiv_data1/oa_pdf/23/54/kjpathol-47-405.PMC3830986.pdf
http://dx.doi.org/10.1159/000354079.,Non-OADS,/arxiv_data1/oa_pdf/23/54/kjpathol-47-405.PMC3830986.pdf
"411 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Hepatocellular adenoma (HCA) is a benign hepatic tumor  with a low risk of malignant transformation and a known associ - ation with oral contraceptives.1 The incidence of HCA in wom - en with long-term use of oral contraceptives is less than 4 per  100,000/yr.2 Use of oral contraceptives or anabolic steroids has  been proposed as a major risk factor for HCAs1,2 although diabe - tes, glycogen storage disease, and other metabolic disorders are  also risk factors.3 There are few reported cases of HCA in Korea.",Non-OADS,/arxiv_data1/oa_pdf/5c/d7/kjpathol-47-411.PMC3830987.pdf
"Department of Pathology, Korea University College  of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul  136-705, Korea Tel: +82-2-920-6142 Fax: +82-2-953-3130 E-mail: nhw@korea.ac.krThe Korean Journal of Pathology  2013; 47: 411-417 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.411▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/5c/d7/kjpathol-47-411.PMC3830987.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.411412 • Kim H, et al.",OADS,/arxiv_data1/oa_pdf/5c/d7/kjpathol-47-411.PMC3830987.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.411Hepatocellular Adenoma: Report of Eight Korean Cases • 413 sis.6 β-Catenin and GS immunostaining was used to detect  β-HCAs.12,13 Diffuse or focal cytoplasmic GS staining was in - terpreted as a positive result.",OADS,/arxiv_data1/oa_pdf/5c/d7/kjpathol-47-411.PMC3830987.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.411414 • Kim H, et al.",OADS,/arxiv_data1/oa_pdf/5c/d7/kjpathol-47-411.PMC3830987.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.411Hepatocellular Adenoma: Report of Eight Korean Cases • 415 nuclear staining (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5c/d7/kjpathol-47-411.PMC3830987.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.411416 • Kim H, et al.",OADS,/arxiv_data1/oa_pdf/5c/d7/kjpathol-47-411.PMC3830987.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.411Hepatocellular Adenoma: Report of Eight Korean Cases • 417 Conflicts of Interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/5c/d7/kjpathol-47-411.PMC3830987.pdf
"418 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Ovarian cancer is the sixth most common cancer in women  and the seventh most common cause of cancer death worldwide.1  Serous carcinomas comprise the majority of ovarian carcinomas,  and most serous carcinomas are high grade.",Non-OADS,/arxiv_data1/oa_pdf/44/68/kjpathol-47-418.PMC3830988.pdf
"Department of Pathology, Kyungpook National  University Hospital, Kyungpook National University  School of Medicine, 130 Dongdeok-ro, Jung-gu,  Daegu 700-721, Korea Tel: +82-53-420-5247 Fax: +82 -53-426-1525 E-mail: jyparkmd@knu.ac.krThe Korean Journal of Pathology  2013; 47: 418-425 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.418▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/44/68/kjpathol-47-418.PMC3830988.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.418MAD2 Expression in Ovarian Carcinoma • 419 The role of aberrant expression of MAD2 in cellular drug re - sistance to chemotherapeutic agents has been studied extensive - ly in cell culture models.11 However, there are few published  studies on human clinical cancer specimens.",Non-OADS,/arxiv_data1/oa_pdf/44/68/kjpathol-47-418.PMC3830988.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.418420 • Park PE, et al.",OADS,/arxiv_data1/oa_pdf/44/68/kjpathol-47-418.PMC3830988.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.418MAD2 Expression in Ovarian Carcinoma • 421 p53 showed positive staining in 42 cases (49.4%) and nega - tive staining in 43 cases (50.6%).,Non-OADS,/arxiv_data1/oa_pdf/44/68/kjpathol-47-418.PMC3830988.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.418422 • Park PE, et al.",OADS,/arxiv_data1/oa_pdf/44/68/kjpathol-47-418.PMC3830988.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.418MAD2 Expression in Ovarian Carcinoma • 423 DISCUSSION When scoring expression of MAD2 on light microscopy, the  heterogeneity of staining was the most troublesome.",Non-OADS,/arxiv_data1/oa_pdf/44/68/kjpathol-47-418.PMC3830988.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.418424 • Park PE, et al.",OADS,/arxiv_data1/oa_pdf/44/68/kjpathol-47-418.PMC3830988.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.418MAD2 Expression in Ovarian Carcinoma • 425 morphology	 and	molecular	 biology	and	their	clinical	implications.,Non-OADS,/arxiv_data1/oa_pdf/44/68/kjpathol-47-418.PMC3830988.pdf
"426 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Renal cell carcinoma (RCC) patients occasionally have meta - static disease at the time of presentation (25-30%)1 and local or  distant recurrences after nephrectomy in the case of localized  RCC (20-40%).2 Although a large study showed that the 5-year  survival rate of metastatic RCC patients is less than 10%,3 new  therapeutic methods have been developed for the treatment of  advanced RCC,4,5 and some can play a prominent role in the  treatment of certain subtypes of RCC.6 Therefore, it has become  more important to diagnose metastatic RCC and to determine  the subtype of the corresponding primary lesion.",Non-OADS,/arxiv_data1/oa_pdf/0c/6f/kjpathol-47-426.PMC3830989.pdf
"Department of Pathology, Kidney Research Institute,  Medical Research Center, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 110-799, Korea Tel: +82-2-2072-1767 Fax: +82-2-743-5530 E-mail: blue7270@snu.ac.krThe Korean Journal of Pathology  2013; 47: 426-432 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.426▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/0c/6f/kjpathol-47-426.PMC3830989.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.426Histologic Variations of Metastatic CCRCC • 427 sy specimen consists of tumor cells showing only non-typical  histologic features.,Non-OADS,/arxiv_data1/oa_pdf/0c/6f/kjpathol-47-426.PMC3830989.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.426428 • Lee C, et al.",OADS,/arxiv_data1/oa_pdf/0c/6f/kjpathol-47-426.PMC3830989.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.426Histologic Variations of Metastatic CCRCC • 429 were also present in the primary lesions.,Non-OADS,/arxiv_data1/oa_pdf/0c/6f/kjpathol-47-426.PMC3830989.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.426430 • Lee C, et al.",OADS,/arxiv_data1/oa_pdf/0c/6f/kjpathol-47-426.PMC3830989.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.426Histologic Variations of Metastatic CCRCC • 431 ity than non-rhabdoid areas in the same tumors.15 Molecular  genetic studies in a few cases have shown concordant loss of  chromosome 3p and a VHL gene mutation in rhabdoid and  clear cells from the same case, suggesting divergent differentia - tion from the same clone.22 Rhabdoid RCC is associated with  sarcomatoid RCC in a significant number (22%) of cases.22 In  this study, rhabdoid features were observed in approximately  30% of metastatic CCRCCs, and this frequency is quite higher  than in primary lesions of RCC.12-16 This finding also suggests  that rhabdoid features are associated with a poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/0c/6f/kjpathol-47-426.PMC3830989.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.426432 • Lee C, et al.",OADS,/arxiv_data1/oa_pdf/0c/6f/kjpathol-47-426.PMC3830989.pdf
"433 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Neuroblastic tumors (NTs) are the most common extracranial  solid tumors in children with highly variable biologic features  and clinical outcomes.1,2 The natural history of NTs range from  spontaneous regression to rapid and potentially fatal progres - sion.",Non-OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
"Department of Pathology, Samsung Medical Center,  Sungkyunkwan University School of Medicine,   81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-2767 Fax: +82-2-3410-0025 E-mail: jsunkim@skku.eduThe Korean Journal of Pathology  2013; 47: 433-442 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433434 • Bae GE, et al.",OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433Metastatic Neuroblastic Tumor after Chemotherapy • 435 these cases were eventually confirmed to be NTs by excisional  biopsy after chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433436 • Bae GE, et al.",OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433Metastatic Neuroblastic Tumor after Chemotherapy • 437 Clinical significance of histological findings in metastatic  neuroblastic tumors  in bone marrow We analyzed the relationship between histological findings in  metastatic NTs in bone marrow and clinical outcomes by focus - ing on the histologic findings known to have significant correla - tion to the primary tumor.,OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433438 • Bae GE, et al.",OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433Metastatic Neuroblastic Tumor after Chemotherapy • 439 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433440 • Bae GE, et al.",OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433Metastatic Neuroblastic Tumor after Chemotherapy • 441 poorly differentiated NTs in bone marrow may be correlated  with poor outcome.,Non-OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.433442 • Bae GE, et al.",OADS,/arxiv_data1/oa_pdf/ab/92/kjpathol-47-433.PMC3830990.pdf
"443 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Tumor cells can display immunogenic tumor-associated anti - gens (TAAs) that become targets for cellular immune respons - es.1 Th2 immune responses are inefficient at protecting the host  from malignancy, while Th1 immune reactions promote tumor  immune responses as they activate and proliferate CD8+ T  cells.2 CD8+ T cells kill tumor cells by releasing toxic gran - ules.3 A high density distribution of CD8+ T cells has been  found to be correlated with reduced tumor metastasis and fa - vorable prognosis in colorectal cancer (CRC).4,5 In contrast, oth - er previous studies have not observed these findings in CRC.6,7  Cancer cells also escape from the host immune system through  a number of mechanisms.8 Regulatory T cells (Tregs) are known  to contribute to tumor immune evasion in a variety of cancers.8  Tregs are suppressive CD4+CD25+ T cells that express the  forkhead box P3 (FOXP3) transcription factor and inhibit acti - vation of conventional T cells against self antigens, including  TAAs, through direct cell-to-cell contact or the release of cyto - kines.9,10 The number of Tregs is increased in tumor tissues in  CRC.11-13 A high density of Tregs is associated with poor out - comes in most varieties of cancer; however, many publications have shown that a high frequency of tumor-infiltrating Tregs is  correlated with a favorable prognosis in CRC.6,7,14 Tumor-infil - trating Tregs in CRC reduce conventional T cell activation via  the expression of cytotoxic T lymphocyte antigen-4.13 Several  publications have suggested that interactions among T cell sub - sets is an important factor that regulates the host-tumor reac - tion and is predictive of disease outcome in CRC.12,15,16 Recent - ly, the tumor-infiltrating CD8+ T cells/Tregs ratio was found  to be associated with survival prognosis in CRC.15 The afore - mentioned reports indicate that altered T cell composition in  tissues of CRC will influence immune response against cancer  cells.",Non-OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
"Department of Pathology, Dongguk University  College of Medicine, 123 Dongdae-ro, Gyeongju  780-714, Korea Tel: +82-54-770-2410 Fax: +82-54-770-2447 E-mail: taejung@mail.dongguk.ac.krThe Korean Journal of Pathology  2013; 47: 443-451 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.443▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.443444 • Jang TJ conducted to examine the distribution of T cells expressing  CD8 and FOXP3, measure the CD8+ T cell/Tregs ratio, inves - tigate the relationship between Tregs and COX-2 expression  during CRC development, and then compare these values to  clinicopathological parameters in CRC.",OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.443CD8+ T Cells and Regulatory T Cells during CRC Development • 445 Statistical analysis Statistical analyses consisted of Kruskal-Wallis test (KW),  Mann-Whitney (MW), t-test and Fisher’s exact test.",OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.443446 • Jang TJ Fig.,Non-OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.443CD8+ T Cells and Regulatory T Cells during CRC Development • 447 non-neoplastic colonic mucosa.,Non-OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.443448 • Jang TJ p<.001).,Non-OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.443CD8+ T Cells and Regulatory T Cells during CRC Development • 449 test, p <.001).",Non-OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.443450 • Jang TJ positive association between COX-2 expression and the number  of Tregs.,OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.443CD8+ T Cells and Regulatory T Cells during CRC Development • 451 sive front of invasive CRC were associated with clinicopatho - logical parameters such as gender, tumor differentiation, node  metastasis, and tumor budding.",OADS,/arxiv_data1/oa_pdf/96/f3/kjpathol-47-443.PMC3830991.pdf
"452 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Renal cancer is a common cancer, with an incidence of about  10.1% in Korean males in 2010.1 Renal cell carcinoma (RCC)  of adults represents 90% of all renal cancers.2 The 5-year surviv - al rate of patients with localized RCC is more than 70%, which  is relatively excellent, although there are some differences ac - cording to the subtype.",Non-OADS,/arxiv_data1/oa_pdf/22/34/kjpathol-47-452.PMC3830992.pdf
"Department of Pathology, Kidney Research Institute,  Medical Research Center, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 110-799, Korea Tel: +82-2-2072-1767 Fax: +82-2-743-5530 E-mail: blue7270@snu.ac.krThe Korean Journal of Pathology  2013; 47: 452-457 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.452▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/22/34/kjpathol-47-452.PMC3830992.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.452ALK-Positive RCC • 453 a single institution for ALK protein expression by immunohis - tochemistry, and then we performed fluorescence in situ  hybrid - ization (FISH) analysis to confirm the ALK gene alteration in  ALK immunohistochemistry-positive cases.",OADS,/arxiv_data1/oa_pdf/22/34/kjpathol-47-452.PMC3830992.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.452454 • Lee C, et al.",OADS,/arxiv_data1/oa_pdf/22/34/kjpathol-47-452.PMC3830992.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.452ALK-Positive RCC • 455 medullary carcinoma and RCC undetermined.18,19 Renal medul - lary carcinoma was almost exclusively associated with sickle cell  trait.2 However, the following 4 cases were adult cases without  history of sickle cell trait and subtypes were papillary RCC in 3  cases and one unclassified RCC.20,21 In this study, we screened  829 RCCs and found one case with ALK immunohistochemical positivity and ALK gene rearrangement.",Non-OADS,/arxiv_data1/oa_pdf/22/34/kjpathol-47-452.PMC3830992.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.452456 • Lee C, et al.",OADS,/arxiv_data1/oa_pdf/22/34/kjpathol-47-452.PMC3830992.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.452ALK-Positive RCC • 457 a comparative immunohistochemical study.,Non-OADS,/arxiv_data1/oa_pdf/22/34/kjpathol-47-452.PMC3830992.pdf
"458 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Malignant lymphoma is the 10th most frequent malignancy  in Korea.1 In patients with malignant lymphoma, an accurate  diagnosis facilitates effective treatment, which leads to improved  outcomes.",Non-OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
"Department of Pathology, Chonnam National  University Hospital, Chonnam National University  Medical School, 160 Baekseo-ro, Dong-gu,  Gwangju 501-746, Korea  Tel: +82-62-220-4321 Fax: +82-62-227-3429 E-mail: jhnam@chonnam.ac.krThe Korean Journal of Pathology  2013; 47: 458-465 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.458▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.458BIOMED-2 PCR Assay in Lymphoproliferative Diseases • 459 rearrangements in other ethnic groups including Asians with  LPDs have been insufficient.,Non-OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.458460 • Kim Y, et al.",OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.458BIOMED-2 PCR Assay in Lymphoproliferative Diseases • 461 cases with nodal MZLs, three (100%) had clonality for IGH and  two (66.7%) showed clonality for IGK.",Non-OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.458462 • Kim Y, et al.",OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.458BIOMED-2 PCR Assay in Lymphoproliferative Diseases • 463 cases, 93.8% showed clonality for IG, which was similar to a  European study that revealed 98.0% clonality.15 The other  types of B cell lymphomas showed 100% clonality, similar to  what was observed in a European study.14,15 The FL cases  showed 100% (6/6) clonality for IG including IGH and IGK;  however, no clonality was observed for DH-JH rearrangements  of IGH in this study, as compared to a 19.0% rearrangement  rate in a European study.15 BLL/L showed quite different clonality results from other  types of B cell lymphomas.",Non-OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.458464 • Kim Y, et al.",OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
Available from: http://www.can - cer.go.kr/mbs/cancer/subview.jsp?id=cancer_040102000000.,Non-OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.458BIOMED-2 PCR Assay in Lymphoproliferative Diseases • 465 versus Southern blot hybridization: detection of immunoglobulin  heavy-chain gene rearrangements.,Non-OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/af/12/kjpathol-47-458.PMC3830993.pdf
"466 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Three distinct lesions can affect the parathyroid gland and  cause primary hyperparathyroidism (PHPT): parathyroid hy - perplasia, adenoma, and carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/49/c0/kjpathol-47-466.PMC3830994.pdf
"Department of Pathology, Korea Cancer Center  Hospital, 75 Nowon-ro, Nowon-gu, Seoul 139-706,  Korea Tel: +82-2-970-2545 Fax: +82-2-970-2430 E-mail: pathsycho@naver.comThe Korean Journal of Pathology  2013; 47: 466-471 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.466▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/49/c0/kjpathol-47-466.PMC3830994.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.466Fine Needle Aspiration of Parathyroid Lesion • 467 onto four glass slides that were immediately fixed in 95% alco - hol and subjected to Papanicolaou staining.,Non-OADS,/arxiv_data1/oa_pdf/49/c0/kjpathol-47-466.PMC3830994.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.466468 • Heo I, et al.",OADS,/arxiv_data1/oa_pdf/49/c0/kjpathol-47-466.PMC3830994.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.466Fine Needle Aspiration of Parathyroid Lesion • 469 tological findings were a papillary pattern with scattered naked  nuclei, tight clusters, a follicular pattern, anisokaryosis, and stip - pled chromatin.",Non-OADS,/arxiv_data1/oa_pdf/49/c0/kjpathol-47-466.PMC3830994.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.466470 • Heo I, et al.",OADS,/arxiv_data1/oa_pdf/49/c0/kjpathol-47-466.PMC3830994.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.466Fine Needle Aspiration of Parathyroid Lesion • 471 of PL.2,3,6 The sensitivity of cytological diagnosis varied substan - tially depending upon available clinicoradiologic information,  such as serum PTH, ultrasonography, and location.",Non-OADS,/arxiv_data1/oa_pdf/49/c0/kjpathol-47-466.PMC3830994.pdf
"472 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Fibromatoses comprise a broad group of tumors characterized  by fibroblast and myofibroblast proliferation with variable col - lagen production, infiltrative growth, lack of severe cellular  atypia, and low mitotic activity.",Non-OADS,/arxiv_data1/oa_pdf/f5/9a/kjpathol-47-472.PMC3830995.pdf
"Department of Pathology, Chonbuk National  University Medical School, 567 Baekje-daero,  Deokjin-gu, Jeonju 561-756, Korea Tel: +82-63-270-3072 Fax: +82-63-270-3135  E-mail: mjchung@jbnu.ac.kr The Korean Journal of Pathology  2013; 47: 472-476 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.472▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/f5/9a/kjpathol-47-472.PMC3830995.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.472Abdominal Fibromatosis in a Young Child • 473 mor was microscopically composed of parallel long fascicles of  spindle-cells with a uniform appearance (Fig.,Non-OADS,/arxiv_data1/oa_pdf/f5/9a/kjpathol-47-472.PMC3830995.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.472474 • Chu HH, et al.",OADS,/arxiv_data1/oa_pdf/f5/9a/kjpathol-47-472.PMC3830995.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.472Abdominal Fibromatosis in a Young Child • 475 Those authors speculated that childhood fibromatosis is biologi - cally different from the adult counterpart.,Non-OADS,/arxiv_data1/oa_pdf/f5/9a/kjpathol-47-472.PMC3830995.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.472476 • Chu HH, et al.",OADS,/arxiv_data1/oa_pdf/f5/9a/kjpathol-47-472.PMC3830995.pdf
"477 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Cotyledonoid dissecting leiomyoma (CDL), also known as a  Sternberg tumor or “grape-like” leiomyoma, is an extremely  rare variant that mimics malignant gross features but has a be - nign histology and biological behavior.1 The name “cotyle - donoid” leiomyoma originated from the characteristic gross  morphology, which includes extrauterine dark red, spongy, bul - bous protuberances, also resembling a placenta.2 To date, 41  cases of CDLs have been reported in the English literature.1-9  Here, we report an additional case of CDL.",Non-OADS,/arxiv_data1/oa_pdf/d5/09/kjpathol-47-477.PMC3830996.pdf
"Department of Pathology, Gachon University Gil  Medical Center, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 405-760, Korea Tel: +82-32-460-3865 Fax: +82-32-460-3073 E-mail: hicho@gilhospital.comThe Korean Journal of Pathology  2013; 47: 477-480 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.477▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/d5/09/kjpathol-47-477.PMC3830996.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.477478 • Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/d5/09/kjpathol-47-477.PMC3830996.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.477Cotyledonoid Dissecting Leiomyoma of the Uterus • 479 A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/d5/09/kjpathol-47-477.PMC3830996.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.477480 • Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/d5/09/kjpathol-47-477.PMC3830996.pdf
"481 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Low-grade cribriform cystadenocarcinoma (LGCCC) is a rare  salivary gland tumor characterized by cystic, papillary, and crib - riform proliferation that histologically resembles atypical ductal  hyperplasia (ADH) and low-grade ductal carcinoma in situ  (LG- DCIS) of the breast.",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/kjpathol-47-481.PMC3830997.pdf
"Department of Pathology, Kyungpook National  University Hospital, Kyungpook National University  School of Medicine, 130 Dongdeok-ro, Jung-gu,  Daegu 700-721, Korea Tel: +82-53-420-5247 Fax: +82-53-426-1525  E-mail: jyparkmd@knu.ac.krThe Korean Journal of Pathology  2013; 47: 481-485 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.481▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/kjpathol-47-481.PMC3830997.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.481482 • Jeong JY, et al.",OADS,/arxiv_data1/oa_pdf/d4/1d/kjpathol-47-481.PMC3830997.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.481Cytology of Low-Grade Cribriform Cystadenocarcinoma of the Salivary Gland • 483 gland but was nonencapsulated.,Non-OADS,/arxiv_data1/oa_pdf/d4/1d/kjpathol-47-481.PMC3830997.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.481484 • Jeong JY, et al.",OADS,/arxiv_data1/oa_pdf/d4/1d/kjpathol-47-481.PMC3830997.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.481Cytology of Low-Grade Cribriform Cystadenocarcinoma of the Salivary Gland • 485 is characterized by an infiltrative growth pattern with mainly  lobular, trabecular, or ductal structures.",Non-OADS,/arxiv_data1/oa_pdf/d4/1d/kjpathol-47-481.PMC3830997.pdf
"486 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Malignant rhabdoid tumors (MRTs) are rare high-grade ma - lignancies in the renal or extrarenal organs.",Non-OADS,/arxiv_data1/oa_pdf/01/80/kjpathol-47-486.PMC3830998.pdf
"Due to voluminous hepatic mass formation and no in - creased tumor markers such as AFP and CEA, primary liver A Primary Malignant Rhabdoid Tumor in Adult Liver Yu Na Kang ·Sang Pyo Kim ·Byoung Kuk Jang1 Departments of Pathology and 1Internal Medicine, Keimyung University School of Medicine, Daegu, KoreaThe Korean Journal of Pathology  2013; 47: 486-488 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.486▒ BRIEF CASE REPORT ▒ Corresponding Author Yu Na Kang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/01/80/kjpathol-47-486.PMC3830998.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.486A Primary Malignant Rhabdoid Tumor in Adult Liver • 487 Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/80/kjpathol-47-486.PMC3830998.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.486488 • Kang YN, et al.",OADS,/arxiv_data1/oa_pdf/01/80/kjpathol-47-486.PMC3830998.pdf
"489 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Nesidioblastosis is a clinically, pathologically, and genetically  heterogenous disease observed in neonates with persistent hy - perinsulinemic hypoglycemia of infancy, but it is very rare in  adults.1 Although progression from nesidioblastosis and islet  hyperplasia to pancreatic tumors has been observed in an ani - mal study using transgenic mice,2 islet cell tumors associated  with nesidioblastosis in human are exceedingly rare.3,4 Herein  we report a very unusual case of nesidioblastosis coexisting with  a pancreatic non-functioning islet cell tumor in an adult with  type 2 diabetes mellitus (type 2 DM).",Non-OADS,/arxiv_data1/oa_pdf/3a/b3/kjpathol-47-489.PMC3830999.pdf
"She remained free of any sign of  recurrent tumor and her diabetic symptoms were controlled Nesidioblastosis and Pancreatic Non-functioning Islet Cell Tumor in an  Adult with Type 2 Diabetes Mellitus Ji Eun Choi ·Sang Jae Noh ·Jong Jin Sung ·Woo Sung Moon Department of Pathology, Research Institute for Endocrine Sciences and Research Institute of Clinical Medicine, Chonbuk National University   Medical School, Jeonju, KoreaThe Korean Journal of Pathology  2013; 47: 489-491 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.489▒ BRIEF CASE REPORT ▒ Corresponding Author Woo Sung Moon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/3a/b3/kjpathol-47-489.PMC3830999.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.489490 • Choi JE, et al.",OADS,/arxiv_data1/oa_pdf/3a/b3/kjpathol-47-489.PMC3830999.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.489Nesidioblastosis and Neuroendocrine Tumor • 491 strated that mice carrying a Moloney murine sarcoma virus- simian virus 40 large T transgene develop nesidioblastosis and  islet cell proliferation and finally progress to pancreatic neuro - endocrine tumors.2 A patient with a spectrum ranging from  nesidioblastosis and islet cell hyperplasia of the pancreas to  multiple adenomas with metastases has been reported, suggest - ing the association of nesidioblastosis with proliferative and  neoplastic conditions.4 Islet cell tumors associated with nesidio - blastosis are usually insulinoma,2,4 and only a few cases of non- functioning islet cell tumors associated with nesidioblastosis  have been reported, as in our case.3,6 Similarly, among 23 devel - oped pancreatic tumors in transgenic mice, 91% of the tumors  were insulinoma, and one was a non-functioning neuroendo - crine tumor, based on immunohistochemical stain.2  Sporadic hyperinsulinemic hypoglycemia is the main clinical  feature of nesidioblastosis and almost all cases have been detect - ed because of hypoglycemia-related symptoms.1,3-5 However,  our case had no symptoms of sporadic hyperinsulinemic hypo - glycemia.",Non-OADS,/arxiv_data1/oa_pdf/3a/b3/kjpathol-47-489.PMC3830999.pdf
"492 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Primary extraskeletal mesenchymal chondrosarcoma (EMC) of  the mediastinum is an extremely rare disease.",Non-OADS,/arxiv_data1/oa_pdf/f3/1b/kjpathol-47-492.PMC3831000.pdf
"The pa - tient is still alive with a residual tumor at the time of writing  this report (8 months postoperatively).Primary Extraskeletal Mesenchymal Chondrosarcoma of the Anterior  Mediastinum Sang Seok Jeong ·Phil Jo Choi ·Dong Won Kim1·Choonhee Son2·Mee Sook Roh3 Departments of Thoracic and Cardiovascular Surgery, 1Radiology, 2Internal Medicine, and 3Pathology, Dong-A University College of Medicine, Busan, KoreaThe Korean Journal of Pathology  2013; 47: 492-494 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.492▒ BRIEF CASE REPORT ▒ Corresponding Author Mee Sook Roh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f3/1b/kjpathol-47-492.PMC3831000.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.492Primary Mediastinal Extraskeletal Mesenchymal Chondrosarcoma • 493 DISCUSSION To date, a total of 11 cases of primary chondrosarcoma of the  mediastinum have been reported in the literature.",Non-OADS,/arxiv_data1/oa_pdf/f3/1b/kjpathol-47-492.PMC3831000.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.492494 • Jeong SS, et al.",OADS,/arxiv_data1/oa_pdf/f3/1b/kjpathol-47-492.PMC3831000.pdf
"495 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Neuroendocrine dysplasia in the large intestine is a rare dis - ease entity that mostly encountered in association with inflam - matory bowel disease, especially ulcerative colitis.1 Neuroendo - crine dysplasia is defined primarily by the size of the neuroendo - crine cell nests, and differs from neuroendocrine hyperplasia or  microcarcinoid tumors.",Non-OADS,/arxiv_data1/oa_pdf/ba/3d/kjpathol-47-495.PMC3831001.pdf
"A desmo -Neuroendocrine Dysplasia Combined in a Tubular Adenoma of Rectum:   A Case Report So-Young Lee ·Dae-Yong Hwang1·Tae Sook Hwang ·Wan-Seop Kim ·So Dug Lim ·Wook Youn Kim ·  Se-Hun Kim ·Hye Seung Han Departments of Pathology and 1General Surgery, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, KoreaThe Korean Journal of Pathology  2013; 47: 495-498 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.495▒ BRIEF CASE REPORT ▒ Corresponding Author Hye Seung Han, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ba/3d/kjpathol-47-495.PMC3831001.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.495496 • Lee S-Y, et al.",Non-OADS,/arxiv_data1/oa_pdf/ba/3d/kjpathol-47-495.PMC3831001.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.495Neuroendocrine Dysplasia Combined in a Tubular Adenoma • 497 DISCUSSION Neuroendocrine dysplasia is an extremely rare disease condi - tion in the large intestine.,Non-OADS,/arxiv_data1/oa_pdf/ba/3d/kjpathol-47-495.PMC3831001.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.495498 • Lee S-Y, et al.",OADS,/arxiv_data1/oa_pdf/ba/3d/kjpathol-47-495.PMC3831001.pdf
"499 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Intravascular papillary endothelial hyperplasia (IPEH) is an  exuberant proliferation of endothelial cells that may occur with - in the lumen of a pre-existing vessel or vascular malformation.1  Although IPEH is regarded as a non-neoplastic reactive process,  misdiagnoses as a malignancy have been reported, particularly  based on fine needle aspiration (FNA) findings.2-4 We report a  case of IPEH on the chest wall that was initially misdiagnosed  as an adenocarcinoma on FNA.",Non-OADS,/arxiv_data1/oa_pdf/27/2b/kjpathol-47-499.PMC3831002.pdf
"Although trauma is believed to be a factor in  the development of IPEH, a history of trauma was elicited in Intravascular Papillary Endothelial Hyperplasia of the Chest Wall  Misdiagnosed as a Malignancy on Fine Needle Aspiration Yoo-Duk Choi ·Young Kim ·Sung-Sun Kim ·Jo-Heon Kim ·Jong-Hee Nam ·Chan Choi ·Chang-Soo Park Department of Pathology, Chonnam National University Medical School, Gwangju, KoreaThe Korean Journal of Pathology  2013; 47: 499-501 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.499▒ BRIEF CASE REPORT ▒ Corresponding Author Yoo-Duk Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/27/2b/kjpathol-47-499.PMC3831002.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.499500 • Choi YD, et al.",OADS,/arxiv_data1/oa_pdf/27/2b/kjpathol-47-499.PMC3831002.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.499Cytology of Papillary Endothelial Hyperplasia • 501 cytochemical stains for Factor VIII and CD31 can also added to  the cytologic diagnosis of vascular lesion.,Non-OADS,/arxiv_data1/oa_pdf/27/2b/kjpathol-47-499.PMC3831002.pdf
"502 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The Korean Journal of Pathology  2013; 47: 502 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.502▒ CORRESPONDENCE ▒ Erratum: Correction of Author Name Intraductal Carcinoma of Prostate: A Comprehensive and Concise  Review Jordan A. Roberts1·Ming Zhou2·Yong Wok Park3·Jae Y. Ro1,4 1Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX; 2Department of Pathology, New York University Langone Medical Center,   New York, NY, USA; 3Department of Pathology Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea; 4Weill Cornell Medical College of  Cornell University, New York, NY, USA To the Editor: We found an error in our published article.",Non-OADS,/arxiv_data1/oa_pdf/7d/7d/kjpathol-47-502.PMC3831003.pdf
Korean J Pathol  2013; 47(4): 307-15. http://dx.doi.org/10.4132/KoreanJPathol.2013.47.4.307.,Non-OADS,/arxiv_data1/oa_pdf/7d/7d/kjpathol-47-502.PMC3831003.pdf
"503 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920The Korean Journal of Pathology  2013; 47: 503 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.5.503▒ CORRESPONDENCE ▒ Erratum: Correction of Acknowledgments ERG Immunohistochemistry as an Endothelial Marker for Assessing  Lymphovascular Invasion Sehun Kim ·Hyung Kyu Park ·Ho Young Jung ·So-Young Lee ·Kyueng-Whan Min ·Wook Youn Kim ·Hye Seung Han   Wan Seop Kim ·Tae Sook Hwang ·So Dug Lim Department of Pathology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea To the Editor: We found an error in our published article.",Non-OADS,/arxiv_data1/oa_pdf/db/2f/kjpathol-47-503.PMC3831004.pdf
Korean J Pathol 2013; 47(4): 355-64. http://dx.doi.org/10.4132/   KoreanJPathol.2013.47.4.355.,Non-OADS,/arxiv_data1/oa_pdf/db/2f/kjpathol-47-503.PMC3831004.pdf
"Commonly used sec-ond-generation drugs in stents are zotarolimus, an immunosup -Review http://dx.doi.org/10.4070/kcj.2013.43.10.645 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Bumpy and Winding but Right Path  to Domestic Drug-Eluting Coronary Stents Jae Yeong Cho, MD, Youngkeun Ahn, MD, and Myung Ho Jeong, MD Korea Cardiovascular Stent Research Institute of Chonnam National University, Gwangju, Korea Restenosis and stent thrombosis remain major concerns after percutaneous coronary intervention for the treatment of coronary artery  disease.",Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pressant and semisynthetic derivative of rapamycin, everolimus, a  derivative of sirolimus that works as an inhibitor of the mammalian target of rapamycin (mTOR), and biolimus, an equipotent semi-syn-thetic sirolimus analog with a biodegradable polymer, polylactic acid, with ten times the lipophilicity of sirolimus.",Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
646 New Drug-Eluting Stent http://dx.doi.org/10.4070/kcj.2013.43.10.645 www.e-kcj.org The second generation: everolimus and zotarolimus Everolimus is the 40-O-2-hydroxyethyl derivative of sirolimus and  works similar to sirolimus as an inhibitor of mTOR.,Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.645 www.e-kcj.org factor of key mitochondrial enzymes, such as pyruvate dehydroge- nase and α-ketoglutarate dehydrogenase.29) α-LA is endogenous  and improves diabetes-induced endothelial dysfunction, probably due to its antioxidant effects and direct free-radical scavenging pro-perties.",Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
648 New Drug-Eluting Stent http://dx.doi.org/10.4070/kcj.2013.43.10.645 www.e-kcj.org between functional groups of the drug and -OH groups of plasma  modified TiO 2 film.,Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.645 www.e-kcj.org NIH.,OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
"650 New Drug-Eluting Stent http://dx.doi.org/10.4070/kcj.2013.43.10.645 www.e-kcj.org phy with acetylcholine (10 mL, 3 µg/mL) stimulation tests and were  then euthanized for histological analysis.",Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.645 www.e-kcj.org erated re-endothelialization, as indicated by detectable anti-CD31- positive stained cells compared with a commercially available PES.90) Conclusion The conventional requirements for developing a new DES have  been considered to include 1) the inhibitory efficacy of eluting agent against the development of NIH, 2) the stability of the coating agent on the metal stent strut, and 3) cost-effectiveness.",Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
652 New Drug-Eluting Stent http://dx.doi.org/10.4070/kcj.2013.43.10.645 www.e-kcj.org 21.,Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.645 www.e-kcj.org a TiO2 film deposited by plasma enhanced chemical vapour deposi- tion as a drug-combining matrix.,Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
"654 New Drug-Eluting Stent http://dx.doi.org/10.4070/kcj.2013.43.10.645 www.e-kcj.org drug-eluting stents reduce the risk of stent thrombosis at 4 years in  patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.",Non-OADS,/arxiv_data1/oa_pdf/c7/dd/kcj-43-645.PMC3831010.pdf
"1) Normally, both QT and RR Original Article http://dx.doi.org/10.4070/kcj.2013.43.10.655 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Maximal Exercise-Corrected QT as a Predictor  of Coronary Artery Disease: Comparison of Simpler  Heart Rate Corrections Aydın Akyuz, MD, Seref Alpsoy, MD, Dursun Cayan Akkoyun, MD, Hasan Degirmenci, MD, and Niyazi Guler, MD Department of Cardiology, Namık Kemal University Medical School, Tekirdag, Turkey Background and Objectives: The relationship between QT prolongation and myocardial ischemia is widely known.",Non-OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.intervals shorten with exercise due to parasympathetic withdrawal  and sympathetic activation.2)3) In particular, during the period from  rest to exercise, the relationship between QT and RR intervals is com-plex, due to the fact that QT fails to shorten while the heart rate in-creases.",Non-OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
"656 QTc Response to Exercise for Predicting Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2013.43.10.655 www.e-kcj.org sis during exercise, some investigators focused on QT changes and,  consequently, an increased QT dispersion of ≥70 ms during the exer- cise has been proposed as a predictor of CAD.12)13) Although the as- sociation of both CAD and increased QTc is a well-known synergis-tic risk factor of sudden cardiac death, 14) no study thus far has in- vestigated the QTc response in terms of simpler heart rate correction formulae to maximal exercise to predict CAD.",Non-OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.655 www.e-kcj.org dian (minimum-maximum) values for normal and abnormal distribu- tion, respectively.",Non-OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
"658 QTc Response to Exercise for Predicting Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2013.43.10.655 www.e-kcj.org ercise, and peak HR, the mean maximal exercise METs values,  achievement time from resting HR to peak HR, systolic, and diastolic BP in maximal exercise were similar in the two groups (all p>0.05).",OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.655 www.e-kcj.org (0.551-0.688), p<001 }.",OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
660 QTc Response to Exercise for Predicting Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2013.43.10.655 www.e-kcj.org Table 5.,Non-OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.655 www.e-kcj.org control group consisted of non-CAD subjects with ST depression or  exercise-induced angina.,Non-OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
662 QTc Response to Exercise for Predicting Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2013.43.10.655 www.e-kcj.org the preceding two-minute RR intervals.,Non-OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.655 www.e-kcj.org 411-20.,Non-OADS,/arxiv_data1/oa_pdf/cf/b0/kcj-43-655.PMC3831011.pdf
"Among many inflamma-Original Article http://dx.doi.org/10.4070/kcj.2013.43.10.664 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Impact of Ischemic Time on the Predictive Value  of High-Sensitivity C-Reactive Protein in ST-Segment Elevation  Myocardial Infarction Patients Treated by Primary Percutaneous  Coronary Intervention Kyung Hwan Kim, MD1, Wan Kim, MD1, Won Yu Kang, MD1, Sun Ho Hwang, MD1, Sang Cheol Cho, MD1,   Weon Kim, MD2, Myung Ho Jeong, MD3, and Other Korean Working Group in Myocardial Infarction Investigators 1Division of Cardiology, Department of Internal Medicine, Gwangju Veterans Hospital, Gwangju,  2Department of Cardiovascular Medicine, Kyung Hee University College of Medicine, Seoul,  3Department of Cardiovascular Medicine, Chonnam National College of Medicine, Gwangju, Korea  Other Korean Working Group in Myocardial Infarction Investigating Hospitals Background and Objectives: The high-sensitivity C-reactive protein (hs-CRP), a marker of inflammation, has been known to be elevated  in patients with coronary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tory markers, high-sensitivity C-reactive protein (hs-CRP) is the most  extensively studied biomarker of inflammation in cardiovascular dise-ase.",Non-OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.664 www.e-kcj.org dividuals with risk factors, and the risk of recurrent cardiovascular  events among patients with established coronary heart disease.2)3) The role of hs-CRP as a predictor of the prognosis of cardiovas- cular disease has also been studied by many investigators.",Non-OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.664 www.e-kcj.org cial Sciences (SPSS) Version 18 (SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.664 www.e-kcj.org Table 2.,OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.664 www.e-kcj.org and the Pearson chi-square test for categorical variables.,OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.664 www.e-kcj.org death, MI, and the repeat of PCI were also compared between the  four groups.",OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.664 www.e-kcj.org To clarify the effect of ischemic time on the prognostic value of  hs-CRP, we compared the cumulative incidence of cardiovascular  events and performed a Cox regression multivariate analysis in ear - ly and late presenting patients, respectively.",Non-OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.664 www.e-kcj.org value of hs-CRP for long-term clinical outcomes was not conclu- sive for the total group of STEMI patients who were treated by pri-mary PCI in our study.,Non-OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.664 www.e-kcj.org of non-cardiac death and recurrence rate of MI was not significant- ly different among the four groups.,OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.664 www.e-kcj.org ties Angina Pectoris Study Group.,Non-OADS,/arxiv_data1/oa_pdf/46/59/kcj-43-664.PMC3831012.pdf
"1) In this regard, stress tests using additional imaging tests, Original Article http://dx.doi.org/10.4070/kcj.2013.43.10.674 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Improved Detection of Ischemic Heart Disease by Combining  High-Frequency Electrocardiogram Analysis  with Exercise Stress Echocardiography Jin-Oh Choi, MD, Sung-A Chang, MD, Sung Ji Park, MD, Sang-Chol Lee, MD, and Seung Woo Park, MD Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background and Objectives: Because the exercise treadmill test (ETT) based on ST-segment analysis is limited due to low sensitivity and  specificity, there has been an interest in the additional analysis of high-frequency components of QRS (HFQRS) for the detection of coronary artery disease (CAD).",Non-OADS,/arxiv_data1/oa_pdf/77/db/kcj-43-674.PMC3831013.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.such as exercise stress echocardiography (ESE), stress cardiac mag- netic resonance imaging, and coronary computed tomographic an - giography (CCTA) are more reliably used in clinical practice.2) Among  these non-invasive tests, ESE has the advantage of noninvasiveness and no need for contrast agents or radiation.",Non-OADS,/arxiv_data1/oa_pdf/77/db/kcj-43-674.PMC3831013.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.674 www.e-kcj.org coronary angiography (CAG).,Non-OADS,/arxiv_data1/oa_pdf/77/db/kcj-43-674.PMC3831013.pdf
676 HFQRS Analysis with Stress EchoCG http://dx.doi.org/10.4070/kcj.2013.43.10.674 www.e-kcj.org Coronary CT and invasive coronary angiography The presence of significant CAD was evaluated by either CCTA or  invasive CAG.,OADS,/arxiv_data1/oa_pdf/77/db/kcj-43-674.PMC3831013.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.674 www.e-kcj.org sis of significant CAD were 0.765 {95% confidence interval (CI) of  AUC=0.680-0.849 }, slightly greater than those of prediction mod- els with age, sex and ST-segment analysis (0.679, 95% CI of  AUC=0.592-0.766).",OADS,/arxiv_data1/oa_pdf/77/db/kcj-43-674.PMC3831013.pdf
678 HFQRS Analysis with Stress EchoCG http://dx.doi.org/10.4070/kcj.2013.43.10.674 www.e-kcj.org additional information to ETT and ESE.,OADS,/arxiv_data1/oa_pdf/77/db/kcj-43-674.PMC3831013.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.674 www.e-kcj.org Seventy-one patients were excluded due to poor ECG quality for  HFQRS analysis.,Non-OADS,/arxiv_data1/oa_pdf/77/db/kcj-43-674.PMC3831013.pdf
680 HFQRS Analysis with Stress EchoCG http://dx.doi.org/10.4070/kcj.2013.43.10.674 www.e-kcj.org tion.,OADS,/arxiv_data1/oa_pdf/77/db/kcj-43-674.PMC3831013.pdf
"1-3) Now-Original Article http://dx.doi.org/10.4070/kcj.2013.43.10.681 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Balloon Occlusive Diameter of Non-Circular Atrial Septal Defects  in Transcatheter Closure with Amplatzer Septal Occluder Kwang Hoon Kim, MD1, Jinyoung Song, MD1, I-Seok Kang, MD1,   Sung-A Chang, MD2, June Huh, MD1, and Seung Woo Park, MD2 1Departments of Pediatrics and 2Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background and Objectives: The aim of this study was to investigate the balloon occlusive diameter (BOD) of non-circular defects in the  transcatheter closure of atrial septal defect (ASD).Subjects and Methods: A total of 67 patients who had undergone transcatheter closure of an ASD were reviewed retrospectively.",OADS,/arxiv_data1/oa_pdf/80/26/kcj-43-681.PMC3831014.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.adays, successful device closure is reported even in small children.4)  For successful device closure of the ASD, a detailed anatomical  evaluation of the size, morphology, and spatial relationship with the surrounding structures is crucial.",Non-OADS,/arxiv_data1/oa_pdf/80/26/kcj-43-681.PMC3831014.pdf
"682 Balloon Occlusive Diameter in ASD Closure http://dx.doi.org/10.4070/kcj.2013.43.10.681 www.e-kcj.org Subjects and Methods This was a retrospective study of patients who had undergone a  percutaneous closure of ASD with ASO (AGA Medical, Golden Val- ley, MN, USA) at the Samsung Medical Center from January 2010 to September 2012.",Non-OADS,/arxiv_data1/oa_pdf/80/26/kcj-43-681.PMC3831014.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.681 www.e-kcj.org Results All the data are described in Table 1.,OADS,/arxiv_data1/oa_pdf/80/26/kcj-43-681.PMC3831014.pdf
684 Balloon Occlusive Diameter in ASD Closure http://dx.doi.org/10.4070/kcj.2013.43.10.681 www.e-kcj.org 0.05).,Non-OADS,/arxiv_data1/oa_pdf/80/26/kcj-43-681.PMC3831014.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.681 www.e-kcj.org References 1.,Non-OADS,/arxiv_data1/oa_pdf/80/26/kcj-43-681.PMC3831014.pdf
"It is also effective in left ventricular dysfunction, Original Article http://dx.doi.org/10.4070/kcj.2013.43.10.686 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Preventive Effects of the Angiotensin-II Receptor Blocker on Atrial Remodeling in an Ischemic Heart Failure Model of Rats Namsik Yoon, MD, Kye Hun Kim, MD, Keun Ho Park, MD, Doo Sun Sim, MD, Hyun Ju Youn, MD,  Young Joon Hong, MD, Hyung Wook Park, MD, Ju Han Kim, MD, Youngkeun Ahn, MD,  Myung Ho Jeong, MD, Jeong Gwan Cho, MD, and Jong Chun Park, MD Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea Background and Objectives: It is widely known that angiotensin-II receptor blockers (ARBs) have reverse remodeling effects in atrium.",Non-OADS,/arxiv_data1/oa_pdf/63/3e/kcj-43-686.PMC3831015.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.has a reno-protective effect reducing proteinuria, and an atrial re- verse-remodeling effect as an electrophysiologic stabilizer.1) Studies  of the reverse-remodeling effect are relatively rare, and some in-vestigators do not agree on some points of view.",Non-OADS,/arxiv_data1/oa_pdf/63/3e/kcj-43-686.PMC3831015.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.686 www.e-kcj.org angiotensin-aldosterone system has a relationship with atrial re- modeling, which has a relationship with AF development and ma-intenance.",OADS,/arxiv_data1/oa_pdf/63/3e/kcj-43-686.PMC3831015.pdf
688 Atrial Reverse-Remodeling Effect of ARB in Heart Failure http://dx.doi.org/10.4070/kcj.2013.43.10.686 www.e-kcj.org formed under anesthesia.,Non-OADS,/arxiv_data1/oa_pdf/63/3e/kcj-43-686.PMC3831015.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.686 www.e-kcj.org blot analysis was performed on lysates from frozen tissue.,OADS,/arxiv_data1/oa_pdf/63/3e/kcj-43-686.PMC3831015.pdf
690 Atrial Reverse-Remodeling Effect of ARB in Heart Failure http://dx.doi.org/10.4070/kcj.2013.43.10.686 www.e-kcj.org steady.,Non-OADS,/arxiv_data1/oa_pdf/63/3e/kcj-43-686.PMC3831015.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.686 www.e-kcj.org heart failure-ARB group were 2.192% and 0.744%, respectively.",OADS,/arxiv_data1/oa_pdf/63/3e/kcj-43-686.PMC3831015.pdf
"692 Atrial Reverse-Remodeling Effect of ARB in Heart Failure http://dx.doi.org/10.4070/kcj.2013.43.10.686 www.e-kcj.org art failure model was induced by myocardial infarction, formed by  left coronary artery ligation in this experiment.",Non-OADS,/arxiv_data1/oa_pdf/63/3e/kcj-43-686.PMC3831015.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.686 www.e-kcj.org tologically, the ARB, losartan, has atrial reverse-remodeling effects.",Non-OADS,/arxiv_data1/oa_pdf/63/3e/kcj-43-686.PMC3831015.pdf
"Case On September 25, 2012, a 51-year-old man visited the emergency Case Report http://dx.doi.org/10.4070/kcj.2013.43.10.694 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Case of Three Consecutive Events of Acute  Myocardial Infarctions in Three Different Vessels Hyun Yang, MD1, Sung-Ho Her, MD1, Mahn Won Park, MD1, Jung Sun Cho, MD1,   Chan Joon Kim, MD1, Jong-Bum Kwon, MD2, Sang Mi Ro, MD1, and Yun Kyung Park, MD1 1Division of Cardiology, Department of Internal Medicine and 2Division of Thoracic and Cardiovascular Surgery, Daejeon St. Mary’s Hospital, College of Medicine,   The Catholic University of Korea, Daejeon, Korea A 51-year-old man was being admitted to the emergency department with chest pains.",Non-OADS,/arxiv_data1/oa_pdf/35/72/kcj-43-694.PMC3831016.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.room for acute retrosternal squeezing chest pains for the past tw- elve hours.",Non-OADS,/arxiv_data1/oa_pdf/35/72/kcj-43-694.PMC3831016.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.694 www.e-kcj.org flow in the proximal portion of the LAD, which was successfully  treated with a zotarolimus eluting stent (2.75 ×30 mm, ENDEAV- OR®, Medtronic Inc., Minneapolis, MN, USA) and overlapping a siro-limus eluting stent (3.0 ×23 mm, CYPHER®, Cordis Corporation, War - ren, NJ, USA) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/35/72/kcj-43-694.PMC3831016.pdf
696 Three Consecutive Events of AMI in Three Different Vessels http://dx.doi.org/10.4070/kcj.2013.43.10.694 www.e-kcj.org ratory rate was 20/min.,OADS,/arxiv_data1/oa_pdf/35/72/kcj-43-694.PMC3831016.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.694 www.e-kcj.org umol/L).,OADS,/arxiv_data1/oa_pdf/35/72/kcj-43-694.PMC3831016.pdf
"698 Three Consecutive Events of AMI in Three Different Vessels http://dx.doi.org/10.4070/kcj.2013.43.10.694 www.e-kcj.org deficiency13)), or other specific underlying diseases.",Non-OADS,/arxiv_data1/oa_pdf/35/72/kcj-43-694.PMC3831016.pdf
"Case Report http://dx.doi.org/10.4070/kcj.2013.43.10.699 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Very Early Onset of Amiodarone-Induced Pulmonary Toxicity Wonho Lee, MD1, Dong Rueol Ryu, MD1, Seon-Sook Han, PhD1, Sook-Won Ryu, MD2,   Byung Ryul Cho, MD1, Hyucki Kwon, MD1, and Bo Ra Kim, MD1  1Departments of Internal Medicine and 2Laboratory Medicine, Kangwon National University Hospital, Chuncheon, Korea Amiodarone is a widely used antiarrhythmic agent.",Non-OADS,/arxiv_data1/oa_pdf/d9/c6/kcj-43-699.PMC3831017.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case  A 54-year-old man was admitted to the hospital with chest pain  and ST elevation myocardial infarction.",Non-OADS,/arxiv_data1/oa_pdf/d9/c6/kcj-43-699.PMC3831017.pdf
"700 Amiodarone-Induced Pulmonary Toxicity Occurred within a Few Days http://dx.doi.org/10.4070/kcj.2013.43.10.699 www.e-kcj.org oxyribonucleic acid antibodies, rheumatoid factor, as well as C’3  and C’4 were all within normal limits.",Non-OADS,/arxiv_data1/oa_pdf/d9/c6/kcj-43-699.PMC3831017.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.699 www.e-kcj.org action and minimal myocardial depression.,Non-OADS,/arxiv_data1/oa_pdf/d9/c6/kcj-43-699.PMC3831017.pdf
"We describe here an adult case of isolated left apical diverticulum that could not have been accurately diagnosed in the absence of cardiac magnetic res-onance (CMR) technique.Case Report http://dx.doi.org/10.4070/kcj.2013.43.10.702 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Isolated, Broad-Based Apical Diverticulum: Cardiac Magnetic  Resonance Is a “Terminator” of Cardiac Imaging Modality  for the Evaluation of Cardiac Apex Hyo-Suk Ahn, MD1,2, Hyung-Kwan Kim, MD1,2, Eun-Ah Park, MD3,   Whal Lee, MD3, Jae-Hyung Park, MD3, and Dae-Won Sohn, MD1,2 1Cardiovascular Center, Seoul National University Hospital, Seoul,  2Departments of Internal Medicine and 3Radiology, Seoul National University College of Medicine, Seoul, Korea In spite of the frequent involvement of many cardiac diseases, it is difficult to evaluate the left ventricular apex in detail with transtho- racic echocardiography, a first-line imaging modality in cardiovascular diseases, because the apex is very closely located at the echocar-diographic probe.",Non-OADS,/arxiv_data1/oa_pdf/57/06/kcj-43-702.PMC3831018.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 30-year-old woman was referred to our center with complaints  of headache and right side weakness.",Non-OADS,/arxiv_data1/oa_pdf/57/06/kcj-43-702.PMC3831018.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.702 www.e-kcj.org ticoagulation with warfarin, she was given permission to leave the  hospital.",Non-OADS,/arxiv_data1/oa_pdf/57/06/kcj-43-702.PMC3831018.pdf
704 Apical Diverticulum in CMR http://dx.doi.org/10.4070/kcj.2013.43.10.702 www.e-kcj.org ful.,Non-OADS,/arxiv_data1/oa_pdf/57/06/kcj-43-702.PMC3831018.pdf
"3)4) A combination of abdominal situs inver-Case Report http://dx.doi.org/10.4070/kcj.2013.43.10.705 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Case of Unusual Visceral Heterotaxy Syndrome  with Isolated Levocardia Dae Sun Jo, MD1, Sung Su Jung, MD1, and Chan Uhng Joo, MD1,2 1Department of Pediatrics and 2Institute of Cardiovascular Research, Chonbuk National University Medical School, Jeonju, Korea Situs inversus of the abdominal organs in the presence of normally placed heart on the left side of the thorax is known as situs inversus  with isolated levocardia.",Non-OADS,/arxiv_data1/oa_pdf/a0/e7/kcj-43-705.PMC3831019.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.sus with structurally normal levocardia, bilateral bi-lobed lungs,  polysplenia, left-sided IVC draining to the right atrium is extremely rare.",Non-OADS,/arxiv_data1/oa_pdf/a0/e7/kcj-43-705.PMC3831019.pdf
706 Polysplenia with Isolated Levocardia  http://dx.doi.org/10.4070/kcj.2013.43.10.705 www.e-kcj.org raphy of the thorax and abdomen showed situs inversus with le- vocardia and multiple spleens in the right upper quadrant of the abdomen (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a0/e7/kcj-43-705.PMC3831019.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.705 www.e-kcj.org the left side (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a0/e7/kcj-43-705.PMC3831019.pdf
708 Polysplenia with Isolated Levocardia  http://dx.doi.org/10.4070/kcj.2013.43.10.705 www.e-kcj.org differentiates further through septation of the cardiac chambers  and great vessels.,Non-OADS,/arxiv_data1/oa_pdf/a0/e7/kcj-43-705.PMC3831019.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.10.705 www.e-kcj.org rics), University of Texas Health Science Center, San Antonio, Texas,  for his comments and assistance with this manuscript.",Non-OADS,/arxiv_data1/oa_pdf/a0/e7/kcj-43-705.PMC3831019.pdf
"A repeat echocardiogram eight days later indicated that the biventricular thrombi had com-Images in Cardiovascular Medicine http://dx.doi.org/10.4070/kcj.2013.43.10.710 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Hampton’s Hump in a Patient with Severe Left Ventricular  Dysfunction and Biventricular Thrombosis Saidul Islam, MBBS, James Hayton, MBChB, and Dong-Yeon Kim, MD  Department of Internal Medicine, LAMB Hospital, Rajabasor, Parbatipur, Dinajpur, Bangladesh Received: March 29, 2013 / Revision Received: June 16, 2013 / Accepted: June 19, 2013 Correspondence: Dong-Yeon Kim, MD, Department of Internal Medicine, LAMB Hospital, Rajabasor, Parbatipur, Dinajpur 5250, Bangladesh Tel: 8802 882 9846, Fax: 8802 882 9846, E-mail: dongyeonk@lambproject.org • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/5c/6f/kcj-43-710.PMC3831020.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pletely resolved.",Non-OADS,/arxiv_data1/oa_pdf/5c/6f/kcj-43-710.PMC3831020.pdf
http://dx.doi.org/10.4070/kcj.2013.43.10.710  www.e-kcj.orgFig.,OADS,/arxiv_data1/oa_pdf/5c/6f/kcj-43-710.PMC3831020.pdf
"712 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Erratum http://dx.doi.org/10.4070/kcj.2013.43.10.712 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Case of Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome with Intracardiac Thrombus Jung-Chul Joo, MD, Myung Do Seol, MD, Jin Won Yoon, MD, Young Soo Lee, MD,  Dong-Keun Kim, MD, Yong Hoon Choi, MD, Hyo Seong Ahn, and Wook Hyun Cho, MD Sahmyook Medical Center Seoul Hospital, Seoul, Korea Korean Circ J 2013;43:204-6 http://dx.doi.org/10.4070/kcj.2013.43.3.204 In this article, on page 204, the title has been spelled incorrectly: “MEALS” should have appeared as “MELAS” .",Non-OADS,/arxiv_data1/oa_pdf/0d/24/kcj-43-712.PMC3831021.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 2018 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/46/0c/mt2013153a.PMC3831034.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/e3/a9/mt2013185a.PMC3831041.pdf
"For cellular metabolism assays, an XF24 extracellular flux analyzer  (Seahorse Bioscience, http://www.seahorsebio.com/company/about.php)was used to determine ECAR and OCR.",OADS,/arxiv_data1/oa_pdf/0b/4f/mt2013195a.PMC3831043.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 2086 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/0b/4f/mt2013195a.PMC3831043.pdf
"The Public and Professional Policy Committee (PPPC), 2013; https://www.eshg.org/pppc.0.html.",Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
"5 European Society of Human Genetics, 2013; http://www.eshg.org/.",Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
"6 European Society of Human Reproduction and Embryology, 2013; http://www.esh- re.eu/.",Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://www.iso.org/iso/home/store/catalogue_ics/catalogue_detail_ics.htm?csnumber=56115.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://www.cpa-uk.co.uk/.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:- L:2004:102:0048:0058:en:PDF.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ :L:2006:038:0040:0052:EN:PDF.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://eur-lex.europa.eu/LexUriServ/Lex UriServ.do?uri=OJ:L:2006:294:0032:0050:EN:PDF.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
Good Clinical Treatment in Assisted Reproduction—An ESHRE position paper 2008; http://www.eshre.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
Considering fertility treatment abroad: issues and risks 2009; http://www.hfea.gov.uk/fertility-clinics-treatment-abroad.html.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://www.fertilityeurope.eu/.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://www.cftr2.org.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
176 International Organization for Standardization—ISO 9001 2008; http://www.iso.org/ iso/catalogue_detail?csnumber=46486.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
https://wcd.coe.int/ViewDoc.jsp?id=1660977&Site=COE.,OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
Direct-to-consumer genetic testing 2012; http://www.easa-c.eu/ﬁleadmin/PDF_s/reports_statements/Easac_12_DTCGT-Lay_Web.pdf.,OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://www.acog.org/.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
197 Health Council of the Netherlands Advisory report – Screening: between hope and hype 2008; http://www.gezondheidsraad.nl/sites/default/ﬁles/200805E_0.pdf.Accessed: July 2013.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
203 The Family Tree DNA: Richard Hill’s Story 2012; http://www.familytreedna.com/ landing/richard-hill.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
"204 Stories From 23andMe Blog: ‘Hey, Bro’ 2011; http://blog.23andme.com/23andme- customer-stories/stories-from-23andme-neil-schwartzman/.",Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
Background document on preimplantation and prenatal genetic testing 2011; http://www.coe.int/t/dg3/healthbioethic/Source/INF_2010_6_dpidpn_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
"25 Recommendations on the ethical, legal and social implications of genetic testing 2004; http://ec.europa.eu/research/conferences/2004/genetic/pdf/recommendations_en.pdf.",Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
Human Fertilisation and Embryology Act 2008; http://www.legislation.gov.uk/ukpga/2008/22/contents.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
: 164 1997; http://conventions.coe.int/Treaty/Commun/QueVoulezVous.asp?NT=164&CL=ENG.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
"International Consortium on Stem Cells, Ethics & Law: Consensus Statement: Science, Ethics and Policy Challenges of PluripotentStem Cell-Derived Gametes 2008; http://www.hinxtongroup.org/Consensus_HG08_FINAL.pdf.",Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://www.gesetze-im-internet.de/bundesrecht/gendg/gesamt.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:088:0045:0065:EN:PDF.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
Summary of Conference: Prenatal Diagnosis—Individuals and Society 2010; http://ncbio.org/nordisk/arkiv/oslo-summary-ﬁnal.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
ACCE Model Process for Evaluating Genetic Testing 2004; http://www.cdc.gov/genomics/gtesting/ACCE/ index.htm.,OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
292 European Court of Human Rights 2012; http://www.echr.coe.int/.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
European Convention of Human Rights 2010; http://www.echr.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
57813/00) 2011; http://hudoc.echr.coe.int/sites/eng/pages/ search.aspx?i=001-107325#{%22itemid%22:[%22001-107325%22]}.,OADS,/arxiv_data1/oa_pdf/f6/3a/ejhg2013219a.PMC3831061.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003604).,Non-OADS,/arxiv_data1/oa_pdf/c9/ba/bmjopen-2013-003604.PMC3831092.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003622).,Non-OADS,/arxiv_data1/oa_pdf/d9/89/bmjopen-2013-003622.PMC3831093.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/89/bmjopen-2013-003622.PMC3831093.pdf
"Stockholm: Centre for Epidemiology, 1998. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/8708/2008-125-1_20081251_rev.pdf(accessed 27 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/d9/89/bmjopen-2013-003622.PMC3831093.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003678).,Non-OADS,/arxiv_data1/oa_pdf/b5/8b/bmjopen-2013-003678.PMC3831094.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003059).,Non-OADS,/arxiv_data1/oa_pdf/b3/c4/bmjopen-2013-003059.PMC3831095.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-002957).,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
The full set of ques- tions is accessible at http://www.sbg-marcom.ch/sat-eu/Study_plan.html.,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
"Acknowledgements The SAT-EU Study group gratefully acknowledges the collaboration of the following organisations, industry, clinical trial associations and online communities in recruiting survey respondents: Applied Clinical Trials(ACT) http://www.appliedclinicaltrialsonline.com/; European Forum for Good Clinical Practice (EFGCP) http://www.efgcp.be; European Federation of Pharmaceutical Industry Associations (EFPIA) http://www.efpia.eu/; European Biotech Industry Association (EuropaBio) http://www.europabio.org/; Perugia University, Italy http://facolta.unipg.it/medicina/; Drug Information Association(DIA) http://www.diahome.org/DIAHome/Home.aspx; Virtuoso Consulting, Geneva, Switzerland http://www.virtuoso.ch/model.html; European Vision Institute Clinical Research Network (Disease Network) http://www.evicr.net; EUCOMED Clinical Trial Interest Group http://www.eucomed.be/; and Pharma IQ http://www.pharma-iq.com/.",Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
EU speech/11/607 ; 28 September 2011. http://europa.eu/rapid/ press-release_SPEECH-11-607_en.htm (accessed 1 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
http://www.imi.europa.eu (accessed 1 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
http://ec.europa.eu/research/era/ index_en.htm(accessed 6 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
http://ec.europa.eu/ health/human-use/clinical-trials/index_en.htm#rlctd (accessed6 Sep 2012).6.,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
http://ec.europa.eu/health/files/ clinicaltrials/2012_07/proposal/2012_07_proposal_en.pdf (accessed17 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
http://www.escardio.org/about/press/press-releases/pr-13/Pages/esc-clinical-trials-directive-revisions.aspx?hit=dontmiss(accessed 13 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
http://ec.europa.eu/research/fp7/index_en.,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
http://ec.europa.eu/europe2020/index_en.htm (accessed 11Jul2012).,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
2011. http://iri.jrc.ec.europa.eu/research/docs/2011/SB2011.pdf (accessed 17 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/f7/b9/bmjopen-2013-002957.PMC3831096.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003534).,Non-OADS,/arxiv_data1/oa_pdf/e8/02/bmjopen-2013-003534.PMC3831098.pdf
"Department of Health, Stationery Office, 2002.http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4009293 5.",Non-OADS,/arxiv_data1/oa_pdf/e8/02/bmjopen-2013-003534.PMC3831098.pdf
"Department of Health, Stationery Office, 2001. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyandGuidance/DH_4006801 7.",Non-OADS,/arxiv_data1/oa_pdf/e8/02/bmjopen-2013-003534.PMC3831098.pdf
http://www.expertpatients.co.uk/ (accessed 17 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/e8/02/bmjopen-2013-003534.PMC3831098.pdf
http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/e8/02/bmjopen-2013-003534.PMC3831098.pdf
http://www.crd.unimelb.edu.au/heiq/ 32.,Non-OADS,/arxiv_data1/oa_pdf/e8/02/bmjopen-2013-003534.PMC3831098.pdf
METHODS AND ANALYSIS Project design The active buildings project (http://www.activebuildings.co.uk) will be carried out in three phases.,Non-OADS,/arxiv_data1/oa_pdf/72/1b/bmjopen-2013-004103.PMC3831099.pdf
Measurement instruments Accelerometer Participants taking part in objective monitoring will beasked to wear the ActivPal (http://www.paltech.plus.,Non-OADS,/arxiv_data1/oa_pdf/72/1b/bmjopen-2013-004103.PMC3831099.pdf
"These badges are part of the OpenBeacon (http://www.openbeacon.org) sensor system, previously used to study contact patterns between individuals forsocial 20and epidemiological21 22research.",Non-OADS,/arxiv_data1/oa_pdf/72/1b/bmjopen-2013-004103.PMC3831099.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/72/1b/bmjopen-2013-004103.PMC3831099.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003292).,Non-OADS,/arxiv_data1/oa_pdf/65/e8/bmjopen-2013-003292.PMC3831100.pdf
http://guidanceniceorguk/PH38 2012. http://guidance.nice.org.uk/PH38 (accessed 26 Jul2012).,Non-OADS,/arxiv_data1/oa_pdf/8e/e2/bmjopen-2013-003585.PMC3831101.pdf
http://www.nice.org.uk/guidance/index.jsp?action=download&o=57044 5.,Non-OADS,/arxiv_data1/oa_pdf/8e/e2/bmjopen-2013-003585.PMC3831101.pdf
2008; http://www.mrc.ac.uk/ Utilities/Documentrecord/index.htm?d=MRC004871.,OADS,/arxiv_data1/oa_pdf/8e/e2/bmjopen-2013-003585.PMC3831101.pdf
http://www.mrc.ac.uk/complexinterventionsguidance 38.,Non-OADS,/arxiv_data1/oa_pdf/8e/e2/bmjopen-2013-003585.PMC3831101.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003725).,Non-OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2013-003725.PMC3831102.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003508).,Non-OADS,/arxiv_data1/oa_pdf/39/4f/bmjopen-2013-003508.PMC3831103.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.7k048.,OADS,/arxiv_data1/oa_pdf/39/4f/bmjopen-2013-003508.PMC3831103.pdf
http://www.nesug.org/proceedings/nesug07/sa/sa13.pdf 24.,Non-OADS,/arxiv_data1/oa_pdf/39/4f/bmjopen-2013-003508.PMC3831103.pdf
"ISBN 3 – 900051 –07–0, http://www.R-project.org.",Non-OADS,/arxiv_data1/oa_pdf/39/4f/bmjopen-2013-003508.PMC3831103.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003451).,Non-OADS,/arxiv_data1/oa_pdf/04/8a/bmjopen-2013-003451.PMC3831104.pdf
"uk, the Department of Health publish monthly open access activity data forNHS 111 services available at http://transparency.dh.gov.uk/category/statistics/ nhs-111-statistics/ Disclaimer This is an independent report commissioned and funded by the Policy Research Programme in the Department of Health.",Non-OADS,/arxiv_data1/oa_pdf/04/8a/bmjopen-2013-003451.PMC3831104.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/04/8a/bmjopen-2013-003451.PMC3831104.pdf
2008. http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH_085825 4.,Non-OADS,/arxiv_data1/oa_pdf/04/8a/bmjopen-2013-003451.PMC3831104.pdf
2012. http://www.connectingforhealth.nhs.uk/systemsandservices/pathways/comms/corenav.pdf6.,Non-OADS,/arxiv_data1/oa_pdf/04/8a/bmjopen-2013-003451.PMC3831104.pdf
http://transparency.dh.gov.,OADS,/arxiv_data1/oa_pdf/04/8a/bmjopen-2013-003451.PMC3831104.pdf
"NHS Information Centre, 2012. http://www.ic.nhs.uk/statistics-and-data-collections/audits-and-performance/ambulance/ambulance-services – england-2011 –12 14.",Non-OADS,/arxiv_data1/oa_pdf/04/8a/bmjopen-2013-003451.PMC3831104.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003555).,Non-OADS,/arxiv_data1/oa_pdf/d9/dd/bmjopen-2013-003555.PMC3831105.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/dd/bmjopen-2013-003555.PMC3831105.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003998).,Non-OADS,/arxiv_data1/oa_pdf/ca/a3/bmjopen-2013-003998.PMC3831106.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ca/a3/bmjopen-2013-003998.PMC3831106.pdf
"IRB Concussion Guideleines, 2011. http://www.irbplayerwelfare.com/pdfs/IRB_Concussion_Guidelines_ EN.pdf (accessed 10 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/ca/a3/bmjopen-2013-003998.PMC3831106.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003474).,Non-OADS,/arxiv_data1/oa_pdf/62/66/bmjopen-2013-003474.PMC3831107.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003464).,Non-OADS,/arxiv_data1/oa_pdf/1f/69/bmjopen-2013-003464.PMC3831108.pdf
Published Online First: 2011. http://www.sciencedirect.com/ science/article/pii/S1743919111005620 (accessed 6 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/1f/69/bmjopen-2013-003464.PMC3831108.pdf
Published Online First: 2008. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266844/ (accessed 6 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/1f/69/bmjopen-2013-003464.PMC3831108.pdf
doi:10.1136/bmjopen-2013- 003583 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003583).,Non-OADS,/arxiv_data1/oa_pdf/c2/ed/bmjopen-2013-003583.PMC3831109.pdf
"lindalliance.org/), INVOLVE (http://www.involve.org.uk/) and the entirely patient-led Diabetes.co.uk Forum (http://www.diabetes.co.uk) advised on the develop- ment of and recruitment to an Advisory Group for thestudy.",Non-OADS,/arxiv_data1/oa_pdf/c2/ed/bmjopen-2013-003583.PMC3831109.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/ed/bmjopen-2013-003583.PMC3831109.pdf
doi:10.1136/bmjopen-2013- 003840 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003840).,Non-OADS,/arxiv_data1/oa_pdf/0e/6c/bmjopen-2013-003840.PMC3831110.pdf
"Geneva: WHO, 2007. http://www.who.int/healthsystems/task_shifting_booklet.pdf (accessed 4 May 2012).",Non-OADS,/arxiv_data1/oa_pdf/0e/6c/bmjopen-2013-003840.PMC3831110.pdf
Hum Resour Health 2010;8:8. http://www.biomedcentral.com/content/pdf/ 1478-4491-8-8.pdf (accessed 14 Jul 2010).,Non-OADS,/arxiv_data1/oa_pdf/0e/6c/bmjopen-2013-003840.PMC3831110.pdf
"Geneva: WHO, 2007. http://www.who.int/ healthsystems/task_shifting/TTR_tackle.pdf (accessed 10 Aug 2010).",Non-OADS,/arxiv_data1/oa_pdf/0e/6c/bmjopen-2013-003840.PMC3831110.pdf
"Cape Town: MSF, 2009. http://www.msf.org.za/ 2009-aids/documents/MSF_Lesotho_Programme_Report_2006-2008.pdf (accessed 10 Aug 2010).",Non-OADS,/arxiv_data1/oa_pdf/0e/6c/bmjopen-2013-003840.PMC3831110.pdf
Hum Resour Health 2006;4:1.http://www.human-resources-health.,Non-OADS,/arxiv_data1/oa_pdf/0e/6c/bmjopen-2013-003840.PMC3831110.pdf
http://www.plosone.org (accessed 30 No 2010).,Non-OADS,/arxiv_data1/oa_pdf/0e/6c/bmjopen-2013-003840.PMC3831110.pdf
Hum Resour Health 2009;7:49. http://www.human-resources-health.com/content/7/1/49(accessed 30 Nov 2010).,Non-OADS,/arxiv_data1/oa_pdf/0e/6c/bmjopen-2013-003840.PMC3831110.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.or g/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ab/9d/ijbsv09p1013.PMC3831114.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d3/89/ijbsv09p1021.PMC3831115.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/04/ijbsv09p1032.PMC3831116.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/69/7d/ijbsv09p1043.PMC3831117.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1c/49/ijbsv09p1050.PMC3831118.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/af/af/ijbsv09p1057.PMC3831119.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/55/ijbsv09p1070.PMC3831120.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003630).,Non-OADS,/arxiv_data1/oa_pdf/d5/c8/bmjopen-2013-003630.PMC3831155.pdf
http://www.thl.fi/publications/monica/manual/index.htm 21.,Non-OADS,/arxiv_data1/oa_pdf/d5/c8/bmjopen-2013-003630.PMC3831155.pdf
"It is well known that  phenotype standardization is crucial in order to disentangle the  signals from noise.13 To evaluate whether electronic health care record databases  can be used to recruit patients with severe adverse drug reac- tions, we first chose CPRD as the database to undertake this  feasibility study because of the quality of data contained within,  which has resulted in a large number of important drug safety  findings (http://www.cprd.com).",Non-OADS,/arxiv_data1/oa_pdf/68/a7/clpt2013161a.PMC3831180.pdf
"From a cohort of ~600,000  patients receiving statins identified in the CPRD (http://www.cprd.com),  a case–control design was used to identify suitable patients for the study.",Non-OADS,/arxiv_data1/oa_pdf/68/a7/clpt2013161a.PMC3831180.pdf
"Meta-analysis A search of PubMed (http://www.ncbi.nlm.nih.gov/pubmed accessed  January 2012) using the search terms “SLCO1B1” and “statin” yielded  108 publications, of which 96 were original research articles.",OADS,/arxiv_data1/oa_pdf/68/a7/clpt2013161a.PMC3831180.pdf
"Due  to the high degree of heterogeneity among the included studies (I2 =  84.1%), a DerSimonian-Laird random effects model was applied to the  meta-analysis in StatsDirect version 2.6.8 (StatsDirect, Altrincham, UK) SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/cpt ACKNOWLEDGMENTS This work was funded by a grant from the e-Health Initiative funded  jointly by the Medical Research Council (reference: MC_qA137929), the Wellcome Trust, the Engineering and Physical Sciences Research Council, and The Economic and Social Research Council.",Non-OADS,/arxiv_data1/oa_pdf/68/a7/clpt2013161a.PMC3831180.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-nd/3.0/ CLiNiCAL  PhARMACOLOgy & TheRAPeUTiCS  | VOLUME 94 NUMBER 6 | DECEMBER  2013  701",Non-OADS,/arxiv_data1/oa_pdf/68/a7/clpt2013161a.PMC3831180.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ce/3e/srep03236.PMC3831192.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3236 | DOI: 10.1038/srep03236 6",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/srep03236.PMC3831192.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f4/cd/srep03234.PMC3831193.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3234 | DOI: 10.1038/srep03234 6",Non-OADS,/arxiv_data1/oa_pdf/f4/cd/srep03234.PMC3831193.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The author declares no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d9/45/srep03237.PMC3831235.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3237 | DOI: 10.1038/srep03237 9",Non-OADS,/arxiv_data1/oa_pdf/d9/45/srep03237.PMC3831235.pdf
The seconda ry structures were predicted by PSIPRED v3.3 on the PSIPRED server (http://bioinf.cs.ucl.ac.uk/psipred.html)32.,OADS,/arxiv_data1/oa_pdf/c6/9f/srep03235.PMC3831237.pdf
Structure predicting .The secondary structures of the proteins were predicted by PSIPRED v3.3 on PSIPRED server (http://bioinf.cs.ucl.ac.uk/psipred.html)32.,OADS,/arxiv_data1/oa_pdf/c6/9f/srep03235.PMC3831237.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c6/9f/srep03235.PMC3831237.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3235 | DOI: 10.1038/srep03235 10",Non-OADS,/arxiv_data1/oa_pdf/c6/9f/srep03235.PMC3831237.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9f/a9/srep03238.PMC3831238.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3238 | DOI: 10.1038/srep03238 9",Non-OADS,/arxiv_data1/oa_pdf/9f/a9/srep03238.PMC3831238.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/a1/54/ncomms3742.PMC3831279.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ratcliff, W.C. et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/54/ncomms3742.PMC3831279.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3742 ARTICLE NATURE COMMUNICATIONS | 4:2742 | DOI: 10.1038/ncomms3742 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a1/54/ncomms3742.PMC3831279.pdf
21. International Technology Roadmap for Semi conductors (2011) http://www.itrs.net/.,Non-OADS,/arxiv_data1/oa_pdf/36/ae/ncomms3702.PMC3831280.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Yu, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/36/ae/ncomms3702.PMC3831280.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3702 ARTICLE NATURE COMMUNICATIONS | 4:2702 | DOI: 10.1038/ncomms3702 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/36/ae/ncomms3702.PMC3831280.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/cd/94/ncomms3721.PMC3831281.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Sauer, D. B. et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/94/ncomms3721.PMC3831281.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3721 ARTICLE NATURE COMMUNICATIONS | 4:2721 | DOI: 10.1038/ncomms3721 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/cd/94/ncomms3721.PMC3831281.pdf
"For example, the absolute phase shifts in polystyrene beads of 100 mm diameters were compared with theoretical proﬁles calculated from the refractive index of poly- styrene at 22.5 keV (http://www.nist.gov/pml/data/ffast/index.",OADS,/arxiv_data1/oa_pdf/fb/b8/ncomms3659.PMC3831282.pdf
"On the basis of the refractive index of chitin37(http://www.nist.gov/pml/data/ffast/index.cfm), the primary constituent of insect wings, the thickness of the wing membrane was estimated to be between 0.6 and 1.8mm in this area.",OADS,/arxiv_data1/oa_pdf/fb/b8/ncomms3659.PMC3831282.pdf
"We simulated the phase-difference signal from cylinders of water buried in typical soft tissue (ICRU 4- component tissue, http://physics.nist.gov/cgi-bin/Star/com- pos.pl?matno=262) for cylinder diameters of 50, 100, 200 and 500mm, and pixel sizes of 1.6 and 50 mm.",OADS,/arxiv_data1/oa_pdf/fb/b8/ncomms3659.PMC3831282.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/fb/b8/ncomms3659.PMC3831282.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wen, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/fb/b8/ncomms3659.PMC3831282.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3659 ARTICLE NATURE COMMUNICATIONS | 4:2659 | DOI: 10.1038/ncomms3659 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/fb/b8/ncomms3659.PMC3831282.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/7c/b8/ncomms3743.PMC3831283.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Asenbaum, P. et al.",Non-OADS,/arxiv_data1/oa_pdf/7c/b8/ncomms3743.PMC3831283.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3743 ARTICLE NATURE COMMUNICATIONS | 4:2743 | DOI: 10.1038/ncomms3743 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/7c/b8/ncomms3743.PMC3831283.pdf
These data can be obtained free ofcharge from CCDC via http://www.ccdc.cam.ac.uk/data_request/cif Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/29/81/ncomms3646.PMC3831289.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Tan, Y.-Z.",Non-OADS,/arxiv_data1/oa_pdf/29/81/ncomms3646.PMC3831289.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3646 ARTICLE NATURE COMMUNICATIONS | 4:2646 | DOI: 10.1038/ncomms3646 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/29/81/ncomms3646.PMC3831289.pdf
Preprint at http://arXiv.org/abs/1306.5504 (2013).,Non-OADS,/arxiv_data1/oa_pdf/76/f3/ncomms3635.PMC3831290.pdf
Preprint at http://arXiv.org/abs/1308.3526 (2013).,Non-OADS,/arxiv_data1/oa_pdf/76/f3/ncomms3635.PMC3831290.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/76/f3/ncomms3635.PMC3831290.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Borshch, V. et al.",Non-OADS,/arxiv_data1/oa_pdf/76/f3/ncomms3635.PMC3831290.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3635 8 NATURE COMMUNICATIONS | 4:2635 | DOI: 10.1038/ncomms3635 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/76/f3/ncomms3635.PMC3831290.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/21/fa/ncomms3717.PMC3831296.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Sun, C-Y.",Non-OADS,/arxiv_data1/oa_pdf/21/fa/ncomms3717.PMC3831296.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3717 8 NATURE COMMUNICATIONS | 4:2717 | DOI: 10.1038/ncomms3717 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/21/fa/ncomms3717.PMC3831296.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/b7/TODENTJ-7-140.PMC3831304.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License  (http://creativecommons.org/licenses/by -nc/3.0/) which permits unrestricted , non -commercial use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/fc/TODENTJ-7-146.PMC3831306.pdf
Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm5935a1.htm.,OADS,/arxiv_data1/oa_pdf/dc/7e/IJCM-38-192.PMC3831687.pdf
Available from: http://www.fao.org/english/newsroom/ focus/2003/fruitveg2.htm.,Non-OADS,/arxiv_data1/oa_pdf/dc/7e/IJCM-38-192.PMC3831687.pdf
Available from: http://nutritionfoundationofindia.res.in/ archives.,Non-OADS,/arxiv_data1/oa_pdf/dc/7e/IJCM-38-192.PMC3831687.pdf
Available from: http://www.fao.org/ docrep/014/mb060e/mb060e00.pdf [Last accessed on 2012 Jan].,Non-OADS,/arxiv_data1/oa_pdf/dc/7e/IJCM-38-192.PMC3831687.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/dc/7e/IJCM-38-192.PMC3831687.pdf
Available from:  http://www.who.int/blindness/causes/en/.,Non-OADS,/arxiv_data1/oa_pdf/cb/ee/IJCM-38-198.PMC3831688.pdf
Available from:  http://pbhealth.gov.in/pdf/Blindness.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cb/ee/IJCM-38-198.PMC3831688.pdf
Available  from: http://npcb.nic.in/writereaddata/mainlinkfile/File200.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cb/ee/IJCM-38-198.PMC3831688.pdf
Available from: http://www.cehjournal.org/indian/journal/21/ jceh_21_68_s115.html.,Non-OADS,/arxiv_data1/oa_pdf/cb/ee/IJCM-38-198.PMC3831688.pdf
Available  from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/cb/ee/IJCM-38-198.PMC3831688.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/e7/ed/IJCM-38-217.PMC3831691.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/e7/ed/IJCM-38-217.PMC3831691.pdf
Available from: http://www.angul.nic.in/UF- AMG-RKS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/cd/IJCM-38-223.PMC3831692.pdf
Available  from: http://www.agpunjab.gov.in/reports/2010/civil_chap2.pdf.,OADS,/arxiv_data1/oa_pdf/6f/cd/IJCM-38-223.PMC3831692.pdf
Available from: http://www.sitesources.,Non-OADS,/arxiv_data1/oa_pdf/6f/cd/IJCM-38-223.PMC3831692.pdf
Available from: http://www.mohfw.,Non-OADS,/arxiv_data1/oa_pdf/6f/cd/IJCM-38-223.PMC3831692.pdf
Available  from: http://www.mohfw.nic.in/NRHM/CRM/CRM_files/Fifth_ CRM.htm.,OADS,/arxiv_data1/oa_pdf/6f/cd/IJCM-38-223.PMC3831692.pdf
Available from: http://www.nihfw.,Non-OADS,/arxiv_data1/oa_pdf/6f/cd/IJCM-38-223.PMC3831692.pdf
Available from: http://www.nihfw.org/pdf/RAHI- II%20Reports/Uttarakhand.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/cd/IJCM-38-223.PMC3831692.pdf
Available from: http://www.mohfw.nic.in/NRHM/ Documents/Mission_Documents.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/cd/IJCM-38-223.PMC3831692.pdf
Available from: http://www.cag.,Non-OADS,/arxiv_data1/oa_pdf/6f/cd/IJCM-38-223.PMC3831692.pdf
Available from http://data.unaids.org/pub/ Report/2005/JC1255_resource_needs _en.pdf [Last accessed  2012 Feb 12].,OADS,/arxiv_data1/oa_pdf/e9/43/IJCM-38-229.PMC3831693.pdf
Available from: http://www.indiaprwire.com/pressrelease/  telecommunications/200701251690.htm [Last accessed on 2012  Jan 31].,Non-OADS,/arxiv_data1/oa_pdf/e9/43/IJCM-38-229.PMC3831693.pdf
Available from: http://www.imaginmor.com/ telecom-india [Last accessed on 2012 Jan 31].,Non-OADS,/arxiv_data1/oa_pdf/e9/43/IJCM-38-229.PMC3831693.pdf
Available from: http://pharmabiz.com/NewsDetails.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e9/43/IJCM-38-229.PMC3831693.pdf
Available from: http://blogs.wsj.com/health/2007/11/20/health- info-in-a-text-message/|~http://blogs.wsj.com/health/2007/11/20/ health-info-in-a-text-message/ [Last accessed on 2012 Jan 5].,Non-OADS,/arxiv_data1/oa_pdf/e9/43/IJCM-38-229.PMC3831693.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/37/9d/IJCM-38-234.PMC3831694.pdf
Available from: http://www.who.int/cholera/publications/ cholera_outbreak/en.,Non-OADS,/arxiv_data1/oa_pdf/5d/58/IJCM-38-240.PMC3831695.pdf
Available from: http://www.ijcm.org.in/article.asp?issn=097002 18;year=2011;volume=36;issue=4;spage=308;epage=308;aul ast=Shah.,Non-OADS,/arxiv_data1/oa_pdf/75/06/IJCM-38-245.PMC3831697.pdf
Available from: http://www.iapindia.org/files/IAP%20 Immunization%20Guide%20Book_2009_2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/06/IJCM-38-245.PMC3831697.pdf
Available from: http://www.phac‑aspc.gc.ca/publicat/cig‑gci/ p04‑bcg‑eng.php#effimm.,Non-OADS,/arxiv_data1/oa_pdf/75/06/IJCM-38-245.PMC3831697.pdf
Available from: http://www.whoindia.org/LinkFiles/Routine_ Immunization_Immunization_Handbook_for_Medical_ Officers_.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/06/IJCM-38-245.PMC3831697.pdf
Available from: http://www.indianpediatrics.net/august2000/ august‑906.htm.,Non-OADS,/arxiv_data1/oa_pdf/75/06/IJCM-38-245.PMC3831697.pdf
Available  from: http://screening.iarc.fr/planningmanual.php?lang=1.,Non-OADS,/arxiv_data1/oa_pdf/34/1e/IJCM-38-246.PMC3831698.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/73/13/IJCM-38-249.PMC3831699.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs134/en/ [Last accessed on 2013 May 28].,Non-OADS,/arxiv_data1/oa_pdf/8f/9d/IJPhS-75-457.PMC3831728.pdf
Available from: http://www.fda.gov/cder/foi/label/2008/125085s1451bl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/18/5e/IJO-61-475.PMC3831761.pdf
Available from: http://www.turkstat.gov.tr/VeriBilgi.do [Last accessed on 2011 Sept 20].,Non-OADS,/arxiv_data1/oa_pdf/08/d8/IJO-61-497.PMC3831765.pdf
Available from: http://www.arvo.org [Last accessed on 2011 Dec 29].,Non-OADS,/arxiv_data1/oa_pdf/6f/62/IJO-61-531b.PMC3831777.pdf
Available from: http://www.arvo.org [Last accessed on  2011 Dec 29].,Non-OADS,/arxiv_data1/oa_pdf/6f/62/IJO-61-531b.PMC3831777.pdf
See: http://www.qualitative- research.net/index.php/fqs/article/view/1089/2386).,Non-OADS,/arxiv_data1/oa_pdf/4f/06/10.1177_2042533313487332.PMC3831852.pdf
"/C2232013 The Author(s) This is an open-access article distributed under the terms of the Creative Commons Non-commercial Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.8 Journal of the Royal Society of Medicine Short Reports 4(11)",Non-OADS,/arxiv_data1/oa_pdf/4f/06/10.1177_2042533313487332.PMC3831852.pdf
"/C2232013 The Author(s) This is an open-access article distributed under the terms of the Creative Commons Non-commercial Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.Hu et al.",Non-OADS,/arxiv_data1/oa_pdf/f3/16/10.1177_2042533313493270.PMC3831853.pdf
"/C2232013 The Author(s) This is an open-access article distributed under the terms of the Creative Commons Non-commercial Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.Bitar et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/6e/10.1177_2042533313494376.PMC3831854.pdf
"J Exp Clin Cancer Res 2010; 29:24 #2013 The Authors(s) This is an open-access article distributed under the terms of the Creative Commons Non-commercial Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/1b/10.1177_2042533313476690.PMC3831859.pdf
"Jpn J Chest Dis 2006;65:1046–9 /C2232013 The Author(s) This is an open-access article distributed under the terms of the Creative Commons Non-commercial Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.Journal of the Royal Society of Medicine Short Reports 4J R Soc Med Sh Rep 2013: 4:1–4.",Non-OADS,/arxiv_data1/oa_pdf/c4/ae/10.1177_2042533313476699.PMC3831860.pdf
"/C2232013 The Author(s) This is an open-access article distributed under the terms of the Creative Commons Non-commercial Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.procedures on the patients and con- tributed the samples for analysis.",Non-OADS,/arxiv_data1/oa_pdf/2f/9f/10.1177_2042533313478003.PMC3831861.pdf
"Ultrastruct Pathol 2009; 33:141–50 /C2232013 The Author(s) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.Journal of the Royal Society of Medicine Short Reports 6J R Soc Med Sh Rep 2013: 4:1–6.",Non-OADS,/arxiv_data1/oa_pdf/a0/46/10.1177_2042533313490516.PMC3831862.pdf
See http://www.gov.je/jersey/pages/ profile.aspx (last checked 4 May 2013) 2.,Non-OADS,/arxiv_data1/oa_pdf/99/0d/10.1177_2042533313492513.PMC3831863.pdf
"EEC, 1965, http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31965L0065:EN:HTML 7.",Non-OADS,/arxiv_data1/oa_pdf/99/0d/10.1177_2042533313492513.PMC3831863.pdf
"See http://www.mhra.gov.uk/howweregulate/ index.htm (last checked 6 June 2013) /C2232013 The Author(s) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.Journal of the Royal Society of Medicine Short Reports 4J R Soc Med Sh Rep 2013: 4:1–4.",Non-OADS,/arxiv_data1/oa_pdf/99/0d/10.1177_2042533313492513.PMC3831863.pdf
4 Design The dates of birth for UK Nobel laureates wereobtained from the official web site of Nobel Prize (http://www.nobelprize.org/nobel_prizes/lists/ birthdays.html).,Non-OADS,/arxiv_data1/oa_pdf/a6/59/10.1177_2042533313492514.PMC3831864.pdf
"Ann N Y Acad Sci 1994 709:9–28 /C2232013 The Author(s) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/59/10.1177_2042533313492514.PMC3831864.pdf
"Psychol Med 2007; 37:917–26 /C2232013 The Author(s) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.How distressing is medical research participation?",Non-OADS,/arxiv_data1/oa_pdf/02/2a/10.1177_2042533313493271.PMC3831865.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits   non-commercial re-use, distribution, and reproduction in any medium, provided the original   work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/1c/cmt055.PMC3832126.pdf
http://www.ginasthma.org .,Non-OADS,/arxiv_data1/oa_pdf/e5/1c/cmt055.PMC3832126.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/cb/mder-6-175.PMC3832381.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2013:6 175–184Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  175ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S5259 0ExtaviJect® 30g device for subcutaneous   self-injection of interferon beta-1b for multiple  sclerosis: a prospective European study gabriel Boeru1 ivan Milanov2 Francesca De Robertis3 Wojciech Kozubski4 Michael lang5 sònia Rojas-Farreras6 Mark T omlinson7 1Military hospital, Bucharest, Romania;   2University hospital saint n aum, sofia,   Bulgaria; 3Department of neurology,   Vito Fazzi hospital of lecce, lecce,   italy; 4Department of n eurology,   Poznan University of Medical sciences,   Poznan, Poland; 5neuroPoint Patient  academy and neurological Practice,   Ulm, germany; 6iMs health, Barcelona,   spain; 7novartis Pharma ag, Basel,   switzerland correspondence: Mark Tomlinson   novartis Pharma ag, WsJ-210-4-20.5,  ch-4056 Basel, switzerland   Tel +41 613 249 447   Email mark.tomlinson@novartis.co mBackground:  The ExtaviJect® 30G autoinjector was developed to facilitate parenteral self- administration of interferon beta-1b (Extavia®), a first-line disease-modifying therapy in patients  with multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/70/cb/mder-6-175.PMC3832381.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/70/cb/mder-6-175.PMC3832381.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/e6/cia-8-1539.PMC3832382.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1539–1546Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1539OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5330 5health-related quality of life in elderly patients  hospitalized with chronic heart failure Predrag erceg1,2 nebojsa Despotovic1,2 Dragoslav P Milosevic1,2 Ivan soldatovic3 sanja Zdravkovic2 snezana T omic2 Ivana Markovic2 gordana Mihajlovic2 Milan D Brajovic4,5 Ognjen Bojovic6 Bojana Potic2 Mladen Davidovic1 1Department of gerontology, Faculty  of Medicine, University of Belgrade,   2Clinical Department of geriatrics,   Zvezdara University hospital,   3Institute of Medical statistics and  Informatics, Faculty of Medicine,   4Department of Internal Medicine,   Faculty of Dentistry, University of  Belgrade, 5Clinical Department of  Cardiology, Zvezdara University  hospital, Belgrade, serbia;   6Department of Biomedicine,   University of Bergen, Bergen, norway Correspondence: Predrag erceg   Department of gerontology, Faculty of  Medicine, University of Belgrade,   Dr subotica 8, 11000 Belgrade, serbia   Tel +381 11 241 7094   Fax +381 11 241 7494   email predrag.erceg@mfub.bg.ac.r sBackground:  Chronic heart failure is a very common condition in the elderly, characterized  not only by high mortality rates, but also by a strong impact on health-related quality of life  (HRQOL).",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/cia-8-1539.PMC3832382.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/cia-8-1539.PMC3832382.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/e6/cia-8-1539.PMC3832382.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/81/dddt-7-1377.PMC3832383.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1377–1384Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1377Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5129 8in vitro and in vivo characterization   of the antimalarial lead compound ssJ-183   in Plasmodium  models sarah schleiferböck1,2 christian scheurer1,2 Masataka ihara3,4 isamu itoh3,4 ian Bathurst5,† Jeremy n Burrows5 Pascal Fantauzzi5 Julie lotharius5 susan a charman6 Julia Morizzi6 David M shackleford6 Karen l White6 reto Brun1,2 sergio Wittlin1,2 1swiss Tropical and Public health  institute, Basel, 2University of Basel,  Basel, switzerland; 3Drug Discovery  science research center, hoshi  University, shinagawa, Tokyo, Japan;  4synstar Japan co, ltd, Odawara,  Japan; 5Medicines for Malaria Venture,  geneva, switzerland; 6centre for  Drug candidate Optimisation,  Monash institute of Pharmaceutical   sciences, Parkville, Vic, australia †ian Bathurst passed away on   26 June 2011 correspondence: sergio Wittlin   swiss Tropical and Public health institute,   socinstrasse 57, 4002 Basel, switzerland   Tel +41 61 284 8136   Fax +41 61 284 8101   email sergio.wittlin@unibas.c hAbstract:  The objective of this work was to characterize the in vitro ( Plasmodium falciparum )  and in vivo ( Plasmodium berghei ) activity profile of the recently discovered lead compound  SSJ-183.",Non-OADS,/arxiv_data1/oa_pdf/e2/81/dddt-7-1377.PMC3832383.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e2/81/dddt-7-1377.PMC3832383.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/81/dddt-7-1377.PMC3832383.pdf
"Available from: http://www.who.int/malaria/world_ malaria_report_2011/wmr2011_summary_keypoints.pd f. Accessed  September 8, 2012.",Non-OADS,/arxiv_data1/oa_pdf/e2/81/dddt-7-1377.PMC3832383.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/cc/cia-8-1505.PMC3832384.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1505–1517Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1505RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S33087what is an appropriate blood pressure goal   for the elderly: review of recent studies   and practical recommendations Matthew G Denker Debbie L Cohen Perelman School of Medicine, Renal,   electrolyte and Hypertension  Division, University of Pennsylvania,   Philadelphia, PA, USA Correspondence: Debbie L Cohen   Perelman School of Medicine, Renal,  electrolyte and Hypertension Division,  University of Pennsylvania, 1 Founders  Building, 3400 Spruce Street,   Philadelphia, PA, 19104, USA   Tel +1 215 662 7934   Fax +1 215 615 0349   email debbie.cohen@uphs.upenn.ed uAbstract:  Hypertension is common in the elderly, and isolated systolic hypertension is   responsible for the majority of hypertension in this population.",Non-OADS,/arxiv_data1/oa_pdf/e7/cc/cia-8-1505.PMC3832384.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/e7/cc/cia-8-1505.PMC3832384.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/cc/cia-8-1505.PMC3832384.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/d4/cia-8-1527.PMC3832385.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1527–1537Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1527OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4397 6Efficacy of micronutrient supplementation on  skin aging and seasonal variation: a randomized,  placebo-controlled, double-blind study Ferial Fanian1,2 Sophie Mac-Mary3 Adeline Jeudy1,2 Thomas lihoreau1,2 rafat Messikh1,2 Jean-Paul Ortonne4 Jean-Marie sainthillier3 Ahmed Elkhyat1,2 Alexandre guichard1,2 Kamran hejazi Kenari1,2 Philippe humbert1,2,5,6 1Center for studies and research on  the Integument (C erT), Department  of Dermatology, University Hospital  of Besançon, Besançon, France;   2Clinical Investigation Center,   CIC-BT 506, CHRU Besançon,   France; 3SKINEXIGENCE, University  hospital of Jean Minjoz, Besançon,   France; 4Department of Dermatology,   University Hospital of L’archet, Nice,   France; 5University of Franche-Comté,   Besançon, France; 6InserM 1098,   Structure Fédérative de Recherche,   Besançon, France Correspondence: Philippe humbert   Center for studies and research on   the Integument (CerT), Department   of Dermatology, University Hospital   of Besançon, 2 place st Jacques,   F-25000 Besançon, France   email p hilippe.humbert@univ-fcomte.f rBackground:  Several studies have confirmed dramatic changes in skin surface parameters  during the winter months.",Non-OADS,/arxiv_data1/oa_pdf/f8/d4/cia-8-1527.PMC3832385.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f8/d4/cia-8-1527.PMC3832385.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/d4/cia-8-1527.PMC3832385.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/ba/cia-8-1483.PMC3832386.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1483–1488Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1483OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5269 7Prostatectomy using different lasers   for the treatment of benign prostate   hyperplasia in aging males Wei-Chang lee1,* Yu-hsiang lin1,* Chen-Pang hou1 Phei-lang Chang1 Chien-lun Chen1 horng-heng Juang2 Ke-hung Tsui1 1Department of Urology, Chang gung  Memorial hospital-linko and Chang  gung University, College of Medicine,   Taiwan, 2Department of Anatomy,   College of Medicine, Chang gung  University, Kweishan-shan, Taoyuan,   Taiwan, republic of China *These authors contributed equally to  this work Correspondence: Ke-hung Tsui   Department of Urology, Chang gung  Memory hospital-linko, Chang gung  University, 5 Fu-shing street Kwei-shan,  Taoyuan 333, Taiwan, republic of China   Tel +886 3 328 1200 ext 2137   Fax +886 3 211 8112   email khtsui@yahoo.co mPurpose:  Endoscopic lasers have become a treatment option for benign prostate hyperplasia  (BPH).",Non-OADS,/arxiv_data1/oa_pdf/cb/ba/cia-8-1483.PMC3832386.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/cb/ba/cia-8-1483.PMC3832386.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/ba/cia-8-1483.PMC3832386.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/aa/clep-5-449.PMC3832387.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2013:5 449–459Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  449Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S5300 9antidepressant exposure in pregnancy   and risk of autism spectrum disorders Merete Juul sørensen1 Therese Koops grønborg2 Jakob Christensen3,4 Erik Thorlund Parner2 Mogens Vestergaard5,6 Diana schendel7 lars henning Pedersen8,9 1regional Centre of Child and  adolescent Psychiatry, aarhus  University hospital, risskov,  Denmark; 2Department of Public  health, section of Biostatistics,  aarhus University, aarhus, Denmark;  3Department of neurology, aarhus  University hospital, aarhus,  Denmark; 4Department of Clinical  Pharmacology, 5Department of  Public health, section of general  Practice, 6research unit for general  Practice, aarhus University, aarhus,  Denmark; 7Centers for Disease  Control and Prevention, atlanta,  ga, Usa; 8Danish Epidemiological  science Centre, institute of Public  health, 9Department of Obstetrics  and gynecology, institute of Clinical  Medicine, aarhus University, aarhus,  Denmark Correspondence: Merete Juul sørensen   regional Centre of Child and adolescent   Psychiatry, Department C, skovagervej 2,   DK-8240, risskov, Denmark   Tel +45 78 47 31 18   Fax +45 77 89 41 99   Email meresoer@rm.d kBackground:  Both the use of antidepressant medication during pregnancy and the prevalence  of autism spectrum disorder have increased during recent years.",Non-OADS,/arxiv_data1/oa_pdf/54/aa/clep-5-449.PMC3832387.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/54/aa/clep-5-449.PMC3832387.pdf
Available from: http://www.whocc.no/atc_ddd_index /.,OADS,/arxiv_data1/oa_pdf/54/aa/clep-5-449.PMC3832387.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/96/dddt-7-1359.PMC3832388.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1359–1364Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1359Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5340 1Profile of gantenerumab and its potential   in the treatment of Alzheimer’s disease Dijana Novakovic1 Marco Feligioni2 Sergio Scaccianoce1 Alessandra Caruso1 Sonia Piccinin2 Chiara Schepisi1,2 Francesco errico3 Nicola B Mercuri4 Ferdinando Nicoletti1,5 Robert Nisticò1,4 1Department of Physiology and  Pharmacology, Sapienza University  of Rome, Rome, Italy; 2european  Brain Research Institute, Rome, Italy;   3Ceinge Biotecnologie Avanzate,   Naples, Italy; 4Laboratory of  experimental Neurology, istituto di  Ricerca e Cura a Carattere Scientifico,    Santa Lucia Foundation, Rome, Italy;   5istituto di Ricerca e Cura a Carattere  Scientifico, Neuromed, Pozzilli, Italy Correspondence: Robert Nisticò  Department of Physiology and  Pharmacology, Sapienza University of  Rome, P Aldo Moro 5, Rome 00185, italy   Tel +39 065 0170 3122   Fax +39 066 0513 244   email robert.nistico@uniroma1.i tAbstract:  Alzheimer’ s disease, which is characterized by gradual cognitive decline associated  with deterioration of daily living activities and behavioral disturbances throughout the course  of the disease, is estimated to affect 27 million people around the world.",Non-OADS,/arxiv_data1/oa_pdf/43/96/dddt-7-1359.PMC3832388.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/43/96/dddt-7-1359.PMC3832388.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/96/dddt-7-1359.PMC3832388.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/48/dddt-7-1365.PMC3832410.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy  2013:7 1365–1375Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1365ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5066 5Antituberculosis nanodelivery system   with controlled-release properties based   on para-amino salicylate–zinc aluminum-layered  double-hydroxide nanocomposites Bullo Saifullah1 Mohd Zobir Hussein1 Samer Hasan Hussein-Al-Ali2 Palanisamy Arulselvan3 Sharida Fakurazi3,4 1Materials Synthesis and  Characterization Laboratory,   2Laboratory of Molecular Biomedicine,   3Laboratory of Vaccines and  Immunotherapeutics, 4Department  of Human Anatomy, Universiti Putra  Malaysia, Serdang, Selangor, Malaysia Correspondence: Mohd Zobir Hussein   Materials Synthesis and Characterization  Laboratory (MSCL), Institute of Advanced  Technology (ITMA), Universiti Putra  Malaysia, Serdang, Selangor 43400,  Malaysia   Tel +60 3 8946 6801   Fax +60 3 8943 5380   Email mzobir@putra.upm.edu.m yAbstract:  We report the intercalation and characterization of para-amino salicylic acid (PASA)  into zinc/aluminum-layered double hydroxides (ZLDHs) by two methods, direct and indirect, to  form nanocomposites: PASA nanocomposite prepared by a direct method (PASA-D) and PASA  nanocomposite prepared by an indirect method (PASA-I).",Non-OADS,/arxiv_data1/oa_pdf/29/48/dddt-7-1365.PMC3832410.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/29/48/dddt-7-1365.PMC3832410.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/48/dddt-7-1365.PMC3832410.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2013:6 415–421Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  415PersPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S5456 1Future developments in health care   performance management Maria crema chiara verbano Department of Management and  engineering, University of Padova,   vicenza, italy correspondence: chiara verbano   Department of Management and  engineering, University of Padova,   stradella san Nicola 3, 36100 vicenza, italy   tel +39 04 4499 8731   Fax +39 04 4499 8888   email chiara.verbano@unipd.i tAbstract:  This paper highlights the challenges of performance management in health  care, wherein multiple different objectives have to be pursued.",Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Available  from: http://www.euro.who.int/en/publications/policy-documents/ the-ljubljana-charter-on-reforming-health-care,-1996.",Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Available from: http://www.euro.who.int/en/ publications /policy-documents/health21-health-for-all-in-the-21st- centur y. Accessed October 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Available  from: http://www.un.org/en/documents/udhr/history.shtm l. Accessed  October 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Available from: http://www.ahrq.gov/news/newsroom/ speech/index.htm l. Accessed October 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Available from: http://www.who.int/management/quality/ assurance/QualityCare_B.Def.pd f. Accessed October 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Available from: http://www.ahrq.gov/research/ findings/nhqrdr/nhqr11/nhqr11.pd f. Accessed October 14, 2013.",OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Available from:  http://www.patientforsakring.se/resurser/dokument/patientsakerhet/_ OvretTolfCost AEsafety9Oct09.pd f. Accessed October 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
"Available from: http://www.oecd.org/health/ healthataglanceeurope.ht m. Accessed October 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/09/46/jmdh-6-415.PMC3832411.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/0e/tcrm-9-457.PMC3832460.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 457–462Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  457ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S4838 7Efficacy and safety analysis of once per cycle   pegfilgrastim and daily lenograstim in patients with   breast cancer receiving adjuvant myelosuppressive   chemotherapy FEC 100: a pilot study luigi Rossi1 Federica T omao2 giuseppe lo Russo1 anselmo Papa1 Federica Zoratto1 Raffaella Marzano3 enrico Basso1 erika giordani1 Monica Verrico1 Fabio Ricci4 giulia Pasciuti5 edoardo Francini6 silverio T omao1 1Oncology Unit, ICOT Hospital,   2Department of Gynecology and  Obstetrics, Policlinico Umberto  I Hospital, University of Rome,   3Institute of Hematology and Blood  Transfusion, 4Department of Surgery,   S Maria Goretti Hospital, Latina,   5Oncology Unit, Don Luigi Liegro  Hospital, Gaeta, 6Oncology Unit,   Policlinico Umberto I Hospital,   University of Rome, Italy Correspondence: luigi Rossi   Oncology Unit, ICOT Hospital,   Policlinico Umberto I Hospital,   University of Rome, via Franco   Faggiana, 1668, Latina, Italy   Tel +39 349 564 3418   email dr.rossi@ymail.co mBackground:  Neutropenia is a common toxicity in patients receiving myelosuppressive  chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/d6/0e/tcrm-9-457.PMC3832460.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d6/0e/tcrm-9-457.PMC3832460.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/0e/tcrm-9-457.PMC3832460.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/34/opth-7-2235.PMC3832461.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2235–2237Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2235Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/DOI: 10.2147/OPTH.S54231purtscher’s retinopathy followed   by neovascular glaucoma Masasko Kuroda1 akihiro Nishida1 Masashi Kikuchi2 Yasuo Kurimoto1 1Department of Ophthalmology,    Kobe City Medical Center General  Hospital, Kobe, Hyogo, Japan; 2Kikuchi   eye Clinic, Kobe, Hyogo, Japan Correspondence: akihiro Nishida   Department of Ophthalmology,   Kobe City Medical Center   General Hospital, 2-1-1, Minatojima-   Minamimachi, Chuo-ku, Kobe City,   Hyogo, 650-0047, Japan   tel +81 783 024 321   Fax +81 783 027 537   email aki_n@kcho.j pAbstract:  We report the case of a 66-year-old Japanese man who developed neovascular glau - coma secondary to Purtscher’ s retinopathy following a head injury.",Non-OADS,/arxiv_data1/oa_pdf/18/34/opth-7-2235.PMC3832461.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/18/34/opth-7-2235.PMC3832461.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/34/opth-7-2235.PMC3832461.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2013:6 125–137Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  125Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S3947 6internet gaming addiction: current perspectives Daria J Kuss Psychology Research and Behavior  Management, Birmingham City  University, Birmingham, UK Correspondence: Daria J Kuss   Birmingham City University,   City North Campus,   Birmingham B42 2SU, UK   Tel +44 78 9111 9490   email daria.kuss@ bcu.ac.u kAbstract:  In the 2000s, online games became popular, while studies of Internet gaming addiction  emerged, outlining the negative consequences of excessive gaming, its prevalence, and associated  risk factors.",Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
Available from: http://pcgamingalliance.org/press/entry/ pc-gaming-alliance-releases-two-member-exclusive-reports-covering- pc-gaming .,Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
Available from: http://venturebeat.com/2013/05/02/chinas-pc-online- game-market-to-hit-11-19b-in-2013 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
Available from: http://www.theesa.,Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
Available from: http://uk.ign.com/articles/2013/05/08/ world-of-warcraft-loses-13-million-subscribers .,Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
Available from: http://tech2.in.com/news/general/japan- plans-fasting-camps-for-webaddicted-children/912284 .,Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
Available from: http://www.nimh.nih.,Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
Available from: http://www.asam.org /.,Non-OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
Available from: http://www.who.int/classifications/icd/en/bluebook.,OADS,/arxiv_data1/oa_pdf/d3/a4/prbm-6-125.PMC3832462.pdf
"Ongoing phase III study Based on the encouraging results obtained with low-dose NGR-hTNF in MPM patients, arandomized, double-blind, phase III study of NGR-hTNF plus best investigator’s choice (BIC) versus placebo plus BIC in previously treated patients with advancedMPM started in 2010 ( http://www.clinicaltrialsfeeds.org/ clinical-trials/show/NCT01098266 ).",Non-OADS,/arxiv_data1/oa_pdf/42/63/40259_2013_Article_48.PMC3832761.pdf
The results obtained in the phase IIstudy in MPM and HCC patients enabled NGR-TNF to be granted ‘Orphan Drug’ designation for these indications in the EU and the USA ( http://www.molmed.com/eng/ pipeline_arenegyr.asp ).,Non-OADS,/arxiv_data1/oa_pdf/42/63/40259_2013_Article_48.PMC3832761.pdf
http://www.census.gov/ population/international/data/idb/worldpop.php (Accessed 10 Sep 2013).,OADS,/arxiv_data1/oa_pdf/71/cd/40266_2013_Article_126.PMC3832771.pdf
Available from: http://www.cdc.gov/diabetes/pubs/ pdf/ndfs_2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/92/bb/40266_2013_Article_128.PMC3832772.pdf
Available from: http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm071624.pdf .,Non-OADS,/arxiv_data1/oa_pdf/92/bb/40266_2013_Article_128.PMC3832772.pdf
( http://icbp.lbl.gov/ccc/index.,Non-OADS,/arxiv_data1/oa_pdf/8f/85/10549_2013_Article_2743.PMC3832776.pdf
( http://smd.stanford.edu/ )[22].,Non-OADS,/arxiv_data1/oa_pdf/8f/85/10549_2013_Article_2743.PMC3832776.pdf
Statistical analyses Biologic analysis of microarray data was performed with DAVID annotation tool ( http://david.abcc.ncifcrf.gov/ ) [64.,OADS,/arxiv_data1/oa_pdf/8f/85/10549_2013_Article_2743.PMC3832776.pdf
"ANOVA, Student’s ttests, and exact hypergeometric probability for gene expression data and Pearson correla- tion for protein–gene expression were performed using R (http://cran.r-project.org ).",OADS,/arxiv_data1/oa_pdf/8f/85/10549_2013_Article_2743.PMC3832776.pdf
Availablefrom: http://clinicaltrials.gov/ ct2/show/NCT01155661?term= LY2216684&rank=21 NLM Identifier: NCT01155661 9.,Non-OADS,/arxiv_data1/oa_pdf/62/ac/228_2013_Article_1572.PMC3832778.pdf
Availablefrom: http://clinicaltrials.gov/ct2/show/NCT01185340?term= LY2216684&rank=26 NLM Identifier: NCT01185340 11.,Non-OADS,/arxiv_data1/oa_pdf/62/ac/228_2013_Article_1572.PMC3832778.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01370499?,Non-OADS,/arxiv_data1/oa_pdf/62/ac/228_2013_Article_1572.PMC3832778.pdf
"Methyla-tion data from 21,986 CpG sites from 813 breast tumors and 123 adjacent non-tumor breast tissue samples was obtained from the TCGA Data Portal ( https://tcga-data.nci.",OADS,/arxiv_data1/oa_pdf/8d/83/10549_2013_Article_2738.PMC3832780.pdf
"Finally, R ( http://www.R-project.org ) was used to plot the contributors to signiﬁcant inverse correlations of methyla-tion with gene expression (Figs.",OADS,/arxiv_data1/oa_pdf/8d/83/10549_2013_Article_2738.PMC3832780.pdf
AAnnaallyyssiiss  ooff  pprrootteeiinn  ssttaabbiilliittyy  cchhaannggee   bbyy  II--MMuuttaanntt  22..00 We predicted nsSNP causing protein stability  change using the I-Mutant 2.0 tool [16] available  from the University of  Bologna (http://gpcr.biocomp.,Non-OADS,/arxiv_data1/oa_pdf/ac/20/AMS-9-18576.PMC3832808.pdf
We chose SI FT [17] available from http://sift.jcvi .,Non-OADS,/arxiv_data1/oa_pdf/ac/20/AMS-9-18576.PMC3832808.pdf
"Arch Med Sci 5, October / 2013 901 Evaluation and identification of damaged single nucleo tide polymorphisms in COL1A1 gene involved in osteoporosi s  SSiimmuullaattiioonn  ooff  ffuunnccttiioonnaall  cchhaannggee   iinn  nnssSSNNPP  bbyy  PPoollyyPPhheenn  sseerrvveerr PolyPhen [21] av ailable from Harvard School of Medicine (http://genetics.bwh.harvard.edu/pph/) is a computational tool for identification of poten - tially functional nsSNPs.",OADS,/arxiv_data1/oa_pdf/ac/20/AMS-9-18576.PMC3832808.pdf
AAnnaallyyssiiss  ooff  ffuunnccttiioonnaall  nnssSSNNPPss  aanndd  eessttiimmaattiioonn ooff  rriisskk  ssccoorree  bbyy  FFAASSTTSSNNPP The Functional Analysis and Selection Tool for  Single Nucleotide Polymorphism (FAST SNP) is a web  server (http://fastsnp.ibms.sinica.e du.tw/) which  connects many progr ams and databases for pro - cessing analysis [23].,OADS,/arxiv_data1/oa_pdf/ac/20/AMS-9-18576.PMC3832808.pdf
"National Medicines Institute, Warsaw, Poland http://www.antybiotyki.edu.pl/ pdf/ RekomendacjeA42009.pdf  14.",Non-OADS,/arxiv_data1/oa_pdf/54/ea/AMS-9-18799.PMC3832809.pdf
http://ec.europa.eu/health/antimicrobial_resistance/docs/ ebs_338_en.pdf A survey of patient behaviours  and beliefs regarding antib iotic self-medicati on for respiratory tract inf ections i n Poland,Non-OADS,/arxiv_data1/oa_pdf/54/ea/AMS-9-18799.PMC3832809.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3256 | DOI: 10.1038/srep03256 4",Non-OADS,/arxiv_data1/oa_pdf/ed/66/srep03256.PMC3832852.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/45/21/srep03253.PMC3832854.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3253 | DOI: 10.1038/srep03253 4",Non-OADS,/arxiv_data1/oa_pdf/45/21/srep03253.PMC3832854.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/26/04/srep03242.PMC3832860.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3242 | DOI: 10.1038/srep03242 10",Non-OADS,/arxiv_data1/oa_pdf/26/04/srep03242.PMC3832860.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1c/bd/srep03260.PMC3832871.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3260 | DOI: 10.1038/srep03260 8",Non-OADS,/arxiv_data1/oa_pdf/1c/bd/srep03260.PMC3832871.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5f/7e/srep03258.PMC3832872.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3258 | DOI: 10.1038/srep03258 8",Non-OADS,/arxiv_data1/oa_pdf/5f/7e/srep03258.PMC3832872.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/srep03254.PMC3832874.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3254 | DOI: 10.1038/srep03254 7",Non-OADS,/arxiv_data1/oa_pdf/eb/b3/srep03254.PMC3832874.pdf
A software tool for the generation of reference samples is available at http://webservices.nmi.de/samplepooler.,OADS,/arxiv_data1/oa_pdf/ce/33/srep03259.PMC3832875.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ce/33/srep03259.PMC3832875.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3259 | DOI: 10.1038/srep03259 5",Non-OADS,/arxiv_data1/oa_pdf/ce/33/srep03259.PMC3832875.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/84/srep03251.PMC3832876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3251 | DOI: 10.1038/srep03251 8",Non-OADS,/arxiv_data1/oa_pdf/95/84/srep03251.PMC3832876.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1084/jem.2004193 0 Chen, L.S., P .C.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
16:22. http://dx.doi   .org/10.1186/1423-0127-16-2 2Antibodies and flow cytometry.,OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1084/jem.2004080 9 D’Amico, A., and L. Wu.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/   10.1038/nature0781 5 Gautier, G., M. Humbert, F. Deauvieau, M. Scuiller, J. Hiscott, E.E.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1084/jem.2004196 4 Gilliet, M., W. Cao, and Y.J.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1038/nri235 8 Hahm, B., M.J. Trifilo, E.I.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1084/jem.2003032 3 Kondo, M., I.L.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"91:661– 672. http://dx.doi.org/10.1016/S0092-8674(00)80453- 5 Levy, D.E., I.J.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1016/j.coviro.2011.11.00 1 Li, H.S., A. Gelbard, G.J.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1182/blood-2011-04-34976 1 Li, H.S., C.Y.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1182/blood-2012-07-44131 1 Liu, Y.J.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1146/annurev.immunol.23.021704.11563 3 Liu, K., G.D. Victora, T.A.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1126/science.117124 3 Longman, R.S., D. Braun, S. Pellegrini, C.M.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1182/blood-2006-05-02346 5 McKenna, H.J., K.L.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.05.00 6 Naik, S.H., A.I.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1084/jem.2005164 5 Onai, N., A. Obata-Onai, M.A.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1038/ni151 8 Sathe, P., D. Vremec, L. Wu, L. Corcoran, and K. Shortman.",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10   .1182/blood-2012-02-41333 6 Schmid, M.A., D. Kingston, S. Boddupalli, and M.G.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
http://dx.doi.org/10.1111/j.0105-2896.2009.00877.,Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10.1016/j.immuni.2004.06.01 1 Stirewalt, D.L., and J.P .",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/10   .1038/nrc116 9 Swiecki, M., Y. Wang, W. Vermi, S. Gilfillan, R.D.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi   .org/10.1084/jem.2011065 4 Waskow, C., K. Liu, G. Darrasse-Jèze, P .",OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
"http://dx.doi.org/   10.1038/ni.161 5 Whitlock, C.A., G.F. Tidmarsh, C. Muller-Sieburg, and I.L.",Non-OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
http://dx.doi.org/10.1016/0092-8674(87)90709- 4,OADS,/arxiv_data1/oa_pdf/d2/51/JEM_20130536.PMC3832917.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1146/   annurev-immunol-040210-09291 5 Aletaha, D., T. Neogi, A.J.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1002/art   .2758 4 Aricescu, A.R., W .",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10   .1107/S090744490602979 9 Bailey, T.L., M. Boden, F.A.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi   .org/10.1093/nar/gkp09 1 Bharadwaj, M., P .",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1146/annurev-pharmtox-010611-13470 1 Bongartz, T., T. Cantaert, S.R.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1093/rheumatology/kel20 2 Brömme, D., Z. Li, M. Barnes, and E. Mehler.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1021/bi982175 f Broughton, S.E., J. Petersen, A. Theodossis, S.W .",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.07.01 3 Colaert, N., K. Helsens, L. Martens, J. Vandekerckhove, and K. Gevaert.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1038/nmeth1109-78 6 Dessen, A., C.M.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80369- 6 Dudek, N.L., C.T.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.2337/db11-133 3 Foulquier, C., M. Sebbag, C. Clavel, S. Chapuy-Regaud, R. Al Badine, M.C.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"56:3541– 3553. http://dx.doi.org/10.1002/art.2298 3 Gregersen, P .K., J.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1002/art.178030110 2 Hammer, J., P .",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1016/0092-   8674(93)90306- B Hammer, J., F .",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1084/jem.181.5.184 7 Harre, U., D. Georgess, H. Bang, A. Bozec, R. Axmann, E. Ossipova, P .J.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
http://dx.doi.org/10.1172/JCI6097 5protein in Sf9 insect cells using the Bac-to-Bac Baculovirus Expression Sys - tem (Invitrogen).,Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/   10.1182/blood-2004-12-484 8 Mannering, S.I., L.C.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1016/   j.immuni.2009.03.01 9 Miyara, M., G. Gorochov, M. Ehrenstein, L. Musset, S. Sakaguchi, and  Z. Amoura.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/   10.1016/j.autrev.2011.05.00 4 Padyukov, L., C. Silva, P. Stolt, L. Alfredsson, and L. Klareskog.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1002/art.2055 3 Pang, S.S., R. Berry, Z. Chen, L. Kjer-Nielsen, M.A.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1038/nature0944 8 Petersen, J., A.W.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1007/s00109-009-0526- 4 Pettit, A.R., K.P.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1002/1529- 0131(200004)43:4<791::AID-ANR9>3.0.CO;2- E Raychaudhuri, S., C. Sandor, E.A.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1038/ng.107 6 Reeves, P.J., N. Callewaert, R. Contreras, and H.G.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi   .org/10.1073/pnas.212519299 Scarsi, M., T. Ziglioli, and P. Airò.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.3899/jrheum.09117 6 Schönland, S.O., C. Lopez, T. Widmann, J. Zimmer, E. Bryl, J.J. Goronzy, and  C.M.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi   .org/10.1073/pnas.223356110 0 Sempere-Ortells, J.M., V. Pérez-García, G. Marín-Alberca, A. Peris-Pertusa,  J.M.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.3109/0891693090306149 1 Sette, A., J. Sidney, C. Oseroff, M.F .",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1002/art.3044 5Helmick, C.G., D.T.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1002/art.2317 7 Henderson, K.N., J.A.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/   10.1084/jem.2007205 1 Hsieh, C.S., Y. Liang, A.J.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi   .org/10.1016/j.immuni.2004.07.00 9 Huizinga, T.W., C.I.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1002/art.2138 5 Illing, P.T., J.P. Vivian, N.L.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"6:271– 282. http://dx.doi.org/10.1038/nri180 5 Klareskog, L., J. Rönnelid, K. Lundberg, L. Padyukov, and L. Alfredsson.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1146/annurev.immunol.26   .021607.09024 4 Klareskog, L., A.I.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1016/S0140-6736(09)60008- 8 Kuhn, K.A., L. Kulik, B. Tomooka, K.J.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1172/JCI2542 2 Law, S.C., S. Street, C.H.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1186/ar384 8 Li, G., D. Diogo, D. Wu, J. Spoonamore, V. Dancik, L. Franke, F.  Kurreeman, E.J.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1371/   journal.pgen.100348 7 Lundberg, K., A. Kinloch, B.A.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10   .1002/art.2393 6 Makrygiannakis, D., M. Hermansson, A.K.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
http://dx.doi.org/10.1136/ard   .2007.07519 2,Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1016/j.immuni.2012   .10.02 1 Tung, J.W., K. Heydari, R. Tirouvanziam, B. Sahaf, D.R.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi   .org/10.1016/j.cll.2007.05.00 1 van der Woude, D., B.A.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1002/   art.2736 6 van Gaalen, F .A., J. van Aken, T.W .",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi   .org/10.1002/art.2031 6 Viatte, S., D. Plant, and S. Raychaudhuri.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi   .org/10.1038/nrrheum.2012.23 7 von Delwig, A., J. Locke, J.H.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi   .org/10.1002/art.2506 4 Vossenaar, E.R., and W.J.",Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1186/ar118 4 Vossenaar, E.R., T.R.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
"http://dx.doi.org/10.1136/ard.2003.01221 1 Wegner, N., K. Lundberg, A. Kinloch, B. Fisher, V. Malmström, M. Feldmann,  and P.J.",OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
http://dx.doi.org/10.1111/j.0105-2896.2009.00850.,Non-OADS,/arxiv_data1/oa_pdf/03/61/JEM_20131241.PMC3832918.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1152/   physrev.00006.200 9 Balducci, C., M. Beeg, M. Stravalaci, A. Bastone, A. Sclip, E. Biasini, L. Tapella,  L. Colombo, C. Manzoni, T. Borsello, et al.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1073/pnas.091182910 7 Barclay, A.N., and M.H.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10   .1038/nri185 9 Bremer, J., F .",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/nn.248 3 Büeler, H.R., M. Fischer, Y .",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/356577a 0 Calella, A.M., M. Farinelli, M. Nuvolone, O. Mirante, R. Moos, J. Falsig, I.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1002/emmm.20100008 2 Cebecauer, M., J. Cerný, and V .",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"243:706– 710. http://dx.doi.org/10.1006/bbrc.1998.814 9 Chao, M.P ., I.L.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1016/j.coi.2012.01.01 0 Chimini, G. 2001.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/sj.cdd.440083 3 Cissé, M., P .E.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1459-11.201 1 Collinge, J., M.A.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/370295a 0 Crusio, W .E., D. Goldowitz, A. Holmes, and D. Wolfer.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1007/s00018-005-4511- y de Almeida, C.J., L.B.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
http://dx.doi.org/10   .1189/jlb.110353 1maximum 10 multi-hits were allowed in the alignment.,Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
Online supplemental material is avail - able at http://www.jem.org/cgi/content/full/jem.20131274/DC1.,Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1210/en.2008-023 6 Korom, M., K.M.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1128/JVI.02559-1 2 Kumar, P., S. Henikoff, and P.C.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/nprot.2009.8 6 Kuwahara, C., A.M. Takeuchi, T. Nishimura, K. Haraguchi, A. Kubosaki,  Y. Matsumoto, K. Saeki, Y. Matsumoto, T. Yokoyama, S. Itohara,  and T. Onodera.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/2224 1 Larson, M., M.A.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .1858-12.201 2 Laurén, J., D.A.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi   .org/10.1038/nature0776 1 Legrand, N., N.D. Huntington, M. Nagasawa, A.Q.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"12:323. http://dx.doi.org/10.1186/1471-2105-12-32 3 Li, L., X. Xiao, S. Li, X. Jia, P. Wang, X. Guo, X. Jiao, Q. Zhang, and  J.F.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1371/journal.pone.001945 8 Linden, R., V.R.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1152/physrev.00007.200 7 Lledo, P.M., P. Tremblay, S.J.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1007/BF0278066 2 Matozaki, T., Y. Murata, H. Okazawa, and H. Ohnishi.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1016/j.tcb.2008.12.00 1 Moore, R.C., N.J. Redhead, J. Selfridge, J.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/   nbt0995-99 9 Ng, P .C., and S. Henikoff.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1101/gr.17660 1 Nico, P.B., F. de-Paris, E.R.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1016/j.bbr.2005.02.00 3 Nitta, K., A. Sakudo, J. Masuyama, G. Xue, K. Sugiura, and T. Onodera.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1007/s00335-005-0107- y Dorahy, D.J., L.F .",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1016/j.bbi.2010.05.00 2 Fischer, M., T. Rülicke, A. Raeber, A. Sailer, M. Moser, B. Oesch, S.  Brandner, A. Aguzzi, and C. Weissmann.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1016/j.bbr.2011.03.01 2 Gal, A., Y. Li, D.A.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/8155 5 Gao, A.G., F .P .",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1074/jbc.271.1.2 1 Gerlai, R. 1996.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1016/S0166-2236(96)20020- 7 Gimbel, D.A., H.B.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"30:6367– 6374. http://dx.doi.org/10.1523/JNEUROSCI.0395-10.201 0 Greenman, C., P. Stephens, R. Smith, G.L.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/nature0561 0 Heikenwalder, M., M.O.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1016/j.immuni.2008.10.01 4 Hochreiter-Hufford, A., and K.S.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1101/   cshperspect.a00874 8 Holmdahl, R., and B. Malissen.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1002/eji.20114204 8 Inagaki, K., T. Yamao, T. Noguchi, T. Matozaki, K. Fukunaga, T. Takada,  T. Hosooka, S. Akira, and M. Kasuga.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1093/emboj/19.24.672 1 Ivakine, E.A., O.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1021/bi991666 c Kessels, H.W., L.N.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1073/pnas.83.19.735 8 Steele, A.D., S. Lindquist, and A. Aguzzi.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi   .org/10.4161/pri.1.2.434 6 Striebel, J.F ., B.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1016/j.neuroscience.2013.02.00 4 Strom, A., G.S.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi   .org/10.1097/MPA.0b013e3181f7e54 7 Strowig, T., A. Rongvaux, C. Rathinam, H. Takizawa, C. Borsotti, W .",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1073/pnas.110976910 8 Takenaka, K., T.K.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"8:1313– 1323. http://dx.doi.org/10.1038/ni152 7 Theocharides, A.P ., L. Jin, P .Y .",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1084/jem.2012050 2 T omizawa, T ., Y .",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.2353/ajpath.2008.07106 2 Um, J.W ., H.B.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/nn.317 8 Uraki, R., A. Sakudo, S. Ando, H. Kitani, and T. Onodera.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
40:1679– 1682. http://dx.doi.org/10.1111/j.1528-1157.1999.tb01583.,Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1016/S0166-2236(02)02192- 6 Yamauchi, T., K. Takenaka, S. Urata, T. Shima, Y .",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi   .org/10.1182/blood-2012-06-44035 4 Y okoyama, T., K.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
http://dx.doi.org/10.1074/   jbc.M00873420 0and dendritic cells.,OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.2174/09298660978760170 5 Oh, J.M., H.Y.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1016/j.mcn.2008.07.00 3 Oh, J.M., E.K.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.4161/auto.2116 4 Ohnishi, H., T. Murata, S. Kusakari, Y. Hayashi, K. Takao, T. Maruyama,  Y.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1083/jcb.146.4.84 3 Peyron, P., C. Bordier, E.N.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi   .org/10.1371/journal.pone.000387 2 Rangel, A., F. Burgaya, R. Gavín, E. Soriano, A. Aguzzi, and J.A.",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/   10.1002/jnr.2121 5 Ratté, S., M. Vreugdenhil, J.K. Boult, A. Patel, E.A.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10   .1016/j.neuroscience.2011.01.05 3 Ridgway, W.M., B. Healy, L.J.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/ni0707-66 9 Rossi, D., A. Cozzio, E. Flechsig, M.A.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1093/emboj/20.4.69 4 Sakaguchi, S., S. Katamine, K. Shigematsu, A. Nakatani, R. Moriuchi, N.  Nishida, K. Kurokawa, R. Nakaoke, H. Sato, K. Jishage, et al.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1042/   0264-6021:344066 7 Scott, R.S., E.J.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
"http://dx.doi.org/10.1038/3507560 3 Seitz, H.M., T.D.",OADS,/arxiv_data1/oa_pdf/3a/dc/JEM_20131274.PMC3832919.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1002/eji.20083845 6 Allen, C.D., K.M.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
http://dx.doi.org/   10.1038/ni110 0VDJ sequence analysis.,OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1006/smim.1996.002 2 Khalil, A.M., J.C. Cambier, and M.J. Shlomchik.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1126/science.121336 8 Kinet, J.P. 1999.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/   10.1146/annurev.immunol.17.1.93 1 Kraus, M., M.B.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/   10.1016/j.cell.2004.05.01 4 Kurosaki, T., Y. Aiba, K. Kometani, S. Moriyama, and Y. Takahashi.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
http://dx.doi.org/10.1111/j.1600-065X.2010.00939.,Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1038/ni.231 3 Lam, K.P ., R. Kühn, and K. Rajewsky.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)80373- 6 Liu, Q., A.J.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1084/jem.188.7.133 3 Lorenz, M., S. Jung, and A. Radbruch.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10   .1126/science.789260 7 Luger, E.O., V. Fokuhl, M. Wegmann, M. Abram, K. Tillack, G. Achatz,  R.A. Manz, M. Worm, A. Radbruch, and H. Renz.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10   .1016/j.jaci.2009.06.04 7 Mandler, R., F.D.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1016/0092-8674(90)90247- C Meyer-Hermann, M.E., P.K.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1093/imammb/dql01 2 Meyer-Hermann, M., E. Mohr, N. Pelletier, Y .",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1016/j.celrep   .2012.05.01 0 Mootha, V.K., C.M.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1038/ng118 0 Okada, H., S. Bolland, A. Hashimoto, M. Kurosaki, Y. Kabuyama, M. Iino,  J.V.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1084/jem.181.6.207 7 Pape, K.A., J.J. Taylor, R.W.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1002/eji.183027012 0 Camberis, M., G. Le Gros, and J.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi   .org/10.1084/jem.194.9.134 9 Cyster, J.G., and C.C.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10   .1038/ni.181 4 Erazo, A., N. Kutchukhidze, M. Leung, A.P .",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/   10.1016/j.immuni.2006.12.00 6 Figge, M.T., A. Garin, M. Gunzer, M. Kosco-Vilbois, K.M.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1084/jem.2008116 0 Finkelman, F.D., I.M.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1038/nm.275 5 Garin, A., M. Meyer-Hermann, M. Contie, M.T.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.07.00 5 Gould, H.J., and B.J.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1038/nri227 3 Hackney, J.A., S. Misaghi, K. Senger, C. Garris, Y.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1016/S0065-2776(08)01005- 5 Heng, T.S., and M.W .",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10   .1038/ni1008-109 1 Hou, P., E. Araujo, T. Zhao, M. Zhang, D. Massenburg, M. Veselits, C.  Doyle, A.R.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1371/journal.pbio.004020 0 Jabara, H.H., R. Loh, N. Ramesh, D. Vercelli, and R.S.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1002/   eji.20053549 5 Katona, I.M., J.F .",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi   .org/10.1126/science.120173 0 Rabbitts, T.H., A. Forster, W. Dunnick, and D.L.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1038/283351a 0 Saeed, A.I., V. Sharov, J.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi   .org/10.1016/S1074-7613(94)80022- 7 Smith, K.G., A.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1084/jem.191.3.47 5 Smyth, G.K. 2004.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1038/ni.225 6 Tarlinton, D.M., and K.G.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10   .1016/S0167-5699(00)01687- X Thaunat, O., A.G. Granja, P .",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10   .1126/science.121410 0 Urban, J.F .",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
http://dx.doi.org/10.1111/j.1600-065X.1992.tb01415.,Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1016/j.coi.2006.11.01 1 Victora, G.D., and M.C.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1146/annurev-immunol-   020711-07503 2 Victora, G.D., T.A.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi   .org/10.1016/j.cell.2010.10.03 2 Victora, G.D., D. Dominguez-Sola, A.B.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1182/   blood-2012-03-41538 0 Vieira, P., and K. Rajewsky.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10   .1002/eji.183018022 1 Wesemann, D.R., A.J.",Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/   10.1073/pnas.121028610 9 Xiong, H., M.A.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/   10.1016/B978-0-12-394300-2.00004- 1 Xiong, H., J. Dolpady, M. Wabl, M.A.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/   10.1084/jem.2011194 1 Yang, Z., B.M.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
"http://dx.doi.org/10.1016/   j.immuni.2012.02.00 9 Yoshida, K., M. Matsuoka, S. Usuda, A. Mori, K. Ishizaka, and H. Sakano.",OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
http://dx.doi.org/10.1084/jem   .2012015 0,Non-OADS,/arxiv_data1/oa_pdf/93/c1/JEM_20131539.PMC3832920.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"7:29. http://dx.doi.org/   10.1186/1742-4690-7-2 9 Bennett, A.E., K. Narayan, D. Shi, L.M.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1371/journal.ppat.100059 1 Chen, P ., W .",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1128/JVI   .00381-0 7 Chertova, E., O. Chertov, L.V .",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1128/JVI.01013-0 6 Chu, H., J.-J.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/   10.1016/j.chom.2012.07.01 1 Chu, H., J.-J.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1371/ journal.pone.003529 7 Collins, R.F ., N. T ouret, H. Kuwata, N.N.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1074/jbc   .M109.04510 4 Daviet, L., R. Buckland, M.D.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1083/jcb.20060905 0 Endemann, G., L.W .",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1016/   S0092-8674(01)00506- 2 Gaudin, R., B.C.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1083/jcb.20120114 4 Gaudin, R., S. Berre, B. Cunha de Alencar, J. Decalf, M. Schindler, F .-X.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10   .1371/journal.pone.006945 0 Goujon, C., V .",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1128/   JVI.01181-0 8 Gyorkey, F ., J.L.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"1:106.  http://dx.doi.org/10.1016/S0140-6736(85)91995- 6 Heit, B., H. Kim, G. Cosío, D. Castaño, R. Collins, C.A.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
http://dx.doi.org/10.1111/j.1462-5822.2009.01326.,Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
79:1054– 1061. http://dx.doi.org/10.1172/JCI11291 8,Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1161/   01.ATV .20.4.102 7 Miao, W.-M., E. Vasile, W.S.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1182/blood.V97.6.168 9 Mörner, A., A. Björndal, J. Albert, V .N.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1128/   JVI.74.7.3264-3272.200 0 Nozaki, S., H. Kashiwagi, S. Y amashita, T .",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1172/JCI11823 1 Nydegger, S., S. Khurana, D.N.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1083/   jcb.20050816 5 Ono, A., and E.O.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1083/jcb.20030400 8 Pelchen-Matthews, A., S. Giese, P .",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.7326/0003-4819-108-3-32 1 Primo, L., C. Ferrandi, C. Roca, S. Marchiò, L. di Blasio, M. Alessio, and F.  Bussolino.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
http://dx.doi   .org/10.1034/j.1600-0854.2002.31004.,Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1371/journal   .pone.003663 2 Roberts, W ., S. Magwenzi, A. Aburima, and K.M.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1182/blood-2010-01-26556 1 Roesch, F ., O. Meziane, A. Kula, S. Nisole, F .",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
http://dx.doi.org/10.1371/journal.ppat.100279 2Syk-mediated signaling of CD36 internalization.,OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1016/j.devcel.2013.01.00 7 Hoebe, K., P .",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/   10.1038/nature0325 3 Huang, W ., M. Febbraio, and R.L.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1371/journal.pone.002909 2 Jaqaman, K., H. Kuwata, N. T ouret, R. Collins, W .S.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/   10.1016/j.cell.2011.06.04 9 Jarry, A., A. Cortez, E. René, F .",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
http://dx.doi.org/10.1111/j.1365-2559.1990.tb01081.,Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1016/j.chom.2007   .06.01 1 Kazerounian, S., M. Duquette, M.A.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"117:4658– 4666. http://dx.doi.org/10.1182/blood-2010-09-30528 4 Koenig, S., H.E.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1126/science.301690 3 Koppensteiner, H., C. Banning, C. Schneider, H. Hohenberg, and M. Schindler.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1128/JVI.05915-1 1 Krementsov, D.N., P .",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
http://dx.doi.org/10.1111/j.1600-0854.2010.01111.,Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1016/S0014-   5793(03)00096- 6 Kunjathoor, V .V ., M. Febbraio, E.A.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi   .org/10.1074/jbc.M20964920 0 Malaud, E., D. Hourton, L.M.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"364:507– 515. http://dx.doi.org/10.1042/BJ2001137 3 Manel, N., B. Hogstad, Y .",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1038/   nature0933 7 Marsh, M., K. Theusner, and A. Pelchen-Matthews.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi   .org/10.1042/BST037018 5 Matsumoto, K., K. Hirano, S. Nozaki, A. Takamoto, M. Nishida, Y .",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"24:2481– 2489. http://dx.doi.org/10.1038/sj.emboj.760070 7 Sourisseau, M., N. Sol-Foulon, F .",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1128/JVI   .01629-0 6 Stuart, L.M., J. Deng, J.M.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi   .org/10.1083/jcb.20050111 3 Swerlick, R.A., K.H.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1016/0008-8749(83)90262- 9 Tan, J., and Q.J.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1146/annurev   .immunol.23.021704.11581 6 Wang, J.-H., C. Kwas, and L. Wu.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1128/JVI.00006-0 9 Welsch, S., O.T.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/   10.1128/JVI.00834-1 1 Wolf, Z., E. Orsó, T. Werner, H.H.",Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
"http://dx.doi.org/10.1074/jbc.M30772220 0 Zhang, J., and I. Crandall.",OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
6:24. http://dx.doi.org/10.1186/1476-511X-6-2 4,Non-OADS,/arxiv_data1/oa_pdf/35/50/JEM_20130566.PMC3832921.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1084/   jem.2010024 4 de Villartay, J.P. 2009.",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1007/978-1-4419-0296-2_ 4 Degner, S.C., J. V erma-Gaur, T .P .",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1084/jem.2008191 5 Du, L., R. Peng, A. Björkman, N. Filipe de Miranda, C. Rosner, A. Kotnis,  M. Berglund, C. Liu, R. Rosenquist, G. Enblad, et al.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1084/jem.2011032 5 Kaur, M., C. DeScipio, J. McCallum, D. Yaeger, M. Devoto, L.G.",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1002/ajmg.a.3091 9 Kawauchi, S., A.L.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1371/journal.pgen.100065 0 Kracker, S., K. Imai, P .",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1073/   pnas.101259110 8 Liu, J., and G. Baynam.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1371/journal.pbio.100011 9 Manis, J.P., J.C. Morales, Z. Xia, J.L.",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1038/ni106 7 Michaelis, C., R. Ciosk, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)80007- 6 Moore, J.K., and J.E.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1146/annurev-   genet-102108-13423 3 Noordzij, J.G., N.S.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1002/yea.290 6 Oka, Y ., K. Suzuki, M. Yamauchi, N. Mitsutake, and S. Yamashita.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1016/j.bbrc.2011   .07.02 1 Pan-Hammarström, Q., A.M. Jones, A. Lähdesmäki, W. Zhou, R.A. Gatti,  L. Hammarström, A.R.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1084/jem.2004077 2 Pié, J., M.C.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1002/ajmg.a.3334 8 Reina-San-Martin, B., J. Chen, A. Nussenzweig, and M.C.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1002/eji.20063678 9 Schär, P., M. Fäsi, and R. Jessberger.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1093/nar/gkh71 6 Schoumans, J., J. Wincent, M. Barbaro, T. Djureinovic, P .",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi   .org/10.1038/sj.ejhg.520173 7 Seitan, V .C., B. Hao, K. Tachibana-Konwalski, T. Lavagnolli, H. Mira-Bontenbal,  K.E.",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1038/nature1031 2Sharbeen, G., C.W.",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1084/jem.2011237 9 Sjögren, C., and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00271- 8 Stavnezer, J., A. Björkman, L. Du, A. Cagigi, and Q. Pan-Hammarström.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1016/B978-0-12-380995-   7.00003- 3 Stewart, G.S., T. Stankovic, P .J.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1002/1521-4141(200203)32:3<701:: AID-   IMMU701>3.0.CO;2- T Vrouwe, M.G., E. Elghalbzouri-Maghrani, M. Meijers, P. Schouten,  B.C.",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi   .org/10.1093/hmg/ddm09 8 Watrin, E., and J.M.",OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
"http://dx.doi.org/10.1038/emboj.2009.20 2 Yan, C.T., C. Boboila, E.K.",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
http://dx.doi.org/10.1038/nature0602 0,Non-OADS,/arxiv_data1/oa_pdf/dc/2b/JEM_20130168.PMC3832922.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi   .org/10.1084/jem.2004078 9 Cekic, C., C.R.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80092- 8 Fredholm, B.B., A.P .",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1124/pr.110.00328 5 Ghazawi, F .M., E.M. Faller, S.M.",Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80093- X Hand, T.W ., W .",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1038/nrd263 8 Heng, T.S., and M.W .",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10   .1038/ni1008-109 1 Henriques, C.M., J. Rino, R.J. Nibbs, G.J.",Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi   .org/10.1182/blood-2009-10-24687 6 Huang, Y .J., Y .",Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1038/ni.168 9 Kim, S., K. Jee, D. Kim, H. Koh, and J. Chung.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1074/jbc.M00149220 0 Lappas, C.M., J.M.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/   10.1038/4177 1 Lee, P .P ., D.R.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
http://dx.doi.org/10   .1016/S1074-7613(01)00227- 8were prepared by passing tissues through 40-µM mesh filters.,Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
Online supple - mental material is available at http://www.jem.org/cgi/content/full/jem   .20130249/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/   10.1161/ATVBAHA.111.22683 7 Lou, L., J. Urbani, F .",Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1074/jbc.M20149120 0 Muranski, P ., B. Chmielowski, and L. Ignatowicz.",Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1038/414916 a Ohta, A., A. Ohta, M. Madasu, R. Kini, M. Subramanian, N. Goel, and M.   Sitkovsky .",Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.4049/jimmunol.090124 7 Pallard, C., A.P .",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)   80052- 7 Rathmell, J.C., R.L.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1002/eji.20032404 8 Resta, R., S.W .",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1172/JCI11921 1Riou, C., B. Yassine-Diab, J.",Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1084/jem.2006168 1 Schwindinger, W .F ., L.J.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi   .org/10.1074/jbc.M110.14262 0 Sprent, J., and C.D.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1038/ni.201 8 Su, A.I., T. Wiltshire, S. Batalov, H. Lapp, K.A.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi   .org/10.1084/jem.192.4.F 9 Surh, C.D., and J. Sprent.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/10.1016/j.immuni.2008   .11.00 2 Yang, K., G. Neale, D.R.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
"http://dx.doi.org/   10.1038/ni.206 8 Yao, S.Y ., A.M. Ng, C.E.",OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
http://dx.doi.org/10.1074/jbc.M111.23611 7,Non-OADS,/arxiv_data1/oa_pdf/60/6f/JEM_20130249.PMC3832923.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1038/344442a 0 Hogan, C., S. Dupré-Crochet, M. Norman, M. Kajita, C. Zimmermann,  A.E.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/   10.1038/ncb185 3 Kantarjian, H., N.P.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1056/   NEJMoa100231 5 Koschmieder, S., B. Göttgens, P. Zhang, J. Iwasaki-Arai, K. Akashi, J.L.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10   .1182/blood-2003-12-436 9 Lahaye, T., B. Riehm, U. Berger, P. Paschka, M.C.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1002/cncr.2092 2 Li, S., R.L.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1084/jem.189.9.139 9 Long, B., H. Zhu, C. Zhu, T. Liu, and W. Meng.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"30:8. http://dx.doi.org/10.1186/1756-9966-30- 8 Lord, B.I., L.B.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)63921- 1 Maze, R., B. Sherry, B.S.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1038/nature0366 9 Mumprecht, S., C. Schürch, J. Schwaller, M. Solenthaler, and A.F.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1182/blood-2008-09-17969 7 Nair, R.R., J. Tolentino, and L.A. Hazlehurst.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1016/j.bcp   .2010.04.00 3 Naka, K., T. Hoshii, T. Muraguchi, Y. Tadokoro, T. Ooshio, Y. Kondo, S.  Nakao, N. Motoyama, and A. Hirao.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1038/nature0873 4 Pear, W.S., J.P. Miller, L. Xu, J.C. Pui, B. Soffer, R.C.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1084/jem.185.1.11 1 Basu, S., and H.E.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/   10.4049/jimmunol.090054 2 Bhatia, R., P.B.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi   .org/10.1172/JCI11814 1 Broxmeyer, H.E., B. Sherry, S. Cooper, L. Lu, R. Maze, M.P.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi   .org/10.1084/jem.189.12.198 7 Chasty, R.C., G.S.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1172/JCI3572 1 Dierks, C., R. Beigi, G.R.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1016/j.ccr.2008.08.00 3 Druker, B.J., F. Guilhot, S.G. O’Brien, I. Gathmann, H. Kantarjian, N.  Gattermann, M.W.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1056/NEJMoa06286 7 Dunlop, D.J., E.G.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
http://dx.doi.org/10   .1073/pnas.90.24.1201 5,Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10 .1016/   S0092-8674(00)80679- 0 Ren, R. 2005.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/   10.1038/nrc156 7 Saglio, G., D.W. Kim, S. Issaragrisil, P. le Coutre, G. Etienne, C. Lobo,  R. Pasquini, R.E.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"340:1330– 1340. http://dx.doi.org/10.1056/NEJM19990429340170 6 Seke Etet, P.F., L. Vecchio, and A.H. Nwabo Kamdje.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"24:1883– 1888. http://dx.doi.org/10.1016/j.cellsig.2012.05.01 5 Singh, V.K., O.O.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi   .org/10.1038/sj.gt.330095 1 Tang, M., M. Gonen, A. Quintas-Cardama, J. Cortes, H. Kantarjian, C.  Field, T.P.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1038/sj.onc.120191 4 Wertheim, J.A., K. Forsythe, B.J.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1182/blood   .V99.11.412 2 Zhang, B., Y .W .",Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.02.01 8 Zhang, J., C. Niu, L. Ye, H. Huang, X.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1038/nature0204 1 Zhang, Y., H. Yoneyama, Y. Wang, S. Ishikawa, S. Hashimoto, J.L.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1093/jnci/djh02 4 Zhao, C., A. Chen, C.H.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
"http://dx.doi.org/10.1038/nature0773 7 Zou, Y.R., A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R.",OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
http://dx.doi.org/   10.1038/3126 9,Non-OADS,/arxiv_data1/oa_pdf/c4/12/JEM_20130112.PMC3832924.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after the  publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported   license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.1126/science.272.5258.5 4 Arpin, C., J. Banchereau, and Y.J.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1084/   jem.186.6.93 1 Asao, H., C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D. Foster, and K.  Sugamura.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1038/ni.176 4 Ettinger, R., G.P.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"3:721– 732. http://dx.doi.org/10.1038/nri118 1 Good, K.L., and S.G. Tangye.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1038/ni.190 0 Griffin, D.O., N.E.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.3324/haematol.2013.08374 1 Hodgkin, P.D., J.H.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1084/jem.184.1.27 7 Holland, S.M., F.R.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1056/NEJMoa07368 7 Horikawa, K., S.W.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1084/jem.2006192 3 Ives, M.L., C.S.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1016/j.jaci.2013.05.02 9 Jabara, H.H., D.R.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1038/   ni.230 5 Kotlarz, D., R. Beier, D. Murugan, J. Diestelhorst, O. Jensen, K. Boztug,  D. Pfeifer, H. Kreipe, E.D.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1053/j.gastro.2012.04.04 5 Kotlarz, D., N. Zi ętara, G. Uzel, T. Weidemann, C.J.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1182/blood-2008-02-14274 5 Avery, D.T., E.K.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1084/jem.2009170 6 Banchereau, J., F. Brière, Y.J.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1002/stem.553012030 4 Bernasconi, N.L., E. Traggiai, and A. Lanzavecchia.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1126/science.107607 1 Bernasconi, N.L., N. Onai, and A. Lanzavecchia.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1182/blood-2002-11-356 9 Boisson-Dupuis, S., X.F.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1016/   j.coi.2012.04.01 1 Bryant, V.L., C.S.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.1016/j.immuni.2012.03.01 6 Chapgier, A., S. Boisson-Dupuis, E. Jouanguy, G. Vogt, J. Feinberg, A.  Prochnicka-Chalufour, A. Casrouge, K. Yang, C. Soudais, C. Fieschi,  et al.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1371/ journal.pgen.002013 1 Chapgier, A., X.F.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1172/JCI3708 3 Chevalier, N., D. Jarrossay, E. Ho, D.T.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.4049/jimmunol.100282 8 Craxton, A., D. Magaletti, E.J.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
http://dx.doi.org/10.1126/science   .106115 4,Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1016/j.smim.2011.08.01 0 Pène, J., J.F.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1002/eji.183024121 1 Rajewsky, K. 1996.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1038/381751a 0 Recher, M., L.J.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.1182/blood-2011-06-36253 3 Sampaio, E.P., H.I.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1007/   s10875-012-9659- 2 Sheerin, K.A., and R.H. Buckley.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1016/0091-6749(91)90126- 9 Tangye, S.G. 2011.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1016/j.it.2011.09.00 1 Tangye, S.G., and D.M.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.1002/eji.20093953 1 Tangye, S.G., Y.J.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.1084/jem.188.9.169 1 Tangye, S.G., D.T.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
http://dx.doi.org/10.1111/j.1749-6632.2011.06361.,Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1182/   blood-2005-07-295 5 Yefenof, E., V.M.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
http://dx.doi.org/10.1182/blood-2006-10-05497 3syndrome.,Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1084/jem   .2011122 9 Leung, D.Y., D.M.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.1016/0091-6749(88)90873- 1 Litinskiy, M.B., B. Nardelli, D.M.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1038/ni82 9 Liu, Y.J., C. Barthélémy, O. de Bouteiller, C. Arpin, I. Durand, and J.  Banchereau.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1016/1074-   7613(95)90048- 9 Ma, C.S., N.J. Hare, K.E.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"116:322– 333. http://dx.doi.org/10.1172/JCI2572 0 Ma, C.S., G.Y.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1084/jem.2008021 8 Ma, C.S., D.T.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.1182/blood-2011-11-39298 5 Macallan, D.C., D.L.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.1182/blood-2004-09-374 0 Martin, S.W., and C.C.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1038/ni75 2 Mazerolles, F., C. Picard, S. Kracker, A. Fischer, and A. Durandy.",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi   .org/10.1016/j.jaci.2012.12.151 9 Minegishi, Y ., M. Saito, S. Tsuchiya, I. Tsuge, H. Takada, T. Hara, N. Kawamura,  T. Ariga, S. Pasic, O. Stojkovic, et al.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1038/nature0609 6 Nilsson, A., A. de Milito, F .",Non-OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
"http://dx.doi.org/10.1016/j.exphem.2005.10.00 5 Notarangelo, L.D., G. Lanzi, S. Peron, and A. Durandy.",OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
http://dx.doi.org/10.1016/j.jaci.2006.01.04 3,OADS,/arxiv_data1/oa_pdf/22/4a/JEM_20130323.PMC3832925.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1126/science.107287 3 Abe, N., A. Almenar-Queralt, C. Lillo, Z. Shen, J. Lozach, S.P.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1007/BF0029481 2 Gao, Y., A.P.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1038/sj.jcbfm.960006 2 Ghosh, A.S., B. Wang, C.D.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"194:751– 764. http://dx.doi.org/10.1083/jcb.20110315 3 Hardingham, G.E., and H. Bading.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1038/nrn291 1 Hayashi, S., and A.P.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1006/dbio.2002.059 7 Hellier, J.L., and F.E.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/j.modgep.2004.12.00 2 Hirai, S., F. Cui, T. Miyata, M. Ogawa, H. Kiyonari, Y. Suda, S. Aizawa,  Y. Banba, and S. Ohno.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2272-06.200 6 Holtmaat, A.J., J.T.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/   10.1016/j.neuron.2005.01.00 3 Hunot, S., M. Vila, P. Teismann, R.J. Davis, E.C.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi   .org/10.1083/jcb.20130306 6 Jordan, B.A., B.D.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1128/   MCB.20.3.1030-1043.200 0 Kim, J.H., D. Liao, L.F. Lau, and R.L.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)81008- 9 Kuan, C.Y., A.J.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10   .1007/s00424-010-0809- 1 Lewcock, J.W ., N. Genoud, K. Lettieri, and S.L.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.09.00 9 Li, K.W., M.P.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"284:34628– 34639. http://dx.doi.org/10.1074/jbc.M109.03502 2 Ankarcrona, M., J.M.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/0896-6273(95)90186- 8 Atasoy, D., Y. Aponte, H.H.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.1954-08.200 8 Ayalon, G., J.Q.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/j.cell.2008.10.01 8 Behrens, A., M. Sibilia, and E.F. Wagner.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1038/685 4 Ben-Ari, Y.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/0306-4522(85)90299- 4 Bogoyevitch, M.A., K.R.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10   .1016/j.bbapap.2009.11.00 2 Bonfoco, E., D. Krainc, M. Ankarcrona, P. Nicotera, and S.A. Lipton.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1038/nm91 1 Cavalli, V., P. Kujala, J. Klumperman, and L.S.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"168:775– 787. http://dx.doi.org/10.1083/jcb.20041013 6 Chang, L., Y. Jones, M.H.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/S1534-5807(03)00094- 7 Charriaut-Marlangue, C., I. Margaill, A. Represa, T. Popovici, M. Plotkine,  and Y. Ben-Ari.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1097/00004647-199603000-0000 2 Chen, X., M. Rzhetskaya, T. Kareva, R. Bland, M.J. During, A.W.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/0304-   3940(85)90069- 2 Coffey, E.T., G. Smiciene, V. Hongisto, J. Cao, S. Brecht, T. Herdegen, and  M.J. Courtney.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
http://dx.doi   .org/10.1111/j.1471-4159.2005.03507.,Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"483:213– 217. http://dx.doi.org/10.1038/nature1084 1 Dawson, V.L., V.M.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1074/jbc.271.28.1688 8 McLin, J.P., and O.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
http://dx.doi   .org/10.1111/j.1460-9568.2006.05111.,Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"396:433– 439. http://dx.doi.org/10.1038/2479 0 Miller, B.R., C. Press, R.W.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1038/nn.229 0 Morishima, Y ., Y .",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi   .org/10.1016/j.coph.2005.12.00 2 Murai, K.K., D. Misner, and B. Ranscht.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/   S0960-9822(02)00680- 2 Papouin, T., L. Ladépêche, J. Ruel, S. Sacchi, M. Labasque, M. Hanini, L.  Groc, L. Pollegioni, J.P. Mothet, and S.H.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/j.cell.2012.06.02 9 Peng, J., M.J. Kim, D. Cheng, D.M.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1074/jbc.M40010320 0 Saito, T., and N. Nakatsuji.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1006/dbio.2001.043 9 Sampedro, M.N., C.M.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi   .org/10.1016/S0006-8993(96)01387- X Sheng, M., and E. Kim.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1101/ cshperspect.a00567 8Sherrin, T., T. Blank, C. Hippel, M. Rayner, R.J. Davis, and C. Todorovic.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.3492-10.201 0 Shin, J.E., Y. Cho, B. Beirowski, J. Milbrandt, V. Cavalli, and A. DiAntonio.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi   .org/10.1016/j.neuron.2012.04.02 8 Simon, R.P ., J.H.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1126/science   .609325 6 Snider, B.J., F.J. Gottron, and D.W. Choi.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1083/jcb.20051105 5 Thakur, A., X. Wang, S.L.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1002/jnr.2129 8 Virgili, M., P. Migani, A. Contestabile, and O. Barnabei.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/   0028-3908(92)90085- 4 Waetzig, V., and T. Herdegen.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1073/   pnas.121107411 0 Xiong, X., X. Wang, R. Ewanek, P. Bhat, A. Diantonio, and C.A.",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1038/3989 9 Yoshimura, Y., Y. Yamauchi, T. Shinkawa, M. Taoka, H. Donai, N.  Takahashi, T. Isobe, and T. Yamauchi.",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1046/j.1471-4159.2003   .02136. x Zhu, Y ., D. Pak, Y .",Non-OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
"http://dx.doi.org/10.1016/j.neuron.2005.04.03 7 Zuo, Y ., A. Lin, P .",OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
http://dx.doi.org/10.1016/j.neuron.2005.04.00 1,OADS,/arxiv_data1/oa_pdf/b3/73/JEM_20122832.PMC3832926.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20122798/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/10   .1126/science.109361 6 Flygare, J., T. Kiefer, K. Miyake, T. Utsugisawa, I. Hamaguchi, L. Da Costa,   J. Richter, E.J.",OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/10.1182/blood­2004­   08­311 5 Fournier, E.M., M.G.",Non-OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/10   .1084/jem.2012033 2 Fukui, R., S. Saitoh, F .",OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/10   .1084/jem.2008231 6 Fukui, R., S. Saitoh, A. Kanno, M. Onji, T. Shibata, A. Ito, M. Onji, M.  Matsumoto, S. Akira, N. Y oshida, and K. Miyake.",OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/10.1016/j.immuni   .2011.05.01 0 García ­Ortiz, H., R. Velázquez ­Cruz, F .",OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/   10.1186/ar391 8 Green, N.M., and A. Marshak­Rothstein.",Non-OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/10.1016/j.smim.2011.01.01 6 Green, N.M., A.",OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/10.4049/   jimmunol.080389 9 Hakkim, A., B.G.",Non-OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/   10.1073/pnas.090992710 7 Hall, J.C., L. Casciola­Rosen, and A. Rosen.",OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/10.1016/j.rdc.2004.04.01 2 Han, J.H., S. Akira, K. Calame, B. Beutler, E. Selsing, and T. Imanishi­Kari.",OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.05.01 8 Hwang, S.H., H. Lee, M. Yamamoto, L.A. Jones, J. Dayalan, R. Hopkins,   X.J.",OADS,/arxiv_data1/oa_pdf/4c/46/JEM_20122798.PMC3832927.pdf
